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Personalized, pre-emptive and predictive medicine is the capstone of contemporary medical care. 
The central aim of this dissertation is to address clinical challenges in prescribing personalized 
therapy to patients with acute phonotrauma. Inflammation and healing, which are innate tissue 
responses to mechanical stress/ trauma, are regulated by a complex dynamic system. A systems 
biology approach, which combines empirical, mathematical and computational tools, was taken 
to study the biological complexity of this dynamic system in vocal fold injury.  
Computational agent-based models (ABMs) were developed to quantitatively 
characterize multiple cellular and molecular interactions around inflammation and healing. The 
models allowed for tests of various hypothetical effects of motion-based treatments in 
individuals with acute phonotrauma. A phonotrauma ABM was calibrated and verified with 
empirical data of a panel of inflammatory mediators, obtained from laryngeal secretions in 
individuals following experimentally induced phonotrauma and a randomly assigned motion-
based treatment. A supplementary ABM of surgically induced vocal fold trauma was developed 
and subsequently calibrated and verified with empirical data of inflammatory mediators and 
extracellular matrix substances from rat studies, for the purpose of gaining insight into the “net 
effect” of cellular and molecular responses at the tissue level.    
ABM simulations reproduced and predicted trajectories of inflammatory mediators and 
extracellular matrix as seen in empirical data of phonotrauma and surgical vocal fold trauma. 
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The simulation results illustrated a spectrum of inflammatory responses to phonotrauma, surgical 
trauma and motion-based treatments. The results suggested that resonant voice exercise may 
optimize the combination of para- and anti-inflammatory responses to accelerate healing.  
Moreover, the ABMs suggested that hyaluronan fragments might be an early molecular index of 
tissue damage that is sensitive to varying stress levels – from relatively low phonatory stress to 
high surgical stress.  
We propose that this translational application of biosimulation can be used to 
quantitatively chart individual healing trajectories, test the effects of different treatment options 
and most importantly provide new understanding of laryngeal health and healing. By placing 
biology on a firm mathematical foundation, this line of research has potential to influence the 
contour of scientific thinking and clinical care of vocal fold injury. 
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 1 
1.0  STATEMENT OF THE PROBLEM, SIGNIFICANCE AND SPECIFIC AIMS 
Phonotrauma involves vocal fold injury associated with phonation (i.e., voice production). When 
people speak or sing, the vocal folds oscillate at a relatively high frequency. Typically, the vocal 
folds make contact at some point during the vibratory cycle. The associated motions generate 
various types of biomechanical forces within the oscillating vocal fold tissues (Gunter, 2003, 
2004; Jiang, Diaz, & Hanson, 1998; I.R. Titze, 1994). Although microinjury likely occurs within 
the tissue across the time course of any given day involving phonation, injury may or may not 
result in clinically appreciable entities, depending on the conditions of voice use as well as the 
host. Specifically, under conditions of typical voice use, the tissues are generally competent to 
withstand the biomechanical forces physiologically, probably with relatively minor and transient 
inflammatory responses locally. In such cases, the levels of tissue injury are sufficiently 
microscopic to be regenerated “intrinsically,” without a full scale inflammatory or wound 
healing response. On the other hand, when phonation conditions are frankly phonotraumatic, the 
associated biomechanical forces are sufficiently large to cause substantial cell death and 
macroscopic tissue damage. If such conditions persist without adequate rest, the damaged tissue 
does not have time needed to repair (I. R. Titze, Svec, & Popolo, 2003). As a result, benign 
lesions at the mid-membranous vocal folds may develop, leading to dysphonia and voice-related 
changes in quality of life (Fulljames & Harris, 2006; B. H. Jacobson et al., 1997; Ma & Yiu, 
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2001; Rosen, Murry, Zinn, Zullo, & Sonbolian, 2000; E. Smith et al., 1996; Thomas, de Jong, 
Cremers, & Kooijman, 2006).  
Therapeutic management of phonotrauma may involve medical or sometimes surgical 
intervention. However, behavioral voice therapy is generally considered central to any treatment 
program, and is usually preferred as the first-line approach (Boone & McFarlane, 1994; Colton 
& Casper, 1996; Johns, 2003). Unfortunately, strong scientific evidence is still lacking regarding 
the effectiveness and efficacy of voice therapy for phonotrauma.  
Evidence-based medicine (EBM), which aims to illuminate the relative benefits of 
various approaches to treatment of health problems in general, has been endorsed 
enthusiastically in clinical practice and also within the research realm. EBM emphasizes the 
importance of basing clinical practice on the results of scientific inquiry. Relevant research 
findings are ideally derived from randomized controlled trials, which are regarded as the highest 
level of evidence (Sackett, Richardson, Rosenberg, & Haynes, 1997). Although outcome data 
from a handful of randomized clinical studies indicate voice therapy can produce some benefits 
for patients with phonotrauma (Bassiouny, 1998; Behrman, Rutledge, Hembree, & Sheridan, 
2008; Gillivan-Murphy, Drinnan, O'Dwyer, Ridha, & Carding, 2006; MacKenzie, Millar, 
Wilson, Sellars, & Deary, 2001; Rattenbury, Carding, & Finn, 2004; Roy et al., 2001; Roy et al., 
2003; Roy et al., 2002; Sellars, Carding, Deary, MacKenzie, & Wilson, 2002; Simberg, Sala, 
Tuomainen, Sellman, & Ronnemaa, 2006; Verdolini-Marston, Burke, Lessac, Glaze, & 
Caldwell, 1995), the typical mode of treatment remains reactive and fails to elucidate preferred 
treatment options for individual patients, potentially increasing the costs of treatment. In reality, 
patients do not seek medical attention until an acute phonotraumatic event has occurred or more 
commonly, a chronic condition requires them to do so. In fact, when patients come to seek 
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medical attention, phonotraumatic tissue changes are typically advanced in their development 
and may require phonosurgical excision in addition to behavioral treatment. Also, even if 
published data suggest that some individuals may be more genetically susceptible to vocal fold 
injury than others (Gray, Hirano, & Sato, 1993; Gray, Pignatari, & Harding, 1994), no predictive 
tools for phonotraumatic risk are available to permit early detection and prevention of 
phonotrauma. Most importantly, humans are known to differ remarkably along a variety of 
relevant parameters, such as genetic polymorphism. Thus, a “one-size-fits-all” approach to 
treatment is not necessarily the most rational one. The same treatment may help one patient and 
either harm or have no effect for another. Further, even if information were available about the 
particular dosage of a treatment that can heal a patient, increasing the treatment dosage does not 
necessarily increase the treatment benefit. Experimental data have already suggested that the 
benefits of behavioral voice exercises are patient-specific and dose-dependent, at least in the case 
of acute phonotrauma (Verdolini et al., in preparation). However, data from existing clinical 
studies are insufficient to inform us how to select treatments based on individual patient profiles. 
If clinicians could identify which patients are likely to benefit from which treatment, patients 
would be spared unnecessary and costly treatments and their potentially harmful side effects.  
To move forward from the current state, the vision of voice care must be revolutionized 
towards seeking a predictive, pre-emptive and personalized approach to treatment and prevention 
of voice problems (Hood, Heath, Phelps, & Lin, 2004).  Research within this domain would 
benefit from gearing towards developing clinical tools that can: (1) identify molecular signatures 
or biomarkers that are predictive of phonotrauma or treatment outcome; (2) characterize 
individual’s probabilistic future health history or risk to pre-empt the development or 
exacerbation of phonotraumatic tissue changes; and (3) prescribe personalized treatment regimes 
 4 
for individual patients with existing phonotraumatic tissue changes depending on their unique 
probabilistic future health histories.   
We argue that this vision is beyond the capacity of EBM as it is generally conceived 
currently. First, the “evidence” collected under the rubric of EBM typically only informs us of an 
“average” value for outcomes in groups of patients, especially where randomized clinical studies 
are involved. However, we need outcomes that inform clinicians and patients about individual 
outcomes. In other words, even if we have evidence-based treatments, we still need to know 
whom those evidence-based treatments may benefit. Although more adequately powered, 
prospective, randomized controlled trials could arguably help to identify patient-specific 
treatments, the number of such trials would be prohibitively large to consider all biological, 
temporal and contextual factors that are relevant to the question. Moreover, typical approaches to 
statistical management of the data are generally inadequate to identify the roles of numerous 
variables for individual outcomes, especially given the likely interactive, non-linear nature of 
those variables. Second, and following from the foregoing point, randomized controlled trials are 
typically reductionistic in essence and only work to explain simple systems at best. However, 
phonotrauma, with its accompanying inflammation and healing, is a highly complex process 
induced by a variety of stimuli and modulated by numerous cells and their products. 
Reductionism is conceptually poorly equipped to appreciate non-linear dynamics and evolution 
in health and disease relevant to voice and other phenomena (De Simone, 2006a, 2006b; 
Jacobson, Edwards, Granier, & Butler, 1997; Jenicek, 2006; Little, 2003). We argue that a more 
systems-oriented tactic should be sought to decipher the biological complexity in health and 
disease, including disease affecting the voice.  
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A systems biology approach is emerging that may ultimately overwhelm typical 
evidence-based approaches to medicine. Modeling and simulation, which comprise a working 
methodology used within systems biology, have the capability to (1) handle a large number of  
system components and interactions within complex processes simultaneously; (2) quantify 
interrelationships (organization or structure) and interactions (dynamics or behavior) of genes, 
proteins and metabolites; and (3) integrate this information into visible working models that can 
provide predictive hypotheses to elucidate emergent phenomena behind complex processes 
(Hood, 2003; Hood et al., 2004; Vodovotz, 2006; Vodovotz, Clermont, Chow, & An, 2004; 
Vodovotz, Csete, Bartels, Chang, & An, 2008). With the integration of rapidly accumulating and 
high-throughput genetic and molecular data within the domain of voice science, systems biology 
has the capability to bridge a critical gap between benchside and bedside, in a novel way.  We 
argue that systems biology with its predictive power can accelerate the advent of predictive, pre-
emptive and personalized care of voice.  
Work from our laboratory has made good early progress in translating a systems biology 
approach to the encoding of cellular and molecular responses to the case of phonotrauma, and in 
reproducing the tissue level effects of these elements in silico. Specifically, we have developed a 
series of systems-oriented biological models, including Agent-Based Models (ABMs) and 
Ordinary Differential Equations Models (ODMs) that predict expected time-varying pro-
inflammatory and anti-inflammatory responses to physical insult to vocal fold tissue as a 
function of  individual-specific inflammatory profiles (N. Y. Li et al., 2008; N. Y. K. Li et al., 
2007; N. Y. K. Li, Verdolini, Clermont, Mi, Hebda et al., 2006; N. Y. K. Li, Verdolini, 
Clermont, Mi, Vodovotz et al., 2006; N.Y.K. Li, Verdolini, Qi, Vodovotz, & Hebda, 2005). We 
have calibrated the models using baseline and early follow-up inflammatory mediator data from 
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the laryngeal secretions of individuals subjected to experimentally induced acute phonotrauma 
and subsequent behavioral treatment modalities (voice rest, resonant voice exercise and 
spontaneous speech) (Verdolini et al., in preparation). Molecular outputs from these models have 
shown good correspondence with experimental human data for the same subjects at a 24-hr post-
baseline time point. However, these models are currently limited in terms of (1) the number of 
inflammatory mediators and extracellular matrix substance represented and (2) the validation of 
the model’s tissue-level outputs with experimental data. This thesis addressed the foregoing gaps 
by targeting the following aims.  
The central aim of this thesis is to address clinical challenges in prescribing personalized 
therapy to patients with acute phonotrauma. A systems biology approach was applied to study 
the inflammatory and healing response to mechanical stress in vocal folds. Computational 
models, ABMs, were developed to produce elaborated route maps of cellular and molecular 
interactions around inflammation and healing, with the capability of allowing in silico (in 
computer) testing of various hypothetical effects of motion-based treatments in individuals 
following acute phonotrauma (Main study: Specific Aim 1). A secondary aim of this thesis is to 
gain insight into the “net effect” of cellular and molecular responses at the tissue level in vocal 
fold inflammation and healing. For this purpose, we developed a supplementary ABM of 
surgically induced vocal fold trauma and attempted experimental cross-scale (molecule-tissue) 
model validation (Supplementary study: Specific Aim 2). The relevant specific aims are: 
MAIN STUDY  
Specific Aim 1:  
(1a) Expand the existing agent-based model (ABM) of phonotraumatic vocal fold 
inflammation and healing to compute temporal trajectories of (i) cytokines (interleukin [IL]-1β, 
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IL-6, IL-8, IL-10 and tumor necrosis factor [TNF]-α), (ii) a collagenase (matrix 
metalloproteinase [MMP]-8), (iii) growth factors (transforming growth factor [TGF]-β1 and 
basic fibroblast growth factor [bFGF]) and (iv) extracellular matrix (ECM) substances (collagen 
type I, elastin and hyaluronan [HA]) across time following injury.  
(1b) Specify the model’s parameters to reproduce individual-specific inflammatory and 
healing responses to acute phonotrauma and subsequent motion-based treatments, using cytokine 
and collagenase data empirically obtained from human laryngeal secretions at baseline, 
immediate post vocal loading and post a 4-hr treatment.    
(1c) Assess the expanded model’s prediction accuracy for cytokines and the collagenase 
at a 24-hr post baseline time point by comparing model outputs to the empirical data set.  
(1d) Compare the adequacy of the original and expanded models, with specific reference 
to whether the elements added in the expanded model increase the model’s prediction accuracy 
or not.   
SUPPLEMENTARY STUDY 
Specific Aim 2: 
(2a) Specify the ABM’s parameters (from 1a) to reproduce the inflammatory and healing 
response to surgically induced vocal fold trauma, using published rat messenger ribonucleic acid 
(mRNA) data of (i) cytokines (IL-1β and TNF-α), (ii) a growth factor (TGF-β1) and (iii) matrix 
markers (procollagen subtype I, elastin synthase and hyaluronan synthase-2 (HAS-2)) at 
baseline, 1-hr, 4-hr, 8-hr, 16-hr and 24-hr post-injury time points.  
(2b) Assess the models’ prediction accuracy for the same set of markers (2a) at a 72-hr 
post-injury time point by comparing model outputs to the empirical data set. 
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(2c) Examine data generated from both models developed in this series (1b and 2a) to 
determine whether they point to new understanding in wound healing in general and 
phonotrauma, surgical trauma, and motion-based treatments in particular. 
 
The thesis is organized as follows. Chapter 2 provides discussion of principles of 
evidence-based medicine and existing evidence around voice therapy for phonotrauma. Chapter 
3 presents a discussion of the biological complexity involved in inflammation and healing along 
with the motivation to use a systems biology approach to unravel this complexity. Focus then 
turns to a promising computational modeling tool that has been used to study the dynamics of 
biological complexity in other tissues, namely, agent-based modeling (ABM). Chapter 4 presents 
our preliminary studies on the biosimulation of vocal fold inflammation and healing in acute 
phonotrauma, followed by discussion of limitations found in existing ABMs. Chapter 5 presents 
the methodologies used to develop ABMs to simulate the trajectories of inflammation and 
healing in acute phonotrauma and surgically induced vocal fold trauma. In Chapter 6, the ABM 
simulation results are presented. In Chapter 7, the significant findings are discussed as are the 
implications for understanding the complex system of inflammation and healing. The thesis 
concludes with discussion of both challenges and future directions in applying biosimulation in 
voice research. A comprehensive literature review relating to this thesis is provided in Appendix 
A – C for the readers’ interest.  
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2.0  BACKGROUND 
Phonotrauma is a source of vocal fold injury due to phonation. When people speak or sing, 
nearly continuous biomechanical stresses are exerted upon and within the vocal fold mucosal 
tissues. These phonation-related forces include tensile, contractile, aerodynamic, inertial, impact 
(collision) and shear stresses. Depending on the vocal style, phonation-related forces can induce 
physiological or pathological changes in the extracellular matrix of the vocal fold tissues 
(Gunter, 2003, 2004; J. J. Jiang, Diaz, & Hanson, 1998; I.R. Titze, 1994).  The cells in the vocal 
fold tissues are responsible for maintaining the fine balance between the synthesis and 
degradation of extracellular matrix in response to the biomechanical environment. These load-
sensitive cells continually produce mediators and extracellular matrices in an effort to maintain 
tissue homeostasis. Under typical vocal styles, the vocal fold cells and tissues are competent to 
adapt to the biomechanical forces by adjusting physiological parameters, probably with very 
minor and transient inflammatory response to repair the stressed or damaged tissues. In this case, 
the inherent mucosal repair process is effective to restore healthy tissue structure and function in 
a scar-free fashion, without inducing a full-scale inflammatory or wound healing process. 
In contrast, when a vocal style is phonotraumatic, the biomechanical forces, especially 
impact and shear stresses, are abnormally high and can cause substantial cell death and 
macroscopic tissue damage. In that case, the sensitive balance between extracellular matrix 
synthesis and degradation are perturbed, and pathological states can result that impair the quality 
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of healing.  If the phonotraumatic conditions persist without adequate rest, the stressed or 
damaged tissues do not have the time required to repair properly (Gray, 1991; Gray & Titze, 
1988; Gray, Titze, & Lusk, 1987). Frank benign lesions, which are characterized by excessive 
and poorly organized matrices, may be deposited within the vocal folds, typically at the midpoint 
of the vibratory margin of the membranous folds. The deposition of phonotraumatic lesions 
destroys normal vocal fold tissue architecture and compromises proper vocal fold vibratory 
functions, leading to clinical dysphonia and related quality-of-life changes (B. H. Jacobson et al., 
1997; Ma & Yiu, 2001; Raaijmakers, Dekker, & Dejonckere, 1998; E. Smith et al., 1996; 
Verdolini, Rosen, & Branski, 2006).  
Alongside medical (pharmaceutical or surgical) treatments, behavioral voice therapy is 
also prescribed to treat phonotrauma and is typically the first-line treatment approach (Boone & 
McFarlane, 1994; Colton & Casper, 1996; Johns, 2003). Unfortunately, extremely few well-
designed, prospective, controlled studies have been conducted on the treatment of phonotrauma 
to date. Therefore, investigations are still ongoing in search of scientific evidence of the benefits 
of voice therapy in treating phonotrauma. Studies using an evidence-based medicine model have 
become a recent focus of intervention reports in voice care.   
2.1 EVIDENCE-BASED MEDICINE: TENETS AND LIMITATIONS  
Evidence-based medicine (EBM) promotes the idea that clinical decision making should be 
based on rational analysis of evidence. Evidence in this case is derived from scientific research 
with the objective of determining “best practice.” Randomized controlled trials (RCTs) are 
 11 
considered the “gold-standard” in research methodology in this regard. The five basic tenets of 
EBM have been suggested to be the following (Davidoff, Haynes, Sackett, & Smith, 1995): 
1. Clinical decisions should be based on the best available scientific evidence. 
2. The clinical problem determines the evidence to be sought. 
3. Identifying the best evidence involves epidemiological and biostatistical thinking. 
Conclusions based on the available evidence are useful only if put into action for 
individual patients or for population health care decisions. 
4. Clinical performance should be constantly evaluated.  
 
EBM has been enthusiastically endorsed in medical practice and clinical research, and 
represents a clear advance over previous practice, which often failed to take into consideration 
evidence beyond personal observation (Bernstein, 2004; Cook & Levy, 1998; Davidoff et al., 
1995; Dickenson & Vineis, 2002; Haynes, 2002; L. D. Jacobson et al., 1997; Sackett et al., 
1997). The fundamental problem with the anecdotal approach is that it is drenched in 
idiosyncrasy and as such fails to elucidate principles of treatment that may be generalizable.  
As such, EBM’s tenets are, in principle, generally sound.  However, problems are 
encountered in the way that EBM is typically played out, and that is, through RCTs that are 
considered the “summit” of EBM research. Major criticisms of RCTs include but are not 
restricted to (1) their limited usefulness for individual patients, (2) their cost-ineffectiveness and 
(3) their characteristic reductionism (Cohen, Stavri, & Hersh, 2004; De Simone, 2006a, 2006b; 
Feinstein & Horwitz, 1997; L. D. Jacobson et al., 1997; Little, 2003; Miles, Bentley, 
Polychronis, Grey, & Price, 1998; Miles et al., 2000; Miles, Grey, Polychronis, Price, & 
Melchiorri, 2003, 2004; Miles, Polychronis, & Grey, 2006; Parker, 2001; Summerton, 1997).   
Considerations around these notions are as follows.  First, results from typical RCTs are 
limited by their direct applicability only to an “average” randomized patient who fulfilled the 
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criteria for enrollment in the trial. The methodology does not allow for predictions about 
treatment options for patients who do not fit the specific profiles of the patients who participated 
in the study. Moreover, in reality, every individual is unlike the “average” person and thus the 
results of RCTs often fail to predict an individual’s response even if the individual is similar to 
study participants. Information about an individual’s current clinical state and previous response 
to treatment are essential to adjust treatment dosages to optimize outcome for any given person. 
Unfortunately, results from RCTs typically do not have the capability to take this information 
into account.  
Second, RCTs are characteristically expensive and time-intensive. Adequately powered 
prospective, randomized controlled trials may help to identify a few standard therapeutic 
interventions based on numerical evidence. However, impressively large clinical trials would be 
needed to establish optimized patient-specific treatment interventions that consider all relevant 
biological, temporal and contextual factors. Therefore, reliance on this purely empirical approach 
is actually not always realistic towards the end of gathering “the best available” evidence for 
personalized and predictive treatment. 
Last, RCTs are overwhelmingly linked to a reductionist discipline, which takes complex 
phenomena and breaks them down into constituent parts in order to see how they work. Stated 
differently, RCTs and by extension EBM, as it is generally conceived, implies a simplistic and 
mechanistic world view in which cause and effect can be easily distinguished. Unfortunately, 
health and disease are complex in nature.  Constituent parts of these phenomena work in an 
interconnected, interacting and interdependent fashion. Therefore, information about the 
relationship among parts may be lost in what is considered the highest level of evidence within 
EBM.  
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In contrast to this approach, some pockets of contemporary thinking are now turning 
towards a predictive, pre-emptive and personalized model of medical practice. General aims of 
the emerging approach are to (1) identify molecular signatures or biomarkers that are predictive 
of disease or treatment outcome; (2) characterize individual’s probabilistic future health history 
for a range of diseases and design pre-emptive treatment program for the highly probable 
disease; and (3) prescribe personalized treatment regimes for individual patients depending on 
their unique probabilistic future health histories. A biomarker usually refers to a candidate 
molecule that contributes to a disease, i.e., vocal fold pathology herein. The definition of a 
biomarker can be read as a ‘characteristic that is objectively measured and evaluated as an 
indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a 
therapeutic intervention’ (Voit, 2009). Speculations have been made that predictive, preventive 
and personalized medicine may extend the normal life span by 10 to 30 years and improve 
quality of life (Hood, 2003; Hood et al., 2004). This vision is largely beyond the capacity of 
EBM as it is currently conceived and practiced.  To address this problem, systems thinking, 
which conceptualizes the complex system as a whole, is needed to improve the current paradigm 
of clinical research. We now proceed to review existing evidence around behavioral treatments 
for phonotrauma and we then discuss the application of systems biology in clinical research.   
2.2 CURRENT EVIDENCE OF BEHAVIOURAL INTERVENTIONS FOR 
PHONOTRAUMA 
The primary goal of voice therapy is to restore the affected individual’s vocal function by 
behavioral means that target an approach to voice production that generates the best possible 
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sounds and helps to reverse or prevent phonotraumatic injury and resultant voice disorders. Two 
primary orientations to voice therapy for phonotrauma include voice rest and voice production 
exercise. In many cases, these two approaches may be founded in opposite belief systems. 
Proponents of voice rest hold that elimination of voice use allows the tissue to heal and 
minimizes the aggravation or addition of trauma to vocal fold mucosal tissue. In contrast, 
proponents of voice production exercises hold that vocal training can improve coordination 
within and across voice production sub-systems (respiration, phonation and resonance), generally 
understood in some non-specific way as targeting “better” voice performance. Additionally, 
novel thinking is that vocal fold tissue mobilization involved in voice production exercise may 
have the ability to actively improve mucosal healing of the stressed or traumatized vocal folds 
(R. C. Branski et al., 2006; Verdolini et al., in preparation). 
2.2.1 Evidence for voice rest 
Published data on the efficacy of voice rest are limited and scattered across animal surgical 
trauma, human surgical trauma, vocal loading, and chronic phonotrauma studies (Behrman & 
Sulica, 2003; Cho, Kim, Lee, Kim, & Park, 2000; Hoover, Sataloff, Lyons, & Hawkshaw, 2001; 
Koufman & Blalock, 1989; van der Merwe, 2004; Vintturi et al., 2001). The primary goal of 
voice rest for phonotrauma is intuitive and sensible on the surface. If voice use is the cause of the 
problem (phonotrauma), removing the cause (voice use) should reverse the problem 
(phonotrauma). When it is used, absolute voice rest (abstinence from any phonation) is usually 
prescribed for periods ranging from a few days to a week in cases of acute vocal fold trauma 
(Emerich, Spiegel, & Sataloff, 2000; Hoover et al., 2001; R. T. Sataloff, 2001). Partial voice rest, 
i.e., reducing the amount of voice use, is usually recommended for conditions involving chronic 
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vocal pathology and vocal fatigue (Colton & Casper, 1996; R.T. Sataloff, 1997). The use of 
voice rest for the treatment of phonotrauma is largely anecdotal rather than evidence-based 
(Behrman & Sulica, 2003; Koufman & Blalock, 1989; R.T. Sataloff, 1997). Limited evidence 
suggests either confirmation or rejection of the idea that voice rest may benefit either surgical or 
phonotrauma (Behrman & Sulica, 2003; Hoover et al., 2001; Koufman & Blalock, 1989; R.T. 
Sataloff, 1997). The benefits of voice rest may partly depend on whether acute or chronic trauma 
is involved, and the severity of the condition.  
2.2.2 Evidence for voice production work  
Scientific evidence generally supports the idea that targeting voice production work (with or 
without a so-called indirect therapy or “vocal hygiene” component) can be effective for a 
spectrum of voice disorders (Bassiouny, 1998; S. H. Chen, Hsiao, Hsiao, Chung, & Chiang, 
2006; Gillivan-Murphy et al., 2006; Kotby, El-Sady, Basiouny, Abou-Rass, & Hegazi, 1991; 
MacKenzie et al., 2001; Rattenbury et al., 2004; Roy et al., 2001; Roy et al., 2003; Sellars et al., 
2002; Simberg et al., 2006; R.  Speyer et al., 2002; R. Speyer, Wieneke, & Dejonckere, 2004a, 
2004b; R. Speyer, Wieneke, van Wijck-Warnaar, & Dejonckere, 2003; Wingate, Brown, 
Shrivastav, Davenport, & Sapienza, 2006). Evidence has been clearest for some specific benign 
vocal fold pathologies in particular, namely, contact granuloma and nodules (Behrman et al., 
2008; Holmberg, Hillman, Hammarberg, Sodersten, & Doyle, 2001; McCrory, 2001; Murry & 
Woodson, 1992; Verdolini-Marston et al., 1995; Ylitalo & Hammarberg, 2000). 
Nine randomized controlled studies thus far have investigated the effectiveness of voice 
production work for phonotrauma (Bassiouny, 1998; Behrman et al., 2008; Gillivan-Murphy et 
al., 2006; MacKenzie et al., 2001; Roy et al., 2001; Roy et al., 2003; Sellars et al., 2002; Simberg 
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et al., 2006; Verdolini-Marston et al., 1995). These studies concurrently show that significant 
pre-post treatment improvements in psychosocial and physiological measures (quality-of-life, 
auditory perceptual voice quality, acoustic and aerodynamic) were found only in treatment 
groups focusing on voice production but not in control groups. For instance, Roy et al. (2001) 
conducted a randomized control study comparing results from instructions in “vocal function 
exercises” (Stemple, Lee, D'Amico, & Pickup, 1994) to those from vocal hygiene instructions 
and a no-treatment control condition. Subjects were 58 teachers with self-reported current and/ or 
previous voice problems. The vocal function exercise treatment group showed improvement in 
both Voice Handicap Index scores and self-reported voice severity ratings, whereas the vocal 
hygiene group and the control group did not have significant improvements in either of these 
measures. Three other studies pointed to benefits from resonant voice therapy over vocal hygiene 
training. Verdolini et al. (1995) compared results from resonant voice therapy (N=3) to those 
from confidential voice therapy (N=5) and those from a voice hygiene control group (N=5). 
Results showed that the resonant voice therapy and confidential voice therapy groups had a 
greater probability of improvement in voice quality, laryngeal appearance and phonatory effort 
as compared to the vocal hygiene group. Similarly, Roy et al. (2001) conducted a study 
comparing the results from resonant voice therapy to those from respiratory muscle training and 
amplification (a specific vocal hygiene technique) in 64 teachers with self-reported current and/ 
or previous voice problems. Results showed that both resonant voice therapy and amplification 
groups had significant improvements in Voice Handicap Index (VHI) scores and self-reported 
voice severity ratings after training.  In contrast, these gains were not found for the respiratory 
muscle training group. Recently, Behrman et al. (2003) conducted a study comparing the results 
from resonant voice therapy (N=31) to those from a hygiene control group (N=31) in females 
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with phonotrauma. Results showed that only resonant voice therapy had significant 
improvements in VHI scores after training.  
Compared to the aforementioned benefits of voice production work on psychosocial and 
physiological aspects of vocal function, the benefits of voice production work on improving 
laryngeal appearance is less obvious. The ideal outcome of voice therapy would, of course, 
involve the regeneration of damaged vocal folds. However, complete resolution of 
phonotraumatic lesions is rarely reported following voice therapy targeting voice production, in 
carefully documented reports. In fact, only four randomized controlled of which we are aware, 
group studies thus far, even include laryngeal appearance as an outcome measure (Bassiouny, 
1998; MacKenzie et al., 2001; Simberg et al., 2006; Verdolini-Marston et al., 1995). Reduction 
in phonotraumatic lesion size or overall severity after voice production work is reported in two 
out of the four studies (Bassiouny, 1998; Verdolini-Marston et al., 1995). However, only one of 
the studies documents complete resolution of phonotraumatic lesions in four of nine subjects 
(MacKenzie et al., 2001). Besides these randomized controlled studies, data from one within-
subjects study in which all subjects received different treatment foci, randomly ordered during 
treatment, suggested that significant improvements were seen in size and surrounding edema of 
the vocal folds in nine of eleven subjects with bilateral vocal nodules after voice therapy 
targeting voice work (one subject had incomplete laryngeal images and one subject did not 
complete the therapy) (Holmberg et al., 2001)  In sum, the data around the benefits of voice 
production work for phonotrauma are sparse. Currently available data do not allow for confident 
support or refutation of potential regenerative benefits of voice production exercise for 
phonotrauma. The results are encouraging at psychosocial and physiological levels. However, 
they seem to indicate benefits of voice production work seem tilted to more compensatory rather 
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than wholly regenerative effects, based on psychosocial and physiological versus lesion data 
respectively.    
Having said as much, considering the data that do exist as well as logic, first, the benefits 
of voice production exercises may depend on the chronicity of the lesion. Unfortunately, 
information about chronicity is commonly lacking in published studies. In fact, an obstacle to 
such reporting is that no clinical assessment tools are available to determine the “age” of a 
phonotraumatic lesion, although it may be grossly estimated based on subject reports of 
symptom onset. Second, vocal fold status is assessed variably in the literature. Different imaging 
techniques (rigid versus flexible endoscopy with or without stroboscopy) and rating scales are 
used across the studies. A specific imaging technique and scaling method may have effects on 
the judgment of vocal fold appearance but no studies have yet systematically tested these 
potential effects. Thus, the diverse imaging techniques and rating scales make data comparison 
difficult across studies. Third, data around the inter- and intra-judge reliability of vocal fold 
appearance ratings—which are indeed perceptual—are not commonly reported. Therefore, the 
quality of data associated with rating vocal fold status is in question. Last, only two studies on 
voice production work of which we are aware have reported results from delayed follow-up after 
the completion of treatment (Simberg, 2004; Verdolini-Marston et al., 1995). Morphological 
changes in phonotraumatic lesions may take time to be visually identified. To conclude, evidence 
exists to support the idea that some types of voice exercises may be effective for improving 
psychosocial and physiological functions in individuals with phonotrauma. However, current 
literature is insufficient to elucidate the direct effects of voice production exercises on tissue 
healing for phonotrauma, specifically. Targeted experimental study of this issue is warranted. 
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2.2.3 Evidence from in vitro and in vivo experiments 
At the time of this writing, no experimental studies using biological data have been completed on 
the effects of tissue mobilization for chronic phonotrauma. Only two experimental studies to date 
examined the effects of tissue mobilization for acute vocal fold inflammation (R. C. Branski et 
al., 2006; Verdolini et al., in preparation). The first study used an in vitro model to evaluate the 
effects of cyclic equibiaxial tensile strain (CTS) on rabbit vocal fold fibroblast cultures in the 
presence or absence of interleukin (IL)-1β-induced (IL-1β) inflammation (R. C. Branski et al., 
2006). IL-1β is a key pro-inflammatory cytokine and induces numerous pro-inflammatory 
mediators, such as inducible-nitric oxide synthase (iNOS), nitric oxide (NO), cyclooxygenase-2 
(COX-2), prostaglandin E2 (PGE2) and matrix metalloproteases (MMPs). Excessive synthesis of 
pro-inflammatory markers generally leads to unfavorable healing outcomes (Dinarello, 1997, 
2000; Guirao & Lowry, 1996). In this in vitro study, CTS was manipulated in the time domain (4 
-36 continuous hrs), in the magnitude domain (0 - 18%) and in the frequency domain (static – 0.5 
Hz) in cell cultures in the presence or absence of IL-1β. Results showed that when the rabbit 
vocal fold fibroblast cultures were inflamed with IL-1β and stimulated with CTS for four hours, 
iNOS mRNA expression was reduced most under a specific CTS regimen: low magnitude (6%) 
and relatively high frequency (0.5 Hz). This CTS regimen was then used in two subsequent 
experiments. The first experiment tested the effects of CTS on the synthesis of COX-2, MMP-1, 
PGE2 and NO in the fibroblast cultures. Results showed that low magnitude CTS blocked COX-
2, MMP-1 and PGE2 synthesis up to 24 hours and NO up to 36 hours in the IL-1β-induced 
inflamed cultures, compared to the absence of CTS condition. The second experiment tested the 
effects of CTS on the synthesis of matrix proteins, namely, procollagen type I. IL-1β, which is 
known to inhibit the synthesis of procollagen type I, as for example, in dermal fibroblasts 
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(Mauviel et al., 1991), lung fibroblasts (Diaz, Munoz, Johnston, Korn, & Jimenez, 1993) and 
osteoblastic cells (Harrison, Vargas, Petersen, Lorenzo, & Kream, 1990). Counter-intuitively, the 
results from these two experiments showed that CTS up-regulated procollagen type I synthesis 
after 24 or 48 hours of CTS exposure in the IL-1β-induced inflamed vocal-fold fibroblast 
cultures. 
The second study investigated the biological effects of voice rest versus two different 
forms of tissue mobilization (resonant voice exercises and spontaneous speech) for 
experimentally-induced acute vocal fold inflammation in human subjects (Verdolini et al., in 
preparation). The main obstacle for this line of research, initially, was the lack of a technology to 
quantify vocal fold inflammatory in human subjects. Recently, a laboratory at the University of 
Pittsburgh developed an approach that addresses the relevant technological gap. That approach 
indicated that vocal fold inflammatory and healing state could be assessed by biochemically 
assaying vocal fold surface secretions (Branski, Rosen, Hebda, & Verdolini, 2003; Branski, 
Rosen, Verdolini, & Hebda, 2005b; Branski, Verdolini, Rosen, & Hebda, 2004; Verdolini et al., 
in preparation; Verdolini, Rosen, Branski, & Hebda, 2003). A concern can be voiced about the 
extent to which information in laryngeal secretions reflects information within the tissue. The 
concern is a valid one, which we are pursuing empirically in our laboratories. Preliminary data 
indicate a correspondence between inflammatory mediator concentrations in secretions and those 
in tissue in the rabbit subglottis, albeit with relatively small lag in time and magnitude 
(Sandulache et al., 2007). Other human surgical data are currently under analysis (Rosen, Li, 
Hebda, & Verdolini, in preparation). Pending the outcome of those analyses, existing evidence 
increases confidence in the ability of mediator concentrations in laryngeal secretions to 
reasonably quantitatively reflect concentrations in tissue. At that level, a methodology has 
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become available to pursue the novel hypothesis that certain forms of tissue mobilization may 
have value for the modulation of inflammatory and healing states in human vocal folds. 
Voice rest, resonant voice exercises and spontaneous speech can be considered on a 
continuum of tissue mobilization and especially vocal fold impact stress magnitude: none (voice 
rest), normal- to large-amplitude vocal fold oscillations and low impact stress (resonant voice 
exercises) and normal-to large-amplitude oscillations but potentially larger impact stress, 
depending on the speaker (spontaneous speech). Specifically, compared to pressed and breathy 
phonation modes, resonant voice involves comparatively large-amplitude but low-impact vocal 
fold vibrations (Berry et al., 2001; Peterson, Verdolini-Marston, Barkmeir, & Hoffman, 1994; 
Verdolini, 2000; Verdolini, Druker, Palmer, & Samawi, 1998). The vocal fold vibratory 
characteristics associated with spontaneous speech vary, but are thought to tend towards pressed 
speech in many speakers. In Verdolini et al.’s study, nine vocally health human participants were 
subjected to a vocal loading task involving 45 minutes  of loud voice phonation (75-90 dB SPL 
at 15 cm microphone-to-mouth distance) during a 1-hr period. Then, the participants were 
randomly assigned to one of three treatment groups: voice rest, resonant voice exercises or 
spontaneous speech as monitored for 4 hours in the clinic. The resonant voice condition involved 
cycles of 4 minutes of resonant voice exercises followed by 16 minutes of voice rest, whereas the 
spontaneous speech condition involved 16 minutes of conversational speech followed by 4 
minutes of silence. After a 4-hour treatment period, participants were discharged to home with 
instructions to continue to follow their corresponding treatment condition (with slight temporal 
modifications for the resonant voice and spontaneous speech groups). The next morning, 
participants were required to observe complete voice rest between awakening and their arrival at 
the clinic in the morning. Laryngeal secretions were sampled from the vocal fold surfaces at the 
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following time points: pre-loading (baseline), immediately post-loading, 4 hr post-treatment 
onset, and 24 hr post baseline. Enzyme-Linked ImmunoSorbent Assays (ELISA) were then run 
to measure the concentrations of a panel of biomarkers in the secretions.  
Biomarkers concentration results showed high subject variability. Most importantly, the 
secretion data suggested that some of the participants had “pre-inflamed” vocal folds that post 
hoc violated the inclusion criteria of the study (denial or evidence of a current voice problem).  
Also, some subjects did not respond to the vocal loading task and failed to demonstrate an 
inflammatory response after loading. As a result, data from only one subject from each treatment 
condition could be used for further analysis in the most rigorous sense. For those subjects, results 
showed that the concentrations of pro-inflammatory mediators (IL-1β, IL-6 and MMP-8) were 
lowest following resonant voice exercises and highest following the spontaneous speech 
condition at the 24-hour post baseline time point. At the same time, the concentration of the anti-
inflammatory marker IL-10 showed something of an opposite trend at the 24-hour time point, 
i.e., concentrations for this marker were highest following resonant voice exercises and lowest 
following voice rest. These preliminary findings suggest that large-amplitude, low-impact vocal 
fold tissue mobilization, as reported for resonant voice exercises, may relatively optimize the 
quality of the healing response for acute phonotrauma by attenuating pro-inflammatory and 
stimulating anti-inflammatory response responses. Although at first glance it may appear that a 
confound in the data involved the differing durations of voice use across resonant voice and 
spontaneous speech conditions (4 versus 16 minutes in every 20-minute period for 4 hr), a 
further factor limits concern in this regard.  If treatment benefits were inversely attributable to 
amount of voice use alone, the voice rest condition would have produced the best results, 
followed by resonant voice and then spontaneous speech. However, results were not graded in 
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this fashion. Rather, resonant voice generated benefits that were even greater than those for voice 
rest, suggesting there may be something therapeutic about this particular form of voice 
production. 
Initial results from both human and in vitro data in our laboratory provide optimism that 
some – but not all forms of tissue mobilization may indeed enhance both the speed and final 
level of recovery from phonotraumatic inflammation, at least in the short term. However, further 
data are needed. With unlimited resources, the issues could be pursued with additional human 
clinical trials. However, such clinical trials are invasive and the dollars to subject ratio is 
prohibitive for the large subject cohort that would be needed. An appealing alternative is 
systems-oriented modeling-simulation of complex biological systems, which we will pursue 
within the current study.   
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3.0  DECIPHERING THE COMPLEXITY OF INFLAMMATORY AND HEALING IN 
PHONOTRAUMA: FROM EVIDENCE-BASED TO SYSTEMS BIOLOGY 
Personalized, predictive and pre-emptive medicine is a central goal of modern medicine 
(Zerbouni, 2008). To approach this goal, the complexity of biological processes must be tamed. 
Even as demand for evidence-based medicine reaches a crescendo, this purely empirical 
approach is deemed to be unattractive due to the aforementioned concerns of its (1) limited 
applicability of research findings derived from randomized controlled trials, (2) cost-
ineffectiveness and (3) typical reductionism. Although evidence-based medicine is only now in 
its infancy in the field of speech-language pathology, we propose that the paradigm of voice care 
may benefit from a shift in vision of what constitutes “good evidence”. 
Systems-oriented modeling-simulation of complex systems is a possible avenue to pursue 
in this light. Such modeling has recently shown promise as an approach by which to tame the 
seemingly unpredictable behavior of complex biological phenomena and account for the plethora 
of known and unknown interactions among biologic pathways (Kitano, 2002a, 2002b; Vodovotz, 
2006). A modeling approach can yield testable predictions and establish new paradigms. 
Moreover, a systems biology approach that involves mathematical modeling may prove useful in 
settings such as phonotrauma, in which it is difficult to obtain statistically sufficient sample sizes 
for the types of questions asked (Whitcomb, Aoun, Vodovotz, Clermont, & Barmada, 2005). 
Investigators within our research group have recently coined the term “translational systems 
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biology” to refer to the process of creating, calibrating, and validating computational simulations 
in settings of complex diseases, simulations that are designed a priori for the purpose of 
modifying clinical treatment, carrying out in silico clinical trials, generating novel therapies, and 
refining diagnosis (Vodovotz et al., 2008). Those investigators have pioneered the use of 
translational systems biology in the settings of sepsis and trauma (An, Hunt, Clermont, 
Neugebauer, & Vodovotz, 2007), and now we extend this approach to phonotrauma. A detailed 
background of the application of computational modeling for clinical research and different 
approaches in simulation modeling is in Appendix C. This chapter is focused on the discussion 
around biological complexity and the use of biosimulation to unravel the complexity underlying 
inflammation and healing.  
3.1.1 Biological complexity in inflammation and healing 
Vocal fold biomechanical stresses generated during phonation are widely acknowledged as the 
primary cause of phonotrauma (Gray, 1997; Gray & Titze, 1988; Gray, Titze, Alipour, & 
Hammond, 2000; Gray et al., 1987; Hunter, Titze, & Alipour, 2004; J. J. Jiang et al., 1998). 
Phonotrauma, like all other forms of trauma, is a highly complex process induced by a variety of 
stimuli, modulated by numerous cells and their molecular products, and affecting different 
tissues in diverse ways. At the heart of the response to phonotrauma is the intertwined process of 
inflammation and wound healing (Calvin, 1998; Clark, 1988; R. A. F. Clark, 1998; R.A.F. Clark, 
1998; Gillitzer & Goebeler, 2001; Mast & Schultz, 1996; Werner & Grose, 2003).  
Inflammation is a complex, dynamic and multi-scale biologic process that distinguishes 
itself by definition from linearity and reductionism (Vodovotz et al., 2008). Inflammation is the 
earliest and necessary response for subsequent wound healing (Hardy, 1989). Inflammation can 
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be understood in terms of an information system that processes and controls the biochemical 
signals induced by injury and/ or infection. These signals include: (1) “Go” signals to initiate the 
inflammatory reactions, (2) “Stop” signals to temper the inflammation, and (3) “Switch” signals 
to convert a hostile damaging tissue response mode to a synthetic healing mode (Nathan, 2002). 
Also, these signals are actively monitored and regulated by a number of checkpoints within the 
system. If any of the aforementioned signals is missing or if the checkpoints malfunctions, the 
normal inflammatory process is disturbed possibly resulting in persistent inflammation, 
abnormal healing and tissue distortion. A prompt transition from the inflammatory phase to the 
healing phase is a key determinant of good wound healing, which involves the replacement of 
traumatized tissue by living tissue (Walter & Israel, 1987).  
Two possible healing processes can occur, namely, reparative regeneration and 
constructive repair. Reparative regeneration is scarless wound healing, in which traumatized 
tissue is completely restored in normal architecture and function, by proliferation of surrounding 
undamaged specialized cells and replacement of specialized structures. Reparative regeneration 
usually occurs when (1) the damaging stimuli are cleared quickly, (2) no necrosis (death of cells 
and tissues) occurs, (3) there is minimal inflammatory cell infiltrate, and (3) the tissue 
framework has remained intact. On the other hand, constructive repair results from injuries 
involving necrosis and a destroyed tissue framework. The lost tissue is replaced by granulation 
tissue which matures into a scar. Depending on the amount of scarring, scarred tissue does not 
usually restore the architecture and perform the normal function of the original tissue.  
Typically, the vocal folds are capable of withstanding phonatory stresses and have the 
reparative capability to resolve microscopically phonotraumatic damage incurred during daily 
phonation. Biomechanical loadings have been suggested to play roles in regulating cellular 
 27 
functions, including gene expression, protein synthesis, cell growth and differentiation (J. H. 
Wang & Thampatty, 2006). Especially in load-sensitive cells, such as fibroblasts, mechanical 
forces are important in regulating the balance of cellular synthesis and degradation of matrix 
components for tissue homeostasis. However, when mechanical forces are excessive, the 
equilibrium may tilt from cellular anabolism to catabolism. Also, abnormal mechanical forces 
would cause macroscopic cell death and tissue damage. In that case, inflammation becomes 
clinically evident and constructive repair is involved. Consequently, tissue pathophysiological 
conditions result, as seen in benign vocal fold lesions with accompanying prolonged dysfunction 
in vocal fold vibratory functions (Catten, Gray, Hammond, Zhou, & Hammond, 1998; Gray, 
2000).   
Contemporary therapeutic interventions in phonotrauma are oriented towards modulating 
the inflammatory and healing processes to promote reparative healing of the traumatized vocal 
folds. A plausible approach is to both blunt the inflammatory response and activate the healing 
program. Upon mechanical challenges, the acute inflammatory cascade is immediately activated 
in damaged or stressed (exercised) tissues (Butterfield, Best, & Merrick, 2006; Toumi, F'Guyer, 
& Best, 2006). The inflammatory cells infiltrate into the area of injury to remove damaged and 
dead cells and tissue debris. This inflammatory reaction brings out additional tissue damage and 
cell death, which exacerbates the initial tissue damage and amplifies the signals for scarring. 
Theoretically, inflammation-blocking interventions may reduce the “secondary” tissue damage 
and the possibility for fibrosis and scarring. At the same time, this approach may potentially 
reduce the supply of growth factors and cytokines from the inflammatory cells to facilitate tissue 
repair. Thus, a therapeutic balance between the need to limit inflammation from causing tissue 
damage and the need for inflammation to initiate tissue repair is important to optimize the quality 
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of healing outcomes and the recovery of physiological functions (Butterfield et al., 2006; Eming, 
Krieg, & Davidson, 2007; Stramer, Mori, & Martin, 2007; Tidball, 1995; Toumi et al., 2006). In 
the literature related to sports injury, evidence suggests that modified mobilization exercise may 
blunt the cells’ pro-inflammatory responses but enhance their anti-inflammatory responses, 
depending on the time and dose of the exercise (Agarwal et al., 2004; Keylock et al., 2008; J. M. 
Peake et al., 2005; Petersen & Pedersen, 2005; J. A. Smith & Pyne, 1997).  
This assertion provides a good testing platform to uncover the potential therapeutic 
effects of vocal exercises in treating phonotrauma. The relevant research program starts with 
studying the dynamics of inflammation and healing at cellular and molecular levels and the 
responses of these agents to various biomechanical loading conditions, i.e. loading magnitude, 
and frequency and duration of various types of voice production. Also, the interaction between 
mechanical forces and soluble factors, including growth factors and cytokines should be 
investigated to discern how changes in mechanical forces are associated with the development 
and remodeling of vocal fold tissues as well as the functional disorders that ensue from them. To 
date, vocal fold inflammatory and healing responses have mainly been studied in animal models 
of vocal fold surgical trauma (Hansen & Thibeault, 2006; Lim, Tateya, Tateya, Munoz-Del-Rio, 
& Bless, 2006; I. Tateya, Tateya, Lim, Sohn, & Bless, 2006; T. Tateya, Tateya, Sohn, & Bless, 
2006; S.L. Thibeault, Gray, Li et al., 2002; S. L. Thibeault, Rousseau, Welham, Hirano, & Bless, 
2004; Welham, Lim, Tateya, & Bless, 2008). However, specific information about how multiple 
cells and molecules respond to phonotrauma and more clinically relevant – how inflammation 
can be systematically controlled in phonotrauma by voice production exercises – is not clear. 
As discussed previously, two studies have been carried out to investigate how tissue 
mobilization involved in voice production exercise may modify inflammation following acute 
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phonotrauma. The recent in vitro and human data derived from concentrations of inflammatory 
mediators in vocal fold surface secretions suggest that some forms of vocal fold tissue 
mobilization may help to control inflammation and promote healing following acute 
phonotrauma (R.C. Branski, 2005; Verdolini et al., in preparation). Equally important, both in 
vitro and human data suggest that the benefits of tissue mobilization for acute vocal fold 
inflammation are dose-dependent and subject-specific (R.C. Branski, 2005; Verdolini et al., in 
preparation). These observations suggest a commonality across tissue types in the response to 
injury, given that active rehabilitation is now used to treat many types of injuries (Burroughs & 
Dahners, 1990; Eiff, Smith, & Smith, 1994; Kerkhoffs et al., 2002; Kerkhoffs et al., 2003; Kvist, 
2004; Mulligan, 1995; Paungmali, O'Leary, Sowvlis, & Vicenzino, 2003; Pijnenburg, Van Dijk, 
Bossuyt, & Marti, 2000; Salter, 1994, 1996; Thornton, Shrive, & Frank, 2003; Threlkeld, 1992; 
Visser et al., 1998; Williams, Moran, Thonar, & Salter, 1994). However, details are lacking 
about mobilization doses that may optimize healing in the vocal folds, and how optimized doses 
may interact with the specific initial inflammatory status of the tissue.  
One might argue that in order to identify vocal fold mobilization doses that can optimize 
tissue healing post-traumatically, randomized clinical trials would be the most straightforward 
and sufficient approach. That is, one can experimentally correlate the change of inflammatory 
mediator concentrations with a variety of vocal dose intensities across a large subject cohort, and 
then prescribe the dose that has the highest effectiveness. However, as already indicated, the 
problem with this approach is that the time-evolution of inflammation depends on the 
combination of initial conditions and the specific vocal dose used in mobilization. Also, the 
cumbersome nature of data collection complicates the potential for biologically oriented clinical 
trials on the value of therapeutic interventions for phonotrauma in humans. To overcome the 
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prohibitively large number of experiments needed to characterize the multitude of possible 
combinations, we propose to adopt a systems biology approach to elucidate apparently 
contradictory and unpredictable behavior emerging from the plethora of interactions among 
biologic pathways involved in the acute inflammatory response (Chow et al., 2005; Day et al., 
2006; Prince et al., 2006).   
3.1.2 Promise of systems biology in deciphering complexity in inflammation and healing 
Physiologic systems, whether in their healthy or pathologic states, exhibit a remarkable 
variability in structural patterns and temporal behaviors (Bassingthwaighte, Liebovitch, & West, 
1994; Goldberger, 1996, 2006; Goldberger et al., 2002; Goldberger, Bhargava, West, & Mandell, 
1986; Goldberger & West, 1987; Goldenfeld & Kadanoff, 1999). Classical concepts of 
homeostasis, linear constructs and reductionist methodologies are inadequate to understand such 
physiological complexity (Goldberger, 2006). Specifically, the reductionist approach fails to 
illuminate the behavior of whole systems in which system behavior is different from the simple 
sum of reactions in isolated system parts. The understanding of such complex processes requires 
an understanding of inter-relationships and non-linear patterns of interactions among component 
parts over time.  
Systems biology is an emerging approach that addresses this issue by studying the 
behavior of biological systems as unities (K. D. Smith & Bolouri, 2005). Systems biology is used 
to (1) handle a large number of system components and interactions within complex processes; 
(2) quantify interrelationships (organization or structure) and interactions (dynamics or behavior) 
of genes, proteins and metabolites; and (3) integrate this information into visible working models 
that can provide predictive hypotheses to elucidate emergent phenomena behind complex 
 31 
processes (Hood et al., 2004; Kitano, 2002a, 2002b; Wolkenhauer, 2001). Mathematical and 
computational modeling-simulation are the essential tools for system analysis in clinical 
research, especially in knowledge discovery (data-mining) and simulation-based analysis 
(Kitano, 2002a, 2002b). Modeling’s role is to transfer real-world system components and 
interactions into an abstracted representation. For knowledge discovery, model abstraction is 
useful to conceptualize the “hidden order/pattern” behind the observed phenomena (e.g., 
inflammatory response) from huge volumes of experimental data (e.g., genomic and proteomic 
data). For instance, knowledge discovery has been extensively applied to predict protein 
structure from genetic sequence (Baldi & Brunak, 2001). 
 On the other hand, simulation-based analysis is used to test hypotheses with computer 
(in silico) experiments and then to provide predictions to be tested by in vivo/in vitro 
experiments (Kitano, 2002a, 2002b). In clinical research, simulation-based analysis can sharpen 
our understanding and intuition of a particular (patho-) physiological process of interest. 
Simulations from computer-executable models predict a range of scenarios relevant to the 
properties of systems. For instance, systems-level modeling can be used to simulate and predict 
the responses of a whole inflammatory/wound healing system, rather than the response of 
particular inflammatory mediators alone. Through modeling and simulation, the dynamic 
outcome of interactions and feedback loops among the component system parts at multi-scale 
levels (signal pathway, molecules, cell, organ, and organism) can be illustrated effectively (An, 
2004, 2005; Kumar, Clermont, Vodovotz, & Chow, 2004; Vodovotz et al., 2004).  
The application of systems-oriented modeling-simulation to clinical practice is 
acknowledged in drug discovery and gene therapy to pursue the goal of predictive, preventive 
and personalized clinical care (Hood, 2003; Hood et al., 2004; Kitano, 2002a, 2002b). Also, 
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system-level analysis has begun to be applied to study pathogenesis in various diseases such as 
tumor growth, malaria, and systemic inflammatory response syndrome (An, 2004, 2005; Kumar 
et al., 2004; Vodovotz et al., 2004; Vodovotz et al., 2008).  For instance, in systemic 
inflammatory responses, the interaction between pro-inflammatory (e.g., tumor necrosis factor 
(TNF)-α) and anti-inflammatory (e.g., interleukin (IL)-10) mediators has been shown to be time- 
and context-dependent in the establishment of a long-term equilibrium state of a system (An, 
2005; Smallwood, Holcombe, & Walker, 2004; Vodovotz et al., 2004; Walker, Hill, Wood, 
Smallwood, & Southgate, 2004). This equilibrium state is achieved by multiple positive and 
negative feedback loops among the inflammatory mediators. System-level analysis has 
successfully shown that the pathologic state of the inflammatory response (e.g., sepsis) results 
from a disruption of the interaction among the aforementioned mediators, rather than the 
deficiency of any individual mediator. 
In summary, the robust systems-approach with its predictive power can overcome the 
problems of carrying out prohibitively large number of experiments needed to (1) collect 
comprehensive data in considering all known relevant temporal and contextual factors and (2) 
extract and integrate useful information and patterns from huge quantities of data. By direct 
modeling/ simulating of a complex system, one can observe, manipulate and understand the 
behavior of the whole system in an efficient way. As such, systems-oriented modeling-
simulation improves both biological sight and insight into mechanisms within complex systems 
(Goldenfeld & Kadanoff, 1999; Kitano, 2002a, 2002b; Vicsek, 2002).  
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3.1.3 Agent-based modeling in inflammation and healing 
The systems-level modeling of interest for the present study involves Agent-Based Models 
(ABMs), which are a relatively new approach for system modeling and simulation to study the 
macroscopic world through defining a system at a microscopic level. Agent-based modeling is 
stochastic modeling that simulates the behavior of real-world systems under random conditions 
(Gilbert & Bankes, 2002). In such models, individual components of a given complex system 
interact based on rules whose outcomes are partially based on stochastic processes (Ermentrout 
& Edelstein-Keshet, 1993). More specifically, ABM involves discrete event simulation to study 
the behavior of complex systems. "Agents" in ABM represent the component parts of the system 
that contribute to the system’s behavior. The rules can involve mathematical equations or 
"If…Then" conditional statements. On the basis of these rules, a simulated environment is 
created to allow agents to respond and interact, and to allow for quantitative outputs of the 
simulation. The relative importance of various rules is dictated by model parameters.  
The ABM is particularly suitable for modeling complex adaptive systems, e.g., biological 
systems (Holland, 1992, 1995; Mitchell, 2003). Complex adaptive systems are composed of 
diverse entities that interact nonlinearly and dynamically. These systems display self-
organization and adaptation to produce emergent structures and behaviors, which cannot be 
easily predicted (Cilliers, 2005). In biology, the interactions are often context-dependent and 
time-dependent, which makes biological systems adaptive. Also, biological systems are complex 
in terms of their structures, functional processes and evolutionary processes (Mitchell, 2003). 
Agent-based modeling provides a robust and flexible framework to handle these three 
complexities.  
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ABMs have been used to simulate the temporal evolution of complex systems and to 
encode complicated time-dependent cellular and molecular events that occur during 
inflammation and wound healing (An, 2001; Mi, Riviere, Clermont, Steed, & Vodovotz, 2007; 
Smallwood, Holcombe, & Walker, 2004; Vodovotz et al., 2004; Walker, Hill, Wood, 
Smallwood, & Southgate, 2004). We previously developed a preliminary ABM that simulates 
the biological dynamics of vocal fold inflammation and wound healing (N. Y. Li et al., 2008). In 
brief, the model currently has generally good ability to predict clinically expected time-varying 
consequences for a limited panel of inflammatory mediators in the vocal folds (IL-1β, TNF-α, 
IL-10, transforming growth factor-beta [TGF-β]) up to 24 hr post-baseline, following intervening 
induction of phonotrauma. Details around that model are provided shortly.  
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4.0  DEVELOPMENT OF PRELIMINARY BIOLOGICAL MODELS OF VOCAL 
FOLD INFLAMMATION 
We have developed a patient-specific ABM for acute vocal fold inflammation, with the ultimate 
goal of identifying individually optimized treatments (N. Y. Li et al., 2008). The freeware 
Netlogo (Center for Connected Learning and Computer-Based Modeling, Northwestern 
University, Evanston, IL) was used as the platform for model building and simulation. An 
overview of our model building and simulation is provided in the next paragraphs, followed by 
more detailed discussion.   
First, detailed literature on inflammation and wound healing from the skin setting was 
reviewed to identify the essential components and rules for building the structure (or framework) 
of the model (Cockbill, 2002; P. Martin, 1997; Robson, Steed, & Franz, 2001; Witte & Barbul, 
1997). Skin literature was used to glean information about the general cellular and mediator 
processes for model development because (1) inflammation and healing have been 
comprehensively studied in the skin domain, (2) knowledge of vocal fold wound healing was 
limited at the time of the original work, and (3) cellular and molecular processes are believed to 
involve similar mechanisms in wound healing across tissue domains, although some differences 
may exist in magnitude and timing of responses across tissue types (Robson et al., 2001). 
Once basic wound healing rules were established, the model’s parameter values for the 
cellular and molecular responses to insults had to be estimated numerically. We iteratively 
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calibrated these values by verifying the model’s simulation outputs against (1) generally 
recognized patterns of cellular and molecular responses reported in the wound healing literature 
up to a 2-week time point (Cockbill, 2002; P. Martin, 1997; Robson et al., 2001; Witte & Barbul, 
1997), adjusting parameter values accordingly as needed to obtain a general  match between 
model output and those patterns (qualitative verification-calibration), and subsequently (2) 
experimental measures of inflammatory mediators in human laryngeal secretions from an acute 
phonotrauma study, up to a 4-hr post injury time point (Verdolini et al., in preparation). The 
model’s parameters were then again iteratively adjusted until the patterns of simulation outputs 
and the empirical data were well matched, subjectively (quantitative verification-calibration). 
Last, we input subject-specific initial inflammatory profiles into the model and ran 
simulations to evaluate the model’s accuracy in predicting the levels of inflammatory mediators 
at a 24-hr time point following baseline, which had been followed by vocal loading and 
behavioral treatments. The details of the aforementioned process (model structure, model 
verification-calibration and model evaluation) are described shortly.  
4.1 OVERVIEW OF MODEL STRUCTURE 
The ABM of phonotrauma represents processes thought to occur in the vocal fold mucosal tissue 
and aims to simulate the mucosal repair response to biomechanical damage during phonation. 
For each simulation, the user can define the initial levels of three inflammatory mediators (IL-1β, 
TNF-α and IL-10), add a phonotraumatic event, and then a 4-hr treatment event (voice rest, 
resonant voice exercises or spontaneous speech). In the model, one step of simulated time 
represents 0.1 day (2.4 hr). 
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The model consists of platelets, inflammatory cells (neutrophils and macrophages) and 
fibroblasts, mediators that regulate inflammation and wound healing (IL-1β, TNF-α, IL-10, and 
TGF-β1), a representative component of the extracellular matrix (collagen type I), and, perhaps 
most important, a tissue damage function functionally analogous to alarm/ danger signals 
(Matzinger, 2002) that produces positive feedback to induce further inflammation (Vodovotz, 
2006) (Figure 1). The model assumes that biomechanical stress during phonation causes mucosal 
tissue damage and activates platelets, neutrophils and macrophages. Platelets release TGF-β1, 
which chemoattracts both neutrophils and macrophages. Activated neutrophils and macrophages 
secrete pro-inflammatory mediators, which in turn induce anti-inflammatory mediator release. 
Pro-inflammatory mediators also induce neutrophils and macrophages to produce free radicals 
that damage tissue. In our model, the activity of free radicals was subsumed in the actions of 
TNF-α. Anti-inflammatory mediators contribute to fibroblast activation. Activated fibroblasts 
secrete an extracellular matrix molecule, collagen, which mediates tissue repair. In the model, 
collagen accumulation is considered as the surrogate for healing outcome following 
phonotrauma. Collagen is an important extracellular matrix protein involving both structural and 
biomechanical functions in the vocal folds (Gray & Titze, 1988; Gray et al., 2000). The changes 
in temporal concentration of inflammatory cells, mediators, tissue damage and collagen were 
plotted and refolded into the model at each time step. The details of the ABM codes are available 
in the published paper (N. Y. Li et al., 2008). 
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Figure 1. An overview of the model structure. The model assumes that biomechanical stress during 
phonation causes mucosal damage and activates platelets, neutrophils and macrophages. Platelets produce 
TGF-β1, which chemoattracts both neutrophils and macrophages. Activated neutrophils and macrophages 
secrete pro-inflammatory mediators, which in turn induce anti-inflammatory mediator release. Pro-
inflammatory mediators also induce neutrophils and macrophages to produce free radicals that damage 
tissue. In our model, the activity of free radicals was subsumed in the actions of TNF-α. Anti-inflammatory 
mediators contribute to fibroblast activation. Activated fibroblasts secrete collagen that mediates tissue 
repair. In the model, collagen accumulation is considered as the surrogate for healing outcome following 
phonotrauma. Collagen is an important ECM protein involving both structural and biomechanical functions 
in the vocal folds (Gray & Titze, 1988; Gray et al., 2000).  (Reprint from Li, N. Y., Verdolini, K., Clermont, 
G., Mi, Q., Rubinstein, E. N., Hebda, P. A., et al. (2008). A patient-specific in silico model of inflammation and 
healing tested in acute vocal fold injury. PLoS ONE, 3(7), e2789. Permission not required.) 
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4.2 PARAMETER ESTIMATTION THROUGH ITERATIVE VERIFICATION AND 
CALIBRATION  
 
Pattern-oriented analysis (Grimm et al., 2005; Railback, 2001) was used to estimate the model’s 
parameters for the cellular and molecular responses to insults through an iterative validation and 
calibration process (Figure 2). Using this approach, we compared the patterns of simulation-
generated data curves with (1) the patterns of inflammatory and wound healing reported in the 
wound healing literature across a roughly 2-week period (qualitative verification-calibration) and 
(2) the empirical data of inflammatory mediators in laryngeal secretions from an acute 
phonotrauma study following insult (quantitative verification-calibration). If the model-predicted 
and empirical curves failed to match according to subjective evaluation, the model would be 
calibrated to minimize differences between model predictions. Of note, not the structure of the 
model (i.e., components and rules) but only the values of the parameters were adjusted during 
the calibration process. Finally, an ABM was developed having a single set of parameters (i.e., a 
single model) that simulated patient-specific treatment response following acute phonotrauma. 
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Figure 2. Iterative verification-calibration process in the existing ABM. 
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4.2.1 Qualitative verification-calibration of the model using literature data 
In greater detail, first, a qualitative verification was carried out to test whether the model 
reproduces the generally-accepted patterns of cellular and molecular responses reported in the 
wound healing literature (Cockbill, 2002; P. Martin, 1997; Robson et al., 2001; Witte & Barbul, 
1997) (Table 1). The user-defined initial magnitude of mucosal injury (range 0 – 40 in arbitrary 
units of damage) was first set at a value of 20 and the initial pre-injury values of IL-1β, TNF-α 
and IL-10 were set as zero. We then ran simulations to determine model outcome in the case of 
an acute phonotraumatic event and compared the model’s outputs with pre-specified patterns 
reported in the wound healing literature up to a 2-wk time point (Cockbill, 2002; P. Martin, 
1997; Robson et al., 2001; Witte & Barbul, 1997) (Table 1). If the model-predicted and empirical 
curves failed to match subjectively, the model’s parameters were calibrated iteratively to produce 
a better qualitative match.  
  
 42 
Table 1. Patterns Used for the Existing ABM in the “Comparison Condition”, i.e., the Condition with 
Intermediate Magnitude of Initial Mucosal Injury Input. 
Patterns of Inflammation and 
Healing 
Reference 
Neutrophils arrive in wound site in the 
first few hours 
(Cockbill, 2002; P. Martin, 1997; Robson et al., 2001; 
Witte & Barbul, 1997) 
Neutrophil number is at maximum by 
24 hours 
(Cockbill, 2002; P. Martin, 1997; Robson et al., 2001; 
Witte & Barbul, 1997) 
Neutrophil number decreases rapidly on 
Day 3 
(Cockbill, 2002; P. Martin, 1997; Robson et al., 2001; 
Witte & Barbul, 1997) 
Macrophage number is at maximum by 
24-48 hours 
(Cockbill, 2002; P. Martin, 1997; Robson et al., 2001; 
Witte & Barbul, 1997) 
Fibroblast number is at maximum by 
Day 5-7 
(Cockbill, 2002; P. Martin, 1997; Robson et al., 2001; 
Witte & Barbul, 1997) 
Fibroblast number decreases gradually 
on Day 7 
(Cockbill, 2002; P. Martin, 1997; Robson et al., 2001; 
Witte & Barbul, 1997) 
Collagen curve is sigmoid-shaped (Robson et al., 2001; Witte & Barbul, 1997) 
 
4.2.2 Quantitative verification-calibration of the model using empirical laryngeal data 
When qualitative behavior of the simulation appeared satisfactory, we proceeded to quantitative 
verification-calibration of the model by adjusting parameter values not found in the literature to 
fit the quantity and time-course of measured vocal fold mediators. The user-defined initial 
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magnitude of mucosal injury, which represented the phonotraumatic event, was set at a value of 
20. The initial values of IL-1β, TNF-α and IL-10 and the simulated treatment event (voice rest, 
resonant voice exercises or spontaneous speech) were subject-specific, based on values obtained 
in the acute phonotrauma study (Verdolini et al., in preparation). Specifically, we ran simulations 
for three subjects (Subjects 1 – 3), using their baseline mediator levels in laryngeal fluid as initial 
inputs for the model, added a phonotraumatic event and then a 4-hr treatment event (Subject 1: 
voice rest, Subject 2: resonant voice and Subject 3: spontaneous speech). The treatment event 
was modeled by introducing additional mechanical stress to the simulated mucosal tissue. The 
magnitude of mechanical stress for the treatment was arbitrarily set as 0 for voice rest, 10 for 
resonant voice and 15 for spontaneous speech.  
Subsequently, we compared each subject’s model outputs for IL-1β, TNF-α and IL-10 
with those from the empirical data, immediately after phonotrauma induction, and following a 4-
hr treatment (Verdolini et al., in preparation). If the model-predicted and empirical data did not 
match subjectively, the parameter values were calibrated iteratively to optimize the model’s 
prediction of vocal fold mediators. The quantitative verification-calibration iterative process 
continued until it eventually yielded a satisfactory model, based on subjective judgment. 
4.2.3 Evaluating the model’s prediction accuracy of inflammatory mediator outputs 
Last, we input individual-specific inflammatory profiles (IL-1β, TNF-α and IL-10) at baseline 
and the category of treatment conditions (voice rest, resonant voice exercises or spontaneous 
speech) into the model and ran simulations up to 5 days. Then, we evaluated the ABM by 
comparing the predicted mediator levels with the empirical mediator levels at 24 hr (1) for 
Subjects 1, 2 and 3 whose data from early time points had been used for model calibration, as 
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well as (2) for Subjects 4 – 7 whose data had never been used for the model but only their 
individual inflammatory profiles at baseline were used as input to the model for simulation. 
Individual Z-tests using the p-value approach to testing statistical significance were carried out to 
compare the human empirical data to the data predicted by the model for IL-1β, TNF-α and IL-
10 at the 24-hr time point for (1) the base cohort (Subjects 1 – 3), and (2) the remaining subjects 
(Subjects 4 – 7). Z-tests were carried out for each mediator for each subject. 
4.3 THE AGENT-BASED MODEL OF PHONOTRAUMA: SIMULATION RESULTS 
In general, the ABM reproduced and predicted subject-specific trajectories of inflammatory 
mediators as seen in our human data. Results are shown in Figures 3 – 4. For the base cohort 
(Subjects 1 – 3), the ABM predicted empirically obtained mediator values at 24 hr for 80% of 
mediators (12/15; p < 0.05). In Subjects 4 – 7, the ABM predicted 24-hr mediator values 67% 
(2/3; p < 0.05) of cases for markers that were categorized “valid” and 44% (4/9; p < 0.05) of the 
instances that were categorized as “pre-inflamed and/or non-responsive”. Predicted levels of pro-
inflammatory marker IL-1β for spontaneous speech were significantly higher than for either 
voice rest or resonant voice conditions (p < 0.05, both comparisons). In contrast, levels of anti-
inflammatory marker IL-10 for voice rest were significantly lower than for either resonant voice 
or spontaneous speech (p < 0.05, both comparisons). This work, although preliminary and small-
scale, demonstrates a concrete realization of the synergistic power of modeling iterating with 
clinical data to provide a new understanding of the process of acute phonotrauma, with real 
implications for therapy.   
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Figure 3. Empirical and model-predicted inflammatory and wound healing responses to acute 
phonotrauma in a single human subject (Subject 3) following spontaneous speech (Panels A-C), voice rest 
(Panels D-F) and resonant voice treatment conditions (Panels G-I). Panels A, D and G display empirical and 
predicted trajectories of IL-1β. Panels B, E and H show empirical and predicted trajectories of TNF-α. Panels 
C, F and I show empirical and predicted trajectories of IL-10.  Inflammatory marker concentrations are in 
pg/ml. The grey bars represent the mean of the simulated data, and the error bars represent standard 
deviations in the simulated data. The dark circles represent the input data for the first three time points 
(baseline, post-loading, 4-hr post treatment onset), obtained from human laryngeal secretion data. The empty 
circles represent the validation data at the 24-hr time point from the human laryngeal secretion data. B: 
baseline; PL: post vocal loading; 4hrPRx: following a 4-hr treatment. Note that human validation data for 
Days 2-5 have not yet been generated. (Reprint from Li, N. Y., Verdolini, K., Clermont, G., Mi, Q., 
Rubinstein, E. N., Hebda, P. A., et al. (2008). A patient-specific in silico model of inflammation and healing 
tested in acute vocal fold injury. PLoS ONE, 3(7), e2789. Permission not required.) 
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Figure 4. Empirical and model-predicted inflammatory and wound healing responses to acute 
phonotrauma in three subjects following spontaneous speech (Subject 3; Panels A-C), voice rest (Subject 1; 
Panels D-F) and resonant voice treatment conditions (Subject 2; Panels G-I). Panels A, D and G display 
empirical and predicted trajectories of IL-1β. Panels B, E and H show empirical and predicted trajectories of 
TNF-α. Panels C, F and I show empirical and predicted trajectories of IL-10. Inflammatory marker 
concentrations are in pg/ml. The grey bars represent the means from the simulated data, and the error bars 
represent the standard deviation from the simulated data. The dark circles represent the input data for the 
first three time points (baseline, post-loading, 4-hr post treatment onset) from the human laryngeal secretion 
data. The empty circles represent the validation data at the 24-hr time point from the human laryngeal 
secretion data. B: baseline; PL: post vocal loading; 4hrPRx: following a 4-hr treatment. Note that human 
validation data for Days 2-5 have not yet been generated. (Reprint from Li, N. Y., Verdolini, K., Clermont, 
G., Mi, Q., Rubinstein, E. N., Hebda, P. A., et al. (2008). A patient-specific in silico model of inflammation and 
healing tested in acute vocal fold injury. PLoS ONE, 3(7), e2789. Permission not required. 
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4.4 ORDINARY DIFFERENTIAL EQUATION MODEL OF PHONOTRAUMA 
In addition to the development of a patient-specific agent-based model of vocal fold 
inflammation, the parallel development of an ordinary differential equation model was pursued 
in the interest of cross-platform comparison of results (N. Y. K. Li, Verdolini, Clermont, Mi, 
Hebda et al., 2006). To test the validity of our agent-based model, “model docking” was used. 
“Model docking” is a well-vetted validation strategy based on a comparison of predictions from 
different models across an array of user input data. The finding of similar predictions in agent-
based and equation-based models would increase confidence in the underlying assumptions 
made in the current agent-based model.  
In the comparison study, the agent-based and equation-based models predicted similar 
cellular and molecular patterns for inflammatory and wound healing responses under small initial 
damage (Figure 5). However, the models’ results diverged in their predictions of inflammatory 
and wound healing responses for a large initial insult (Figure 5). Stated differently, with small 
initial damage, both models seemed to be robust to structural differences and limitations. 
However, beyond a given threshold of input damage, the models did not “dock.” It is unclear 
whether this threshold is beyond commonly observed intensities of phonotraumatic insult. 
Encouragingly, the agent-based and equation-based models both anticipated that net collagen 
deposition peaks on Day 9 post injury. This predictive pattern helps to generate a hypothesis for 
a “wet-lab” experiment designed to identify putative mediators or enzymes correlated with the 
predicted collagen curves. 
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Figure 5. The time course of cellular and molecular tissue abundances in wound healing predicted by 
both agent-based models (ABM) and equation-based models (EBM) under low, control and high initial 
magnitudes of mucosal damage (N. Y. K. Li, Verdolini, Clermont, Mi, Hebda et al., 2006). Panels A-B are the 
predications of a pro-inflammatory mediator. Panels C-D are the predictions of an anti-inflammatory 
mediator. Panels E-F and G-H are the predictions of collagen synthesis and tissue damage respectively. 
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4.5 LIMITATIONS OF THE PRELIMINARY AGENT-BASED MODELS OF ACUTE 
PHONOTRAUMA THAT WILL BE ADDRESSED IN THIS STUDY 
The previous work is encouraging in terms of the potential translational utility of ABM in the 
setting of vocal fold inflammation. However, at least three major limitations are noted and are 
addressed in the current project.  
4.5.1 Underrepresentation of vocal fold extracellular matrix and its biomechanical roles 
in mediating inflammation and healing 
The published ABM used collagen type I as the sole extracellular matrix (ECM) representative 
for the virtual vocal folds. In real vocal folds, elastin and hyaluronan (HA) in addition to 
collagen are also the main ECM substances composing vocal fold tissues and have equally 
important biomechanical effects in controlling vocal fold vibratory properties (Chan, Fu, Young, 
& Tirunagari, 2007; Chan, Gray, & Titze, 2001; Chan & Titze, 2006; Gray et al., 2000; Gray, 
Titze, Chan, & Hammond, 1999). Thus, elastin and HA were added in the new ABM in order to 
make it a more realistic replication of the ECM environment specific to the vocal folds. 
Other than the importance of biomechanical roles in vocal folds, a growing literature 
supports the idea that ECM components have biochemical roles in regulating the wound healing 
process. Studies to date have shown that aberrant scarring/ fibrosis is at least partly due to the 
response of fibroblasts in the wound to both inflammatory mediators and ECM components 
(Hirschi, Gray, & Thibeault, 2002; S.L. Thibeault, Bless, & Gray, 2003; S.L. Thibeault, Gray, 
Bless, Chan, & Ford, 2002; S.L. Thibeault, Gray, Li et al., 2002; I. R. Titze et al., 2004). In 
particular, fragments of some ECM substances are known to constitute alarm/ danger signals that 
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influence cellular responses in the wound environment (Gallucci & Matzinger, 2001; Girish & 
Kemparaju, 2007; D. Jiang, Liang, & Noble, 2007; Lee & Spicer, 2000; Matzinger, 2002; Noble, 
2002; O'Reilly, Gaggar, & Blalock, 2008; Stern, Asari, & Sugahara, 2006). The inflammation 
and healing process in the existing ABM were primarily mediated by interactions between 
inflammatory mediators and cells. The new ABM was augmented to explicitly represent 
biochemical roles of ECM fragments ensuing from initial mechanical injury or collateral damage 
from inflammation throughout the wound healing process. 
4.5.2 Underrepresentation of the interplay among inflammatory mediators, growth 
factors and ECM substances across different phases of inflammation and healing as well as 
their response to tissue mobilization 
The published ABM simulated (1) inflammation, (2) proliferation and (3) collagen formation (N. 
Y. Li et al., 2008). The model did not account for a final phase of the wound healing process, 
which involves extracellular matrix (ECM) reorganization. According to the literature on dermal 
wound healing, ECM reorganization is initiated once neo-matrix such as collagen is deposited at 
the wound site (Cockbill, 2002; P. Martin, 1997; Witte & Barbul, 1997). Collagen is indeed a 
core component of the ECM, and undergoes remodeling that is dependent on both continued 
collagen synthesis and compensatory collagen degradation. The degradation of wound collagen 
is controlled by a variety of collagenase enzymes, and the net increase in wound collagen is 
determined by the balance of these opposing mechanisms. Currently, no in vivo measurement of 
collagen remodeling in human vocal folds is available. At the same time, we may be able to 
capture the collagen dynamics indirectly by including collagenase enzymes in the model.  
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Matrix metallopeptidase-8 (MMP-8), which is a neutrophil collagenase, has been 
reported for its changes in vocal fold tissues following acute phonotrauma (Verdolini et al., in 
preparation). MMP-8 is known to preferentially cleave collagen type I and subsequently collagen 
fragments are generated. Besides MMP-8, several growth factors also influence ECM dynamics 
throughout wound healing. In particular, basic fibroblast growth factor (bFGF) has been 
documented to affect not only collagen but also elastin and HA productions in vocal fold 
fibroblasts. This growth factor has also been suggested for its therapeutic potential for tissue 
regeneration of injured vocal folds (Hirano, Bless, del Rio, Connor, & Ford, 2004; Hirano, Bless, 
Heisey, & Ford, 2003; Hirano et al., 2005; Luo, Kobler, Zeitels, & Langer, 2006). The new 
ABM was augmented with the rules around the interplay among growth factors, collagenase, 
cells and ECM components in order to yield more precise predictions of ECM dynamics 
throughout inflammation and healing.  
Two additional cytokine mediators, IL-6 and IL-8, were incorporated in the new model as 
well. Delayed or aberrant inflammatory and healing response was reported in IL-6- or IL-8- 
deficient animals (Devalaraja et al., 2000; Grose & Werner, 2004; Hang, Frendeus, Godaly, & 
Svanborg, 2000; Lin, Kondo, Ishida, Takayasu, & Mukaida, 2003). Changes in IL-6 and IL-8 
levels following vocal loading were observed in the laryngeal secretion data set from the study of 
acute phonotrauma (Verdolini et al., in preparation). Also, expressions of IL-6 and IL-8 in 
anatomical sites adjacent to the vocal folds are widely reported. Up-regulations of IL-6 and IL-8 
are found in various respiratory diseases, such as bronchial asthma, acute lung injury, pulmonary 
fibrosis, and pneumonia (Coraux, Hajj, Lesimple, & Puchelle, 2005; Kammouni, Figarella, 
Marchand, & Merten, 1997; Kolb, Margetts, Anthony, Pitossi, & Gauldie, 2001; Losa Garcia et 
al., 1999; Lynch, Standiford, Rolfe, Kunkel, & Strieter, 1992; Martinet, Menard, Vaillant, 
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Vignaud, & Martinet, 1996; Maus, Rosseau, Knies, Seeger, & Lohmeyer, 1998; Nakamura et al., 
1995; Rom, 1991; Takizawa, 1998, 2005; Takizawa, Ohtoshi, Yamashita, Oka, & Ito, 1996; 
Takizawa et al., 1997; Vaillant, Menard, Vignaud, Martinet, & Martinet, 1996; van den Berg et 
al., 2005; C. H. Wang et al., 2005; Xaubet et al., 1998). These investigations pointed to IL-6 and 
IL-8 as possible active mediators in inflammation and repair within the respiratory system, at the 
very least.  
Furthermore, IL-6 and IL-8 were found sensitive to mechanical stimulation in muscle 
contraction during exercise work. A marked increase in both mRNA and protein levels of IL-6 
and IL-8 following exercise without indicated tissue damage is consistently reported in literature 
(Akerstrom et al., 2005; Frydelund-Larsen et al., 2007; Nielsen & Pedersen, 2007; Pedersen & 
Hoffman-Goetz, 2000; Pedersen et al., 2003; Pedersen et al., 2001; Petersen & Pedersen, 2006; 
Steensberg, Fischer, Keller, Moller, & Pedersen, 2003). In fact, IL-6 is labeled as the “exercise 
factor” that mediates the health beneficial effects of exercise by suppressing pro-inflammatory 
response and amplifying anti-inflammatory response (Nielsen & Pedersen, 2007; Pedersen & 
Hoffman-Goetz, 2000; Pedersen et al., 2003; Pedersen et al., 2001). Another mechano-sensitive 
cytokine is IL-8, which is a well-studied mediator of its roles in attracting neutrophils into an 
area of tissue injury. Exercise-induced IL-8 is suggested to play a local role in stimulating 
angiogenesis through the activation of cell surface receptors (CXCR2) present in the capillary 
(Frydelund-Larsen et al., 2007). The new ABM with the addition of these two cytokines might 
improve the representation of the biological effects of motion-based treatments in stressed vocal 
fold tissues following vocal loading.  
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4.5.3 Limited validation of the model’s tissue-level outputs 
A third limitation in the existing work is that only the model’s molecular outputs were calibrated 
with cytokine data from human laryngeal secretions (Verdolini et al., in preparation), whereas 
the model’s tissue-level outputs/ predictions were yet to be experimentally validated. The 
integration of cellular and molecular responses and their manifestations at the higher level of 
tissue-wide and physiological changes is necessary to (1) obtain a fuller understanding of the 
pathophysiology of phonotrauma and (2) provide insights on how to manipulate or regenerate the 
stressed or traumatized tissues.  
In the vocal folds, tissue status (damage, scar) is typically characterized by the change of 
extracellular matrix substances following injury. For example, excessive and disorganized 
collagen deposition, and decrease or total loss of elastin and HA within the lamina propria are 
reported in both human and/ or animal scarred vocal folds (R. C. Branski, Rosen, Verdolini, & 
Hebda, 2005a; Hansen & Thibeault, 2006; Hirano, Bless, Rousseau et al., 2003; Hirano et al., 
2008; Rousseau et al., 2004; Rousseau et al., 2003; I. Tateya et al., 2006; T. Tateya, Tateya, 
Sohn, & Bless, 2005; T. Tateya, I. Tateya, J. H. Sohn et al., 2006; S.L. Thibeault et al., 2003; 
S.L. Thibeault, Gray, Bless et al., 2002; S. L. Thibeault et al., 2004). In the past, animal surgical 
models have focused on the changes in extracellular matrix substance in injured vocal folds (R. 
C. Branski et al., 2005a; Hansen & Thibeault, 2006; Hirano, Bless, Rousseau et al., 2003; 
Rousseau et al., 2004; Rousseau et al., 2003; I. Tateya et al., 2006; T. Tateya et al., 2005; T. 
Tateya, I. Tateya, J. H. Sohn et al., 2006; S.L. Thibeault et al., 2003; S.L. Thibeault, Gray, Bless 
et al., 2002; S. L. Thibeault et al., 2004). Until recently, three reports have been published to 
describe the inflammatory mediator profile in injured vocal folds, using animal surgical models 
(R. C. Branski, Rosen, Verdolini, & Hebda, 2005b; Lim et al., 2006; Welham et al., 2008). These 
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animal surgical data seem to provide an excellent opportunity for encoding the inflammatory 
mediator response according to its tissue level effects in injured vocal folds. Also, the time 
points, which have been reported in animal surgical models so far, are more wide-spread and 
abundant, compared to available human phonotrauma data. For instance, in rat models, the 
reported time points have spanned from points as early as 1 hr to as late as 3 months following 
injury (Lim et al., 2006; I. Tateya et al., 2006; T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. 
Sohn et al., 2006; Welham et al., 2008). From the perspective of systems biology, a large number 
of time points in a series helps to improve a models’ accuracy.  
In the second part of this dissertation project, an animal surgical ABM was generated in 
parallel to the augmented human phonotrauma ABMs in the main study. Studies of rats were 
used because the data are the most comprehensive among the animal species (Lim et al., 2006; I. 
Tateya et al., 2006; T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et al., 2006; Welham 
et al., 2008). In the human phonotrauma ABMs, we were only able to calibrate and validate the 
model using inflammatory mediators at best. However, with this supplementary animal ABM, 
we were not only able to conduct modeling for the same inflammatory mediators, but we were 
also able to model ECM substances. This work is valuable because the complex interactions 
among the inflammatory mediators make it necessary to evaluate the “net effect” of these 
mediators at the tissue level. Hopefully, this work led us to predict actual vocal fold tissue status, 
at some integrated level, following injury.  
 55 
4.6 SUMMARY  
Predictive, pre-emptive and personalized mode of intervention is a central goal of modern 
medicine. To approach this goal, the complexity of biological processes must be tamed. We 
suggest that a systems biology approach that involves modeling/ simulation is integral to sorting 
through the perplexing array of factors that dictate success or failure of clinical trials for complex 
diseases (Whitcomb et al., 2005). Our ultimate, long-term goal is to generate in silico models 
that can be queried to identify biomechanical treatments that will optimize the wound healing 
process in the vocal folds, as a function of patient-specific inflammatory profiles. Although our 
long-term interests include both acute and chronic phonotrauma, the present study focuses on the 
acute case. Currently, biologically-based ABMs of acute phonotrauma have been developed 
relevant to this goal. However, several gaps are noted as mentioned in Section 4.5. These gaps 
were addressed in the current study and specific experimental hypotheses are provided shortly.  
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5.0  RESEARCH DESIGN AND METHODS 
The present dissertation project involved the development of agent-based models (ABMs) in the 
context of (1) human phonotrauma and (2) animal surgical trauma to the vocal fold mucosa. The 
particular objective of this work is to construct a quantitative framework for evaluating 
biological effects of motion-based therapies for patients with acute phonotrauma. Ultimately, 
computational tools will be available that empower clinicians to (1) characterize an individual’s 
probabilistic future health risk for the development or exacerbation of phonotraumatic vocal fold 
tissue changes and (2) prescribe personalized treatment regimes for individual patients with 
traumatized vocal folds depending on patients’ current laryngeal status and unique probabilistic 
future health risks.  
The overarching experimental questions for the current project are: (1) Can an ABM 
offer a personalized prediction of biological events within the vocal folds presumed to be closely 
related to tissue status? (2) If so, will the simulated wound healing response vary specifically as a 
function of the initial settings of biomarker level and treatment prescribed? Positive answers to 
these experimental questions would strengthen confidence in the eventual utility of mathematical 
modeling in general, and of ABM in particular, for understanding the complex vocal fold wound 
healing system and for predicting the healing outcome following vocal fold injury and varied 
treatment types. 
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5.1.1 EXPERIMENT 1 (SPECIFIC AIM 1) 
5.1.1.1 Purpose 
The purpose of Experiment 1 was to generate subject-specific agent-based models 
(ABMs) of vocal fold inflammation due to acute phonotrauma to compute variables of (1) 
empirically derived cytokines and a collagenase (interleukin [IL]-1β, IL-6, IL-8, IL-10, tumor 
necrosis factor [TNF]-α and matrix metalloproteinase [MMP]-8), (2) growth factors 
(transforming growth factor [TGF]-β1 and basic fibroblast growth factor [bFGF]) and (3) 
extracellular matrix substances (collagen, elastin and hyaluronan [HA]). The models’ prediction 
accuracy for the cytokines and the collagenase was subsequently evaluated, using empirical data 
generated from our treatment study of acute phonotrauma (Verdolini et al., in preparation). 
5.1.1.2 Hypotheses 
 
H0: The empirical inflammatory marker data (IL-1β, IL-6, IL-8, IL-10, TNF-α, and MMP-8) will 
not be within the 95% confidence interval for the simulated population mean at the 24-hr follow-
up time point, given subject-specific cytokine and collagenase inputs to the model’s baseline, 
immediate post loading and 4-hr post treatment onset time points. 
H1: The empirical inflammatory marker data (IL-1β, IL-6, IL-8, IL-10, TNF-α, and MMP-8) will 
be within the 95% confidence interval for the simulated population mean at the 24-hr follow-up 
time, given subject-specific cytokine and collagenase inputs to the model’s baseline, immediate 
post loading and 4-hr post treatment onset time points. 
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5.1.1.3 Equipment and software 
The freeware Netlogo 4.0.3 (Center for Connected Learning and Computer-Based 
Modeling, Northwestern University, Evanston, IL) were used as the platform for model building 
and simulation. Statistical software, Statistical Package for the Social Sciences (SPSS) 15.0 
(SPSS Inc., Chicago, IL, USA), was used for statistical inspection of the empirical data and 
statistical evaluation of the ABMs’ prediction accuracy. 
5.1.1.4 Experimental protocol of acute phonotrauma in different treatment modalities 
The treatment study of acute phonotrauma (Verdolini et al., in preparation), which 
provided the necessary empirical data for the current modeling study, was approved by the 
Institutional Review Board at the University of Pittsburgh. A total of nine subjects participated in 
the study; six females (21-46 years) and three males (21-29 years). Nine subjects participated in 
a between-subjects study design, which involved exposure to a randomly assigned “treatment” 
condition (voice rest, resonant voice exercises or spontaneous speech) following a vocal loading 
task. One of the female subjects (Subject 3) also participated in a within-subjects design, which 
involved exposure to all three “treatment” conditions. For Subject 3, treatments were randomly 
allocated without replacement on different pairs of days separated by intervals ranging from 1-6 
months.  
Prior to subjects’ participation in the experimental part of the protocol, written informed 
consent was first obtained by an investigator or research coordinator and then subjects received a 
clinical screening to assess for gag response and nasal patency. Exclusion criteria included 
subject report of gagging with tooth-brushing or other history or evidence of exaggerated gag 
reflex, deviated septum (based on otolaryngology exam), report of current or recent voice 
problems (within the past year) or any history of speech or language deficits, use of drugs that 
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may influence the voice (e.g., diuretics, decongestants), or report of allergy to local anesthetics 
(especially lidocaine). 
In this experimental protocol, the vocal loading task aimed to induce acute phonotrauma. 
The protocol for vocal loading entailed three consecutive cycles, each involving 15 minutes of 
loud phonation (~75 – 90 dB @ 15 cm microphone-to-mouth distance) followed by 5 minutes of 
silence, for a total 60 minutes. Then, subjects were randomly assigned to one of three treatment 
groups: voice rest, resonant voice exercises or spontaneous speech for 4 hours in the clinic, under 
the careful supervision of a voice trainer, who — for the majority of subjects — was blinded to 
the experimental hypotheses. These three treatment modalities can be thought of on a two-
dimensional continuum involving vibratory stress (none — voice rest; intermediate — 
spontaneous speech and resonant voice) and impact stress (none — voice rest; low — resonant 
voice; or intermediate — spontaneous speech). The prescription of resonant voice exercises 
involved cycles of 4 minutes of exercise followed by 16 minutes of rest, whereas the 
spontaneous speech treatment involved cycles of 16 minutes of conversational speech followed 
by 4 minutes of silence. In the voice rest condition, subjects did not phonate at all during the 4-hr 
period.  After the 4-hour treatment, participants were discharged to home with instructions to 
continue to follow their corresponding treatment condition, with slight modifications for the 
resonant voice and spontaneous speech groups. The next morning, all subjects were required to 
observe complete voice rest until their arrival at the clinic around 7:00 a.m. or shortly thereafter. 
5.1.1.5 Laryngeal secretion procedure, assessment of inflammatory analytes and data used 
for modeling 
A total of 4 secretion specimens were collected from each subject at 4 different time 
points: baseline, immediately post vocal loading, following the start of the 4-hr treatment and 24 
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hour post baseline. For the initial secretion collection, an otolaryngologist first examined the 
subject’s oral cavity, oropharynx, and nasal cavity and placed a cotton pledget (a flat absorbent 
pad) soaked with lidocaine and decongestant into the subject’s more patent nasal cavity. 
Cetacaine® was sprayed in the oropharynx. Rigid laryngeal stroboscopy was performed to obtain 
a baseline stroboscopic evaluation on the patient. Then 4% lidocaine was dripped into the 
endolarynx through the working channel of the previously noted chip-tip flexible laryngoscope. 
After approximately 5 minutes, subsequent to verification of vocal fold anesthesia to light touch, 
a 1 millimeter plastic cannula was passed through the working channel of the scope and guided 
down to the free edge and superior surface of the vocal folds while suction was applied to the 
catheter. That procedure allowed for the collection of a small amount of vocal fold secretions 
bilaterally (about 100 μl total), while minimizing contact of the scope with the vocal folds. 
Secretions were captured in a modified sinus trap and then transferred into a 0.2 ml microfuge 
tube using a 1cc syringe. The tubes were labeled using codes that could not be traced to the 
subject or the subject’s condition—except by way of a secret list retained by one investigator 
who was not involved with secretion data analysis--and the tubes were placed on dry ice. Tubes 
were then stored at -80 ºC until analysis. 
All secretion analyses were carried out by an investigator who was blinded to subjects’ 
conditions (time point and treatment condition). For the analyses, a known volume was aliquoted 
for analysis and served as the dilution factor. The appropriate volume of sterile saline was added 
to the tube to bring the total volume up to 2.0 ml. Standard Enzyme-Linked ImmunoSorbent 
Assays (ELISAs) were performed for IL-1β, IL-6, IL-8, IL-10, TNF-α and MMP-8 utilizing the 
manufacturer's recommended protocol (R&D Systems, Minneapolis, MN). All samples were run 
on the same kit to avoid inter-kit variability in the data.  
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Inspection of the resulting secretion data was carried out in order to derive the cleanest 
data for the development of ABM. The data were sorted into three main categories across 
subjects and inflammatory markers: (1) data showing high baseline concentrations of pro-
inflammatory markers (> 1 standard deviation relative to the average for the set as a whole; 
designated as “pre-inflamed” data); (2) data showing normal baseline concentrations of markers 
(< 1 standard deviation from average), but paradoxically decreasing post loading (“non-
responsive” data); and (3) data showing normal baseline concentrations of markers (< 1 standard 
deviation from average) and increase after loading (“responsive” data) (Verdolini et al., in 
preparation). In addition, all data from two subjects (Subject 8 and Subject 9) were considered as 
invalid due to thick secretions that compromised interpretation of ELISA results. Therefore, none 
of their data were used in the initial ABM development (N. Y. Li et al., 2008) or in the current 
study.  
The upshot was that a “base dataset” was identified involving data from three subjects 
(Subjects 1, 2 and 3), whose data were considered “responsive” and “not pre-inflamed,” 
according to the schematic used. The first three time points of the base data set (baseline, 
immediate post loading, and 4-hr post treatment initiation) were used for the ABM calibration 
(N. Y. Li et al., 2008). Subject 1 and Subject 2, who were the between-group subjects, received 
voice rest and resonant voice exercises respectively. Data from these two subjects were used to 
calibrate parameters relative to voice rest and resonant voice exercises for immediate post-
loading and 4-hr post treatment initiation time points. For Subject 3, who was the within-group 
subject, all data from the subject were used to calibrate the parameters relative to voice rest, 
resonant voice exercises and spontaneous speech in the ABM for immediate post-loading and 4-
hr post treatment initiation time points. Model validation primarily involved comparison of data 
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from Subjects 1 – 3 at the 24-hr time point vis-a-vis 24-hr data predicted by the model, 
individually for each subject. The details of how empirical data were used for verification-
calibration and validation procedures of the previously reported ABM (N. Y. Li et al., 2008) are 
described in Section 4.2. The same procedures were replicated for the new ABM with minor 
modifications that are described shortly in Sections 5.1.1.9 – 5.1.1.10. 
5.1.1.6 New model components and rules 
A single ABM with expanded components was developed for simulating both human 
phonotrauma (Experiment 1) and animal surgical trauma (Experiment 2). In these two 
experiments, the initial magnitude of mucosal injury and the empirical data set used for model 
verification-calibration and evaluation were different, as described in Sections 5.1.1.9 – 5.1.1.12 
for human phonotrauma simulation and Sections 5.1.2.5 – 5.1.2.7 for animal surgical simulation. 
Otherwise, both experiments used the same general model with identical model structure in 
terms of agent components and rules, as described below.  
The ABM of acute vocal fold inflammation and healing represented biological processes 
that are known to occur within the vocal fold mucosal tissue and simulated the mucosal repair 
response to mechanical injuries. The previously reported model (N. Y. Li et al., 2008) was 
specified to the setting of phonotraumatic injury through iterative verification and calibration 
procedures with vocal fold secretion data from a human phonotrauma study (Verdolini et al., in 
preparation). The model was composed of (1) platelets, (2) cells (neutrophils, macrophages and 
fibroblasts), (3) a growth factor (TGF-β1) and three cytokines (IL-1β, TNF-α, IL-10) involved in 
inflammation and wound healing, (4) a matrix substance (collagen type I) and (5) a tissue 
damage function analogous to alarm/danger signals constituting positive feedback to induce 
additional inflammation (Matzinger, 2002). In the present study, additional mediators, growth 
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factors and matrix substances were introduced to the previously developed ABM (N. Y. Li et al., 
2008) Specifically, in addition to existing model components, six new elements were added into 
the model: two cytokines (IL-6 and IL-8), a collagenase (MMP-8), a growth factor (bFGF) and 
two extracellular matrix substances (elastin and HA). The model was then specified for either the 
human phonotrauma setting (Experiment 1) or the animal surgical trauma setting (Experiment 
2), by calibrating the values of model parameters using the respective empirical data (See 
Section 5.1.11 for human phonotrauma and Section 5.1.2.6 for animal surgical trauma).  
Detailed literature on inflammation and healing was reviewed to identify rules for the 
further development of the ABMs in the present context (Armstrong & Jude, 2002; Broughton, 
Janis, & Attinger, 2006; Calvin, 1998; Cockbill, 2002; Croce et al., 2001; Diegelmann & Evans, 
2004; Gillitzer & Goebeler, 2001; Hackham & Ford, 2002; Henry & Garner, 2003; Kuang et al., 
2007; Leask & Abraham, 2004; P. Martin, 1997; Matsumoto, Okazaki, & Nakamura, 1992; 
Moulin, 1995; O'Reilly et al., 2008; Page-McCaw, Ewald, & Werb, 2007; Palmon et al., 2001; 
Parks, 1999; Parks, Wilson, & Lopez-Boado, 2004; Robson et al., 2001; Schiller, Javelaud, & 
Mauviel, 2004; Weng, Mohan, Li, & Wilson, 1997; Werner & Grose, 2003; Witte & Barbul, 
1997). Further, relevant literature on the vocal folds (Hirano, Bless, Heisey et al., 2003; Hirano, 
Bless, Nagai et al., 2004; Luo et al., 2006) was used to specify the model to the setting of vocal 
fold injury. The cell source and biological functions of the existing and augmented (in italics) 
models are summarized in Table 2.  
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Table 2. Summary of the Components Involved in the ABM. The Items in Italics Represent the 
Extension of the Existing ABM.  
Substances Cell Sources Biological Functions in Wound Healing used in ABM 
TGF-β1 Platelets 
Macrophages 
Fibroblasts 
Chemotactic to neutrophils, macrophages and fibroblasts 
 Inhibit expression of TNF-α in neutrophils, macrophages and fibroblasts 
 Inhibit expression of MMP-8 in neutrophils 
 Inhibit expression of IL-1β in macrophages (minimal effect)  
 Stimulate resting fibroblasts to activated fibroblasts 
 Mitogenic to fibroblasts (proliferation) 
 Stimulate collagen synthesis in fibroblasts 
 Stimulate elastin synthesis in fibroblasts 
 Stimulate native hyaluronan synthesis in fibroblasts 
bFGF Macrophages Chemotactic to neutrophils and macrophages 
 Fibroblasts Mitogenic to fibroblasts (proliferation) 
  Stimulate fibroblast migration 
  Inhibit collagen synthesis in fibroblasts 
  Inhibit elastin synthesis in fibroblasts 
  Stimulate native hyaluronan synthesis in fibroblasts 
TNF-α Neutrophils 
Macrophages 
Fibroblasts 
Chemotactic to neutrophils and macrophages 
 Activate neutrophils and macrophages 
 Stimulate expression of MMP-8 in neutrophils 
 Stimulate expressions of TNF-α, IL-1β, IL-6 and IL-8 in macrophages 
 Stimulate expression of TGF-β in macrophages and fibroblasts 
 Mitogenic to fibroblasts (proliferation) 
 Stimulate expression of IL-6 in fibroblasts 
 Inhibit elastin synthesis in fibroblasts 
 Stimulate native hyaluronan synthesis in fibroblasts 
 Induce tissue damage 
IL-1β Platelets Chemotactic to neutrophils and macrophages 
 Macrophages Activate macrophages 
  Stimulate expressions of TNF-α, IL-1β, IL-6 and IL-8 in macrophages 
  Mitogenic to fibroblasts (proliferation) 
  Inhibit collagen synthesis in fibroblasts 
  Inhibit elastin synthesis in fibroblasts  
  Stimulate native hyaluronan synthesis in fibroblasts 
IL-6 Macrophages 
Fibroblasts 
Chemotactic to neutrophils 
 Stimulate collagen synthesis in fibroblasts 
IL-8 Macrophages 
Fibroblasts 
Chemotactic to neutrophils 
 Inhibit collagen synthesis in fibroblasts 
IL-10 Macrophages Inhibit expression of TNF-α in neutrophils, macrophages and fibroblasts 
  Inhibit expression of IL-1β in macrophages 
  Inhibit expressions of IL-6 and IL-8 in macrophages and fibroblasts 
  Stimulate expression of TGF-β  in macrophages and fibroblasts 
  Stimulate expression of IL-10 in macrophages 
  Inhibit activated neutrophil survival 
  Inhibit activation of neutrophils and macrophages 
  (Cont’d on next page) 
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Substances Cell Sources Biological Functions in Wound Healing used in ABM 
MMP-8 Platelets 
Neutrophils 
Stimulate collagen degradation 
Collagen 
(type I) 
Fibroblasts Native collagen repairs tissue damage 
Collagen fragments are chemotactic to neutrophils and macrophages 
Elastin Fibroblasts Native elastin repairs tissue damage 
Elastin fragments are chemotactic to macrophages 
Hyaluronan Fibroblasts Native HA repairs tissue damage 
  Native HA inhibits expression of TNF-α and IL-8 in fibroblasts 
  Native HA inhibits collagen synthesis in fibroblasts 
  HA fragments stimulate expressions of TNF-α, IL-1β and IL-8 in 
macrophage 
  HA fragments are mitogenic to fibroblasts (proliferation) 
  HA fragments stimulate collagen synthesis in fibroblasts 
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5.1.1.7 Overview of ABM structures: regions, agents and patches 
A typical ABM is composed of three elements: region, agent and patch. The region is 
composed of small patches on which agents move and operate. Agents are “alive” objects that 
follow the rules programmed in ABM, whereas patches are immobile components that 
characterize the physical-spatial environment.  
ABM Structure: Regions 
In the present study, the ABM’s virtual “world” was a square grid, in the dimension of 
120 x 120 units. As shown in Figure 6, four regions were created to simulate (1) lumen, (2) 
epithelium, (3) capillaries and (4) the mucosal tissue itself. Specifically, the “world” represented 
the cross-sectional schematic view of a typical vocal fold at its midpoint. The two right-most 
regions of the world were lumen (height: 120 units; width: 20 units) and epithelium (height: 120 
units; width: 10 units). Next to the epithelium was the mucosal tissue region (height: 120 units; 
width: 90 units).  
In this model, four-capillary regions with a diameter of 9 units were created within the 
mucosal tissue region (yellow region in Figure 6). Platelets and inflammatory cells (neutrophils 
and macrophages) circulated within capillaries and migrated to the wounded mucosal tissue 
region upon injury. The mucosal tissue region was populated with sparse resident cells 
(macrophages and fibroblasts). The mucosal tissue region was the site where phonotraumatic 
injury occurred (native ECM breakdown) and was subsequently repaired by fibroblasts (neo-
ECM deposition). This specific ABM typology was consistent with existing research findings in 
vocal fold microarchitecture (see Appendix A for literature review). 
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Figure 6. The world of the new vocal fold ABM. Four compartments were designed in the model: (1) 
lumen (black); (2) epithelium (brown); (3) blood capillaries (red); and (4) mucosa (yellow). Inflammatory 
cells, namely, neutrophils (blue circles) and macrophages (brown circles), circulated within capillaries. 
Resident cells, including tissue macrophages (brown circles) and fibroblasts (white circles) were populated 
sparsely within the mucosal region. Native hyaluronan (light gray circles) was abundantly distributed 
throughout the mucosal area, whereas elastin (dark gray leaf shape) was randomly distributed in the mucosal 
area. A thin layer of collagen network (purple crosses) was attached immediately below the basement 
membrane zone (BMZ) between epithelium and mucosa.  
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ABM Structure: Agents 
Within the ABM framework, only the class of agents is mobile. In the expanded ABM, 
agent variables were used to represent (1) platelets, (2) cells (neutrophils, macrophages and 
fibroblasts), (3) native ECM substances (collagen type I, elastin and HA), (4) the ECM 
fragments induced by injury and inflammatory responses and (5) tissue damage. Platelets and 
cells (neutrophils, macrophages and fibroblasts) were represented as agents because (1) cells are 
mobile in biological nature, (2) they could be organized based on common behavioral rules, and 
(3) the response of a particular cell type to various mediators is readily characterized in the 
literature (An, 2004). In the ABM, cells had three states: resting, activated or dead. Depending 
on the cell type, the cellular responses included rest, activation, migration, proliferation, death, 
secreting inflammatory mediators and generating ECM substance (Table 2).  
Another class of agents was ECM substances, which are the major structural proteins in 
the vocal folds and their content and organization are prone to disturbance following 
phonotrauma or surgical trauma (Courey, Shohet, Scott, & Ossoff, 1996; Gray, Hammond, & 
Hanson, 1995; Hahn, Kobler, Zeitels, & Langer, 2006; Madruga de Melo et al., 2003; Neves, 
Neto, & Pontes, 2004; T. Tateya, Tateya, & Bless, 2006). The native form of matrices (collagen 
type I, elastin and HA) were modeled as agents. Each matrix substance had unique distribution 
and orientation within the vocal folds in the model, which were consistent with those reported in 
the vocal fold literature (Figure 6; Appendix A for relevant literature review). When the native 
form of matrices was degraded as fragments upon tissue injury or inflammation, these ECM 
fragments were modeled as another class of agents.  
ECM fragments have been reported to interact with various cell types at the site of 
inflammation and thus modulated inflammatory and healing processes (Gallucci & Matzinger, 
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2001; Girish & Kemparaju, 2007; D. Jiang et al., 2007; Lee & Spicer, 2000; Matzinger, 2002; 
Noble, 2002; O'Reilly et al., 2008; Stern et al., 2006). In the current ABM, the initial mechanical 
injury and the subsequent inflammatory response of the pro-inflammatory mediators and the 
collagenase broke down the native matrices into fragments, causing more tissue damage – yet 
another class of agents. Tissue damage itself acted as a stimulus for further inflammation in the 
model.  
ABM Structure: Patches 
In this ABM, patch variables were used to represent (1) tissue status (healthy, damaged, 
and healed); (2) inflammatory mediators (IL-1β, IL-6, IL-8, IL-10, TNF-α and MMP-8), and (3) 
growth factors (TGF-β1 and bFGF). Each patch was characterized by its instantaneous tissue 
status, as well as by the concentration of mediators and growth factors. When an agent moved 
onto a particular patch, all attributes of that patch would be accessed by the agent and the 
behavior of this agent would change according to algorithms (agent rules) programmed in the 
model. The complete rules of the ABM with explanations are described in Appendices E 
(Experiment 1: human acute phonotrauma ABM) and F (Experiment 2: animal surgical vocal 
fold trauma).   
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5.1.1.8 General logic flow of simulating acute phonotrauma  
The overall flowchart of the new ABM is depicted in Figure 7. In the model, the 
assumption was that one step of simulated time represented 0.5 hours. The changes in temporal 
concentration of platelets, cells, mediators, tissue damage and extracellular matrices were plotted 
and refolded into the model at each time step.  
 
 
Figure 7. Schematic depiction of (1) the theoretical modeling framework of acute vocal fold injury 
and repair, as well as (2) proposed effects of tissue mobilization (applied to Experiment 1 only) within this 
modeling framework. In general, initial phonotrauma or surgical injury leads to extracellular matrix (ECM) 
damage and activates platelets, neutrophils, macrophages and fibroblasts. Activated cells secrete an array of 
mediators (such as cytokines, growth factors and proteases), which in turn modulate cell functions (f(x)), 
including migration, proliferation, death, secretion of mediators and ECM substances. The specific cell 
source and functions of each mediator in the current ABM are described in Table 2. Tissue mobilization in 
phonation, namely, impact and vibratory stress, is proposed to perpetuate the injury and repair cascade by 
modulating circulating neutrophil counts in blood vessels and mediator expression in cells. Details about the 
effects of tissue mobilization are described in the text. 
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change in cell f(x)
Mediator-induced  
mediator secretion
Mediator-induced 
tissue damage
“ECM fragments”-induced  
change in cell f(x)
•Impact stress increases the 
number of circulating 
neutrophils and induces pro-
inflammatory mediator 
secretion.
•Vibratory stress induces anti-
inflammatory mediator 
secretion.
Migrate from 
blood to tissue
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In the initial setting of the model, circulatory neutrophils, circulatory macrophages and 
platelets were in the blood capillary region, whereas resident macrophages and fibroblasts were 
present with a random distribution within the tissue region. An initial mucosal injury (with 
magnitude as 20 for phonotrauma and 40 for surgical trauma) was simulated to traumatize the 
mucosal tissue in the middle of region, triggering platelet degranulation and native matrix 
substance degradation. Shortly afterwards, a chemoattractant gradient was created that stimulated 
the infiltration and activation of neutrophils and macrophages from blood capillaries. Shortly 
thereafter, resident macrophages and fibroblasts were activated by mediators and “alarm/ damage 
signals” (also known as “Damage-Associated Molecular Patterns” [DAMPs]) composed of ECM 
fragments. Activated neutrophils and macrophages secreted collagenase (MMP-8) and a pro-
inflammatory mediator (TNF-α) that further degraded the matrices, causing secondary tissue 
damage. Fibroblasts secreted extracellular matrices to repair both the initial and the 
inflammation-induced damage. This modeling wiring was applied for both human phonotrauma 
(Experiment 1) and animal surgical trauma (Experiment 2), except the initial setting of 
mucosal injury was different in magnitude between phonotrauma (magnitude = 20) and surgical 
trauma (magnitude = 40).  
In order to represent the acute phonotrauma study (Verdolini et al., in preparation), 
additional algorithms regarding biological effects of motion-based treatments were implemented 
in the human phonotrauma ABM. For each simulation, the user defined the initial levels of 
inflammatory mediators, added a phonotraumatic event and then a 4-hr motion-based treatment 
event (voice rest, resonant voice exercises or spontaneous speech). The user-defined initial 
magnitude of mucosal injury, which represented the phonotraumatic event, was set at a value of 
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20. The treatment event was represented by additional mechanical stress, specifically, impact 
stress and vibratory stress, applied to the traumatized mucosal tissue.  
The magnitude of mechanical stress for the treatment event was arbitrarily set as: no 
additional vibratory and impact stress for voice rest; intermediate vibratory stress and low impact 
stress for resonant voice; intermediate vibratory stress and intermediate impact stress for 
spontaneous speech (Table 3).  
Table 3. Magnitude of ABM-Simulated Phonatory Stress (range 0 – 10 in arbitrary units). 
Phonation Type Magnitude of Simulated Vibratory 
Stress (in arbitrary unit) 
Magnitude of Simulated Impact 
Stress (in arbitrary unit) 
Voice Rest 0 0 
Resonant Voice 10 5 
Spontaneous Speech 10 10 
 
In the current ABM, phonation-induced impact stress was constructed as “damaging 
stress”. This construct was gleaned from the literature in voice science and exercise physiology. 
First, impact stress between the vocal folds during phonation has been suggested to be 
destructive to vocal fold mucosal tissue and is regarded as a major causative factor of 
phonotraumatic lesions (F.G. Dikkers & Nikkels, 1995; Gray, 1989, 1997; Gray et al., 1995; 
Gunter, 2003, 2004; Jiang et al., 1998; I.R. Titze, 1994). Second, intense muscle loading from 
exercise has been found to induce an immediate “para-inflammatory” response, without 
necessary overt tissue injury. Circulating neutrophil counts and pro-inflammatory mediator 
levels have been found to increase after the onset of exercise and return to baseline quickly after 
exercise (Butterfield et al., 2006; Peake, Nosaka, & Suzuki, 2005; Toumi et al., 2006). In that 
light, the component of impact stress from the 4-hr treatment event was constructed in a similar 
way. Within the specific 4-hr treatment window, circulatory neutrophil counts and pro-
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inflammatory mediator (IL-1β and TNF-α) levels increased in different amounts, depending on 
the magnitude of impact stress generated from a particular treatment (Table 3).  
On the other hand, vibratory stress was considered stress arising from tissue stretching, 
which would cause vocal fold cell deformation. Vibratory stress was constructed as “healing 
stress”, which was linked to the functions of anti-inflammatory responses in the model. As for 
impact stress described above, this construct was based on the literature in voice science and 
exercise physiology. First, the effects of cyclic equibiaxial tensile strain (CTS) on rabbit vocal 
fold fibroblast cultures have been evaluated, in the presence or absence of IL-1β-induced 
inflammation (R. C. Branski et al., 2006). That in vitro study concluded that low magnitude and 
high frequency mobilization (6% CTS & 0.5 Hz) might assist in healing for acute vocal fold 
inflammation by attenuating pro-inflammatory mediator expressions. Second, researchers in 
exercise physiology have looked for an “exercise factor” that mediates the beneficial health 
effects of exercise. Among other cytokines (e.g., IL-1β, TNF-α etc.), IL-6 was identified as the 
“exercise factor” in muscle (Pedersen et al., 2003). Essentially, the level of IL-6 in circulation 
was zero during rest but had a rapid increase (about 100-fold) in response to exercise and 
decreased rapidly in the post-exercise period (Keller et al., 2001; Pedersen & Hoffman-Goetz, 
2000; Pedersen et al., 2003). Also, exercise-induced IL-6 was shown to have inhibitory effects 
on the expression of pro-inflammatory mediator IL-1β and TNF-α, while having stimulatory 
effects on the expression of anti-inflammatory IL-10 in exercised tissue (Gleeson, 2007; J. Peake 
et al., 2005; Petersen & Pedersen, 2005, 2006; Toumi et al., 2006; Woods, Vieira, & Keylock, 
2006). In that light, IL-6 was chosen as the “exercise mediator” of focus in the current ABM. 
The algorithm for the component of vibratory stress from the 4-hr tissue mobilization treatment 
was constructed in a way that IL-6 level increased in different amounts, depending on the 
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magnitude of simulated vibratory stress generated from a particular treatment (Table 3). Also, 
IL-6 was included in the inhibitory term for the functions of secreting pro-inflammatory 
mediator IL-1β and TNF-α, as well as in the stimulatory term for the functions of secreting anti-
inflammatory mediator IL-10, in order to mimic IL-6 functions of suppressing pro-inflammation 
and amplifying anti-inflammation reported in the exercise physiology literature (see Appendix E 
for the relevant ABM rules). 
5.1.1.9 Parameter estimation: iterative verification and calibration process  
Procedures for estimating the values of the model parameters generally replicated those 
from the published ABM (Section 4.2), with minor modifications (Figure 8). The modifications 
were involved in qualitative verification and calibration (describe shortly): (1) the initial 
magnitude of mucosal injury was set as 40 to represent surgical setting and (2) data were 
included from the literature on vocal fold wound healing following surgical trauma. 
Pattern-oriented analysis (Grimm et al., 2005; Railback, 2001) was used to estimate the 
conformity of simulation-generated data curves with empirical data. The model’s parameters 
were then calibrated iteratively until a match was generated between predicted and empirically 
obtained outcomes, as specified shortly. Two tiers of parameter estimation were involved. First, 
qualitative verification-calibration was carried out to compare the simulation curves with the 
general inflammatory and wound healing patterns reported in the literature for skin and vocal 
fold tissue across a roughly 2-week period. Then, quantitative verification calibration was 
carried out to compare the simulation curves with the empirical data of inflammatory mediators 
in laryngeal secretions from an acute phonotrauma study across a 4-hr period. Of note, not the 
structure of the model (i.e., components and rules) but only the values of the parameters were 
adjusted during the calibration process.  
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Figure 8. Iterative verification-calibration process in the new ABM. 
5.1.1.10 Qualitative verification-calibration of the model using literature data 
First, a qualitative verification was carried out to test whether the model reproduced the 
generally-accepted patterns of cellular and molecular responses according to the literature in 
surgical skin wound healing (Cockbill, 2002; Dechert, Ducale, Ward, & Yager, 2006; D. Jiang et 
al., 2007; P. Martin, 1997; Robson et al., 2001; Stern et al., 2006; Witte & Barbul, 1997) as well 
as in surgical vocal fold wound healing (I. Tateya et al., 2006; T. Tateya et al., 2005; T. Tateya, 
I. Tateya, J. H. Sohn et al., 2006) (Table 4). The user-defined initial magnitude of mucosal injury 
Initial Model
Qualitative Model 
Verification-Calibration 
A General Wound 
Healing Model
A Patient-Specific Acute 
Phonotrauma Model
Quantitative Model 
Verification-Calibration 
Initial Simulation 
Condition 
Model Verification- Calibration
• Initial levels of biomarkers: 0
•Initial magnitude of mucosal 
injury: 40
•No treatment
• General cellular and molecular 
patterns reported in the literature 
of skin and vocal fold wound healing 
(Table 4) (Cockbill, 2002; Dechert et al., 
2006; D. Jiang et al., 2007; Martin, 1997; 
Robson et al., 2001; Stern et al., 2006; I. 
Tateya et al., 2006; T. Tateya et al., 2005; T. 
Tateya, I. Tateya, J. H. Sohn et al., 2006; 
Witte & Barbul, 1997)
• Initial levels of biomarkers: 
individual-specific 
•Initial magnitude of mucosal 
injury: 20 
•A 4-hr treatment: Voice rest, 
resonant voice or spontaneous 
speech that the individual 
received in the acute 
phonotrauma study (Verodlini et 
al., in preparation)
• Empirical data of inflammatory 
mediators in laryngeal secretions 
obtained from an acute 
phonotrauma study (Verdolini et al., 
in preparation)
•Subjects 1-3
Model Validation • Same as Quantitative Model 
Verification-Calibration
Initial Simulation 
Condition 
Initial Simulation 
Condition 
Data Source Time Period
Model Verification- Calibration
Data Source Time Period
Model Validation
Data Source Time Period
• 24-hr time point• Same human phonotrauma study 
(Verdolini et al., in preparation) 
•Subjects 1-3
•Subjects 4-7
• 1-day up to 2-
week following 
insult
• Immediate post-
loading, after a 4-
hr treatment
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was first set at a value of 40 (range 0 – 40 in arbitrary units of damage), because that setting 
represented realistic predictions of massive mucosal damage and healing when compared with 
the general consensus around surgical wound healing documented in the literature. The pre-
traumatic values of inflammatory markers (IL-1β, IL-6, IL-8, IL-10, TNF-α and MMP-8) were 
set to zero. We then ran simulations to determine model outcomes and compared the model’s 
outputs with pre-specified patterns reported in the skin and vocal folds wound healing literature 
(Cockbill, 2002; Dechert et al., 2006; D. Jiang et al., 2007; P. Martin, 1997; Robson et al., 2001; 
Stern et al., 2006; I. Tateya et al., 2006; T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et 
al., 2006; Witte & Barbul, 1997) (Table 4). If the model-generated and empirical curves failed to 
match, the model’s parameters were adjusted iteratively to produce a better qualitative match.  
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Table 4. Patterns Used for the Human Phonotrauma ABM in the “Comparison Condition”, i.e., the 
Condition with High Magnitude of Initial Mucosal Injury Input. 
Validation Patterns Source 
Neutrophils arrive at the wound site in the first few 
hours 
(Cockbill, 2002; P. Martin, 1997; 
Robson et al., 2001; Witte & Barbul, 
1997) 
Neutrophil number is at maximum by Day 1-2 (Cockbill, 2002; P. Martin, 1997; 
Robson et al., 2001; Witte & Barbul, 
1997) 
Neutrophil number decreases rapidly around Day 3-4 (Cockbill, 2002; P. Martin, 1997; 
Robson et al., 2001; Witte & Barbul, 
1997) 
Macrophage number is at maximum by Day 2-4 (Cockbill, 2002; P. Martin, 1997; 
Robson et al., 2001; Witte & Barbul, 
1997) 
Fibroblasts start proliferation at Day 1. (I. Tateya et al., 2006)  
Fibroblast number decreases significantly at Day 7 and 
stays low until Day 14. 
(Cockbill, 2002; P. Martin, 1997; 
Robson et al., 2001; I. Tateya et al., 
2006; Witte & Barbul, 1997) 
Hyaluronan is first seen on Day 3 and peaks at Day 5, 
starts to drop significantly at Day 7 and then remains 
at a low level until Day 14. 
(Dechert et al., 2006; D. Jiang et al., 
2007; I. Tateya et al., 2006; T. Tateya 
et al., 2005) 
 (Cont’d on next page) 
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Validation Patterns Source 
The peak of accumulated hyaluronan content occurs at 
the same time as the peak of inflammatory cells 
(neutrophils and macrophages) 
(D. Jiang et al., 2007; Stern et al., 2006) 
Hyaluronan level is generally lower than for uninjured 
vocal folds following injury throughout the healing 
period.  
(I. Tateya et al., 2006; T. Tateya et al., 
2005) 
Collagen type I curve is sigmoid-shaped (Robson et al., 2001; Witte & Barbul, 
1997) 
Collagen type I is first seen on Day 3, peaks at Day 5. (I. Tateya et al., 2006; T. Tateya et al., 
2005) 
Collagen type I level was generally higher than for 
uninjured vocal folds following injury throughout the 
healing period. 
(I. Tateya et al., 2006; T. Tateya et al., 
2005) 
5.1.1.11 Quantitative verification-calibration of the model using empirical 
inflammatory mediator data from laryngeal secretions 
When the qualitative behavior of the simulation appeared satisfactory, quantitative 
verification-calibration of the model was carried out by adjusting parameter values not found in 
the literature to fit the quantity and time-course of measured vocal fold mediators in laryngeal 
secretions. The user-defined initial magnitude of mucosal injury decreased from 40 to 20, 
because that setting represented smaller mucosal damage and healing in phonotrauma when 
compared with the setting of surgical trauma as 40 used in qualitative verification-calibration. 
Also, the magnitude of mechanical stress ensued from the vocal loading task in the acute 
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phonotrauma study (Verdolini et al., in preparation) was expected not as vigorous as those loud 
voice use in real life, such as cheering in football games. The initial inflammatory marker profile 
(IL-1β, IL-6, IL-8, IL-10, TNF-α and MMP-8) and the simulated treatment event (voice rest, 
resonant voice exercises or spontaneous speech) were individual-specific, based on values 
obtained in the acute phonotrauma study (Verdolini et al., in preparation).   
Specifically, we ran simulations for three subjects (Subjects 1 – 3), using their baseline 
inflammatory marker levels in laryngeal fluid as initial inputs for the model, added a 
phonotraumatic event and then a 4-hr treatment event (Subject 1: voice rest, Subject 2: resonant 
voice; Subject 3: voice rest, resonant voice and spontaneous speech). Subsequently, simulation 
outputs for each inflammatory marker (IL-1β, IL-6, IL-8, IL-10, TNF-α and MMP-8) for each 
subject were compared with those of the empirical data at two time points: immediately after 
phonotrauma induction and following a 4-hr treatment (Verdolini et al., in preparation). If the 
model-predicted and empirical data did not match, the parameter values were calibrated 
iteratively to optimize the model’s prediction of inflammatory markers. The quantitative 
verification-calibration iterative process was continued until the model eventually yielded a 
satisfactory match between simulation data and empirical data, based on subjective judgment. 
5.1.1.12 Model validation: evaluating the model’s prediction accuracy of 
inflammatory marker outputs  
Following both qualitative and quantitative verification-calibration, the model was tested 
for its accuracy in predicting individual-specific biomarker levels at a 24-hr time point. The user 
input each individual’s baseline biomarker levels (IL-1β, IL-6, IL-8, IL-10, TNF-α and MMP-8), 
added a phonotraumatic event (initial magnitude of mucosal injury = 20), and then a 4-hr 
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treatment event (voice rest, resonant voice exercises or spontaneous speech), as previously. Due 
to the inherent stochasticity of the ABM framework, the ABM was run 100 times for each 
subject of the full subject cohort (Subjects 1 – 7), i.e., 900 runs (+700 runs from 7 between-group 
subjects, each with 100 runs; + 300 runs from 1 within-group subject – Subject 3 – who received 
each of the treatments ; -100 runs to account for double-counting the “spontaneous” treatment for 
Subject 3 in both between- and within-group measurements; thus 900 different runs in total) in 
order to generate representative population data for the following statistical analysis (Kim, 
personal communication).  
The ABM was statistically evaluated by comparing the predicted inflammatory marker 
levels (IL-1β, IL-6, IL-8, IL-10, TNF-α and MMP-8) with the empirical inflammatory marker 
levels at 24 hr (1) for Subjects 1, 2 and 3 – in which the first three time points of inflammatory 
marker data were used for model calibration as well as (2) the remaining Subjects 4 – 7 – none of 
whose the inflammatory marker data were used for model calibration. Specifically, the ABM for 
Subjects 1 – 3 was run to determine how well the model predicted results for other individuals, 
i.e., Subjects 4 – 7 by inputting individual baseline biomarker levels and mode of treatment. A 
95% confidence interval was computed as follows: for each inflammatory marker for each 
subject at the 24-hr time point from the simulation runs, i.e., 54 confidence intervals were 
generated (+42 mediator measurements from 7 between-group subjects, each with one of the 3 
different treatments; +18 mediator measurements from one within-group subject—Subject 3 – 
who received each of the treatments; -6 mediator measurements to account for double-counting 
the “spontaneous speech” treatment for Subject 3 in both between- and within-group 
measurements; hence 54 different mediator measurements in total). 
Confidence interval = 





±
n
zX ó*  
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X = Mean of a predicted inflammatory marker level  
 z = The value on the standard normal curve with area (1-α) between –z and z 
σ  = Standard deviation of a predicted inflammatory marker level 
n  = Number of simulation run 
If the empirical result for a given marker fell within the 95% confidence interval (α = 5% 
= 0.05; z = 1.96) from the simulation runs, the conclusion was that the model was generally 
adequate to predict the empirically obtained levels of the inflammatory marker. We expected that 
the model would have better accuracy in predicting the inflammatory marker levels for Subjects 
1 – 3 than for Subjects 4 – 7 in general. We did not adjust for alpha inflation in this series 
because we opted to protect from Type II (β) error more than Type I (α) error, at this early stage 
of inquiry in attempting to predict patient-specific biological responses following phonotrauma 
(Kim, personal communication).   
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5.1.2 EXPERIMENT 2 (SPECIFIC AIM 2) 
5.1.2.1 Purposes 
The purpose of Experiment 2 was to generate an animal surgical trauma agent-based 
model (ABM) in parallel to the human phonotrauma ABM from Specific Aim 1, using published 
rat mRNA data, and assess the models’ prediction accuracy for the inflammatory markers (IL-1β, 
TNF-α, TGF-β1) and the matrix markers (procollagen subtype I, elastin synthase and hyaluronan 
synthase-2 (HAS-2)) at a 72-hr post injury time point. The success of this work would aid in 
encoding the inflammatory mediator response for its tissue-level manifestations in injured tissue, 
allowing predictions of acute vocal fold tissue status in silico and ultimately advancing 
understanding of inflammation and healing in a clinically useful way. 
5.1.2.2 Hypotheses 
 
H0: The empirical inflammatory marker data (IL-1β, TNF-α, TGF-β1) and the matrix marker 
data (procollagen subtype I, elastin synthase and HAS-2) will not be within the 95% confidence 
interval for the simulated population mean at the 72-hr post surgery baseline time point. 
H1: The empirical inflammatory marker data (IL-1β, TNF-α, TGF-β1) and the matrix marker 
data (procollagen subtype I, elastin synthase and HAS-2) will be within the 95% confidence 
interval for the simulated population mean at the 72-hr post surgery baseline time point. 
5.1.2.3 Equipment and software 
The same equipment and software was used as for Experiment 1. To reiterate, the 
freeware Netlogo 4.0.3 (Center for Connected Learning and Computer-Based Modeling, 
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Northwestern University, Evanston, IL) was used as the platform for model building and 
simulation. Statistical software, SPSS 15.0 (SPSS Inc., Chicago, IL, USAU), was used for 
statistical inspection of the empirical data and statistical evaluation of the ABMs’ prediction 
accuracy. 
5.1.2.4 Literature on animal surgical trauma in vocal fold mucosa 
Studies of rat vocal folds were used for model calibration and validation because these 
data were the most comprehensive among the animal species in terms of (1) the wide spread of 
time points following injury and (2) the relatively complete profiles of the changes in 
inflammatory mediators and ECM substances following injury (Lim et al., 2006; I. Tateya et al., 
2006; T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et al., 2006; Welham et al., 2008). 
Table 5 summarizes the methods and the major findings from these studies and Figure 9 
summarizes the changes in the extracellular matrix components in rats from the histological 
studies (T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et al., 2006). It turned out that the 
animal surgical protocols were nearly identical across the studies. In brief, Sprague-Dawley male 
rats (4 to 6 months old) were used in all studies. Except for the single cellular study (I. Tateya et 
al., 2006) which made an incision in the mid-third portion of membranous vocal folds in the 
transverse direction,  all other studies using the same approach to create vocal fold injuries.  
Specifically, injuries were induced using a 25-gauge needle and microforceps to strip the vocal 
folds until the thyroarytenoid muscle was exposed. All laryngeal specimens were harvested and 
stored in the same manner following injury. Real-time reverse transcription-polymerase chain 
reactions were used to measure in vivo messenger RNA (mRNA) for the expressions of 
inflammatory mediators and ECM substances. 
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Table 5. Summary of Rat Vocal Fold Scarring Studies.  H&E = hematocylin and eosin; RT-PCR = reverse transcription-polymerase chain 
reaction; mRNA = messenger ribonucleic acid; IL = interleukin; IFN-γ = interferon gamma, TNF-α = tumor necrosis factor alpha; NF-κβ = nuclear 
factor kappa beta; TGF-β1= transforming growth factor beta isoform 1; COX-2 = cyclooxygenase 2; HAS= hyaluronic acid synthase; HA= hyaluronan.  
Studies Animals Methods Biological Analysis Major Findings 
(T. Tateya et 
al., 2005) 
30 Sprague-
Dawley male 
rats (4 to 6 
months old) 
• Injuries were performed by 
vocal fold stripping with a 25-
gauge needle and 
microforceps. 
• Larynges were harvested at 4 
time points post injury:  2, 4, 8 
and 12 weeks. 
• Vocal folds were sectioned at 
10 μm in the axial or coronal 
plane with a cryostat. 
• Hyaluronidase 
digestion technique 
followed by alcian blue 
staining was performed 
for HA 
• Masson’s trichrome 
staining was performed 
for collagen 
• Immunohistochemical 
staining was performed 
for (1) collagen type I, 
(2) collagen type III and 
(3) fibronectin. 
• Collagen type III expression was constantly high for 
the 12 weeks, whereas collagen type I expression 
reduced from Week 2 until 8 and then stabilized until 
Week 12.  
• The total collagen level (type I plus type III) peaked at 
Weeks 2 and 4 and then declined and became stable 
from Weeks 8 to 12. 
• HA density remained significantly lower than control 
levels at all time points in the experiment. 
• The level of fibronectin peaked at Week 2, remained 
high at Week 4, and started to decrease from Week 8 
until Week 12. At the end point of the study (i.e., 
Week 12), the concentration of fibronectin was 
slightly control concentrations. 
(T. Tateya, 
I. Tateya, J. 
H. Sohn et 
al., 2006) 
27 Sprague-
Dawley male 
rats (4 to 6 
months old) 
• Injuries were performed by 
vocal fold stripping with a 25-
gauge needle and 
microforceps. 
• Larynges were harvested at 5 
time points post injury:  1, 3, 
5, 7 and 14 days. 
• Vocal folds were sectioned at 
10 μm in the axial or coronal 
plane with a cryostat. 
• Hyaluronidase 
digestion technique 
followed by alcian blue 
staining was performed 
for HA. 
• Masson’s trichrome 
staining was performed 
for collagen. 
• Immunohistochemical 
staining was performed 
for (1) collagen type I, 
(2) collagen type III and 
(3) fibronectin. 
• Collagen type I was present on Day 3, peaked at Day 
5, decreased significantly from Day 5 to Day 7 and 
was then stabilized until Day 14. 
• Collagen type III expression was present on Day 1 and 
increased and remained intense from Day 3 to 14.  
• HA was first seen on Day 3, peaked at Day 5, dropped 
significantly at Day 7 and then remained at a low level 
until Day 14. 
• Fibronectin deposition was first seen on day 1 and 
remained at high levels until Day 14.  
(Cont’d on next page) 
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Studies Animals Methods Biological Analysis Major Findings 
(I. Tateya 
et al., 
2006) 
24 Sprague-
Dawley male 
rats (4 to 6 
months old) 
• Injuries were performed by 
making a transverse incision 
on the vocal fold at the mid-
third of the epithelium and 
lamina propria down to the 
thyroarytenoid muscle. 
• Immunohistochemical 
staining was performed 
for (1) vimentin, a 
marker for fibroblasts; 
(2) alpha-smooth 
muscle actin, a marker 
for myofibroblasts; (3) 
CD68, a marker for 
macrophages and (4) 5-
bromo-2-deoxyuridine, 
a marker for newly 
proliferated cells at four 
time points: Day 1, 3, 5 
and 14 postoperatively. 
• On Day 1 post injury, epithelization and fibroblast 
proliferation started. 
• On Day 3 post injury, the proliferation of fibroblasts 
in the lamina propria was at peak.  
• On Day 7, the total number of cells decreased about 
33-fold and stayed low until the endpoint of the 
experiment at Day 14 post injury. 
• Myofibroblasts and macrophages were found to 
minimally proliferate at all time points. 
(Lim et 
al., 2006) 
30 Sprague-
Dawley male 
rats (4 to 6 
months old) 
• Injuries were performed by 
vocal fold stripping with a 25-
gauge needle and 
microforceps. 
• Larynges were harvested at 5 
time points post injury: 4, 8, 
16, 24 and 72 hours. 
• Vocal folds were sectioned at 
60 μm in the axial plane for 
mRNA analysis with a 
cryostat. 
• Lamina propria was dissected 
from each section using 30-
gauge needles. 
• Real time RT-PCR was 
used for mRNA 
analysis for IL-1β, IFN-
γ, TNF-α, NF-κβ, TGF-
β1, COX-2, HAS-1, 
HAS2, procollagen type 
I, procollagen type 3, 
elastin, and β2-
microglobuin (as 
housekeeping gene). 
• Compared to the control vocal fold, IL-1β, NF-κB, 
TNF-α and HAS-1 had peak expressions at 4 and 8 
hours. From 8 to 16 hours, procollagen type III 
expression decreased. At 16 hours, HAS-2 peaked. At 
24 hours, IFN-γ expression decreased. At 72 hours, 
TGF-β, HAS-2, procollagen I and procollagen III 
expressions were all at peak.  
• For all time points, COX-2 expressions were 
significantly higher than for control tissue, whereas 
elastin expressions were similar to the expression 
levels of the controls. 
 
(Cont’d on next page) 
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Studies Animals Methods Biological Analysis Major Findings 
(Welham 
et al., 
2008) 
11 Sprague-
Dawley male 
rates (4 to 6 
months old) 
• Injuries were performed by 
vocal fold stripping with a 25-
gauge needle and 
microforceps. 
• Larynges were harvested 1-hr 
post injury 
• Vocal folds were sectioned (1) 
at 60 μm in the axial plane (for 
mRNA analysis) or (2) at 5 
μm in the coronal plane (for 
histological analysis) with a 
cryostat. 
• Lamina propria was dissected 
from each section using 30-
gauge needles. 
• H&E staining was used 
for histological 
analysis. 
• Real time RT-PCR was 
used for mRNA 
analysis of IL-1β, IFN-
γ, TNF-α, NF-κβ, TGF-
β1, COX-2, HAS-1, 
HAS2, procollagen type 
I, procollagen type 3, 
elastin, and β2-
microglobuin (as 
housekeeping gene). 
• Subepithelial bleeding was seen throughout the 
injured vocal folds.  
• mRNA expressions of IL-1β, TNF-α,  COX-2, HAS-1 
in the injured vocal folds were significantly up-
regulated at 1-hr post injury, compared to the 
uninjured control tissue. 
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Figure 9. Schematic representation of collagen, collagen type I, collagen type III, fibronectin and 
hyaluronan in injured rat vocal folds.  
5.1.2.5 Empirical rat mRNA tissue data used for animal surgical trauma model 
Empirical mRNA tissue data from two published rat vocal fold injury papers (Lim et al., 
2006; Welham et al., 2008) were used for model calibration and evaluation in this experiment. 
Research protocols of these two papers are summarized in Table 5. In brief, the materials and 
methods used in terms of animal surgical procedures, tissue preparation, mRNA analysis and 
statistical analysis, were reported as identical in these two papers. 
Rat vocal fold scarring
Day 3 Day 5 Day 7 Day 14 Week 4 Month 2 Month 3
Collagen (Tateya et al., 2005, 2006) Collagen I (Tateya et al., 2005, 2006) Collagen III (Tateya et al., 2005, 2006)
Fibronectin (Tateya et al., 2005, 2006) Hyaluronan (Tateya et al., 2005,2006)
CONTROL LEVEL
INCREASED DEPOSITION
DECREASED DEPOSITION
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In these two rat papers, the mRNA levels were expressed as the ratio of target gene 
concentration to housekeeping gene β-2MG in a natural logarithmic (ln) scale. Mathematically, 
the ln scale can only be defined for positive real numbers or non-zero complex numbers. 
However, from the practical consideration of modeling, we could not exclude the case that zero 
values would be predicted by the ABM, i.e., no mRNA expression for a particular marker. In that 
case, an error output would be returned if a natural logarithmic scale was used in the model. 
Thus, the first authors (Lim and Welham) from the two rat vocal fold papers were contacted. The 
authors graciously agreed to provide individual ln-transformed data and thus we could “un-
transform” the ln data to actual data for our modeling purposes.  
Following data “un-transformation”, inspection of the empirical rat mRNA data was 
carried out to derive the cleanest data for the development of the animal surgical ABM. 
Inspection was carried out using the SPSS 15.0 statistical program for each marker at each time 
point.  Individual data showing more than 3 times the interquartile range (i.e., the difference 
between the 75th percentile and the 25th percentile) were regarded as “extremes”. “Extremes” 
were excluded from the data pool for subsequent model calibration and evaluation.  
In this experiment, the ABM was based on the animal mRNA data. One might question 
the correspondence of the interested studied biomarkers in mRNA levels and protein levels. We 
acknowledged that from the detection of mRNA to the inference of how that mRNA eventually 
leads to a functional protein, several steps are involved, namely, mRNA transcription, mRNA 
stability, mRNA translation and finally protein stability. The question would be answered easily 
if the correspondence between mRNA levels and protein levels for our target biomarkers in vocal 
folds was known in the literature. Unfortunately, after an exhaustive literature search, only one 
published report (S.L. Thibeault, Gray, Li et al., 2002) and one conference paper (I. Tateya, 
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Tateya, & Bless, 2004)  existed that linked the mRNA data to the corresponding protein data in 
the setting of the vocal folds.  
Thibeault and her group used reverse transcriptase-polymerase chain reaction 
amplification (RT-PCR) to measure mRNA expressions and used Western blot analysis to study 
protein expressions for two matrix markers,  fibronectin and collagen type I, in five samples of 
vocal fold polyps. The researchers concluded that the changes in protein levels were parallel to 
those in their mRNA levels for these two matrix markers. In Tateya et al.’s conference paper 
(2004), 38 male rats’ unilateral vocal folds were injured by using the mucosal stripping method. 
The researchers used RT-PCR to study mRNA expressions for two HASs (HAS-1 and HAS-2), 
which are the enzyme of HA synthesis. Also, histological analysis was used to detect the 
presence of HA in the vocal folds. Both HASs and HA in the new granulation tissue were 
notably present at Day 3 after surgery. These results suggested that the induction of HASs gene 
and HA protein were temporally consistent in injured rat vocal folds. Although the existing data 
of mRNA and protein correspondence in the vocal fold setting are not ample, the results from 
these two studies seemed to point to a direction indicating mRNA expressions for matrix markers 
were quite consistent with their corresponding protein levels or functional activities in the 
environment of the vocal folds.  
Given these observations, we assumed that the protein expression would follow 
immediately after the mRNA expression in the current model. Specifically, mRNAs of 
procollagen subtype I (precursor of collagen type I), elastin synthase (enzyme for elastin 
synthesis) and HAS-2 (enzyme for HA synthesis) would led to functional proteins of collagen 
type I, elastin and HA respectively. Of note, mRNA expression profiles of two HASs, HAS-1 
and HAS-2, were studied in the rat papers (Lim et al., 2006; Welham et al., 2008). These two 
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enzymes were suggested to share similar induction pathways in rat vocal fold fibroblast cultures 
(Lim, Bless, Munoz-Del-Rio, & Welham, 2008). At the same time, only HAS-2 showed 
consistent temporal mRNA profiles, namely, peak expressions at Day 3 post surgical injury, 
across two independent in vivo rat vocal fold studies (I. Tateya et al., 2004; Welham et al., 2008). 
Therefore, HAS-2 was selected as the mRNA marker for HA in the animal surgical ABM herein. 
5.1.2.6 Model building and quantitative verification-calibration 
The animal surgical ABM had the identical model structure and components as the 
human phonotrauma ABM developed in Experiment 1. The method of model verification-
calibration and evaluation was essentially the same as in Experiment 1 but the data used for 
calibration and evaluation were changed from human secretion data to rat tissue data. As 
qualitative verification-calibration was already completed in Experiment 1, we proceeded to 
quantitatively calibrate the model by comparing the model outputs with experimental data (Lim 
et al., 2006; Welham et al., 2008). Then, the model’s accuracy in predicting the empirical 
inflammatory markers and matrix markers at 72 hr following surgery was evaluated.  
First, we calibrated the model’s behavior by adjusting parameter values to fit the quantity 
and time-course of measured mRNA levels of vocal fold mediators and ECM products in the 
surgery-traumatic tissue (Lim et al., 2006; Welham et al., 2008). Apart from individual-specific 
simulations in Experiment 1, average trends for the rat population were of interest in 
Experiment 2. We then ran simulations for the rat population up to 24 hr following surgery -- 
input the average baseline mRNA levels of mediators (IL-1β, TNF-α, TGF-β1) and matrices 
(procollagen subtype I, elastin synthase and HAS-2s) in rat laryngeal tissue (Lim et al., 2006; 
Welham et al., 2008) and then add a surgical trauma event.  
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The initial magnitude of mucosal injury, which denoted the surgical trauma event, was 
set at a value of 40 (range 0 – 40 in arbitrary units of damage), which represented a realistic 
prediction of mucosal damage and healing of high magnitude of surgical trauma. Simulation 
outputs for each inflammatory marker (IL-1β, TNF-α, TGF-β1) and matrix (procollagen subtype 
I, elastin synthase and HAS-2) in laryngeal tissue for the rat population were compared with 
those of the empirical data across 5 time points: 1hr, 4hr, 8hr, 16hr and 24hr following surgery  
(Lim et al., 2006; Welham et al., 2008). The model parameter values were iteratively adjusted to 
achieve optimal fit to the empirical laryngeal mRNA data. The quantitative verification-
calibration iterative process was continued until the model eventually yielded a satisfactory 
match between simulation data and empirical data, based on subjective judgment. 
5.1.2.7 Model evaluation 
Following quantitative verification-calibration, the calibrated ABM was tested for its 
accuracy in predicting population-trend mRNA levels of mediators and matrices at the 72-hr 
time point (Welham et al., 2008). The method of model evaluation was the same as for 
Experiment 1 but the context was surgical trauma.  
The user input the population’s baseline levels of IL-1β, TNF-α, TGF-β1, procollagen 
subtype I, elastin synthase and HAS-2, and then added a surgical trauma event (the initial 
magnitude of mucosal injury = 40). The ABM was run 100 times up to five simulated days 
following surgery, in order to generate a representative data pool for the following statistical 
analysis (Kim, personal communication).  
Subsequently, the ABM was statistically evaluated by comparing the predicted the levels 
of each inflammatory marker and matrix marker with the corresponding marker levels at 72 hr 
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for the rat population as a whole. A 95% confidence interval was computed for each marker, i.e., 
6 confidence intervals in total (6 markers: IL-1β, TNF-α, TGF-β1, procollagen subtype I, elastin 
synthase and HAS-2) at the 72-hr time point from the simulation runs: 
Confidence interval = 





±
n
zX ó*  
X = Mean of a predicted biomarker level  
 z = The value on the standard normal curve with area (1-α) between –z and z 
σ  = Standard deviation of a predicted marker level 
n  = Number of simulation runs 
 
If the empirical result for a given marker fell within the 95% confidence interval from the 
simulation runs, the model was considered adequate to predict the levels of markers seen in the 
empirical experiment. As for Experiment 1, unadjusted alpha levels were used because we 
opted to protect from Type II (β) error more than Type I (α) error at this early stage of inquiry in 
predicting biological responses following surgical trauma to rat vocal folds. 
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6.0  RESULTS 
6.1 QUALITATIVE VERIFICATION OF THE ABM 
The new ABM was evaluated to determine if it reproduced generally recognized patterns of 
cellular and molecular responses according to the literature in surgical skin wound healing 
(Cockbill, 2002; Dechert et al., 2006; D. Jiang et al., 2007; P. Martin, 1997; Robson et al., 2001; 
Stern et al., 2006; Witte & Barbul, 1997) as well as in surgical vocal fold wound healing (I. 
Tateya et al., 2006; T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et al., 2006) (Table 5 
in Section 5.1.2.4). Simulations under high magnitude of initial injury input (setting = 40) were 
run up to 14 simulated days. Figures 10 – 12 show representative ABM simulations of cells, HA 
and collagen after qualitative verification-calibration. The simulated cellular and ECM dynamics 
from this general wound healing model showed good concordance with wound healing patterns 
reported in the literature (Table 4 in Section 5.1.1.10). This qualitatively calibrated ABM was 
then specified to the human phonotrauma ABM (Experiment 1) and animal surgical ABM 
(Experiment 2) through the process of quantitative model verification-calibration using laryngeal 
secretion data and tissue mRNA data respectively (Figure 8 in Section 5.1.1.9).  
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Figure 10. Representative ABM simulation results after qualitative verification-calibration of the 
model. The dynamics of activated cells (neutrophils, macrophages and fibroblasts) were consistent with the 
literature on surgical skin and vocal fold wound healing (in boxes; refer to Table 4 in Section 5.1.1.10 for the 
complete list of validation patterns) up to 14 simulated days. 
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Figure 11. Representative ABM simulation results after qualitative verification-calibration of the 
model. The dynamics for hyaluronan were in concordance with the literature on surgical skin and vocal fold 
wound healing (in boxes; refer to Table 4 in Section 5.1.1.10 for the complete list of validation patterns) up to 
14 simulated days. 
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Figure 12. Representative ABM simulation results after qualitative verification-calibration of the 
model. The dynamics for collagen were in concordance with the literature on surgical skin and vocal fold 
wound healing (in boxes; refer to Table 4 in Section 5.1.1.10 for the complete list of validation patterns) up to 
14 simulated days 
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6.2 EXPERIMENT 1: QUANTITATIVE CALIBRATION OF THE ABM 
PREDICTING HEALING OUTCOMES FOLLOWING HUMAN PHONOTRAUMA 
Following qualitative verification-calibration of the model, the ABM was quantitatively 
calibrated using mediator levels in laryngeal mucosal secretion at baseline, immediately after 
phonotrauma induction, and following a 4-hr treatment (voice rest, resonant voice exercises, or 
spontaneous speech) from Subjects 1 – 3 (Figures 13 – 17, dark circles) (Verdolini et al., in 
preparation). Of note, Subject 3 was the within-group subject who had participated in all three 
treatments. The calibrated ABM was run 100 times for each subject to generate individual-
specific predictions of mediator level for the full cohort of 7 subjects up to three days following 
phonotrauma and treatment. The ABM for Subjects 1 – 3 was run to determine how well the 
model predicted results for Subjects 4 – 7 by inputting individual-specific baseline biomarker 
levels and mode of treatments. For each mediator, the model’s prediction accuracy was evaluated 
against the criterion of whether the empirical mediator level at 24 hrs fell within a 95% 
confidence interval for the mean of model predictions, in Subjects 1 – 3 (Figures 13 – 17, empty 
circles) and Subjects 4 – 7 (Table 6).  
Although the same ABM for Subjects 1 – 3 was used to predict results for Subjects 4 – 7, 
the model inputs, i.e., the baselines of inflammatory mediators, were individual-specific. That is, 
empirical data from Subjects 4 – 7 were used for model input (baseline) for the simulation of 
Subjects 4 – 7. Also, the empirical data for validating the model’s outputs at 24-hr time point 
were individual-specific. That is, empirical data for Subjects 1 – 7 were used to compare the 
model’s predicted outputs for Subjects 1 – 7 respectively. The only difference between the 
simulations of Subjects 1 – 3 and Subjects 4 –7 was at the level of model calibration. Empirical 
data at immediate post-loading and after a 4-hr treatment from Subjects 1 – 3 were used for 
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estimating parameter values during model calibration, whereas none of the empirical data from 
Subjects 4 – 6 were used in this regard (c.f. Figure 8 in Section 5.1.1.9 for the procedures of the 
iterative verification-calibration process). 
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Figure 13. Predictions of inflammatory and wound healing responses to acute phonotrauma in the 
between-group Subject 1 following a 4-hr voice rest treatment. Panels A – C are the predicted mediator 
trajectories for IL-1β, TNF-α and IL-10, which were included in the published ABM (N. Y. Li et al., 2008). 
Panels D – F are the predicted mediator trajectories for IL-6, IL-8 and MMP-8, which were the additional 
mediators in the current study.  Inflammatory marker concentrations are in pg/ml. The grey bars represent 
the mean of the simulated data, and the error bars represent 95% confidence intervals in the simulated data. 
The dark circles represent the input data for the first three time points (baseline, post-loading, 4-hr post 
treatment), obtained from human laryngeal secretion data. The empty circles represent the validation data at 
the 24-hr time point from the human laryngeal secretion data. B: baseline; PL: post vocal loading; 4hrPRx: 
following a 4-hr treatment. Note that human validation data for Days 2 – 3 have not yet been generated. 
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Figure 14. Predictions of inflammatory and wound healing responses to acute phonotrauma in the 
between-group Subject 2 following a 4-hr resonant voice treatment. Panels A – C are the predicted mediator 
trajectories for IL-1β, TNF-α and IL-10, which were included in the published ABM (N. Y. Li et al., 2008). 
Panels D – F are the predicted mediator trajectories for IL-6, IL-8 and MMP-8, which were the additional 
mediators in the current study.  Inflammatory marker concentrations are in pg/ml. The grey bars represent 
the mean of the simulated data, and the error bars represent 95% confidence intervals in the simulated data. 
The dark circles represent the input data for the first three time points (baseline, post-loading, 4-hr post 
treatment), obtained from human laryngeal secretion data. The empty circles represent the validation data at 
the 24-hr time point from the human laryngeal secretion data. B: baseline; PL: post vocal loading; 4hrPRx: 
following a 4-hr treatment. Note that human validation data for Days 2 – 3 have not yet been generated. 
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Figure 15. Predictions of inflammatory and wound healing responses to acute phonotrauma in the 
single within-group Subject 3 following a 4-hr spontaneous speech treatment. Panels A – C are the predicted 
mediator trajectories for IL-1β, TNF-α and IL-10, which were included in the published ABM (N. Y. Li et al., 
2008). Panels D – F are the predicted mediator trajectories for IL-6, IL-8 and MMP-8, which were the 
additional mediators in the current study.  Inflammatory marker concentrations are in pg/ml. The grey bars 
represent the mean of the simulated data, and the error bars represent 95% confidence intervals in the 
simulated data. The dark circles represent the input data for the first three time points (baseline, post-
loading, 4-hr post treatment), obtained from human laryngeal secretion data. The empty circles represent the 
validation data at the 24-hr time point from the human laryngeal secretion data. B: baseline; PL: post vocal 
loading; 4hrPRx: following a 4-hr treatment. Note that human validation data for Days 2 – 3 have not yet 
been generated. 
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Figure 16. Predictions of inflammatory and wound healing responses to acute phonotrauma in the 
single within-group Subject 3 following a 4-hr voice rest treatment. Panels A – C are the predicted mediator 
trajectories for IL-1β, TNF-α and IL-10, which were included in the published ABM (N. Y. Li et al., 2008). 
Panels D – F are the predicted mediator trajectories of IL-6, IL-8 and MMP-8, which were the additional 
mediators in the current study.  Inflammatory marker concentrations are in pg/ml. The grey bars represent 
the mean of the simulated data, and the error bars represent 95% confidence intervals in the simulated data. 
The dark circles represent the input data of the first three time points (baseline, post-loading, 4-hr post 
treatment), obtained from human laryngeal secretion data. The empty circles represent the validation data at 
the 24-hr time point from the human laryngeal secretion data. B: baseline; PL: post vocal loading; 4hrPRx: 
following a 4-hr treatment. Note that human validation data for Days 2 – 3 have not yet been generated. 
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Figure 17. Predictions of inflammatory and wound healing responses to acute phonotrauma in the 
single within-group Subject 3 following a 4-hr resonant voice treatment. Panels A – C are the predicted 
mediator trajectories for IL-1β, TNF-α and IL-10, which were included in the published ABM (N. Y. Li et al., 
2008). Panels D – F are the predicted mediator trajectories of IL-6, IL-8 and MMP-8, which were the 
additional mediators in the current study.  Inflammatory marker concentrations are in pg/ml. The grey bars 
represent the mean of the simulated data, and the error bars represent 95% confidence intervals in the 
simulated data. The dark circles represent the input data of the first three time points (baseline, post-loading, 
4-hr post treatment), obtained from human laryngeal secretion data. The empty circles represent the 
validation data at the 24-hr time point from the human laryngeal secretion data. B: baseline; PL: post vocal 
loading; 4hrPRx: following a 4-hr treatment. Note that human validation data for Days 2 – 3 have not yet 
been generated. 
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Table 6. ABM Predictions of Mediator Levels for Subjects 4 – 7 at the 24-hr Time Point (Human 
Laryngeal Secretion Data). Predictions Indicate 95% Confidence Intervals. Parenthesis Indicate the 
Empirical Laryngeal Secretion Data From the Acute Phonotrauma Study. Checkmarks “√” Indicate 
(Empirical) Data that Fell within the 95% Confidence Interval.  
 
 
Subject 
(sex) 
IL-1β 
(pg/ml) 
IL-6 
(pg/ml) 
IL-8 
(pg/ml) 
TNF-α 
(pg/ml) 
MMP-8 
(ng/ml) 
IL-10 
(pg/ml) 
Spontaneous 
Speech 
6 
(F) 
1015-1150 853-962 9260-10420 29-34 
√ 
275-346 
√ 
335-380 
  (466) (98) (1,443) (32) (276) (202) 
Voice 
Rest 
5 
(F) 
1696-1757 223-237 
√ 
5409-5600 37-40 
√ 
86-95 
 
255-314 
√ 
  (39) (236) (411) (39) (32) (300) 
 7 
(F) 
1154-1298 207-229 4861-5441 20-23 
 
28-36 
√ 
100-121 
√ 
  (30) (15) (744) (49) (28) (120) 
Resonant 
Voice 
4 
(M) 
12-14 104-118 1633-1865 
 
33-38 
√ 
14-19 
√ 
350-398 
 
 (34) (371) (701) (34) (18) (213) 
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6.2.1 Predicted trajectories of inflammatory mediators for human phonotrauma 
simulations 
The ABM reproduced and predicted most subject-specific mediator trajectories in Subjects 1 – 3 
following phonotrauma and treatment (Figures 13 – 17). Specifically, the ABM predicted 24-hr 
mediator values in 73% of cases (22/30 were within the 95% confidence intervals: +18 mediator 
measurements from 3 between-group subjects, each with one of the 3 different treatments; +18 
mediator measurements from one within-group subject – Subject 3 – who received each of the 
treatments; -6 mediator measurements to account for double-counting the “spontaneous speech” 
treatment for Subject 3 in both between- and within-group measurements; hence 30 different 
mediator measurements in total). Further post hoc analyses were as follows. Markers were 
broken down into two groups: (1) IL-1β, TNF-α and IL-10 as “old” markers that were 
propagated from the published model to the current model and (2)  IL-6, IL-8 and MMP-8 as 
“new” markers that were added in the current model. The reason for this breakdown was to 
assess whether the addition of these markers affected the models’ accuracy, and if so, in which 
direction.   
For the “old” markers (IL-1β, TNF-α and IL-10), the expanded ABM predicted 
empirically obtained 24-hr mediator value in 80% of cases (12/15 cases were within the 95% of 
confidence interval).  Interestingly, the exact same result was obtained for these markers in the 
earlier published ABM (N. Y. Li et al., 2008). For the “new” markers (IL-6, IL-8 and MMP-8), 
the ABM predicted 24-hr mediator values in 67% of cases (10/15 mediators were within the 95% 
of confidence interval). 
For Subjects 4 – 7, none of whose empirical data were used for model calibration except 
their baseline mediator inputs, the ABM predicted 24-hr mediator values (1) in 42% of cases for 
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the “old” markers (i.e. 5/12 cases were within the 95% confidence interval for markers), and (2) 
in 33% of cases for the “new” markers (4/12 cases were within the 95% confidence interval) 
(Table 6). Thus, the prediction accuracy for “old” markers is higher than the “new” markers 
(44%; 4/9) in this expanded ABM. However, the prediction accuracy for these “old” markers 
slightly decreased in the expanded ABM, compared to the published ABM (50% ; 6/12) (N. Y. 
Li et al., 2008).  
 In sum, the introduction of additional components to the model reduced its prediction 
accuracy overall. Moreover, the ABM showed poorer prediction accuracy for Subjects 4 – 7 than 
for Subjects 1 – 3 whose data were used in calibration. This model breakdown revealed the 
interesting and important finding that patient-specific models that did not produce accurate 
population-general predictions.  Thus, the models indeed speak to personalized medicine rather 
than generalized findings.  
For the single within-group subject (Subject 3; Figures 15 – 17), both empirical data and 
simulation results showed that concentrations of inflammatory mediators had distinctive 
temporal and quantitative expression patterns across treatment assignment. For the spontaneous 
speech condition, the ABM predicted that the inflammatory response would be escalated, i.e., 
would involve massive secretion of both pro- and anti-inflammatory mediators following the 4-
hr treatment. Specifically, concentrations of pro-inflammatory mediators (IL-1β, TNF-α and IL-
8) and collagenase (MMP-8) reached their peaks at Day 1 post injury and resolved to baseline 
concentrations around Day 2 – 3 post injury. One anti-inflammatory mediator, IL-10, was also 
predicted to be secreted in great quantities by wound macrophages. The concentration of the 
“exercise factor”, IL-6, was increased after the 4-hr spontaneous speech treatment and remained 
elevated up to Day 1 post injury.  
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In contrast, under conditions of voice rest and resonant voice exercise, concentrations of 
pro-inflammatory mediators (IL-1β and IL-8) and collagenase (MMP-8) dropped rapidly after 
the 4-hour treatment and then remained low through the end of simulation, i.e., Day 3.  IL-1β 
was particularly down-regulated following resonant voice exercise. The anti-inflammatory 
mediator IL-10 was predicted to be secreted rapidly after the 4-hr treatment and remained at a 
high level at Day 1 post injury. The concentration of “exercise factor”, IL-6, was predicted to be 
strongly secreted following the 4-hr treatment and drop rapidly to a minimal level at Day 1 post 
injury. The degree of drop in IL-6 was lower following resonant voice compared to the voice rest 
condition. Similar mediator patterns were found in the larger dataset for the between-group 
subjects (Figures 13 – 15). 
6.2.2 Predicted trajectories of cells, ECM synthesis and tissue damage for human 
phonotrauma simulations 
For simulations of acute phonotrauma, the ABM predicted massive platelet infiltration and 
remarkable resident fibroblast activation during the first 12-hr period post injury, without the 
intervention of resonant voice or spontaneous speech (Figure 18a). Inflammatory cells 
(neutrophils and macrophages) were predicted to arrive at relatively later time points – between 
12 hr and Day 1 post injury. Fibroblasts were the dominant cell type throughout the simulation 
period. HA was predicted to be secreted in large quantities by activated fibroblasts during the 
acute phase of healing (Figure 18b). This prediction is consistent with the findings in the general 
healing literature indicating HA  accumulates during the earliest phase of inflammation and this 
accumulation is considered one of the cardinal signs of acute inflammation – edema formation 
(swelling) (D. Jiang et al., 2007; Stern et al., 2006). In fact, in a previous report, vocal fold 
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edema was visually observed in a subject immediately following 1 hr of loud phonation (74 – 
121 dB @ 12 inches) (Verdolini, Rosen, Branski, & Hebda, 2003), suggesting a similar  
mechanism of rapid HA accumulation and edema in the vocal folds as in other tissues. In 
contrast, the ABM predicted minimal accumulation of collagen and elastin compared to HA 
following phonotrauma. This prediction suggested that microscopic tissue injury from a single 
event of phonotrauma – at least phonotrauma of the magnitude studied – is unlikely to lead to 
substantial loss of structural proteins (collagen and elastin), in which case fibroblasts would need 
to secrete massive collagen and elastin to repair the loss. In fact, abnormal collagen and elastin 
accumulation has rarely been reported in acute phonotrauma but has been commonly reported in 
benign vocal fold lesions (repeated phonotrauma) and in vocal fold scar (surgical trauma) 
(Hansen & Thibeault, 2006).  
Tissue damage in the current model is considered as a general index of tissue health 
(Figure 18b). Tissue damage in this model was unitless. In the current ABM, the initial 
mechanical injury and the subsequent inflammatory response of collagenase (MMP-8) and 
reactive oxygen species (subsumed as TNF-α actions) broke down the native matrices into 
fragments, causing more tissue damage. Damage was predicted to spike immediately following 
injury and to resolve within the first 24 hours post injury (Figures 18b and 19). Within this time 
window, damage was predicted to be slightly lower following phonotrauma in subjects for whom 
voice rest and resonant voice exercise were prescribed, compared to the spontaneous speech 
condition (Figure 19; the shaded area). Also, the earliest possible time of complete tissue 
recovery was around 12-hr post injury in both voice rest and resonant voice conditions and 
around 18-hr post injury in spontaneous speech (Figure 19; the lower boundary of the shaded 
area). Compared to the voice rest condition, the range of tissue damage in the resonant voice 
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condition was generally larger from 5-hr to 12-hr post injury but smaller from 13-hr to 24-hr post 
injury. Thus, based on the current simulated tissue damage data, confidence around the absolute 
benefits of voice rest and voice exercise is somewhat reduced.  
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Figure 18. Representative ABM predictions of cell counts, extracellular matrix (ECM) synthesis and 
amount of tissue damage in human acute phonotrauma up to 3 simulated days following injury. No tissue 
mobilization treatments (resonant voice or spontaneous speech) were applied in this prediction. Panel A is 
predicted cell trajectories for platelets, activated neutrophils, activated macrophages and activated 
fibroblasts. Panel B is predicted ECM trajectories for new collagen, new elastin and new hyaluronan as well 
as extent of tissue damage. Amount of tissue damage is in arbitrary units.   
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Figure 19. ABM predictions of tissue damage following acute phonotrauma and a 4-hr motion-based 
treatment. Panel A is predicted tissue damage in Subject 1 following a voice rest treatment. Panel B is 
predicted tissue damage in Subject 2 following a resonant voice treatment. Panel C is predicted tissue damage 
in Subject 3 following a spontaneous speech treatment. The shaded area represents the range (maximum-
minimum) of simulated tissue damage for each subject. The numbers on the upper and lower boundaries of 
the shaded area denote the maximum and the minimum amounts of predicted tissue damage respectively. 
The solid lines represent the mean of the simulated data. PRx: following a 4-hr treatment. Amount of tissue 
damage is in arbitrary units.  
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6.3 EXPERIMENT 2: PREDICTION ACCURACY OF THE ANIMAL SURGICAL 
TRAUMA ABM 
The animal surgical ABM was quantitatively calibrated using mean mRNA mediator levels in rat 
laryngeal tissues at baseline, 1hr, 4hr, 8hr, 16hr and 24hr following surgery (Lim et al., 2006; 
Welham et al., 2008). Individual data that categorized as “extremes” were excluded for model 
calibration and subsequent evaluation. The distribution of “extremes” was: 1 from IL-1 β at 4 
hours and 8 hours each, 1 from TNF-α at 8 hours, 1 from TGF-β1 at 72 hours each and, 16 hours, 
24 hours and 72 hours each, 1 from procollagen subtype I at baseline, 1 hour and 24 hours each, 
1 from elastin synthase at baseline and 24 hours each and 1 from HAS-2 at 1 hour. Table 7 lists 
the means and standard deviations of each marker at each time point after removing the extremes 
from the data pool.  
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Table 7. Means (and standard deviations) of mRNA Expression Levels for Inflammatory Markers 
and Matrix Markers after Removal of “Extremes”. “Extremes” were Values that were More than 3 Times the 
Interquartile Range, Defined by SPSS.  This Data Set Corresponded to the Published Papers of Lim et al. 
(2006) and Welham et al. (2008) and was Graciously Provided by the First Authors (Lim and Welham) of 
these Two Papers. 
Time IL-1β TNF-α TGF-β1 Procollagen 
subtype I 
Elastin 
synthase 
Hyaluronan 
synthase-2 
Baseline 0.1 
(0.1) 
0.1 
(0.1) 
0.1 
(0.0) 
0.1 
(0.0) 
0.1 
(0.1) 
0.0 
(0.1) 
1 hour 652.1 
(305.0) 
7.7 
(4.7) 
0.5 
(0.3) 
0.0 
(0.0) 
0.2 
(0.2) 
0.0 
(0.0) 
4 hours 5009.0 
(2766.0) 
1.1 
(1.3) 
0.3 
(0.2) 
0.2 
(0.1) 
0.1 
(0.0) 
0.1 
(0.1) 
8 hours 6448.6 
(4795.3) 
10.4 
(19.3) 
0.3 
(0.1) 
0.0 
(0.0) 
0.1 
(0.0) 
0.1 
(0.1) 
16 hours 707.8 
(872.7) 
0.1 
(0.1) 
0.3 
(0.2) 
0.1 
(0.1) 
0.1 
(0.1) 
1.0 
(1.2) 
24 hours 268.3 
(141.1) 
1.3 
(0.4) 
0.4 
(0.2) 
0.0 
(0.0) 
0.0 
(0.0) 
0.1 
(0.1) 
72 hours 80.4 
(65.6) 
0.3 
(0.1) 
0.6 
(0.2) 
1.6 
(1.0) 
0.1 
(0.0) 
0.5 
(0.2) 
 
The calibrated ABM was run 100 times to generate population-trend predictions of 
mediator and ECM marker levels for the rat population up to five days following surgery. The 
model’s prediction accuracy was evaluated against the criterion of whether the empirical 
mediator and ECM levels at the 72-hr time point fell within the 95% confidence interval for the 
mean of model predictions.  
6.3.1 Predicted trajectories of inflammatory mediators and ECM markers for animal 
surgical vocal fold trauma simulations 
The ABM generally reproduced and predicted population-trend inflammatory mediator and ECM 
marker trajectories in the rat population following surgical trauma (Figure 20). Specifically, the 
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ABM predicted 72-hr mediator values in 83% of cases (5/6 cases were within the 95% 
confidence interval). Overall, compared to the acute phonotrauma ABMs (published and 
Experiment 1), the current animal surgical ABM showed better predictive value possibly due to 
the calibration of more time points (5 calibration data points in the surgical ABM vs 2 calibration 
data points in the phonotrauma ABMs).  
Both empirical and simulation results showed time-dependent changes in mRNA gene 
expression of mediators and ECM markers from rat vocal folds after injury. IL-1β was expressed 
massively and immediately following injury and remained elevated up to 8-hr following injury. 
IL-1β expression decreased notably 16 hr following injury and remained at a low level until the 
end of simulation, i.e., Day 5. TNF-α expression showed relative fluctuation across the 
simulation period. TGF-β1 expression increased progressively following injury up to Day 3, and 
was predicted to progressively drop through the end of the simulation.  
Regarding the ECM markers, elastin synthase showed early expression immediately 
following injury and remained at a notable level until the end of simulation. Compared to elastin 
synthase, expressions of procollagen subtype I and HAS-2 revealed a more protracted course. 
Both procollagen subtype I and HAS-2 were predicted to be expressed in considerable amounts 
starting in Day 1 and to reach at a high level until Day 3 post injury.  
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Figure 20. Predictions of inflammatory and wound healing responses to surgical vocal fold trauma in 
the rat population. Panels A – C are the predicted mediator marker trajectories for IL-1β, TNF-α and TGF- 
β1. Panels D – F are the predicted ECM marker trajectories for procollagen 1, HAS-2 and elastin synthase.  
Marker concentrations are in relative mRNA expression. The grey bars represent the mean of the simulated 
data, and the error bars represent 95% confidence intervals in the simulated data. The dark circles represent 
the input data for the first six time points (baseline, 1-hr, 4-hr, 8-hr, 16-hr, Day 1 following surgery), obtained 
from rat laryngeal tissue data. The empty circles represent the validation data at the 72-hr time point from 
the rat laryngeal tissue data. The dashed lines represent the standard deviations of the empirical rat mRNA 
tissue data. Note that animal validation data for Days 4 – 5 have not yet been generated. 
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6.3.2 Predicted trajectories of cells, ECM synthesis and tissue damage for animal surgical 
vocal fold trauma simulations 
Triggered by the high-magnitude of tissue damage from surgical trauma, a large inflammatory 
response in the form of massive inflammatory cell infiltration was predicted. In particular, a 
large degree of platelets and neutrophil infiltration were predicted for the first 12-hr post-injury 
period (Figure 21a). Macrophages and fibroblasts were predicted to start accumulating in the 
wound area slightly after neutrophils – between 12-hr and Day 1 post injury. Neutrophil and 
macrophage counts declined from Day 3 post injury in the simulation, whereas fibroblasts 
remained at high levels until the end of simulation at Day 5. Compared to predictions for ECM 
levels for acute phonotrauma (Figure 18b), all ECM products, especially collage type I, were 
predicted to be secreted in greater quantities by activated fibroblasts following surgical trauma 
(Figure 21b) The first elevation of collagen was predicted to occur between approximately Days 
1 and 3 post injury. In fact, collagen type I accumulation has been well described in the literature 
on scarred vocal folds following vocal fold “stripping” in different animal models (Hansen & 
Thibeault, 2006).   
The predicted trajectory of tissue damage in surgical trauma (Figure 21b) was very 
different from that seen for acute phonotrauma in voice rest condition (Figure 18b). Damage was 
predicted to be higher and more prolonged following surgical trauma than in phonotrauma. 
Damage slowly subsided until Day 3, which temporally corresponded to the decline of 
inflammatory cell counts (neutrophils and macrophages). A small rebound “bump” was seen 
between Days 0.5 and 1 post injury. Of note, the timing of the “bump” in the damage curve was 
not programmed into the ABM code but rather emerged as a property of the system. This bump 
might be attributed to a positive feedback loop involved in the function of tissue damage. 
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Inflammatory cells produced positive feedback to induce further inflammation due to their 
collateral ECM damage (Figure 7 in Section 5.1.1.8), thereby amplifying the pro-inflammatory 
response and delaying the tissue healing process.  
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Figure 21. Representative ABM predictions of cell counts, extracellular matrix (ECM) substance and 
amount of tissue damage in animal vocal fold surgical trauma up to 5 simulated days following injury. Panel 
A shows predicted cell trajectories for platelets, activated neutrophils, activated macrophages and activated 
fibroblasts. Panel B shows predicted ECM trajectories for new collagen, new elastin and new hyaluronan as 
well as extent of tissue damage. Amount of tissue damage is in arbitrary units.  
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7.0  DISCUSSION 
The published ABM (N. Y. Li et al., 2008) was deficient in: (1) the representation of vocal fold 
extracellular matrix (ECM) and its biochemical roles in mediating inflammation and healing, (2) 
the representation of inflammatory mediators and growth factors and their responses to tissue 
mobilization, and (3) the validation of the model’s tissue-level outputs. This thesis project set out 
to address these shortcomings as follows.  
First, the panel of ECM substances (collagen type I, elastin and hyaluronan [HA]) was 
now expanded in the current ABMs to create a more realistic replication of the ECM 
environment specific to the vocal folds. Also, fragments of the ECM substances ensuing from 
injury or inflammation were now involved in the function of “tissue damage” in the ABM, 
aiming to mimic alarm/ danger signals postulated in Matzinger's model of immunity (Gallucci & 
Matzinger, 2001; Matzinger, 2002).  
Second, the profile of inflammatory mediators and growth factors (interleukin [IL]-1β, 
IL-6, IL-8, IL-10, tumor necrosis factor [TNF]-α, matrix metalloproteinase [MMP]-8, 
transforming growth factor [TGF]-β1 and basic fibroblast growth factor [bFGF]) was now 
expanded in the current ABMs. Each of these signaling molecules is known to be distinctively 
involved in the regulation of cell behavior as well as ECM production and remodeling during 
different phases of inflammation and healing. This model expansion would provide fuller 
coverage of the interplay among cells, inflammatory mediators, growth factors and ECM 
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substances in the progression of vocal fold healing following acute injury. In addition, IL-6, the 
identified “exercise factor” to which exercise benefits in muscle are attributed, was of particular 
interest in the current ABM. The noted biological effects of exercise-induced IL-6 were now 
abstracted and implemented under “treatment” simulations in the human phonotrauma ABM. 
With this addition, the ABM would have greater ability to elucidate cellular and molecular 
responses to varying magnitudes of biomechanical stresses (impact stress and vibratory stress) 
from each motion-based treatment in vocal fold healing following acute phonotrauma. 
Finally, the protocol of model calibration-validation was now extended from molecular 
levels (using inflammatory mediator and growth factor data) to tissue levels (using ECM data) in 
the animal surgical trauma ABM. A biological system is organized in multiple levels from small 
(low) to large (high): molecules  cells  tissues  organs  organisms  populations. To 
understand the pathogenesis of vocal fold lesions, of particular interest in the current extended 
project, we need to know which lower biological levels of molecular events give rise to effects at 
higher levels of biological organization, to damage cells and tissues. Although the cross-scale 
calibration and validation of the ABM was exploratory in this study, the work will hopefully 
shed a ray of light on understanding the “net effect” of the complex interactions among 
inflammatory mediators at the tissue level in order to tease out certain molecular factors in the 
pathogenesis of vocal fold lesions. 
Discussion now turns to detailed consideration of the major findings and potential 
implications from the augmented ABMs. Discussion concludes with the consideration of 
challenges and future research directions for ABM in the field of voice care.  
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7.1 ABMS PROVIDED A PLATFORM TO INTEGRATE, FORMULATE AND 
EXECUTE EMPIRICAL ASSUMPTIONS AROUND INFLAMMATION AND HEALING 
This project demonstrated that modeling is a useful methodology to provide a quantitative 
framework for understanding how the many pieces of the biology puzzle fit together. Vast 
biological data relating to vocal fold healing behavior have been accumulated across several 
laboratories. Still, only a small fraction of the system behavior in vocal fold inflammation and 
healing is represented in a clinically useful way. To obtain a more complete understanding of 
biological systems, a unified representation of the system is required to integrate different scales 
of data or postulations drawn from the data. Computational biological models, such as ABMs in 
this study, are used to integrate various biological events and represent biological reality as an 
abstraction with clinical relevance.   
Computational models are ideally built on available empirical data but they may also be 
based on some educated assumptions derived from theories or anecdotal evidence. To check the 
correctness of the assumptions in the model, we can execute the models and then compare the 
model’s behavior with laboratory-based observation. If the biological model’s behavior is 
consistent with empirical data, confidence increases in the hypothetical mechanisms or 
assumptions underlying the model’s behavior in the current understanding of the system.  
Current ABMs (Experiment 1: phonotrauma ABM; Experiment 2: surgical vocal fold 
trauma ABM) are based on three major assumptions: (1) platelets are the major cell source of 
mediator secretion during the earliest phase of healing, (2) the initiation of injury-induced 
inflammation in phonotrauma and surgical trauma is centered around the release of “alarm/ 
danger” signals from stressed or damaged tissues, and (3) the mode of the tissue’s adaptive 
response to disturbance is related to the magnitude of mechanical stress through the induction of 
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an array of “alarm/ danger” signals as well as downstream pro- and anti-inflammatory mediators. 
The current ABMs’ outputs were compared with empirical data around inflammation and healing 
obtained from laryngeal surface secretions in humans (Experiment 1) or laryngeal tissues in rats 
(Experiment 2). Both models generally reproduced empirically expected trajectories of 
inflammatory mediators and ECM substances following vocal fold injury, suggesting the 
plausibility of the aforementioned postulations underlying the system of vocal fold wound 
healing.  
7.1.1 Current ABMs confirmed the cell source of early inflammatory mediator secretion 
following vocal fold injury 
The presence of platelets has not been reported in any studies of vocal fold wound healing. 
However, Welham et al. (2008) postulated that the early release of inflammatory mediators into 
wounded vocal folds was highly dependent on platelets and probably some resident cells 
following surgical trauma. In the current study, parameters of the surgical ABM were calibrated 
with empirical data up to the first 24 hrs post injury. Within this time window, the adjustment of 
platelet and activated macrophage parameters was noted to be the most effective one to improve 
a match between model outputs and experiment data. This observation was consistent with 
Welham’s assertion that platelets and possibly some resident cells may be involved in mediator 
secretions immediately following surgical vocal fold trauma.  
On the other hand, parameters for the phonotrauma ABM were calibrated with empirical 
data only up to the first 4 hrs post injury (i.e., up to the empirical time point of 4-hr post 
treatment onset). Given this time window, the adjustment of platelet parameters was noted to be 
the most effective one to improve the matching of simulated outputs and experimental data. 
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Varying parameters of inflammatory cells (activated neutrophils and macrophages) did not 
markedly improve the match for this early time window, even though these two cell types 
produced some overlap of inflammatory mediators (IL-1β, TGF-β1 and MMP-8) with platelets.  
In wound healing, this early time window corresponds to the platelet-dominant 
hemostasis response and probably the transition to a neutrophil/ macrophage-dominant 
inflammatory phase depending on the extent of injury. During hemostasis, platelets aggregate to 
the wound site and a fibrin clot is formed to stop the bleeding at the site. Platelets also release 
multiple mediators to activate the subsequent inflammation cascade. Hemostasis is the first 
important line of defense to control the extent of injury, especially in the case of extensive 
trauma following surgery. The current phonotrauma ABM predicted that platelets were markedly 
present and seemed to be the major source of mediators shortly after injury (Figure 18a). 
Although the magnitude of injury in phonotrauma was relatively smaller than injury in surgical 
trauma, this ABM’s prediction suggested that vocal loading could probably change properties of 
blood capillaries followed by platelet aggregation. 
7.1.2 The current ABMs applied the “alarm/ danger” theory to simulate injury-induced 
inflammation and healing 
The current ABMs incorporated the concept of Matzinger’s “alarm/ danger” model to simulate 
the vocal fold inflammatory response following mechanical injuries: phonotrauma or surgical 
trauma (Gallucci & Matzinger, 2001; Matzinger, 2002). Specifically, inflammation is activated 
by the innate immune system in response to noxious stimuli. The classical immunology model of 
“self-non-self” discrimination stipulates that the immune system does not react against the self 
but reacts against the non-self or foreign agents such as pathogenic bacteria, viruses and parasites 
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(C. Janeway, 1989; C. A. Janeway, Jr., 1992). Matzinger proposed a competing “alarm/ danger” 
model (Gallucci & Matzinger, 2001; Matzinger, 2002),  suggesting that the innate immune 
response is induced as a result of “danger” detection, rather than the discrimination between 
“self” and “non-self” antigens.  
The central difference between the “self-non-self” model and the “alarm/ danger” model 
lies with the way in which an innate immune response is triggered. According to the “self-non-
self” discrimination model, an organism classifies its own cells as self and everything else as 
non-self by recognizing proteins found on the surface of foreign cells, i.e., antigens. The surface 
proteins of foreign cells are different in structure and shape from the host cell’s surface proteins, 
i.e., self-antigens. The “self-non-self” model assumes that the detection of a foreign agent is 
sufficient to initiate the innate immune response and direct the adaptive response to external 
entities, i.e., non-self antigens. However, the “self-non-self” model has limited ability to explain 
many scenarios where “self-non-self” classification fallacies occur. For instance, no immune 
reaction is triggered to the bacteria in our intestinal tracts or to the food we eat or to the air we 
breathe that are classified as “non-self”. Also, in auto-immune diseases, the immune system is 
triggered to attack certain host’s cells that are classified as “self”. 
The “alarm/ danger” model offers a potential explanation for the scenarios the “self-non-
self” model missed. The “alarm/ danger” model proposes that the innate immune response is 
provoked by the presence of antigens in the context of tissue damage. The body does not need to 
attack everything that is foreign, unless there is good evidence that cells are injured, stressed or 
destroyed by necrosis. In other words, the body is more alarmed by disruption of homeostasis or 
damage than with foreignness. The “alarm/ danger” theory postulates that an immune response is 
triggered when innate immune cells recognize “signs” of cell or tissue distress. These signs, 
 125 
termed as “alarm/ danger signals”, are molecules that are found exclusively inside cells normally 
but are released into the extracellular space from injured or stressed cells subsequent to exposure 
to pathogens, toxins, or mechanical stimuli.  
Inflammation is an innate immune response that can be triggered by infection or injury. 
In the vocal folds, inflammation caused by phonotrauma and surgical trauma is primarily 
induced by mechanical injury. Bacterial infections are rarely associated with phonotrauma or 
surgical vocal fold trauma. Hence, in these two examples of vocal fold injuries, the principle 
purveyor of the innate immune response to activate injury-induced inflammation is essentially 
from endogenous products of distressed tissues, rather than not from foreign invaders. For 
example, ECM fragments generated from sterile injury such as exercise and surgery constitute 
the endogenous signals of inflammation. The fragments function as “alarm/ danger signals” that 
alert the immune system to cell or tissue damage in the absence of infection. Also, the fragments 
provide a ready means to recruit innate inflammatory cells and elicit an inflammatory response 
and subsequent wound healing cascade to damaged tissues (Matzinger, 2002; Rubartelli & Lotze, 
2007). In that regard, Matzinger’s “alarm/ danger” model is more appropriate than the “self-non-
self” model as a central concept in the current construction of ABMs, in which the driving force 
for the inflammatory response is not from the recognition of foreign bodies but rather from cells 
or tissues undergoing injury or stress. 
The “alarm/ danger” theory fit nicely fitted with the current ABMs. ECM fragments, 
including collagen type I, elastin and HA, were coded as “alarm/ danger signals” in the algorithm 
of “tissue damage” that initiated, sustained or amplified inflammation. Native ECM was 
degraded into fragments due to initial mechanical stimuli and subsequent inflammatory 
responses, where degradation occurred by way of collagenase MMP-8 as well as oxidative stress 
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subsumed in the actions of TNF-α. The functions of ECM fragments are two-fold: pro-
inflammatory (such as recruitment of inflammatory cells and stimulation of inflammatory 
mediator secretion) and anti-inflammatory (such as recruitment of repair cells and stimulation of 
collagen production) (Table 2 in Section 5.1.1.6). Therefore, a balance between pro-
inflammatory signals and anti-inflammatory signals determined the final healing outcome of 
tissue damage. 
The trajectories of simulated tissue damage were predicted to have distinctive temporal 
and magnitude patterns across phonotrauma and surgical trauma. After phonotrauma, simulated 
tissue damage was predicted to be low and to resolve promptly within 24 hr post injury (Figures 
18b and 19). On the other hand, simulated tissue damage was predicted to be high and persist for 
at least three days following surgical trauma (Figure 21b). Also, a small rebound “bump” in 
tissue damage was predicted between Days 0.5 and 1 post injury exclusively in surgical trauma. 
This damage rebound might be attributed to the following cellular and molecular events. Large 
magnitude of surgical trauma resulted in extensive ECM disruption and generated large amounts 
of ECM fragments. These fragments constituted strong “alarm/ danger signals” and triggered an 
exaggerated inflammatory response. Excessive inflammatory cells were recruited and activated. 
The inflammatory cells secreted collagenase and reactive oxygen species (subsumed as TNF-α 
actions in current ABMs) in the wound site, leading to collateral tissue damage. The “alarm/ 
danger” signals in the form of ECM fragments were further amplified, whereas the anti-
inflammatory response was comparatively small and sufficiently prompt to counteract excessive 
collateral tissue damage. As a result, the inflammatory response following surgical trauma was 
prolonged and the transition to the healing phase was delayed. 
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Of note, the cellular and molecular events involved in injury-induced inflammation are 
not as well studied as those of infection-induced inflammation (Medzhitov, 2008). There is 
uncertainty about the extent to which knowledge gained about infection-induced inflammation 
may apply to injury-induced inflammation. For instance, the way that an immune response is 
initiated is markedly different across these two types of inflammation. Nevertheless, current 
work confirmed the proposition suggested by the “alarm/ danger” theory that the immune system 
reacts to situations that are potentially harmful to the body even in the absence of foreign 
substances. The “alarm/ danger signals” were made realistic within computer models in silico. 
Current ABMs yielded a clear view on the generation and flow of the “alarm/ danger signals” 
within the system of inflammation and healing, and such signals can be potential targets for 
manipulation to optimize healing outcomes following tissue damage or stress.  
7.1.3 The current ABMs illustrated a spectrum of inflammatory responses to 
phonotrauma, surgical trauma and motion-based treatments  
Current ABMs aimed to simulate (1) the inflammatory and repair response within vocal fold 
tissues following phonotrauma and surgical trauma, as well as (2) effects of tissue mobilization 
in modulating the inflammatory responses following phonotrauma. The ABM simulation results 
essentially illustrated the central idea around inflammation described by Medzhitov (2008) –   
inflammation is a spectrum of adaptive response to noxious stimulus. Depending on the type and 
magnitude of disturbance, the state of the tissue can be altered from basal, to stressed (or 
malfunctioning), to damaged. Consequently, stress response and tissue adaptation with varying 
magnitudes are induced: from homeostasis, to para-inflammation, to inflammation (Figure 22) 
(Medzhitov, 2008).  
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In Medzhitov’s framework, resident-tissue macrophages and fibroblasts maintain normal 
tissue turnover by a variety of homeostatic control mechanisms in the basal state. When the 
tissue state is disturbed to an extent that the homeostatic mechanisms cannot handle, different 
types of stress response and tissue adaptation are initiated. At the highest end of the spectrum of 
the response is the classic inflammation, which is triggered following tissue damage. This full-
scale inflammatory response is characterized by massive leukocyte influx and scar formation. 
Medzhitov (2008) proposed that an intermediate stress response between homeostatic control 
and a full-scale inflammation, which is termed as “para-inflammation”, is induced by mild tissue 
stress without significant tissue injury. Resident cells are engaged in para-inflammation to assist 
tissues in adapting to the stressful condition and restoring tissue functionality and homeostasis. 
Additional resident cells or leukocytes may be recruited if the para-inflammatory response is 
close to the inflammatory state. Unlike having scar as a distinctive trait of the classic 
inflammation, the outcome of stress adaptation in para-inflammation has not yet been  
characterized (Medzhitov, 2008). Discussion now turns to how Medzhitov’s framework explains 
(1) differentiated inflammatory and healing responses between phonotrauma and surgical trauma 
as well as (2) differences in biological effects following three types of motion-based treatments.   
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Figure 22. Schematic representation of (1) three modes of stress response and tissue adaptation in the 
setting of the vocal folds based on Medzhitov (2008) and (2) proposed mechanisms of phonatory stress in 
modulating the stress response following phonotrauma. The state of a tissue is graded, ranging from basal, to 
stressed, to damaged. Depending on the initial tissue state, tissue responses are varied by engaging different 
cell types. In basal conditions, tissues are maintained in a homeostatic state primarily by resident cells. Tissue 
damage from surgical vocal fold trauma induces a full-blown inflammatory response. Resident cells and 
leukocytes are recruited and activated in the wound site. Consequently, a tissue repair response is initiated 
and a scarred tissue is likely formed. In contrast, no overt tissue destruction but rather only mild tissue stress 
is expected following phonotrauma. An intermediate para-inflammatory response ensues and resident cells 
are engaged for tissue adaptation to the noxious stimuli. Depending on the extent of the problem, a small-
scale recruitment of leukocytes or additional recruitment of resident cells might be involved in para-
inflammation. The outcomes of stress adaptation remain to be characterized clinically. Biomechanical stress 
in phonation, namely vibratory stress and impact stress, are hypothesized to modulate the inflammatory 
response within stressed tissues (relevant discussion is in Section 7.1.3.2). Impact stress is regarded as a 
“damaging force”, which signals recruitment of leukocytes and pro-inflammatory responses in cells and thus 
escalates stress response. Vibratory stress is regarded as a “healing force”, which signals anti-inflammatory 
actions in cells through the induction of IL-6 and thus attenuates the stress response.  
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7.1.3.1 Differentiated inflammatory and healing responses under phonotrauma and 
surgical trauma 
The current ABMs generally reproduced and predicted differentiated inflammatory and 
healing patterns across phonotrauma and surgical trauma. Tissue fibroblasts were predicted as 
dominant in phonotrauma-induced inflammation. Also, minimal depositions of collagen type I 
and elastin but relatively large quantities of HA deposition were expected throughout the healing 
process following phonotrauma. On the other hand, surgical trauma was expected to induce 
massive inflammatory cell infiltration concurrent with activation of tissue fibroblasts and a 
related tissue repair program. Collagen type I was expected to be secreted in relatively greater 
quantities than those for elastin and HA to repair the surgical wound. Aforementioned 
inflammatory patterns from ABM simulations appeared to conform to Medzhitov’s hypothesized 
spectrum of tissue stress adaptation to different tissue states (2008) (Figure 22).  
According to Medzhitov’s framework, relatively mild stress occurring with phonotrauma 
induced intermediate para-inflammatory responses followed by tissue stress adaptation. 
Phonotrauma due to 1 hr of vocal loading did not necessarily cause extensive tissue damage but 
simply stressed the tissues sufficiently to call resident fibroblasts into action. Massive 
inflammatory cell infiltration and scarring were not expected by the simulation of acute 
phonotrauma, which is consistent with the anticipated response and outcome associated with 
para-inflammation in Medzhitov’s framework (2008).  
On the other hand, high magnitude stress as occurs in surgical trauma induced a full-scale 
inflammatory response followed by tissue repair with scar formation. The massive tissue damage 
resulting from surgical trauma may exceed the level that para-inflammatory responses can 
handle. The strong surgical stress broke down a substantial area of ECM within mucosal tissues, 
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subsequently generated strong “alarm/ danger” signals, attracted large amounts of neutrophils 
and macrophages accompanied by collateral tissue damage and then further amplified “alarm/ 
danger” signals in the system. Meanwhile, fibroblasts were activated to secrete ECMs in an 
attempt to “patch” the wound. Damaged tissues would be repaired with excessive collagen 
deposition as predicted by the ABM, a finding that concords with the anticipated outcome of 
full-scale inflammation in Medzhitov’s framework (2008). In fact, increased collagen content in 
scarred vocal folds relative to normal vocal folds following laryngeal surgery has been 
commonly reported empirically and clinically (Hansen & Thibeault, 2006).   
Of note, the differences in the inflammatory response between phonotrauma and surgical 
trauma were not “programmed” in the ABMs but rather emerged by themselves. For instance, 
not a single line of code was written in the model saying that only neutrophils were recruited in 
surgical trauma but not in phonotrauma. The wiring of the phonotrauma and surgical trauma 
ABMs was identical, except for differences in parameter values and initial inputs of injury 
magnitude. We postulated that the initial magnitude of stress or injury (ranging from 0 – 40; 
phonotrauma as 20; surgical trauma as 40) was the main factor to generate the inflammatory 
response. In other words, the magnitude of the immune response reflects the extent of injury. 
Depending on the magnitude of initial stress, affected tissues generate varying amounts of ECM 
fragments, which act as “alarm/ danger” signals to vary the magnitude of stress response across 
homeostasis, para-inflammation and full-blown inflammation. Nevertheless, current ABM 
results echoed Matzinger’s “alarm/ danger” concept of initial immune regulation as well as 
Medzhitov’s suggestions regarding a spectrum of inflammatory responses.  
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7.1.3.2 Biological effects of motion-based treatments in acute phonotrauma 
In Experiment 1, the phonotrauma ABM had the capability of testing three motion-based 
treatment regimes in silico. Voice rest, resonant voice exercise and spontaneous speech, which 
were the three motion-based treatment modalities, can be considered on a continuum of vocal 
fold mobilization magnitude and vocal fold impact stress magnitude: none to minimal 
mobilization and impact stress (voice rest), normal to large amplitude vocal fold oscillations and 
low impact stress (resonant voice exercises) and normal to large amplitude oscillations but 
potentially larger impact stress (spontaneous speech), depending on the speaker (Peterson et al., 
1994; Verdolini et al., 1998).  
The current work successfully incorporated the effects of mechanical stresses in the 
construct of the biologically-based model (Figure 22). Impact stress from phonation was 
constructed as the “damaging stress”, which increased the number of circulating neutrophils in 
capillary compartments. Due to the critical role of neutrophils in most inflammatory events, an 
increase in circulating neutrophils counts could escalate the inflammatory response. On the other 
hand, vibratory stress, another stress component during phonation, was construed as a “healing 
stress”. Vibratory stress was linked to the anti-inflammatory response through the induction of 
IL-6 by macrophages and fibroblasts. IL-6 was noted to be mechano-sensitive during muscle 
stretching in exercise work (Nielsen & Pedersen, 2007; Pedersen et al., 2003; Pedersen et al., 
2001; Petersen & Pedersen, 2006; Woods et al., 2006). The mechano-sensitive property of IL-6 
was also suggested by the empirical data set in the acute phonotrauma study (Verdolini et al., in 
preparation). Following a 4-hr treatment of resonant voice exercise or spontaneous speech, 
robust and immediate up-regulations of IL-6 were noted with a rapid decrease during the post-
treatment period, i.e., at the 24-hr post baseline time point.  
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A novel debate that has emerged from our empirical data set is whether voice rest or 
resonant voice exercise is a better intervention for patients with acute phonotrauma. Traditional 
wisdom suggests that voice rest is the ideal approach. However, the current phonotrauma ABM 
suggested that biomechanical signals generated from resonant voice exercises might optimally 
assist stressed tissues to restore their homeostasis by regulating an array of pro-inflammatory and 
anti-inflammatory mediators, based on the readouts of mediator profile. First, the induction of 
IL-6 was enhanced immediately following the resonant voice treatment (i.e., the time point 
following a 4-hr treatment). Exercise-induced IL-6 has been suggested to stimulate the 
production of IL-10 and inhibit the synthesis of TNF-α and IL-1β in exercised tissues (Gleeson, 
2007; J. Peake et al., 2005; Petersen & Pedersen, 2005, 2006; Toumi et al., 2006; Woods et al., 
2006). Both empirical and simulation data in our series showed that during the post-treatment 
period (i.e., the 24-hr post baseline time point), although IL-10 was on an upward trajectory in 
both voice rest and resonant voice exercise, the trajectory was shaper following resonant voice 
exercise. In other words, although an anti-inflammatory process may be already programmed 
physiologically (as indicated in the voice rest condition), vibratory stress from resonant voice 
enhanced the pre-existing anti-inflammatory process by augmenting the anti-inflammatory 
effects of IL-10 through the induction of IL-6. Also, marked decrease of pro-inflammatory 
mediators (TNF-α and IL-1β) were noted following resonant voice exercises at the 24-hr post-
baseline time point. Those observations suggest that TNF-α/ IL-1β-induced destruction events 
might be optimally attenuated following resonant voice exercise, at least for some individuals 
and some conditions of resonant voice exercise.   
On the other hand, one might dispute this suggestion and argue that voice rest is better 
than resonant voice exercise because “damaging stress” (i.e., impact stress) is absent in voice 
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rest. However, a counterargument is that paradoxically, the magnitude of para-inflammation 
caused by impact stress in resonant voice may not be all bad for healing. In fact, arguably impact 
stresses associated with some forms of resonant voice may actually have some redeeming 
qualities. The argument is as follows. In the embryo, perfect tissue regeneration has been 
reported in the absence of inflammation (Broker & Reiter, 1994; Dang, Ting, Soo, Longaker, & 
Lorenz, 2003; Hantash, Zhao, Knowles, & Lorenz, 2008; Robson et al., 2001; Singer & Clark, 
1999). However, embryonic tissues are much simpler and the cells actively undergo 
morphogenesis and migrations during their developmental program with minimal inflammation. 
Adult wound healing may need inflammation to kick-start cell migration and other functions 
needed for tissue repair. As a matter of fact, a near-total blockage of inflammation, as with 
immunosuppressive treatment, has been reported as not very helpful in clinical therapy for 
inflammation-related diseases (Serhan, Chiang, & Van Dyke, 2008; Stramer et al., 2007). At the 
same time, too much inflammation, possibly in the range of magnitude of “damaging stress” 
from spontaneous speech, could lead to unfavorable collateral tissue damage. Thus, a therapeutic 
balance between the need for inflammation to initiate tissue repair and the need to keep 
inflammation from causing collateral tissue damage appears important to optimize healing 
outcomes. The current work suggests that although the pro-inflammatory markers IL-1β and 
TNF-α showed an immediate increase following resonant voice exercise, their levels decreased 
rapidly to the 24-hr time point. This result suggests that resonant voice exercise might generate 
an optimal level of mixed para-inflammatory and anti-inflammatory response to accelerate the 
transition from inflammation to healing and protect tissues from collateral damage in the process 
of restoring tissue homeostasis.   
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7.2 INSIGHTS FROM THE PREDICTED TISSUE DAMAGE TRAJECTORIES OF 
THE HUMAN PHONOTRAUNA AND ANIMAL SURGICAL ABMS 
In Experiment 2, the surgical trauma ABM was calibrated with experimental data across two 
biological organization levels, i.e., molecules (inflammatory mediators) and tissues (ECM 
substances) with the long-term goal of reconstructing the link between molecular factors and 
their tissue-level manifestation. If we succeed, we will have a fuller understanding of the 
pathophysiology of vocal fold pathology and potentially develop a clinical tool to measure the 
moment that damage is initiated and the subsequent temporal progression of damage due to 
mechanical stress.   
Thus far, research into vocal fold pathology has mainly addressed damage at the tissue 
level. For example, vocal fold scar owing to surgical trauma has been characterized in terms of 
altered ECM structure and distribution, rather by a profile of genetic or protein markers. 
Clinically, instrumental measures, such as phonation threshold pressure and an array of other 
aerodynamic and acoustic measures, are used to capture physiological signs of vocal fold tissue 
changes. These measures may capture accumulated damage but fail to effectively capture the 
early signs of tissue stress/ damage. In order to select the optimal treatment in a given clinical 
scenario, it is important for us to clearly define and detect the earliest signs of tissue stress/ 
damage in molecular terms before histopathologic changes of vocal fold tissues are indicated.  
While the initiating pathophysiologic event involved in surgical trauma occurs primarily 
at the tissue level, numerous cellular and molecular cascades are immediately set in motion by it. 
A previous animal study was carried out to assess in vivo tissue damage resulting from 
compression stress in porcine liver, ureter and small bowel as a function of the magnitude and 
duration of mechanical stress (De, Rosen, Dagan, & Hannaford, 2007). The researchers excised a 
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portion of stressed tissue and carried out histological and image analysis to quantitatively 
measure acute indicators of tissue response to mechanical damage: percent apoptotic cell area 
(cellular death) and neutrophils counts (inflammation). Their data suggested that these two 
indicators were sensitive to varying levels of mechanically induced damage in liver and small 
bowel. De et al.’s study (2007) provided an excellent model for measuring tissue damage in 
animals and probably a similar methodology can be applied in the field of voice research. 
However, if our ultimate goal is to develop a non-invasive (i.e., without tissue excision) clinical 
tool allowing near real-time assessment and multiple measures of vocal fold status in living 
humans, at present the assay of biomarkers in laryngeal secretions appears to be the only non-
invasive and fast tool to capture the progression of inflammation and healing. 
7.2.1  The ABM-simulated tissue damage trajectories are in good correspondence with 
empirical observations  
The trajectories of tissue damage generated from both phonotrauma and surgical ABMs were not 
prospectively calibrated with any empirical data in this study. Surprisingly, these trajectories 
were found to be in good correspondence with recent empirical reports by other authors.  
Specifically, a human study was carried out to chart 86 teachers’ voice recovery 
trajectories after a 2-hr vocal loading task for using loudness comparable to loudness in teaching 
(Hunter & Titze, in press). Following the loading task, subjects were then sent home with audio 
and written instructions and rating forms. Three perceptual rating scales were used as indices of 
voice recovery in the study. Subjects were required to rate their (1) current speaking effort level, 
(2) inability to produce soft voice, and (3) laryngeal discomfort. All ratings were performed 
every two hours on the remainder of the day of loading, one day after loading and two days after 
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loading, beginning at the time subjects woke up until going bed. No teaching duties yet no 
specific control of voice use were required for these subjects during the recovery days. 
The data indicated that, according to these measures, full vocal recovery occurred within 
12 – 18 hr post loading. This result is strikingly consistent with the trajectory of tissue damage 
predicted by the phonotrauma ABM in the current study, in the analogous condition of 
spontaneous speech. Specifically, in the model, tissue damage was predicted to be resolved 
around 18 hrs from vocal loading at the earliest, under the simulation of a 1-hr vocal loading task 
followed by a 4-hr spontaneous speech treatment (Figure 19c). The congruence of tissue damage 
results across these two independent studies is exciting, making a case for cross-validation for 
the perceptual rating data of vocal recovery and the ABM predictions of tissue damage. 
In the current ABM, simulated tissue damage is expressed in molecular terms. On the 
other hand, ratings of vocal recovery pertained to a perceptual level of tissue damage as 
described in Hunter and Titze’s study. From the foregoing findings, if we consider that the 
earliest possible vocal recovery time is 18 hrs and 12 hrs as suggested by the molecular index 
and the perceptual index of tissue damage respectively, a hypothetical correspondence of tissue 
damage at molecular and perceptual levels in phonotrauma is generated herein (Figure 23). A 
threshold factor may be operative – molecular changes in damaged tissues may need to 
accumulated to exceed some critical threshold before the changes are perceived. Stated 
differently, when subjects feel their voice is affected following vocal loading, tissue damage may 
be already operative and accumulated at the molecular level. When subjects start to feel that their 
voice is recovered, some residual damage or “alarm/ damage signals” may be still lie hidden 
deeply in the structure and regulation of inflammation and healing. The hypothetical 
correspondence of tissue damage between the molecular and the perceptual levels as depicted in 
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Figure 23 is worthy of further investigation. Nonetheless, the current work presents an example 
of how biosimulation can be used as a working platform for hypothesis testing as well as 
hypothesis generation for empirical experiments to improve scientific thinking around 
inflammation and healing.  
 
 
Figure 23. Hypothetical trajectories of tissue stress/ damage following vocal loading. The dashed line 
is predicted by the ABM (c.f. Figure 19c), which represents (average) tissue stress/ damage at the molecular 
level. The solid line is deduced from data by Hunter & Titze (in press), which represents hypothetical tissue 
stress/ damage at the perceptual level. 
 
A similar case is found for the surgical ABM. A rat vocal fold study showed that 
epithelization and fibroblast proliferation started on Day 1 post mucosal stripping surgery and 
fibroblasts were at peak number on Day 3 post surgery  (T. Tateya, I. Tateya, J. H. Sohn et al., 
2006). These observations suggested that the degree of ultimate tissue damage might be 
contained with the initiation of a fibroblast-dominant repair program starting on Day 1 following 
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injury. Also, the damaged tissues were expected to be replaced by neo-matrix from Day 3 post 
injury, at the time when fibroblasts were the most abundant in the wound site. Encouragingly, in 
Experiment 2 of the current work (i.e., the rat surgical ABM), the predicted trajectory of tissue 
damage showed a reasonably good correspondence with the afore noted empirical observations – 
simulated damage was in a down-slope from Day 1 post injury and was almost resolved from 
Day 3 post injury (Figure 21b). 
7.2.2 The current ABMs shed lights in identifying the surrogate of tissue damage 
The surrogate of vocal fold tissue damage at the molecular level remains to be empirically 
verified. However, we may be able to rationalize the surrogate of tissue damage from the 
literature and current simulation work. In the current ABMs, the mathematical function of 
simulated tissue damage was basically constructed to be analogous to “alarm/ danger” signals. 
These signals are endogenous inducers of inflammation, which can be constitutive or inducible, 
intracellular or secreted, or even a part of the ECM (Matzinger, 2007; Medzhitov, 2008; 
Rubartelli & Lotze, 2007). Some “alarm/ danger signals” have been empirically identified, 
including heat-shock proteins, chromatin-associated protein high-mobility group box 1 
(HMGB1), adenosine-5'-triphosphate (ATP), uric acid, free DNA, IL-1α, IL-18 and degraded 
matrix components (Behrens et al., 2008; W. Chen, Syldath, Bellmann, Burkart, & Kolb, 1999; 
Davies et al., 2006; Farkas, Kilgore, & Lotze, 2007; Heath & Carbone, 2003; Panayi, Corrigall, 
& Henderson, 2004; Prohaszka & Fust, 2004; Scheibner et al., 2006; Shi, Evans, & Rock, 2003; 
Stern et al., 2006; Taylor et al., 2004). The relevant “alarm/ danger” signals in the current ABMs 
were ECM degradation products from native collagen type I, elastin and HA.  
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We had attempted to empirically measure hydroxyproline, a component of collagen, in 
laryngeal secretions from the subject pool that participated in the acute human phonotrauma 
study (Verdolini et al., in preparation). Unfortunately, no conclusive results were obtained from 
the hydroxyproline experiment (unpublished data). We had several speculations: (1) 
hydroxyproline was too big to migrate across the epithelial barrier in order to be detected in 
secretions, (2) the time points that we measured were too early (up to 24 hr post baseline) for the 
initiation of collagen synthesis or (3) the vocal loading task did not induce any collagen 
disruption at all. However, we do not exclude the possibility of detecting collagen fragments in 
secretions following surgical trauma, in which the superficial lamina propria would be exposed. 
Ideally, we would like to identify a marker that is sensitive to varying stress levels (from 
low phonatory stress to high surgical stress) and indicates the earliest sign of tissue damage, well 
before conventional indicators or overt histopathologic changes of vocal fold damage can be 
seen. Among all ECM candidates in the current ABMs, HA fragments or low molecular weight 
HA seemed to be the potential surrogate of tissue damage. Collagen and elastin are both 
structural proteins in the vocal folds and are sparsely found in the vocal fold superficial lamina 
propria. These structural proteins may be more resistant to destruction than other ECM proteins 
in the vocal folds, at least within the range of physiological stresses typical of phonatory stresses 
examined in the present series. All in all, the chance of detecting collagen and elastin fragments 
in laryngeal surface secretions following phonotrauma may be slight at best.    
On the other hand, HA is abundant in the superficial lamina propria and has high turn-
over rates (Ward, Thiebault, & Gray, 2002). Thus, we speculate that HA would not be as “inert” 
as its matrix counterparts and may be more promptly degraded even under low levels of 
mechanical stress in phonation, compared to its counterparts in surgical stress. Besides the 
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current ECM markers in our ABMs, other potential candidates exist for assessing tissue damage 
empirically. Further discussion of identifying surrogates for tissue damage is entertained in 
Section 7.4 on “Future Directions and Conclusions”. 
In brief, future work will not only help assess tissue damage from surgical stress; it 
should also be especially worthwhile for the case of repetitive phonatory stress. Nowadays, when 
a patient comes to the clinic with an existing vocal fold lesion, it is impossible for clinicians to 
accurately estimate the degree of tissue damage by looking at the appearance of the vocal folds. 
We assume that the ideal prescription dose for motion-based treatments will vary with tissue 
status. Once an in vivo measuring tool of tissue damage is available, clinicians will be able to 
increase their diagnostic accuracy and prescribe a tailored intervention for patients based on 
current tissue status.   
7.3 CHALLENGES FOR THE CURRENT WORK 
The results from current work are encouraging in terms of the potential translational utility of 
ABM in the setting of vocal fold inflammation. That said, at least two shortcomings are noted, 
(1) challenges in making predictions for subjects with a pre-inflamed mediator profile in 
Experiment 1 and (2) challenges in simulating protein on mRNA data in Experiment 2. 
7.3.1 Challenges in predicting results for subjects with pre-inflamed mediator profiles 
The phonotrauma ABM showed a higher accuracy in predicting inflammatory mediator 
level for Subjects 1 – 3, compared to Subjects 4 – 7 whose data were not used for model 
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calibration. As indicated by biomarker profiles, despite subject reports and clinical observations 
that both voice and larynx were healthy, biological data indicated that Subjects 4 – 7 had pre-
inflamed vocal folds on the day of the experiment. The current phonotrauma ABM primarily 
relied on data and assumptions derived from experimental and clinical studies in “pristine” 
larynges, i.e., without history of traumatization or other forms of noxious exposures. Thus, the 
current phonotrauma ABM may not be applicable for the simulation of populations with 
laryngeal inflammation that existed prior to a discrete phonotraumatic event. This observation as 
well as logic suggest that additional factors are required to augment the model to simulate a more 
diverse patient population. For example, genetic variation and epigenetic factors have been 
suggested to influence the evolving inflammatory state (Lowry & Calvano, 2008). Genetic 
variability in inflammation and wound healing is typically mediated via single-nucleotide gene 
polymorphisms (SNPs) of various inflammatory mediators (Clermont et al., 2004; De Maio, 
Torres, & Reeves, 2005; Imahara & O'Keefe, 2004). SNPs are variations in short 
deoxyribonucleic acid (DNA) sequences. These genetic variants are suggested to be linked to the 
presence of particular diseases, such as, type 2 diabetes, age-related macular degeneration, and 
cardiovascular disease (Jakobsdottir, Gorin, Conley, Ferrell, & Weeks, 2009). Epigenetic factors, 
such as age, gender and ethnicity, may also affect individual’s course and outcome of 
inflammation (G. S. Martin, Mannino, Eaton, & Moss, 2003; van Eijk, Dorresteijn, & Pikkers, 
2008; van Eijk et al., 2007). Future model development may need to include not only 
inflammatory history but also genetic and epigenetic factors in order to simulate various patients’ 
behaviors in reality.   
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7.3.2   Challenges in simulating protein basing on animal mRNA data 
In Experiment 2, the animal surgical ABM was calibrated with mRNA data from a panel 
of inflammatory mediators and ECM substances and then was applied to predict their translated 
protein products. The rationale for using animal mRNA data is presented in Section 5.1.2.5 and 
is not repeated here.  
First, we recognized the concern about whether the mRNA data were adequate to predict 
corresponding protein levels. In the example of TGF-β1, its mRNA stability, translation and/or 
post-translational processing have been reported to be altered by tumor, cytosolic factors or other 
growth factors (Fowlis, Flanders, Duffie, Balmain, & Akhurst, 1992; Fraser, Wakefield, & 
Phillips, 2002; Roberts, 1998; Romeo, Park, Roberts, Sporn, & Kim, 1993). In other words, the 
correspondence of mRNA level to protein level in TGF-β1 is not necessarily 1:1 – an induction 
of TGF-β1 mRNA expression might not result in a stimulation of protein synthesis. Thus, we 
must remain cautious in extrapolating the mRNA results to the predicted protein response in 
Experiment 2. Future work is required to investigate the correspondence between mRNA and 
protein expression in biomarkers related inflammation and healing.  
Second, the other issue is whether animal data can be assumed to be predictive of human 
outcomes. This issue has been a long-standing controversy in biomedical research. Proponents 
have argued that animal models are reasonably predictive of human outcomes in biomedical 
research aimed at preventing, developing cures or alleviating human diseases. Supporting 
arguments for using laboratory animals include at minimum the following considerations: (1) 
animals allow for more controlled environmental and genetic manipulation than humans, (2) 
animal studies often provide unique insights into the pathophysiology and etiology of disease as 
well as novel directions for treatments and (3) animal studies offer a relatively cost-effective way 
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of testing a new drug before testing it in humans  (Hackam, 2007). That said, cautions are still 
warranted in the extrapolation of findings from animal research to the case of humans.  
The major concern is that the use of laboratory animals may not adequately model human 
pathophysiology per se. One example is that chimpanzees are regarded as the closest living 
relatives to humans. According to Darwin's theory of evolution, humans are descended from 
chimpanzee species. Chimpanzees have thus been assumed to be the best available models for 
accurately predicting human outcomes in biomedical research. The genomes between 
chimpanzees and humans differ by only 1 – 2%. However, 80% of chimpanzee proteins are 
different from human proteins, leading to remarkable phenotypic differences between 
chimpanzees and humans (Glazko, Veeramachaneni, Nei, & Makalowski, 2005). Other 
laboratory animal species are expected to have even less genetic and phenotypic similarity to 
humans, making people suspicious of extrapolating findings from animal research for 
understanding human diseases.  
Relative to the setting of the vocal folds, besides anatomical differences between vocal 
folds and larynx, phonatory patterns in terms of voice acoustics and amount of voice use are 
obviously distinct between animals and humans. Also such differences may influence vocal fold 
inflammatory and healing responses. Hence, the use of laboratory animals may inadequately 
mimic vocal fold pathophysiology in humans. At the same time, due to existing technology and 
ethical dilemmas, we cannot subject living humans to multiple vocal fold injuries for the sake of 
research purposes. We can only interpret animal data with caution. Although the road in 
translating research findings from animals to humans is full of hurdles, each small step we are 
taking now has potential to pave the way for critical improvements in the clinical success in 
voice care.  
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7.4 FUTURE DIRECTIONS AND CONCLUSIONS 
Systems biology is a fast advancing field that combines empirical, mathematical and 
computational techniques to enhance understanding of complex biological and physiological 
phenomena. The more that genomics, proteomic, bioinformatics and many other growing fields 
reveal about life, the more apparent it becomes that the current understanding of health and 
disease is not up to the task. Systems biology places biology on a solid mathematical foundation 
to make the task of understanding biological complexity (or understanding “life”) more tractable. 
The work presented here successfully demonstrate the even simple computational models 
(ABMs) can be of practical use in voice care and has profound implications for future studies of 
unraveling the complexity of inflammation and wound healing following vocal fold trauma. 
First, the correspondence of mRNA expression and protein expression for the same panel 
of inflammatory and ECM markers will be investigated in the vocal folds during the course of 
inflammation and healing. At present, most of biological data around vocal fold inflammation 
and healing are mRNA-based. If we pursue to make use of the existing mRNA data for 
improving the ABMs, we will need to formulate a correction factor of converting mRNA values 
to protein values. We expect that at least a time lag is likely present between mRNA expression 
and protein expression of biomarkers. The ABM can then be calibrated with correction factors 
accordingly for the ultimate prediction of functional protein expressions.  
Second, the surrogate of tissue damage for vocal folds will be verified prospectively. The 
current dissertation work implicated that HA fragments may be one of the possible surrogates of 
tissue damage, particularly in the case of vocal fold injury. HA fragments are generated during 
the moment of tissue damage and the subsequent inflammatory response and then are removed 
by activated macrophages in the wound site during the transition of inflammation to healing. In 
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fact, HA fragments, due to its hydrophilic properties, was reported to accumulate in inflamed 
tissues and attribute to edema formation, one of the cardinal signs of inflammation and wound 
repair (D. Jiang et al., 2007; Stern et al., 2006). Failure to remove HA fragments was suggested 
to lead to persistent inflammation and probably scar formation (Gao et al., 2008). Thus, the level 
of HA fragments seem to be sensitively associated with the state of tissues. Assuming HA 
fragments are small enough to pass through the epithelial barrier for secretion samplings, we 
hypothesize that the level of HA fragments in laryngeal secretion could be the indicator of very 
early vocal fold stress/ damage and might be in a good concordance with the evolution of 
underneath tissue state following injury.  
Apart from HA fragments, other possible indicators of tissue damage include but not 
limit to: (1) free deoxyribonucleic acid (DNA) released by apoptotic cells, (2) high mobility 
group box 1 (HMGB1; a nuclear chromosomal protein) released by inflammatory cells, as well 
as (3) lactate dehydrogenase (LDH) released by various cell types. Free DNA and HMGB1 are 
only be secreted when tissue damage is indicated. The expression of LDH, which is the enzyme 
constitutively expressed in cells for inter-conversion of pyruvate and lactate, is remarkably up-
regulated in pathologic conditions. All these three candidates have been consistently documented 
for their presence in a serum of body fluids in other organ injuries and were used as clinical 
measures of tissue damage (Atamaniuk et al., 2008; Brancaccio, Maffulli, Buonauro, & 
Limongelli, 2008; Foell, Wittkowski, & Roth, 2007; Klune, Dhupar, Cardinal, Billiar, & Tsung, 
2008; Palumbo et al., 2004; H. Wang, Yang, & Tracey, 2004; Yang & Tracey, 2005; Yun et al., 
2008). Although speculative, these substances may exist in laryngeal surface secretions (another 
form of body fluids) following vocal fold stress/ injury. Once the biomarker of tissue damage is 
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identified, the data can be used to calibrate and validate the parameter of simulated tissue 
damage in ABMs and improve the model’s prediction accuracy of tissue state.  
In conclusion, this thesis showed significant improvement over previous ABMs and 
satisfactory agreements with theoretical framework of inflammation and healing in sorts of ways. 
ABM represents a powerful computational technique in biological simulation, which provides a 
real framework to put all the pieces of puzzle fit together and produces detailed route maps of 
biological networks. We believe that ABM simulation results can be applied to chart 
individualized healing trajectories and help clinicians to determine when, where, and how to 
intervene disease. The success of this research program will reduce animal testing, have better 
targeted clinical trials and make a reality of personalized medicine.   
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APPENDIX A 
VOCAL FOLD MICROARCHITECTURE 
The purpose of this chapter is to describe the microarchitecture of the vocal folds in the order of 
(1) epithelium, (2) basement membrane zone, (3) lamina propria and (4) macula flava. This 
review is primarily based on human adult models. However, data from animal studies may also 
use as supplementary information when appropriate.  
The vocal folds, which are housed in larynx, have distinctive geometry, histology and 
viscoelasticity for efficient oscillation during phonation. Figure A1 describes the schematic 
multi-layer structure of the vocal folds (Gray, 2000; Gray, Hirano, & Sato, 1993; Gray, Pignatari, 
& Harding, 1994; Gray & Titze, 1988; M. Hirano, 1977, 1981; M. Hirano & Kakita, 1985; M. 
Hirano, Kurita, & Nakashima, 1981; M. Hirano & Sato, 1993). Traditionally, the human vocal 
folds are described as three anatomically distinctive layers: epithelium (0.05 - 0.1 mm thick), 
lamina propria (1.5 - 2.5 mm thick at the middle of the vocal folds) and vocalis muscle (7-8 mm 
thick) (M. Hirano, 1977, 1981; M. Hirano et al., 1981). Later, a very thin layer of the basement 
membrane is identified that connects between vocal fold epithelium and lamina propria (Gray, 
1989; Gray, Pignatari, & Harding, 1994). Each epithelium, basement membrane and lamina 
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propria each has its own special layered structure. For example, the lamina propria can be sub-
divided into: superficial (Reinke’s space), intermediate and deep lamina propria.  
 
 
Vocal fold structure can also be described in different schemas (Figure A1). One schema 
is that the epithelium and the superficial lamina propria are grouped as mucosa, whereas the 
intermediate and deep lamina propria are grouped as vocal ligament (M. Hirano, Kurita, & 
Nakashima, 1981). The other schema is based on the cover-body theory of vocal fold vibration 
(M. Hirano & Kakita, 1985). According to the cover-body theory, the human vocal folds can be 
divided into the cover, the transition zone and the body based on the mechanical property of the 
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Figure A1. Schematic presentation of a coronal view of the left human vocal fold (Gray, Hirano, 
& Sato, 1993; M. Hirano, 1981). 
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vocal folds. The cover is composed of the epithelium and the superficial lamina propria, which is 
pliable, elastic and non-contractile. The body is composed of the vocalis muscle, which is 
contractile to adjust the stiffness and concentration of the mass of the vocal folds. The 
intermediate and deep layers of lamina propria are the transition layer between the cover and the 
body.  
That said, the consensus of the exact boundary of the cover and the body related to the 
anatomical structure of the vocal folds has not been reached yet. The boundary of the transition 
zone is especially in debate. For instance, Dikkers, Hammond et al. and Titze (F. G. Dikkers, 
1994; Hammond, Gray, Butler, Zhou, & Hammond, 1998; I. R. Titze, 1994) do not have the 
transition zone in their cover-body models. Dikkers defines the cover as the composition of the 
epithelium and the superficial lamina propria, with the body as conus elasticus and vocalis 
muscle. On the other hand, Hammond et al. and Titze define the cover as the composition of the 
epithelium, the superficial and intermediate lamina propria. At the same time, Titze defines the 
body as the composition of the deep lamina propria and the vocalis muscle, whereas Hammond 
et al. include these two composites plus the intermediate lamina propria for their definition of the 
body.  
Defining the anatomical boundary of the cover and the body within the lamina propria is 
difficult. The amount of tissue in vibration varies with the mode of phonation, age and gender, 
which affects the involvement of the intermediate lamina propria in the cover (Gray, Titze, 
Alipour, & Hammond, 2000; Hammond, Gray, Butler, Zhou, & Hammond, 1998a; Hammond et 
al., 1998b; Hammond, Gray, & Butler, 2000; I. R. Titze, 1994). Nevertheless, the main idea of 
cover-body theory is that during phonation, the mucosal wave primarily occurs on the pliable 
superficial layer of the vocal folds moving over a more rigid deeper layer. The integrity of the 
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cover is especially critical for proper vocal fold vibration to generate proper voice sound. Injury 
of the cover causes a significant loss of vocal fold volume and geometry as well as vocal fold 
mucosal pliability, leading to voice disturbance (Gray, 1991; Gray, Hammond, & Hanson, 1995; 
Gray & Titze, 1988; Hertegard et al., 2006; S. Hirano et al., 2003; Rousseau et al., 2003; 
Thibeault, Gray, Bless, Chan, & Ford, 2002). 
A.1 EPITHELIUM  
The vocal fold epithelium can be described as a three-layer structure (from superior to inferior): 
the squamous cell layer, the basal cell layer and the basement membrane. The whole epithelium 
of the vocal folds is from 0.05 to 0.10 mm thick (M. Hirano, 1977). The surfaces of the 
epithelium appear corrugated with the presence of microvilli in canine vocal folds under electron 
microscopy (Gray, Titze, & Lusk, 1987). Microvilli are also found on the squamous cell layer in 
human vocal folds (M. Hirano, 1977). The microvilli have three proposed functions: (1) trapping 
laryngeal mucus through the increased surface area of the grooves, (2) providing a better traction 
for vocal fold contact during vibration and (3) holding and spreading the mucous droplets in an 
even layer on the vocal fold surface (Gray, 2000; Gray & Titze, 1988). 
Two different populations of squamous cells are found within the epithelium of the vocal 
folds: respiratory epithelium (pseudostratified squamous) on the superior and inferior aspects of 
the vocal folds and (2) non-keratinizing squamous epithelium on the medial contact surface 
(Gray, 2000). The basal layer, which is right underneath the bottom layer of squamous cells, is 
lined by cubodial cells. The basal layer is attached to the basement membrane through 
hemidesmosomes. 
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Desmosomes are strong attachment structures that connect the epithelial cells as indicated 
in an canine vocal fold model (Gray et al., 1987). Desmosomes provide strength and 
cohesiveness to the surface of the cover of the vocal folds. Interestingly, desmosomes are absent 
on the superficial layers of the epithelium but are abundant in the deeper layers of epithelium in 
canine vocal folds (Gray & Titze, 1988). This unique feature allows normal exfoliation of 
surface squamous cells while provides necessary resistance in the deeper layers against 
mechanical damage during vocal fold oscillation. 
A.2 BASEMENT MEMBRANE ZONE 
The basement membrane zone (BMZ) of the vocal folds is a very thin layer of glycoprotein 
between the epithelium and the superficial lamina propria (Figure A2). The BMZ is composed of 
three layers: lamina lucida, lamina densa and sub-lamina densa. These three layers in 
conjunction with the anchoring filaments and anchoring fibres form an anchoring complex of 
joining two different tissue substrates, the cellular epithelium and the acellular lamina propria, 
together (Courey, Shohet, Scott, & Ossoff, 1996; Gray, 2000; Gray et al., 1994; S. Hirano, Bless, 
Heisey, & Ford, 2003; S. Hirano, Bless, Rousseau et al., 2003). Within the epithelium, basal cells 
attach to each other by desmosomes. However, the underneath superficial lamina propria, which 
is non-cellular, has no desmosome-like attachment structures. Due to heterogeneous 
composition, direct and firm attachment between the basal cells of the epithelium and the lamina 
propria is almost impossible. Therefore, the BMZ exists as an anchoring layer for epithelium-
lamina propria attachment.  
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Anchoring filaments and anchoring fibres, which are in similar collagenous structures,  
are particularly important components for the anchoring function of BMZ. Anchoring filaments 
from the basal cells hold the hemidesmosomes into the lamina densa and the lamina lucida. On 
the other hand, anchoring fibres from the lamina densa loop into the superficial lamina propria 
and then attach back to the lamina densa (Figure A2) (Gray et al., 1994). Further, collagen type 
III fibres and reticular fibres in the superficial lamina propria do not directly attach to the lamina 
densa but pass through the loops of the anchoring fibres in normal human vocal folds (Gray et 
Figure A2. Schematic representation of the layered structure and the identified collagen types of 
the basement membrane zone (Courey, Shohet, Scott, & Ossoff, 1996; Gray, 2000; Gray et al., 1994; S. 
Hirano, Bless, Heisey, & Ford, 2003; S. Hirano, Bless, Rousseau et al., 2003). 
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al., 1993; Gray et al., 1994; Sato, 1998). This unique attachment framework enhances the 
flexibility of the tissue to glide and move (Gray et al., 1993). 
The special collagen network of BMZ-superficial lamina propria is critical to the integrity 
of the vocal fold cover during vibration. Collagen III fibres of the superior lamina propria form a 
chain, which attaches firmly to the vocal fold epithelium. Collagen IV, which is found in lamina 
densa and lamina lucida, provides strength and elasticity of the BMZ. Collagen VII is the main 
component of anchoring fibres and anchoring filaments of the BMZ. Other than collagens, 
laminin and fibronectin are also identified in the BMZ. The functions of these two proteins in 
BMZ are not elucidated yet.   
Repetitive and intense phonation may cause BMZ disruption as indicated in the 
histological examination of phonotraumatic vocal nodules (Gray, 1989, 1991; Gray et al., 1995). 
Some people may be anatomically predisposed to BMZ injury due to the lack of anchoring 
fibres. The density of anchoring fibres are suggested to be genetically linked (Gray et al., 1994). 
In human normal vocal folds, about 80-120 fibres per unit area of BMZ are estimated (Gray et 
al., 1994). If an individual has a recessive form of that gene, the individual may have fewer or no 
anchoring fibres and becomes more at risk of epithelium-lamina propria separation during 
phonation.  
A.3 LAMINA PROPRIA 
The lamina propria is a hypocellular composite of various extracellular matrix (ECM) 
molecules (proteoglycans, collagen, elastin and hyaluronic acid). Lamina propria provides 
essential tissue support and maintains proper viscoelasticity of the vocal folds (Chan, Gray, & 
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Titze, 2001; Gray, 2000; Gray et al., 1993; Gray, Titze, Alipour, & Hammond, 2000; Gray, 
Titze, Chan, & Hammond, 1999; M. Hirano et al., 1981; Thibeault, Bless, & Gray, 2003). Cells, 
such as myofibroblasts, macrophages and fibroblasts, distribute sparsely in various locations 
throughout the lamina propria (Boseley & Hartnick, 2006; Catten, Gray, Hammond, Zhou, & 
Hammond, 1998; M. Hirano, Sato, & Nakashima, 1999a, 2000; Jecker, Ptok, Pabst, & 
Westermann, 1996; Pawlak, Hammond, Hammond, & Gray, 1996).  
The lamina propria is a three-layered structure: superficial, intermediate and deep layers 
(Figure A1). This definition is based on the distribution of elastin and collagen fibres under the 
examination of light microscopy (Hammond et al., 1998; Hammond, Gray, & Butler, 2000; M. 
Hirano, 1977, 1981; M. Hirano et al., 1981) and electron microscopy (Ishii, Yamashita, Akita, & 
Hirose, 2000). The superficial lamina propria contains sparse elastin and collagen fibres, which 
make this layer pliable for mucosal oscillation. The intermediate lamina propria contains more 
elastin and collagen fibres. The deep lamina propria has less elastin but more collagen fibres. 
The intermediate and deep lamina propria constitute vocal ligament, which provide elasticity and 
stiffness for the vocal folds (Figure A1). 
The thickness of each layer of the lamina propria at the mid-portion of the human normal 
vocal folds were reported (M. Hirano et al., 1981). The superficial, intermediate and deep lamina 
propria are about 0.4 -0.5 mm, 0.45 – 0.55 mm and 0.2 – 0.3 mm thick respectively. These 
numbers are in a similar magnitude of order with a later report on the regional depth of the 
lamina propria (Gray, Titze et al., 2000; Hammond et al., 2000). The superficial lamina propria 
consists about 25% – 35% of the total depth of the lamina propria in adults. The intermediate and 
the deep lamina propria consist about 45% - 55% and 20% of the total depth of the lamina 
propria respectively (Gray, Titze et al., 2000).  
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On the other hand, a debate exists whether the layered structure of the lamina propria 
should be defined by the distribution of fibrous protein composition or that of cellular 
composition. This argument is particularly prominent when describing the maturation process of 
paediatric vocal fold lamina propria. In the newborn vocal folds, a layered structure of lamina 
propria and vocal ligament is not yet developed (Boseley & Hartnick, 2006; M. Hirano et al., 
1981; M. Hirano, Kurita, & Nakashima, 1983; Ishii et al., 2000; Sato & Hirano, 1995a; Sato, 
Hirano, & Nakashima, 2001a). Conclusions about the time of the formation of a layered structure 
of lamina propria during maturation are differentiated. The discrepancy may be related to if the 
investigators define the vocal fold layers based on their cellular composition or fibrous protein 
composition.  
One study used light microscopy to measure the depth of cell layer for a group of 
paediatric vocal fold specimens (Boseley & Hartnick, 2006). Results suggest that the superficial 
lamina propria is formed as early as 7 years of age. On the other hand, a study used electron 
microscope to examine the changes in collagen and elastic fibres in newborn vocal folds (Ishii et 
al., 2000).  Their results suggest that the superficial lamina propria is formed until 12 years of 
age.  
Furthermore, a study examined both the cellular and fibrous protein compositions of a 
group of paediatric vocal fold specimens (Hartnick, Rehbar, & Prasad, 2005). A clear 
demarcation between the intermediate and deep lamina propria was seen by 7 years of age in 
terms of differential cell density and population. At the same time, the lamina propria with 
layered and organized composition of collagen and elastin fibres were seen until 13 years of age 
(Hartnick et al., 2005).  
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Therefore, findings from these three studies leave an argument that at which time-point of 
the vocal folds can be regarded as “having a mature structure” during vocal fold development. 
Alternative, a more appropriate question may be “when do the vocal folds possess the same 
biomechanical property as in adult vocal folds during development?”. Future research is 
promising to compare the biomechanical properties of the vocal folds in relation to its structure 
from the populations of 7 year-old and 13 year-old specimens. 
The microarchitecture of the lamina propria from the aspects of vasculature, cellularity 
and extracellular matrix are dissected in the following sections.  
A.3.1 Vasculature of lamina propria 
Ten studies have been carried out to study the vasculature and blood supply of the vocal folds 
(Arnstein, Berke, Trapp, Bell, & Natividad, 1990; Arnstein, Berke, Trapp, & Natividad, 1989; 
Franz & Aharinejad, 1994; Frenzel & Kleinsasser, 1982; Matsuo et al., 1987; Mihashi et al., 
1981; Nakai, Masutani, Moriguchi, Matsunaga, & Sugita, 1991; Sato & Hirano, 1997; Stec, 
Hertegard, & Juto, 2007; Tomita, Matsuo, Maehara, Umezaki, & Shin, 1988). The vocal fold 
vascular structure and blood supply are specialized to withstand the high magnitude and 
frequency of mechanical stresses within the vocal fold tissues during phonation. Figure A3 
shows the schematic representation of the vasculature of the normal human vocal folds (Mihashi 
et al., 1981).  
The vascular architecture of the vocal folds has been studied using light and electron 
microscopes (Mihashi et al., 1981; Nakai et al., 1991). The blood vessels of the superficial 
lamina propria are separated from the vocalis muscle in the human normal vocal folds. On the 
mucosal cover, the blood vessels near the free edge run along the longitudinal axis of the vocal 
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folds and arise from the anterior and posterior ends of the vocal folds (Figure A3-1a). This 
parallel distribution minimizes the circulatory disturbance to the vocal fold movement and also 
allows for smooth blood flow from the anterior end of the vocal folds (Nakai, Masutani, 
Moriguchi, Matsunaga, & Sugita, 1991). At the same time, the blood vessels, which are away 
from the free edge, run upward and medially from deep inside the layer (Figure A3-1b). The 
separation of the vascular network permits optimal flexibility for mucosal oscillation over the 
body of the vocal folds.  
 
 
 
 
Figure A3. Schematic representation of vascular network of the human normal vocal folds (Mihashi et al., 
1981).  
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The vocal fold vascular network is characterised by (1) direct anastomosis between 
arterioles and venules and (2) undulating distribution of blood vessels in both animal and human 
vocal folds (Franz & Aharinejad, 1994; Mihashi et al., 1981). The arteriorvenous anatomosis 
suggests local regulation of blood flow within the vocal folds, which ensures stable and 
sufficient blood supply for the vocal folds. This feature is crucial because ischemic changes may 
occur owing to vocal fold vibration or tissue damage (Franz & Aharinejad, 1994; Mihashi et al., 
1981; Nakai et al., 1991). Furthermore, the endothelium of blood vessels are mechanically 
supported and protected by myocytes, the filaments of endothelial cells, and the basal lamina of 
pericytes. This structural lattice protects the blood vessels from mechanical shearing during 
vocal fold movement (Frenzel & Kleinsasser, 1982; Sato & Hirano, 1997b). 
Regarding the blood supply of the vocal folds, a canine study (Mihashi et al., 1981) 
shows that the blood supply for the mucosal layer are from three peripheral branches of three 
arteries: the superior laryngeal, cricothyroid and interior laryngeal arteries. On the other hand, 
the blood supply for vocalis muscle is from one vessel only: branches of the cricothyroid arteries. 
The blood supply in the vocal folds may be affected by the vibratory movement of the 
vocal folds. A canine study (Mihashi et al., 1981) was set out to estimate the blood flow to the 
vocal folds by measuring local tissue oxygen pressure (Pt02) at rest and during phonation. The 
canines were induced to phonate by various stimuli. Results indicated that Pt02 decreased in both 
mucosal cover and vocalis muscle of the vocal folds during phonation, compared to the rest 
condition. Such ischemic response was less prominent that of the mucosal cover (3.5 ± 1.1 mm 
Hg) than that of the vocalis muscle (15.4 ± 5.8 mm Hg).  
In another canine study, the dogs were induced to phonate by stimulating their recurrent 
laryngeal nerves (Tomita, Matsuo, Maehara, Umezaki, & Shin, 1988). Pt02 is found to decrease 
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in the vocalis muscle with the increase in the frequency of nerve stimulation (10 Hz, 30 Hz and 
60 Hz). On the other hand, Pt02 of the mucosal cover is slightly higher under low-frequency 
stimulation (10 and 30 Hz) and is slightly lower under high-frequency stimulation (60 Hz) of 
recurrent laryngeal nerve. The investigators conclude that: (1) the decrease of Pt02 in vocalis 
muscle is due to muscle contraction; (2) the increase of Pt02 in mucosal cover under low-
frequency stimulation is related to an increase in blood flow by the pumping action of perfused 
blood and (3) the decrease of Pt02 in mucosal cover under high-frequency stimulation is related 
to a decrease in blood flow by other unknown factors. The rapid acceleration and deceleration of 
vocal fold tissue during vibration can be one of the factors that disturb the blood flow in the 
vocal folds (Svec & Sram, 2001; I.R. Titze, 1994).  
However, using Pt02 as an estimate the blood flow may be confounded in these two 
canine studies. Pt02 is a factor of both blood flow and arterial oxygenation. Many variables can 
affect oxygenation, such as, metabolic rate. Therefore, the decrease in Pt02 may be related to the 
increase in oxygen consumption during phonation, rather than a change in blood flow (Arnstein 
et al., 1990; Arnstein et al., 1989).  
A new technology is using laser Doppler flowmetry to measure superficial blood flow by 
positioning the laser bean from the cranial direction to the vocal fold tissues (Stec, Hertegard, & 
Juto, 2007). Researchers reported that from their 53 human subjects with normal vocal folds, the 
velocity of moving blood cells (a measure of blood flow) was significantly lower at 
midmembranous position of the vocal folds than that of at the 2 mm behind midmembranous 
position. Also, male subjects showed significantly higher velocity than that of female subjects. 
Furthermore, smokers also showed significantly higher velocity than that of non-smoker subjects 
at both midmembranous position and 2 mm behind midmembranous position of the vocal folds. 
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Researchers suggested that vasoconstrictions of the vocal folds may be accompanied with 
smoking, leading to an increase of blood flow.   
In any case, no research has been done in human so far to study the particular effects of 
blood flow and oxygenation to the general blood supply for the vocal folds at rest and during 
phonation. This line of research will provide important information how vocal fold vibration can 
influence vasculature of the vocal folds, resulting possible inflammatory response and fluid 
leakage. 
To sum, the vasculature for the mucosal cover is distinctive from those for the vocalis 
muscle. The mucosal cover is the striking site of vocal fold oscillation. Thus, the blood vessels in 
the mucosa need special structures and blood supply to prevent blood vessel rupture and the 
disturbance of blood circulation owing to phonation. 
A.3.2 Cellularity of lamina propria 
Myofibroblasts, macrophages and fibroblasts are the three dominant cell populations in human 
lamina propria (Boseley & Hartnick, 2006; Catten et al., 1998; M. Hirano et al., 1999a, 2000; 
Jecker et al., 1996; Pawlak et al., 1996). Table A1 summarizes the distributions and major 
functions of macrophages, myofibroblasts and fibroblasts in human normal vocal folds.  
On the other hand, side population cells were present in a population of about 0.2% of the 
total number of cells in human vocal folds. Side population cells are suggested to be enriched 
with stem cells and may have important roles in tissue regeneration. These cells were found in 
the epithelium, Reineke’s space and the anterior and posterior maculae flavae of the vocal folds 
(Yamashita et al., 2007).  
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Further, the numbers of other immunocompetent cells, such as mast cells, dendritic cells, 
natural killer cells and T and B lymphocytes are very limited at the mucosa level of the normal 
vocal folds in rats and pigs, compared to the supraglottic and subglottic regions of the laryngeal 
mucosa (Ishida, Yoshida, Iwae, & Amatsu, 2005; Jecker et al., 1996). Research in verifying 
these animal findings with human vocal folds is warranted.  
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Table A1. Summary of cellularity and extracelluar matrix distribution and their major functions of the 
adult human vocal fold lamina propria. Annotation of distribution: “++” = most abundant; “+” = present; “-” = 
minimal/absent.  
    Vocal Ligament 
  Main Functions Superficial 
Lamina 
Propria 
Intermediate 
Lamina 
Propria 
Deep Lamina 
Propria 
Cells      
Macrophages -Immune response to mucosal irritants; 
-regulate the inflammatory response by 
cytokine and growth factor secretion;  
-hyaluronic acid synthesis 
++ 1, 2 + 1, 2 +1, 2 
Myo-
fibroblasts 
-Reparative repair of injury due to normal 
use of vocal folds;  
-repair collagen and elastin;  
-wound contraction 
++ 1, 2 + 1, 2 +1, 2 
Fibroblasts -General  maintenance role: deposition, 
degradation and rearrangement of 
extracellular matrix; 
-synthesize hyaluronic acid with hyaluronan 
synthetase; 
- repair of vocal fold injury 
+ 1, 3, 4 + 1 ++ 1 
Extracellular Matrix  
Fibrous protein    
Collagen I -provide tensile strength around the 
basement membrane and deep lamina 
propria to withstand vibratory forces 
+5, 6, 7 (around the 
basement membrane) 
-7 
+5 
++5, 6, 7 
Collagen III -maintain the structure of the lamina propria; 
-provide flexibility and elasticity to the 
lamina propria 
+ 5, 6, 7 +5, 7 
++6 
+7 
++5, 6 
 
Oxytalan and 
elaunin 
-unknown function in the lamina propria ++8,9 (around the 
basement membrane) 
+8 
-9 
+8 
-9 
Mature 
Elastin fibres 
-provide elasticity to the lamina propria +8 (around the 
basement membrane) 
-9 
++8,9 
 
+8,9 
 
Interstitial element    
Fibronectin -not well-documented in the vocal folds, 
probably maintain and assemble the proteins 
and cells in the extracellular matrix. 
+ 10 No 
information 
No 
information 
Decorin -may bind the collagen fibres and reduce 
their size in the superficial lamina propria 
++11 (around the 
basement membrane) 
++ 11, 12 (in the 
superficial lamina 
propria) 
+11, 12 
 
 
 
+11, 12 
 
 
 
Fibromodulin -may affect the vocal ligament performance 
by binding to the collagen fibres there 
-12 
 
++12 
 
++12 
 
Hyaluronan -act as osmotic regular, tissue-damper and 
shock-absorber for the vocal fold tissue; 
-regulate the viscoelasticity property of the 
vocal folds; 
-contribute to the repair of damaged vocal 
fold tissue 
+8, 13 
Not assessed 14 
 
++8,13, 14, 15 
 
+8, 13,15 
Not assessed 14 
 
1(Boseley & Hartnick, 2006); 2(Catten, Gray, Hammond, Zhou, & Hammond, 1998); 3(M. Hirano, Sato, & Nakashima, 1999a); 4(M. 
Hirano, Sato, & Nakashima, 2000); 5(Hahn, Kobler, Zeitels, & Langer, 2006); 6(Madruga de Melo et al., 2003); 7(T. Tateya, Tateya, & Bless, 
2006); 8(Hahn, Kobler, Starcher et al., 2006); 9(Hammond et al., 1998); 10(Courey, Shohet, Scott, & Ossoff, 1996); 11 (Hahn, Kobler, Zeitels, & 
Langer, 2005); 12(Pawlak, Hammond, Hammond, & Gray, 1996); 13(Butler, Hammond, & Gray, 2001); 14(Hammond, Zhou, Hammond, Pawlak, 
& Gray, 1997); 15 (Lebl, Martins, Nader, Simoes Mde, & De Biase, 2007).  
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A.3.3 Macrophages 
Macrophages play important roles in both innate and adaptive immune response. 
Macrophages (1) ingest the microbes by phagocytosis, (2) act directly as the antigen-presenting 
cells and (3) secrete various cytokines and growth factor to regulate the inflammatory process. 
The location of macrophages were found mainly in the superficial lamina propria for both adult 
and children (7 – 14 years old) vocal fold specimen (Boseley & Hartnick, 2006; Catten et al., 
1998). This specific location suggests that macrophages may assist in combating inflammatory 
agents, such as bacteria, viruses and environmental irritants, crossing the epithelium of the 
respiratory tract. Interestingly, the density of macrophages in the vocal folds may be related to 
the history of the exposure of mucosal irritants. Studies showed that macrophages were absent in 
the 2-day-old and 2-month-old paediatric vocal fold specimens (Boseley & Hartnick, 2006). 
Even for adults, macrophages were only found in one-third of the vocal fold specimens (Catten 
et al., 1998). Other than the involvement of the inflammatory response, a study using 
cytoplasmic staining suggest that macrophages may involve in the synthesis of hyaluronic acid 
for superficial lamina propria as well (Pawlak et al., 1996). 
A.3.4 Myofibroblasts 
Myofibroblasts are differentiated from fibroblasts. Myofibroblasts are specialized for 
tissue repair and are present only when injury occurs. Myofibroblasts have contractile property, 
which make the cells capable of contracting the wound during the remodeling phase 
(Chaponnier, Desmouliere, & Gabbiani, 2006). Similar to macrophages, the density of 
myofibroblasts were the highest in the superficial lamina propria for both adult and children (7 – 
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14 years old) vocal fold specimens (Boseley & Hartnick, 2006; Catten et al., 1998). In vocal 
folds, myofibroblasts are suggested to play roles in (1) reparative repair for the microscopic 
injuries related to daily voice use in normal tissues and (2) constructive repair in pathological 
tissues (Boseley & Hartnick, 2006; Catten et al., 1998; Gray, 2000; Pawlak et al., 1996). 
Particularly, myofibroblasts may involve in the synthesis of extracellular matrix (collagen and 
elastin) and wound contraction for vocal fold tissue repair. 
A.3.5 Fibroblasts 
Fibroblasts are the most abundant cells in the lamina propria of the vocal folds. The cells 
exist in all layers of the lamina propria and have the highest density in the deepest layer of the 
lamina propria in adult vocal folds (Catten et al., 1998). Fibroblasts in the lamina propria 
contribute to both the maintenance of the extracellular matrix and the repair for vocal fold injury 
for all levels of the vocal folds (Catten et al., 1998; Gray, 2000). Most of the proteins in the 
basement membrane zone, namely, microfibrils, are synthesized and assembled by the fibroblasts 
(Gray et al., 1993).  
Besides residing within the lamina propria, fibroblasts are also found in the macula flava 
(Gray et al., 1993; M. Hirano et al., 1999a, 2000). The fibroblasts in these two locations exhibit 
different properties. Under transmission electron microscopy, fibroblasts in the superficial 
lamina propria and those in the macula flava are spindles and stellate in shape respectively (M. 
Hirano et al., 1999). Also, the adult vocal fold fibroblasts in the superficial lamina propria have 
higher nucleus/cytoplasm ratio and less developed rough endoplasmic reticulum and Golgi 
apparatus than those in the macula flava (M. Hirano et al., 1999a). The degree of the 
development of rough endoplasmic reticulum and Golgi apparatus is positively related to the 
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activity of fibroblasts in the synthesis of elastic and collagenous fibres. Therefore, the fibroblasts 
in the superficial lamina propria are suggested to be dormant unless vocal fold injury is 
indicated. At the same time, fibroblasts in the macula flava are believed for active synthesis and 
maintenance of the vocal ligaments. Further research is needed to identify the biochemical 
signalling pathways that may lead to differentiated functioning of these two types of fibroblasts.  
The activity of fibroblast is probably age-specific (M. Hirano et al., 1999a, 2000). For the 
fibroblasts in the superficial lamina propria, the percentage of well-developed rough endoplasmic 
reticulum and Golgi apparatus increased with age-population: new-borns 0%; adults: 10% and 
geriatrics: 20%. Investigators suggest that fibroblasts are in their proliferative phase for the new-
borns and so have less developed rough endoplasmic reticulum and Golgi apparatus. For the 
geriatrics, their fibroblasts are relatively active in the superficial lamina propria than those in the 
macula flava, which may account for the increased thickness of the superficial lamina propria of 
geriatric vocal folds.  
On the other hand, for the fibroblasts in the macula flava, the percentage of well-
developed rough endoplasmic reticulum and Golgi apparatus were the highest in adults (66%), 
intermediate in new-borns (40%) and the least in geriatrics (4%). The active macula flava in 
new-borns may involve in the synthesis of collagenous and elastic fibres for the development of 
the vocal ligament. At the same time, for the geriatric population, the decreased activity of the 
macula flava fibroblasts may account for the atrophy of elastic fibres and deterioration of 
collagenous fibre arrangements in the vocal ligament during the aging process. These findings 
suggest that the aging of human vocal ligament may be related to the inappropriate activity of 
fibroblasts. Specifically, the maintenance role of the vocal folds may be switched from the 
fibroblasts in the macula flava to the fibroblasts in the superficial lamina propria during aging.    
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A.3.6 Extracellular Matrix 
As mentioned earlier, the lamina propria of the human vocal folds are mostly non-cellular (Chan 
et al., 2001; Gray, 2000; Gray et al., 1993; Gray, Titze et al., 2000; Gray et al., 1999; M. Hirano 
et al., 1981; Thibeault et al., 2003). This hypocellular layer is a matrix of fibrous proteins 
(collagens, reticular fibres and elastins) and interstitial elements (proteoglycans, glycoproteins 
and glycoaminoglycan), which determines the physical properties of the vocal folds. The fibrous 
proteins provide shape and form for the lamina propria, whereas interstitial elements regulate 
tissue viscosity, water content, tissue size and shock absorption (Gray, Titze et al., 2000; Gray et 
al., 1999). Interstitial elements are situated in the spaces among the fibrous proteins, whereas 
fibrous proteins runs through the spaces (Sato, 1998). Extracellular matrix is important to 
maintain and modulate the viscoelastic properties of the vocal fold lamina propria, which 
subsequently affects the vocal fold vibratory behaviour. Table A1 summarizes the distributions 
and main functions for each extracellular matrix component identified in the human vocal fold 
lamina propria. 
A.3.7 Fibrous proteins (collagen, reticular fibres and elastin) 
Collagen and elastin are the structural proteins for extracellular matrix in the vocal fold 
lamina propria. The distribution of collagen and elastin defines the three layers of the lamina 
propria (M. Hirano et al., 1981) and also determines the mechanical property of the lamina 
propria that in turn affects vocal fold vibratory behaviour. The superficial lamina propria consists 
of sparse and loose fibrous proteins. The intermediate and deep lamina propria are mainy 
composed of elastic fibres and collagenous fibres respectively (Gray et al., 1993).  
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Numerous reports have been published recently to advance our understanding of the 
ultrastructure and distribution of fibrous proteins within the lamina propria of the vocal folds 
(Gray, Chan, & Turner, 2000; Gray, Titze et al., 2000; Hahn, Kobler, Starcher, Zeitels, & 
Langer, 2006; Hahn, Kobler, Zeitels, & Langer, 2006; Hammond et al., 1998b; Hammond et al., 
2000; Hammond, Zhou, Hammond, Pawlak, & Gray, 1997; Madruga de Melo et al., 2003; T. 
Tateya, Tateya, & Bless, 2006, 2007). Research about quantification of fibrous proteins, 
identification of fibrous protein subtypes and their distributions across the lamina propria are of 
particular interest.  
Collagen and reticular fibres. 
Studying collagen in human vocal folds has been a challenge. Collagen was thought to 
lose their antigenicity quickly, which made collagen-specific studies unreliable (Gray, Titze et 
al., 2000). However, recent studies indicate that the antigenicity of collagen is not a problem at 
all (T. Tateya, I. Tateya, & D. M. Bless, 2006; T. Tateya et al., 2007). These studies successfully 
identified the collagen subtypes by using immunohistochemistry. The investigators suggest that 
the success of immunohistochemistry depends on the quality of antibodies and the method of 
tissue preparation. As long as the tissue specimen is obtained within 24 hours post-mortem, the 
reliability of collagen immunolabelling is guaranteed.  
Initial observations suggest that most of the collagen is present in the deep layer of the 
lamina propria (Hammond et al., 2000; M. Hirano et al., 1981). The collagen distributions across 
the lamina propria were quantified by two studies (Hahn, Kobler, Zeitels et al., 2006; Hammond 
et al., 2000). Hammond et al. (2000) reported the relative density of collagen in human lamina 
propria with respect to age and gender. Results showed that collagen was found in the region 
immediately below epithelium and the vocalis muscle. Also, the collagen density was more 
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gender-related than age-related. The adult male vocal folds had about 131.5% of the collagen 
found in female adult vocal folds. On the other hand, Hahn et al. (2006) quantified the collagen 
levels by measuring the absolute amount of tissue hydroxyproline (mg collagen per mg total 
protein) across the lamina propria. Their results showed that collagen made up 43.4% ± 2.6% of 
total protein in human lamina propria. Adult males had approximately 130% of the adult female 
total collagen content in the lamina propria, which generally agree with Hammond et al.’s 
results. Furthermore, the collagen levels in the superficial third, intermediate third and deep third 
regions of the lamina propria (defined by a Mat-lab program) were approximately 0.27, 0.32 and 
0.71 mg per milligram of total protein respectively, which again agreed with the previous 
Hammond et al.’s report.  
Regarding the distribution of collagen subtypes in human vocal folds, collagen types I 
and III are identified in the lamina propria (Gray et al., 1993; Hahn, Kobler, Zeitels et al., 2006; 
Madruga de Melo et al., 2003; T. Tateya, I. Tateya, & D. M. Bless, 2006; T. Tateya et al., 2007). 
Collagen types I and III are the fibrillar collagen, which are made up of tropocollagen units. 
These collagens are nonelastic, i.e., they do not stretch well. Also, collagen types I and III are in 
coil-like shape, which give expansibility and resilience to the lamina propria. Also, these 
collagens are oriented longitudinally from anterior to posterior. This orientation may allow the 
collagens to bear stress and resist deformation while withstanding vibratory forces during 
phonation (Gray, Titze et al., 2000).  
The distribution of collagen types I and III in human vocal folds remain controversial. A 
study used a picrosirius polarization method to examine the distribution and orientation of 
collagen type I and collagen type III in human vocal folds (Madruga de Melo et al., 2003). Their 
results suggest that collagen type I and type III form an organized “wicker-basket-like” network 
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immediately below the epithelium and also a high density network in the deep lamina propria. In 
contrary, a loose and delicate network of collagen type III fibres was indicated in the 
intermediate lamina propria. The investigators conclude that the network of collagen type I and 
type III allows the lamina propria to be stabilized during vibration but also provides flexibility to 
the structure to deform without stretching the collagens. Furthermore, the investigators claim that 
collagen type I fibres are thick and strong, whereas collagen type III fibres are thin and weak in 
the lamina propria.  
However, several studies suggest that collagen type III is the predominant type of 
collagen and appear to make up the thick collagenous fibres in the lamina propria (Gray et al., 
1993; Hahn, Kobler, Zeitels et al., 2006; T. Tateya, I. Tateya, & D. M. Bless, 2006). Tateya et al. 
(T. Tateya, I. Tateya, & D. M. Bless, 2006; T. Tateya et al., 2007) used immunohistochmistry 
and immno-scanning electron microscope to examine the collagen subtypes in the vocal folds. 
Their results show that collagen type I  is relatively thin in structure (T. Tateya, I. Tateya, & D. 
M. Bless, 2006; T. Tateya et al., 2007) and is located in the basement membrane and the deep 
lamina propria (Hahn, Kobler, Zeitels et al., 2006; T. Tateya, I. Tateya, & D. M. Bless, 2006; T. 
Tateya et al., 2007). The distribution of collagen type I indicate that the collagen may contribute 
to the shape of the lamina propria and the tensile strength for the basement membrane and the 
deep lamina propria when subjected to vibratory forces. Most importantly, their results indicate 
that the large bundles of collagen fibres in the vocal fold lamina propria are not collagen type I 
but collagen type III. 
Collagen type III is distributed throughout the lamina propria (Hahn, Kobler, Zeitels et 
al., 2006; T. Tateya, I. Tateya, & D. M. Bless, 2006; T. Tateya et al., 2007) and is organized in 
both thin fibres and wavy and thick fibres (T. Tateya, I. Tateya, & D. M. Bless, 2006). Both thin 
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and thick collagen type III fibres were speculated as reticular fibres and collagenous fibres in 
vocal fold lamina propria respectively (Sato, 1998; T. Tateya, I. Tateya, & D. M. Bless, 2006). A 
later study using immuno-scanning electron microscopy confirms that reticular fibres are 
composed of both collagen type I and type III, whereas the collagenous fibres are composed of 
collagen type I (T. Tateya, Tateya, & Bless, 2007). Reticular fibres are reported to locate in the 
superficial and intermediate layers of the lamina propria of the vocal fold mucosa, especially 
around the vocal fold edge (Sato, 1998). The spaces of the reticular fibres are filled with 
interstitial elements and elastic fibres running through the spaces (Sato, 1998). The network of 
the reticular fibres, interstitial elements and elastic fibres contributes to the biomechanical 
properties of the vocal fold lamina propria. Nevertheless, both thick collagen type III and thin 
collagen type III are important to give the structure and flexibility to the lamina propria.  
Elastin.  
Elastin is the other important structural protein of the vocal fold lamina propria. Recall 
that collagen mainly gives strength and structure to the lamina propria, elastin contributes to the 
elasticity and resilience of the vocal folds. Elasticity and resilience enable the vocal fold tissue to 
be deformed and to return to the original shape when subjected to the vibratory force. Elastin 
materials can be classified into 3 types depending on their elastin-to-fibril ratio: (1) oxytalan (no 
elastin), (2) elaunin (intermediate elastin-to-microfibril ratio) and (3) mature elastic/elastin fibres 
(high elastin-to-microfibril ratio) (Kielty, Sherratt, & Shuttleworth, 2002). Oxytalan is solely 
composed of microfibrils with 10 - 12 nm in diameter. Elaunin has microfibrils and a small 
elastin amorphous component. Mature elastin fibres have high elastin amorphous component as a 
core surrounding by the microfibrils. The high ratio of the elastin component makes the mature 
elastin fibres the most elastic (Kielty et al., 2002). In the vocal fold lamina propria, the elastin 
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fibres are able to be stretched to about two times of their original length and then return to the 
original length after removal of the stretching force. This elastic property is known to be 
important for the proper vocal fold vibration (Gray et al., 1993; Gray, Titze et al., 2000).  
The distribution of elastin materials (all types) in the human lamina propria are described 
in several histological studies (Hahn, Kobler, Starcher et al., 2006; Hammond et al., 1998b; 
Hammond et al., 2000; Hammond et al., 1997; T. Tateya, I. Tateya, & D. M. Bless, 2006), 
whereas the structure and orientation of elastin are examined by electron miscroscopy 
(Hammond et al., 1997; Ishii et al., 2000; Sato & Hirano, 1997a). A general notion is that elastin 
materials are present throughout all layers of the lamina propria but each type of elastin materials 
has different density across the lamina propria (Gray, Chan et al., 2000; Gray, Titze et al., 2000; 
Hahn, Kobler, Starcher et al., 2006; Hammond et al., 1998b; Hammond et al., 2000; Hammond 
et al., 1997).   
Regarding the distribution of elastin materials (all types) in the lamina propria, 
fluorescent elastin materials are found throughout the lamina propria with intense amount in the 
superficial lamina propria immediately below the basement membrane (Gray, Titze et al., 2000). 
This observation is substantiated by another study using immunohistochemistry (T. Tateya, I. 
Tateya, & D. M. Bless, 2006). Elastin materials are found in the superficial lamina propria 
around the basement membrane and in the intermediate and the deep lamina propria as well as 
macula flava. One study quantified the concentration of elastin materials by measuring the amino 
acid desmosine level in the human lamina propria (Hahn, Kobler, Starcher et al., 2006). The 
desmosine levels in the superficial third, the intermediate third and the deep third of the lamina 
propria were approximately 1.1, 2.9 and 4.1 picomoles per mg total protein respectively. Also, 
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the elastin materials constituted approximately 8.5% ± 2.1%, 6.0% ± 0.7%, and 7.5% ± 1.2% of 
human lamina propria total protein.  
The distribution of elastin subtypes have been studied using elastin-van Gieson staining 
and electron microscopy methods (Hammond et al., 1998; Hammond et al., 1997). Results 
suggest that oxytalan and elaunin are dominant in the superficial lamina propria, whereas mature 
elastin fibres are intense in the intermediate and deeper layers of the lamina propria. The 
population density of mature elastin fibres in the lamina propria may be age-related. Infant vocal 
folds have about 23% of the elastin found in adults and geriatric vocal folds have about 879% of 
the elastin found in adults (Hammond et al., 1998). 
The identification of oxytalan and elaunin has been a challenge. Only mature elastin fibre 
is stained well and displays as fibre form with elastin-van Gieson (EVG) staining. To identify 
oxytalan and elaunin, investigators can only make speculation about their presence if a specimen 
shows EVG staining but the staining pattern is not in fibre form under the examination of 
electron microscopy (Gray, Titze et al., 2000; Hammond et al., 1998).  
An alternative method is to use fibrillin-1 staining together with elastin staining (Hahn, 
Kobler, Starcher et al., 2006) to differentiate the oxytalan from the elaunin and mature elastin 
fibres. Relatively strong fibrillin-1 staining but weak elastin staining suggests oxytalan (no 
elastin component). In contrary, relatively weak fibrillin-1 staining but strong elastin staining 
suggest the elaunin or mature elastin fibres (relatively high elastin component). Hahn et al. 
(2006) reported that the superficial lamina propria, especially the region immediately below the 
basement membrane, had high fibrillin-1 staining relative to that of elastin. This observation 
indicates the presence of oxytalan in the superficial lamina propria. At the same time, the 
intermediate lamina propria had relatively weak fibrillin-1 staining but strong elastin staining, 
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which indicates the presence of elaunin or mature elastic fibres. However, the investigators did 
not explain how to differentiate elaunin from the mature elastic fibres in their protocol.  
In sum, the localization of the elastin materials is layer-specific. The least-elastic forms 
of elastin (oxytalan and elaunin) are present in the matrix of the superficial lamina propria. The 
mature elastin fibres are intensely present in the intermediate lamina propria.  
A.3.8 Interstitial elements (glycosaminoglycan, proteoglycans and glycoproteins) 
Glycoaminoglycan (hyaluronic acid), glycoprotein (fibronectin) and proteoglycan 
(decorin and fibromodulin) are the well-studied interstitial elements in the human vocal fold 
lamina propria. (Barbosa et al., 2008; Gray, 2000; Gray et al., 1993; Hahn, Jao, Faquin, & 
Grande-Allen, 2008; Hahn et al., 2005; Hirschi, Gray, & Thibeault, 2002; Lebl et al., 2007; 
Pawlak et al., 1996; Ward, Thiebault, & Gray, 2002)These elements constitute the extracellular 
matrix and modulate the viscosity of the vocal folds. Interstitial elements are closely associated 
with fibrous proteins (collagen and elastin). The elements may bind fibrous proteins to alter the 
mechanics of collagen and elastin fibres (Pawlak et al., 1996). For instance, decorin and 
hyaluronic acid have influence over collagen fibril formation to alter the viscoelastic properties 
of the vocal fold lamina propria (Gray, Chan, & Turner, 2000). Table A1 summarizes the 
distribution and major functions of the interstitial elements in the human vocal fold lamina 
propria.  
Glycoproteins: Fibronectin.  
In human normal vocal folds, fibronectin is abundant in amount (Gray et al., 1995). A 
microarray study reported that the genes of fibronectin are up-regulated over four-fold in the true 
 175 
vocal folds than those in the false vocal folds (Hirschi, Gray, & Thibeault, 2002). Another study 
using immunohistochemical staining reported that fibronectin is particularly abundant in the 
superficial lamina propria of the normal vocal folds (Courey et al., 1996).  
Fibronectin is an adhesive glycoprotein that has binding sites for fibrin (collagens), 
glycosaminoglycan (hyaluronic acid) and cells (fibroblasts and endothelial cells). Fibronectin 
play roles in: (1) extracellular matrix formation and organization, (2) mediating cell-cell and cell-
matrix interactions and (3) being chemoattractant for inflammatory cells and fibroblasts 
(Couchman, Austria, & Woods, 1990; Grinnell, 1984; Grinnell, Toda, & Takashima, 1988). A 
study suggest that fibronectin may contribute more to assemble and maintain the proteins and 
cells in the extracellular matrix, rather than shear-bearing for the vocal fold mucosa (Chan & 
Titze, 1999). Fibronectin also plays an important role in wound healing. After tissue injury, 
fibronectin is deposited on the damaged tissue and form a scaffold, which enhances fibroblast 
migration and collagen deposition (Grinnell, 1984; Grinnell et al., 1988). Benign vocal fold 
lesions are reported to have an increased level of fibronectin within the lamina propria (Courey 
et al., 1996; Gray et al., 1995; Thibeault, Gray, Li et al., 2002). 
Proteoglycans: Decorin and Fibromodulin. 
Decorin and fibromodulin are the small chain proteoglycans identified in the human 
vocal fold lamina propria (Gray et al., 1999; Pawlak et al., 1996). These small chain 
proteoglycans are composed of a leucine-rich protein core and a glycosaminoglycan chain. 
Decorin and fibromodulin bind to and interact with collagen types I and II fibrils with different 
binding sites in other tissue domains (Goetnick, 1991; Hardingham & Fosang, 1992; Oldberg, 
1993). The presence of decorin and fibromodulin in the extracellular matrix may delay collagen 
fibril formation and yield thinner and smaller collagen fibrils (Hardingham & Fosang, 1992).  
 176 
Although decorin and fibromodulin have similar structure and function, their locations in 
the vocal fold lamina propria are different. Decorin is intensely present in the superficial lamina 
propria, whereas fibromodulin is primarily present in the intermediate and the deep lamina 
propria (Gray et al., 1999; Hahn et al., 2005; Pawlak et al., 1996). Table A1 summarizes the 
locations and major functions of decorin and fibromodulin in human normal vocal fold lamina 
propria.  
Decorin. 
Decorin was first identified in the superficial lamina propria in a human study using 
immunohistochemical methods (Pawlak et al., 1996). This finding is substantiated by a later 
study (Hahn et al., 2005). Decorin is found intensely in both the superficial and deep lamina 
propria, whereas the decorin stain is more intense in the superficial lamina propria of human 
vocal folds. At the same time, decorin is minimally present in the intermediate lamina propria.  
The functions of decorin in the vocal folds remain speculative. In other tissues, decorin 
binds to the collagen type I and II fibrils and change their kinetics of formation and assembly, 
resulting the reduction of the collagen fibril size (Goetnick, 1991; Hardingham & Fosang, 1992; 
Oldberg, 1993). Interestingly, within the vocal fold superficial lamina propria, intense decorin is 
present (Gray et al., 1999; Hahn et al., 2005; Pawlak et al., 1996) with sparse and thing collagen 
fibres (Sato, 1998). Speculatively, decorin may inhibit the collagen fibre formation in the 
superficial lamina propria resulting the sparse population of collagen fibres in that layer (Gray et 
al., 1999).  
Fibromodulin. 
Fibromodulin is present in the intermediate and the deep layers of lamina propria. 
Specifically, the staining pattern of fibromodulin demarcates an area that correlates with the 
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vocal ligament (Gray et al., 1999; Pawlak et al., 1996). The identification of fibromodulin in the 
vocal folds has been a challenge. First, fibromodulin analysis requires fresh-frozen tissue or the 
antigenicity is lost. Second, the distribution of fibromodulin is highly variable across individuals 
(Hahn et al., 2005). Hahn et al. (2005) used the antibodies of keratin sulphate, which is the 
glycosaminoglycan attachment of fibromodulin, to locate the fibromodulin in the vocal fold 
lamina propria (Hahn et al., 2005). The results of the intensity and location of keratin sulphate 
stain are inconclusive due to the extreme variations across their human tissue specimens. 
Interestingly, these findings are against the earlier results of Pawlak et al.’s (1996) study, in 
which the keratin sulphate stain are consistently found in the vocal ligament across their human 
tissue specimens (Pawlak et al., 1996).  The contradiction may be related to the age and gender 
of the human specimens between these two studies. Unfortunately, Pawlak et al. (1996) did not 
report the information of their specimens and thus the factors of age and gender on the 
distribution of fibromodulin remain speculative.  
Regarding the functions of fibromodulin in the vocal folds, fibromodulin may be closely 
associated with the surrounding collagen and elastin to maintain the tensile strength and support 
the architecture of the vocal ligament. Further, fibromodulin may lubricate the collagen and 
elastin fibres of the vocal ligament to promote tissue ligament performance for various vocal 
functions (Gray et al., 1999; Pawlak et al., 1996). 
 Glycosaminoglycan: Hyaluronan.  
Hyaluronan or hyaluronic acid is a non-antigenic, negatively-charged, hydrophilic, and 
high-molecular mass (about 100 – 5,000 kilodaton) glycosaminoglycans or mucopolysaccharides 
identified in the extracellular matrix of the vocal fold lamina propria (Butler, Hammond, & Gray, 
2001; Hahn, Kobler, Starcher et al., 2006; Laurent & Fraser, 1992; Pawlak et al., 1996). In the 
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vocal folds, the stellate cells in the macula flava as well as the fibroblasts and macrophages in the 
superficial lamina propria have been suggested to produce hyaluronan acid (Hallen, Dahlqvist, & 
Laurent, 1998). One study investigated a cell surface receptor for hyaluronan, CD44, and its 
relationship to the distribution of hyaluronan in human vocal folds (Sato, Sakamoto, & 
Nakashima, 2006). Results show that many of the stellate cells in the macula flava are stained 
with CD44, whereas sparse fibroblasts in adult Reinke’s spaces are stained with CD-44. Also, 
abundant hyaluronan is around the stellate cells in the macula flava, which suggests that the 
stellate cells can be the main cell source of producing hyaluronan in human vocal folds. Another 
study also indicated HA was concentrated in the anterior and posterior macula flava, esp in the 
middle and deep layers, in a male individual (Barbosa et al., 2008). CD-44 receptors were mainly 
accumulated in the vocal fold epithelium but very few in Reinke’s space.  
The half-life of hyaluronan is short, which is about 3-5 days in rabbit vocal folds (Hallen 
et al., 1998). Hyaluronan appears as globular, porous and loosely folded (Laurent & Fraser, 
1992). Also, hyaluronan is able to form highly polarized chains in the extracellular matrix to 
attract and regulate water content of the surrounding tissues (Ward, Thiebault, & Gray, 2002). 
Hyaluronan has multiple functions. First, hyaluronan regulates cell proliferation and 
differentiation, molecular transport, inflammation, angiogenesis and wound healing in the 
surrounding tissues. Second, hyaluronan acts as interstitial “filler” materials that surround the 
fibrous component (collagen and elastin fibres) within the extracellular matrix of the vocal folds. 
Third, hyaluronan is negative-charged, random-coiled and osmotic-active macromolecule that 
attracts water and cations. Therefore, hyaluronan has the capacity to regulate tissue osmosis, 
tissue viscosity and tissue flow in order to alter the volume of tissue it surrounds. The space 
filling as well as osmotic and viscosity regulation functions are particularly crucial for the vocal 
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folds because these functions directly influence the thickness and viscoelasticity of the vocal fold 
mucosa and subsequently the vocal fold performance (Butler et al., 2001; Chan et al., 2001). 
Further, these capacities allow hyaluronan to act as a shock absorber to resist compression as 
well as a tissue damper to dissipate stress during phonation for vocal fold tissue. Shock 
absorption and stress dampening are important for protecting the vocal fold edges from 
phonotrauma (Butler et al., 2001; Gray et al., 1999; Laurent, Laurent, & Fraser, 1995).  
In addition to the roles of shock absorber and tissue damper, hyaluronan has been shown 
to have biochemical roles in the regulation of the vocal folds’ viscoelasticity (viscosity and 
elasticity) (Chan et al., 2001; Chan & Titze, 1999). Optimal viscosity and elasticity of the vocal 
folds are necessary to initiate and sustain phonation (Chan et al., 2001; Chan & Titze, 1999). The 
effects of hyaluronan on vocal fold viscosity and elasticity were quantified by measuring the 
biomechanical properties of the vocal folds with and without hyaluronan (Chan & Titze, 1999). 
After removing hyaluronan from the lamina propria of human vocal folds in vitro, the stiffness of 
the vocal fold cover decreased by 35% on average, whereas the dynamic viscosity of the vocal 
fold cover at high frequencies (>1 Hz) increased by 70% on average. These results indicate that 
hyaluronan likely contributes to maintain optimal conditions necessary for phonation. Also, 
hyaluronan may contribute to the regulation of tissue stiffness that is essential for vocal 
fundamental frequency control. Generally speaking, a higher concentration of hyaluronan in the 
tissue increases tissue viscosity and gives the tissue more dampening and shocking absorbing 
properties (Chan et al., 2001; Chan & Titze, 1999).  
Regarding the distribution, hyaluronan is present throughout the extracellular matrix of 
the lamina propria and is slightly more concentrated in the intermediate layer (Butler et al., 2001; 
Hahn, Kobler, Starcher, Zeitels, & Langer, 2006; Hammond et al., 1997; Lebl et al., 2007). An 
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immunohistochemical study used Enzyme-Linked ImmunoSorbeny Assay (ELISA) to quantify 
the hyaluronan concentrations across the lamina propria of human vocal folds (Hahn, Kobler, 
Starcher et al., 2006). The hyaluronan concentrations in the superior-third, intermediate-third and 
deep-third of the depths of the lamina propria were estimated as 7.4, 8.7 and 8.5 μg/mg total 
protein respectively. A follow-up study using flurophore-assisted carbohydrate electrophoresis 
showed that normal human vocal folds contained approximately hyaluronan 6.4 +/- 4.1 μg of 
hyaluronan per milligram of total proteins within lamina propria.  (Hahn, Jao, Faquin, & Grande-
Allen, 2008). 
In addition to the layer-specific distribution pattern, the concentration of hyaluronan in 
the lamina propria of the normal human vocal fold is also gender-dependent. One study 
quantified the amount of hyaluronan in the lamina propria in 18 normal adult human vocal folds 
(10 males, 8 females; age range 20-60 year-old) using the acid mucopolysaccharide staining 
method (Hammond et al., 1997). Only the midsections of the membranous vocal folds were 
stained for hyaluronan and the slides were compared using computer imaging software. Despite 
of moderate individual variability in the hyaluronan content per area, male subjects had 
approximately three-fold higher hyaluronan than the female subjects. The individual variability 
may be due to the fact that only the midsections of the vocal folds were analysed.  
Another study used the same staining method to quantify hyaluronan throughout the 
complete depth of the lamina propria at the vocal fold’s leading edge and to examine the age- 
and gender-related effects (Butler et al., 2001). In general, the distribution of hyaluronan is more 
gender-related than age-related. Female subjects had relatively less hyaluronan in the more 
superficial areas (0%-15% depth of the total lamina propria) and had more hyaluronan in the 
deeper areas (40%-100% depth of the total lamina propria). At the same time, male subjects 
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showed a relatively uniform distribution pattern throughout the depth of the lamina propria. 
Furthermore, the male subjects had approximately two-fold higher hyaluronan content than the 
female subjects had in the superficial lamina propria, which corroborates with Hammond et al.’s 
(1997) findings. The noted gender difference in hyaluronan distribution may suggest the male-
female differences in the occurrence of phonotrauma. If the concentration of hyaluronan is 
higher in tissue, the viscosity of the tissue is higher and gives more dampening and shock 
absorbing properties for the tissue. The less hyaluronan in the more superficial areas of the 
female vocal fold may lead to less shock-absorbing and tissue-dampening as well as wound 
healing capability of the tissue against phonotrauma. This finding may explain why 
phonotrauma, clinically, is more common in women than in men (Miller & Verdolini, 1995; Roy 
et al., 2004; Smith, Kirchner, Taylor, Hoffman, & Lemke, 1998). 
Interestingly, another study, which used hyaluronan-binding proteins (HABP) from 
bovine cartilage to detect hyaluronan in human adult vocal folds, reported contradictory results 
(Lebl et al., 2007). Women vocal folds showed approximately two-time higher hyaluronan 
concentrations than that in male vocal folds overall. In studies of Butler et al. and Hammond et 
al., indirect histological method was used to measure HA concentrations, i.e., compare the 
different of staining intensities between tissue samples treated and without treated with 
hyaluronidase. This method did not directly measure HA concentrations in tissue samples and 
may be interference by other GAG proteins. Lebl et al. suggested that HABP used in their study 
provided specific binding to hyaluronan and eliminated the interference of other GAG proteins. 
Further, the researchers acclaimed that the high concentration of HA in female vocal folds may 
act as a protective factor for increased impact-absorption capacity against the production of high-
frequency sounds.  
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A.4 MACULA FLAVA 
The macula flava are situated at the anterior and posterior ends of the intermediate lamina 
propria of the human vocal fold (Sato & Hirano, 1995a, 1995b; K. Sato, M. Hirano, & T 
Nakashima, 2003a). The anterior macular flava forms an oval mass at the anterior end of the 
intermediate lamina propria, which is connected to the anterior commissure of the thyroid 
cartilage. The posterior macula flava is located at the posterior end of the intermediate lamina 
propria, which is connected to the vocal process of the arytenoid cartilage (M. Hirano & Sato, 
1993; Sato & Hirano, 1995). The macula flava form the visible mucosal bulges as seen as 
whitish yellow masses. The macula flava are about 1.5 x 1.5 x 1.0mm in size (Sato & Hirano, 
1995). The functions of the macula flava in human vocal folds are unclear. The macula flava 
may play roles in (1) shock-absorption during phonation, (2) producing elastic and collagenous 
fibres for develop and maintain vocal ligament, (3) regulating the metabolism of extracellular 
matrix for growth, development and aging of the vocal fold mucosa; and (4) inducing 
inflammatory and wound healing responses for the injured vocal folds (Fuja, Probst-Fuja, & 
Titze, 2005a, 2005b; M. Hirano et al., 1999a, 2000; Sato & Hirano, 1995a, 1995b; Sato, Hirano, 
& Nakashima, 2001b; Sato et al., 2003a; K. Sato, M. Hirano, & T. Nakashima, 2003b; Sato & 
Nakashima, 2005; Sato et al., 2006). 
The light and electron microscopic examinations indicate that the macula flava are 
composed of dense fibrous tissue (elastic and collagenous fibres) and ground substance (M. 
Hirano & Sato, 1993; Sato & Hirano, 1995). Three-dimensional imaging supports this 
observation in which numerous elastic, collagenous and reticular fibres are found to run in 
various directions within the human macula flava and to extend to the lamina propria of the vocal 
folds (K. Sato, M. Hirano, & T Nakashima, 2003a). Also, abundant hyaluronic acid is located 
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among the spaces of the fibrous tissue, which enhances shock absorption during phonation (Sato 
et al., 2003a; Sato et al., 2006).  
Regarding the cellularity, Sato et al. (K. Sato, M. Hirano, & T. Nakashima, 2003b) 
discovered a novel cell type in the macula flava, namely, “vocal fold stellate cells”. These cells 
are not identified in the lamina propria but are abundantly present in the macula flava. Vocal fold 
stellate cells compose 82% of the total cells in adult macula flava (M. Hirano et al., 1999a). The 
vocal fold stellate cells have a fibroblast-like structure but have different morphology and 
functions from the fibroblasts in the superficial lamina propria.  
First, the vocal fold stellate cells have smaller ratio of nucleus and cytoplasm and well-
developed intracellular organelles (rough endoplasmic reticulum and Golgi apparatus), compared 
to the fibroblasts in the superficial lamina propria (M. Hirano, Sato, & Nakashima, 1999b; Sato, 
Hirano, & Nakashima, 2001).  
Second, vitamin A-containing lipid droplets are found in the cytoplasm of the vocal fold 
stellate cells (Sato et al., 2003b). Vitamin A in the stellate cells: (1) can be a morphogen that 
controls the cell differentiation and morphogenesis, (2) involve in the induction of transforming 
growth factor-β that stimulates the synthesis of extracellular matrix substances, and (3) strongly 
affects the activity of adenosine triphosphase sulphurylase that related to the synthesis of 
glycosaminoglycan, i.e., hyaluronan in the vocal fold lamina propria (Fuja et al., 2005a, 2005b; 
Glick, Flanders, Danielpour, Yuspa, & Sporn, 1989; Sato et al., 2003a; Sato & Nakashima, 
2005).  
Lastly, vocal fold stellate cells are surrounded by dense reticular fibres and hyaluronan 
(Sato et al., 2001a; Sato & Nakashima, 2005). This observation suggests that stellate cells 
actively and constantly synthesize the extracellular matrix substances, including elastin, 
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collagenous and reticular fibres and hyaluronan under normal conditions of the vocal folds (M. 
Hirano et al., 1999a).  
On the other hand, vocal fold stellate cells have a dual-phenotype (Amir & Kishon-
Rabin, 2004; Fuja et al., 2005a, 2005b). In their resting state, the cells maintain vitamin A in the 
intracellular lipid droplets and have stellate morphology. After a cultured-induced process of 
activation or transdifferentiation, vocal fold stellate cells increase their proliferation, lose vitamin 
A and lipid droplets and express the activated marker of α-smooth muscle actin. Subsequently, 
the activated vocal fold stellate cells express significantly high levels of collagen type 1α1 and 
type III, decorin, laminin-β, matrix metalloproteinase-2 and -14, tissue inhibitors of matrix 
metalloproteinase-1 and -3, connective tissue growth factor, transforming growth factor-β1, 
platelet derived growth factor receptor-β, hyaluronic acid synthase 2, hyaluronidase II, 
plasminogen activator inhibitor I, and peroxisome proliferator-activated receptors γ and β/δ, 
compared to the control fibroblasts from trachea. Also, vocal fold stellate cells show a well-
organized actin cytoskeleton as myofibroblast-like phenotype after culture-induced activation 
(Fuja, Probst-Fuja, & Titze, 2005). Collectively speaking, in addition to the role of extracellular 
matrix synthesis under normal conditions, activated vocal fold stellate cells may also contribute 
to the regulation of  the vocal fold extracellular matrix under pathological conditions.  
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APPENDIX B 
BIOLOGY OF VOCAL FOLD WOUND HEALING 
Mechanical injury associated with phonation or phonosurgery is the common origin of 
vocal fold tissue damage. The purposes of this chapter are to (1) review the biological changes in 
vocal fold tissue after phonotrauma or phonosurgery, (2) postulate the possible healing 
mechanisms in traumatized vocal fold tissue, and (3) discuss the roles of tissue mobilization in 
tissue healing.  
B.1 PHONATORY BIOMECHANICAL INJURY: PHONOTRAUMA 
Phonotrauma is induced by biomechanical stress during phonation (Gunter, 2003, 2004; Jiang et 
al., 1998; I.R. Titze, 1994). The human vocal folds vibrate naturally at frequencies of 100-1000 
Hz and amplitudes of about 1 mm (Titze, 1989). A study reports that teachers turn their voices 
on and off about 1,800 times an hour at work and accumulate up to about 20,000 times a day 
(Titze, Hunter, & Svec, 2007). Various mechanical stresses, namely, tensile, contractile, 
aerodynamic, inertia, impact and shear stresses, act on the mucosa and/or muscles of the vocal 
folds during phonation (Gunter, 2003, 2004; Jiang et al., 1998; I.R. Titze, 1994). Pertinent data 
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suggest that phonatory stresses may (1) alter the tissue’s physical structure by disrupting 
intracellular adhesion and cellular structure (Gray & Titze, 1988; Gray et al., 1987), and/or (2) 
elicit the tissue’s biological responses by altering gene expression and spatial distribution of cells 
and extracellular matrix substances (Branski et al., 2006; Ding & Gray, 2001; Thibeault et al., 
2003; Titze et al., 2004; Verdolini et al., 2003).  
The injury mechanism of phonatory stresses to the vocal fold tissue is not detailed out 
yet. However, speculations can be made from the physical models of vocal fold vibration that 
describe the magnitude and distribution of the phonatory stresses in the tissue (Gunter, 2003, 
2004; Jiang et al., 1998; I.R. Titze, 1994). Among the aforesaid stresses, tensile stress associated 
with tissue stretching has the greatest value (~ 1.0 MPa). Contractile stress induced by the 
thyroarytenoid and cricothyroid muscle contraction is smaller in magnitude (~ 100 kPa), and 
aerodynamic stresses induced by subglottal pressure is the smallest (~1-10 kPa).  
Interestingly, inertia (~1-2 kPa) and impact stresses (~0.5-5.0 kPa), which are 
intermediate in magnitude among the stresses, have been suggested to play a significant role in 
vocal fold injury (Gunter, 2003, 2004; Jiang et al., 1998; I.R. Titze, 1994). Inertial stress can be 
understood as the acceleration and deceleration of the vocal folds without collision. Rapid 
acceleration and deceleration of vocal fold tissue may disturb blood circulation and subsequently 
affect oxygen supply to the tissue (Svec & Sram, 2001; I.R. Titze, 1994; Tomita et al., 1988). In 
fact, the acceleration from vocal fold vibration may build up intravascular pressure by moving 
fluid toward the mid-point of the vocal folds (Czerwonka, Jiang, & Tao, 2008). Physical models 
predicted that vocal fold intravascular pressure rised significantly during vocal fold vibration, 
close to the range of magnitudes causing capillaries damage and the leakage of erythrocytes 
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(Czerwonka et al., 2008). The intravascular pressure was predicted over 20 cmH2O in speaking 
frequency and intensity, whereas the pressure could reach higher levels in singing and speaking.  
On the other hand, impact stress is the compressive force delivered perpendicularly to 
plane of vocal fold contact. Titze (1994) proposes that vocal ligament is structurally more 
accommodated for tensile stress but not for impact stress. The exposed soft tissues of the vocal 
folds absorb most of the impact stress during phonation, which poses a risk of tissue failure. 
Despite of inertia and impact stresses, vertical shear stress (~0.8 kPa), which is the force parallel 
to the plane of contact in the vertical direction, may also involve in vocal fold injury. A three-
dimensional finite element model of vocal fold vibration predicted an increase in both impact 
and vertical shear stresses at the centre of the vocal fold edge during vocal fold collision (Gunter, 
2003, 2004). This vocal fold location is exactly the injury-prone site where phonotraumatic 
lesions normally develop.  
The vocal folds are believed to undergo repetitive microtrauma owing to phonation 
throughout the life. A post-mortem study of 266 adult autopsies reported that 36.5% and 64% of 
the vocal folds were considered as normal and as presenting microscopic vocal fold lesion 
respectively (Salge, Peres, Reis, Teixeira Vde, & Castro, 2006). None of the autopsy cases 
exhibited clinically significant phonotraumatic lesions. These data suggest that the vocal folds 
can generally sustain phonatory injury and do not necessarily develop a macroscopic vocal fold 
lesion throughout the life. The vocal folds may be structurally capable to withstand phonatory 
stresses and/or may have the reparative capabilities to resolve the microscopically 
phonotraumatic damage. However, when the injury culminates in a threshold episode, 
inflammation becomes evident and may eventually develop macroscopic vocal fold lesions. 
Phonotrauma can result from a single traumatic force of relatively large magnitude or from 
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repeated forces of relatively small magnitude. When a single vocal loading (e.g., screaming at a 
football game) produces traumatic injury to vocal fold tissue, the injury is known as acute 
phonotrauma. When repeated or chronic vocal loadings over a period of time produce an injury, 
the injury is known as chronic phonotrauma. The following sections discuss the biological and 
microarchitectural changes of the vocal folds after acute and chronic phonotrauma.  
B.1.1 Acute phonotrauma 
Acute phonotrauma may cause abrasion of epithelium, separation of the surface epithelial cells 
from the beneath lamina propria and disruption of vascular network, which lead to vocal fold 
inflammation. In two similar animal studies, two groups of anesthetized canines were subjected 
to artificially phonate for two and four hours at high phonatory intensity (60-90 dB at 6 ft.)  
(Gray & Titze, 1988; Gray et al., 1987). Electron-microscopic examination indicated disruption 
of the surface microvillae of the epithelial cells and desquamation of the surface epithelial cells 
after two hours of phonation. However, the epithelium geminating layer, the basement 
membrane zone (BMZ) and the lamina propria were relatively preserved. After four hours of 
phonation, injuries extended to the BMZ. Greater area of destruction of epithelium, total 
desquamation of epithelial cells, presence of fluid among epithelial cells and destruction of 
organelles of the remaining epithelial cells were observed in the canine vocal folds. Also, 
interstitial fluid was present (1) between the basal cells of the epithelium and the BMZ and/or (2) 
between the BMZ and the superficial lamina propria among the canines. The collection of 
interstitial fluid may be probably due to the damage of anchoring fibres and detachment of 
collagen fibres in the superficial lamina propria from the BMZ. No vocal fold haemorrhage was 
indicated after four hours of intensive phonation. 
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Beyond cellular rupture and separation of tissue elements, vascular network may also be 
affected following acute phonotrauma. A physical model of vocal fold vibration predicted that 
the magnitude of intravascular pressure built-up during singing and screaming might lead to 
capillaries damage and the trigger of inflammatory response (Czerwonka et al., 2008). A human 
study reported that a female individual developed subtle vocal fold edema along the vocal fold 
free edges after continuous loud vocal loading for an hour (Verdolini, Rosen, Branski, & Hebda, 
2003). This individual showed marked increase in the concentrations of three pro-inflammatory 
cytokines: interleukin-1beta, tumour necrosis factor-alpha, and matrix metalloproteinase-8, from 
baseline to the 10-minute post-loading time point. Acute edema may be the outcome of increased 
intravascular pressure, submucosal capillary rupture, vasodilation, leakage of blood plasma into 
extravascular compartment and the inflammatory cytokine release (Courey et al., 1996; 
Czerwonka et al., 2008) (Courey et al., 1996). Clinically, vocal fold haemorrhage or acute 
laryngitis is manifested after acute phonotrauma.  
Molecular response to experimentally induced phonation was investigated in a rabbit 
study (Rousseau, Ge, French et al., 2008). Results showed a significant increased gene 
expression of MMP-1 and nonsignificant increases in MMP-9 and IL-1β following a prolonged 
(3-hour) phonation within a physiological range of human voice production (77 ± 3 dB; 429 ± 
141 Hz) and a 1-hour recovery. The upregulation of MMP-1 gene expression following 
prolonged phonation may be related to the homestatic control of collagen in response to 
phonation-induced injury. 
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B.1.2 Chronic phonotrauma 
Various types of non-epithelial abnormalities are observed in benign vocal fold lesions 
associated with phonotrauma. These lesions are not operatively defined and their diagnoses are 
typically based on subjective evaluation of macroscopic appearance of the lesions. Also, 
consensus is lacking around diagnostic criteria for the lesions themselves (Rosen & Murry, 2000). 
As a result, data comparison across studies becomes confounded. To avoid further complication 
of defining vocal fold lesions, this section adheres to the nomenclature in The Classification 
Manual of Voice Disorders – I (CMVD-I) (Verdolini, Rosen, & Branski, 2006). To keep in mind, 
the studies discussed below may not use exactly the same set of diagnostic criteria in CMVD-I.  
According to CMVD-I, vocal fold nodules, polyps, cysts (sub-epithelial and ligament) 
and Reinke’s edema are the benign vocal fold lesions, owing to chronic phonotrauma. Although 
the injury and healing mechanism for each type of lesion is not elucidated yet, the literature 
generally agrees that repeated phonotrauma disrupts cell functions in creating and maintaining a 
healthy tissue state and thus lead to pathological tissue changes. Subsequently, the change of 
tissue composition develops into a macroscopic vocal fold lesion, which affects vocal fold 
vibratory properties. Tables B1-5 summarize the histological characteristics of the vasculature, 
epithelium, the basement membrane zone (BMZ) and the superficial lamina propria as well as 
the expression of genes and cytokines for vocal fold nodules, polyps, cysts and Reinke’s edema. 
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Table B1. Summary of histological changes of the vasculature in benign vocal fold lesions. 
 Vocal Fold Nodules Vocal Fold Polyp(s) Vocal Fold Cyst Reinke’s Edema 
(De Biase & 
Pontes, 2008) 
Absence of 
observable vessels.  
Presence of visible 
vessels with 
longtitudinal and 
transverse orientation, 
abrupt reduction, and 
dilatation. 
Presence of visible 
vessels with 
longtitudinal, 
transverse or 
tangled orientation, 
abrupt reduction, 
dilatation and 
tortuosities. 
Not included in the study. 
(Courey et al., 
1996) 
No increase in 
vascularity.  
Large clusters of 
angiomatous-
appearing blood 
vessels are frequently 
found in the lamina 
propria. 
Some may have 
interrupted 
fibronectin 
distribution due to 
increased 
vasculature.  
Some may have interrupted 
fibronectin distribution due to 
increased vasculature. 
(F.G. Dikkers 
& Nikkels, 
1995) 
Absence of 
haemorrhage and 
edematous lake. Less 
frequent pathologic 
changes in 
submucosal blood 
vessels.  
Recent bleeding, 
depositions of iron 
and fibrin and 
thrombosis.  
Not included in the 
study. 
Edematous lakes, extravascular 
erythrocytes and increased thickness 
of submucosal blood vessels. Little 
fibrin, iron and thrombosis. 
(F. G. Dikkers 
& Nikkels, 
1999) 
Minimal hyaluronan 
is accumulated 
around the blood 
vessels.  
Collagen deposition 
around the vessels is 
not specific to the 
lesion.  
Hyaluronan is 
accumulated around 
the blood vessels. 
Collagen deposition 
around the vessels is 
not specific to the 
lesion. 
Not included in the 
study. 
Minimal hyaluronan is accumulated 
around the blood vessels. 
Collagen deposition around the 
vessels is not specific to the lesion. 
(Jovanovic et 
al., 2007) 
Not included in the 
study. 
Not included in the 
study. 
Not included in the 
study. 
Dilated blood vessels in loops and 
branching networks.  
Longitudinal blood vessles in 
different diameters.  
Anastomoses.  
Thin blood vessels walls. 
Discontinusous or turbulent type of 
blood flow.  
Occational “slow motion” of blood 
elements. 
Vascular varicosities and erythrocyte 
accumulations in the inner wall of 
blood vessels. 
(Jovanovic et 
al., 2008) 
Not included in the 
study. 
No mucosal “blue 
lines” seen. 
No included in the 
study.  
Longitudinal arranged mucosal “blue 
lines” were commonly seen in 
subepithelial well-developed hollow 
spaces.  
(Kotby, 
Nassar, Seif, 
Helal, & 
Saleh, 1988) 
Sparse 
vascularization.  
Normal endothelial 
lining of the blood 
vessels.  
Hyaline degeneration 
in the stroma is seen.  
Abundant 
vascularization.  
Normal endothelial 
lining of the blood 
vessels. 
No hyaline 
degeneration in the 
stroma.  
Not included in the 
study. 
Not included in the study. 
(Loire, 
Bouchayer, 
Cornut, & 
Bastian, 
1988) 
Capillaries in the 
lamina propria are 
either normal of with 
hyaline deposition 
(15%).  
Not specifically 
described in the 
paper. 
Not specifically 
described in the 
paper. 
Not specifically described in the 
paper. 
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(Sato, Hirano, 
& Nakashima, 
1999) 
Not included in the 
study. 
Not included in the 
study. 
Not included in the 
study. 
Subepithelial vascularization and 
vessel dilation. Thin endothelium 
with small holes and vesicles and a 
thickened basement membrane of the 
vessels. Endothelial cells and 
pericytes around the vessels are 
degenerated and few in number to 
support the vessels. Fibroblasts and/or 
inflammatory cells secrete vascular 
endothelial growth factor, which may 
increase the capillary permeability.   
(Sone et al., 
2006) 
No hypervascularity 
is present with no 
remarkably high 
blood flows.  
Capillary rupture and 
dilation are seen.  
Hypervascularity is 
present with high 
blood flows.  
Not specifically 
described in the 
paper. 
Not included in the study. 
(Wallis, 
Jackson-
Menaldi, 
Holland, & 
Giraldo, 
2004) 
Smaller areas of 
telangiectasias. 
Larger areas of 
telangiectasias.  
Not included in the 
study. 
Not included in the study. 
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Table B2. Summary of histological changes of the epithelium in benign vocal fold lesions. 
 Vocal Fold Nodules Vocal Fold 
Polyp(s) 
Vocal Fold Cyst Reinke’s Edema 
(Carriero et al., 
2000) 
Not included in the study. Normal epithelium 
with normal cell 
size and 
distribution.  
Not included in the 
study. 
Homogeneous 
epithelium. Cell nuclei 
are larger in size and 
have increased nucleus-
to-cytoplasm ratio.  
(F. G. Dikkers, 
Hulstaert, 
Oosterbaan, & 
Cervera-paz, 
1993) 
Variable degeneration signs 
are observed for the epithelial 
cells, including cytoplasmic 
vacuoles, attenuated cell 
junctions and distorted 
desmosomal junctions.  
The degenerative 
signs of the 
epithelial cells are 
occasionally 
occurred in a few 
restricted areas.  
Not specifically 
described in the 
paper.  
Not specifically 
described in the paper. 
(Kotby et al., 
1988) 
Thickened epithelium 
(80.85μm) with different 
degree of keratinisation. 
Extensive disruption of the 
intercellular junctions 
between the epithelial cells. 
Desmosomal junctions are 
sparse.  
Less thickened 
epithelium than 
nodules (66μm). 
Normal intercellular 
junctions of 
epithelial cells. 
Desmosomal 
junctions are more 
reserved.   
Not included in the 
study. 
Not included in the 
study. 
(Loire et al., 
1988) 
Thickened epithelium with 
incomplete keratinisation.  
Atrophy or 
acantosis of the 
epithelium is 
occasionally seen.  
Mucus retention 
cyst: glandular 
epithelium.  
Epidermoid cyst: 
between 10 to 30 
cellular layers. 
Some with 
keratinisation.  
Irregular thickening of 
the epithelium; some 
regions may acanthotic 
or parakeratotic. 
Duplicate epithelium.  
(Marcotullio et 
al., 2002) 
Normal epithelium or 
keratosis is commonly seen. 
Normal epithelium 
or keratosis is 
commonly seen. 
Not included in the 
study. 
Normal epithelium or 
keratosis is commonly 
seen. Dysplasia is also 
seen in Reinke’s edema 
but not in nodules and 
polyps.  
(Neves, Neto, & 
Pontes, 2004) 
Epithelium abnormality is non-specific to nodules, polyps and Reinke’s edema 
(Sakae et al., 
2008) 
Not included in the study. Not included in the 
study. 
Not included in the 
study. 
Collagen fiber 
arrangements was 
preserved underneath 
epithelium. 
(Tillmann, 
Rudert, 
Schunke, & 
Werner, 1995) 
Not included in the study. Not included in the 
study. 
Not included in the 
study. 
No pathological 
changes in the vocal 
fold epithelium under 
light or electron 
microscopy. 
(van der Velden 
et al., 1996) 
Atrophic epithelium Keratinizing and 
hyperplastic 
epithelium 
Not included in the 
study. 
Not included in the 
study. 
(Volic, Kirincic, 
& Markob, 
1996) 
Not included in the study. Not included in the 
study. 
Not included in the 
study. 
From normal to 
hyperplastic to 
hyperkeratotic to 
parakeratotic 
epithelium 
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Table B3. Summary of histological changes of the basement membrane zone (BMZ) in benign vocal fold 
lesions. 
 Vocal Fold Nodules Vocal Fold Polyp(s) Vocal Fold Cyst Reinke’s Edema 
(Courey et 
al., 1996) 
An average BMZ thickness 
of 1.88μm (range 0.5 to 3.0 
μm) on collagen IV staining 
and 1.63 μ m (range 0.5 to 
2.0 μm) on fibronectin 
staining.  
Thickened BMZ and dense 
fibronectin deposition. 
 
An average BMZ 
thickness of 0.84 μm 
(range 0.5 to 2.0 μm) on 
collagen IV staining and 
1.21 μm (range 0.5 to 5.0 
μm) on fibronectin 
staining. 
Unaltered BMZ width 
except fibronectin 
deposition clustered 
around the neovasculatiry.  
An average BMZ 
thickness of 1.04 
μm on collagen IV 
staining and 1.14 
μm on fibronectin 
staining. 
BMC thickness is 
between polyps 
and nodules.  
An average BMZ thickness of 
0.75 μm on both collagen IV 
and fibronectin staining. 
(F. G. 
Dikkers et 
al., 1993) 
Some parts of BMZ are 
lacking and some parts are 
thickened.  A near absence 
of normal hemidesmosomes 
and anchoring fibres.  
Not specifically described 
in the paper. 
Not specifically 
described in the 
paper. 
Not specifically described in 
the paper. 
(F.G. 
Dikkers & 
Nikkels, 
1995) 
Thickened BMZ is 
commonly seen.  
Thickened BMZ is not 
commonly seen.  
Not included in the 
study. 
Thickened BMZ is commonly 
seen.  
(F. G. 
Dikkers & 
Nikkels, 
1999) 
Collagen deposition in the 
BMZ is not specific to the 
lesion. 
Collagen deposition in the 
BMZ is not specific to the 
lesion. 
Not included in the 
study. 
Collagen deposition in the 
BMZ is not specific to the 
lesion. 
(Gray et 
al., 1995) 
BMZ injury as indicated by  
thick collagen type IV bands.   
Rare BMZ injury.  Not included in the 
study. 
Rare BMZ injury. 
(Loire et 
al., 1988) 
Irregular thickened BMZ Thinning of the BMZ.  Mucus retention 
cyst: quite thin 
BMZ. 
Normal or thickened BMZ are 
seen.  
(Neves et 
al., 2004) 
Thickened BMZ with 
increased collagen type IV 
and laminin. 
BMZ is not significantly 
thickened. 
Not included in the 
study. 
Reinke’s edema was not 
differentiated from nodules 
and polyps under histological 
and immunohistochemical 
analysis.  
(Volic et 
al., 1996) 
Not included in the study. Not included in the study. Not included in the 
study. 
Thickened BMZ. 
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Table B4. Summary of histological changes of the lamina propria in benign vocal fold lesions. 
 Vocal Fold 
Nodules 
Vocal Fold Polyp(s) Vocal Fold Cyst Reinke’s Edema 
(Courey et 
al., 1996) 
Fibronectin lost the 
normal laminar 
pattern. 
Fibronectin generally 
maintained its general laminar 
distribution. 
Fibronectin 
generally 
maintained its 
general laminar 
distribution. 
Fibronectin generally 
maintained its general laminar 
distribution. 
(F. G. 
Dikkers & 
Nikkels, 
1999) 
Unusual 
perpendicular 
orientation of 
elastic fibre to the 
BM is commonly 
seen.  
Minimal 
hyaluronan is 
accumulated in 
connective tissues.  
Unusual perpendicular 
orientation of elastic fibre to the 
basement membrane is 
occasionally present. Minimal 
hyaluronan is accumulated in 
connective tissues 
Not included in the 
study. 
Unusual perpendicular 
orientation of elastic fibre to 
the basement membrane is 
occasionally present. 
Minimal hyaluronan is 
accumulated in connective 
tissues 
(Gray et al., 
1995) 
Intense fibronectin 
deposition.  
Little fibronectin deposition. 
Few structural proteins,collagen 
and elastin.  
Not included in the 
study. 
Little fibronectin deposition. 
Few structural proteins, e.g., 
collagen and elastin. 
(Kotby et al., 
1988) 
No inflammatory 
cell infiltration.  
Abundant collagen 
deposition.  
No inflammatory cell 
infiltration. 
Scattered collagen fibres.  
Not included in the 
study.  
Not included in the study. 
(Loire et al., 
1988) 
Moderate cellular 
infiltration with 
some fibroblasts 
and few 
lymphocytes. 
Edema is not 
common.  
Fibrinous exudates were 
organized in a loose network or 
in cluminuous clumps. 
Probably attached to the 
connective tissue or endothelial 
cells. Diffuse edema and 
cellular infiltration with 
lymphocytes and few 
fibroblasts are present.  
Mucus retention 
cyst: edema or 
fibrosis with some 
lymphocytes.  
Epidermiod cyst: 
commonly fibrous 
than edematous. 
Filled with detached 
parakeratotic cells 
or desquamated 
keratin. 
Marked edema with 
pseudovascularity. Increased 
number of blood vessels. The 
vessels are dilated and packed 
with red blood cells. Infrequent 
cell infiltration with 
lymphocytes and collagen 
deposition. 
(Marcotullio 
et al., 2002) 
Edematous is 
commonly seen. 
Edematous-angiomatous is 
commonly seen. 
Not included in the 
study. 
Edematous is commonly seen. 
(Sakae et al., 
2008) 
Not included in the 
study. 
Not included in the study. Not included in the 
study. 
Collagen fibers were 
fragmented, loosely arranged 
and intermixed with myxoid 
stroma in the deeper region of 
the superficial layer of the 
lamina propria. 
(Sato et al., 
1999) 
Not included in the 
study. 
Not included in the study. Not included in the 
study. 
Plasma is accumulated in 
Reinke’s space.    
(Tillmann et 
al., 1995) 
Not included in the 
study. 
Not included in the study. Not included in the 
study. 
Protein-rich fluid accumulates 
in the highly ramified fissured 
area in Reinke’s space. 
Fibroblasts have their 
cytoplasmic extensions 
overlapped in two to three 
layers. 
(Volic et al., 
1996) 
Not included in the 
study. 
Not included in the study. Not included in the 
study. 
Loose and edematous lamina 
propria with short and 
completely disorganized 
connective fibres. 
 196 
 
Table B5. Summary of genetic-related and other changes in benign vocal fold lesions. 
 Vocal Fold Nodules Vocal Fold Polyp(s) Vocal Fold 
Cyst 
Reinke’s Edema 
Genetics     
(Duflo, 
Thibeault, 
Li, Shu, & 
Prestwich, 
2006) 
Not included in the 
study. 
Genes related to extracellular 
matrix remodeling, cell growth, 
repair proliferation, negative cell 
progression are overexpressed. No 
genes related to protect against 
oxidative stress are expressed.   
Not included 
in the study. 
Genes related to 
protection against 
oxidative stress, 
apoptosis as well as 
control of cell growth 
and differentiation are 
expressed.  
(Thibeault, 
Gray, Li et 
al., 2002) 
Not included in the 
study. 
Upregulated mRNA: procollagen-
I, haluronic acid synthase 2, 
decorin and fibronectin. 
Downregulated mRNA:  
MMP-1, MMP-12 and 
fibromodulin. 
High gene activity.  
Not included 
in the study. 
Upregulared mRNA: 
procollagen-I, 
haluronic acid 
synthase 2, decorin 
and fibromodulin. 
Downregulated 
mRNA:  
MMP-1, MMP-12, 
fibronectin. 
Low gene activity. 
     
Others     
(Kang, 
Hsiung, & 
Wang, 
2005) 
iNOS (inducible 
form of nitric oxid 
synthase) and 3-NT 
(3-nitrotyrosine) are 
less accumulated in 
nodules, compared 
to polyps.   
iNOS and 3-NT are significantly 
higher in polyps than in nodules. 
That may suggest the increase in 
peroxynitrite production may have 
a pathogenic role in polyps.  
Not included 
in the study. 
Not included in the 
study. 
(Karahan, 
Baspinar, 
Yariktas, & 
Kapucuoglu, 
2009) 
Not included in the 
study. 
MMP-2, MMP-9 and COX-2 are 
significantly higher in stromal 
spindle cells and vascular wall of 
polyps than t the normal vocal 
folds. 
Not included 
in the study.  
Not included study. 
(Verdolini et 
al., 2003) 
Not included in the 
study. 
PGE-2 is dominantly present in 
the laryngeal secretions. 
PGE-2 is 
dominantly 
present in the 
laryngeal 
secretions. 
Not included in the 
study. 
(Wallis et 
al., 2004) 
Lesion size less than 
0.3 cm. 
Lesion size larger than 0.3 cm. Not included 
in the study. 
Not included in the 
study. 
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Two issues are still under debate in the literature of benign vocal fold lesions. The first 
one is if the epithelium layer of the vocal folds is affected in chronic phonotraumatic lesions. The 
second one is whether vocal fold nodules, polyps, cysts and Reinke’s edema can be differentiated 
by chronicity, i.e., the age of the lesions.  
Regarding the first issue of the epithelial changes in chronic phonotraumatic lesions, 
hyperproliferative responses of the epithelium have been suggested to be absent in most of 
phonotraumatic lesions (Gray, 1997; Zeitels & Healy, 2003). A study used contact endoscopy 
with methylene blue staining (Carriero et al., 2000) to visualize the superficial layer of vocal fold 
epithelium. Although the epithelial cells of Reinke’s edema had higher nuclear density, most of 
the polyps and Reinke’s edema in their specimens exhibited homogenous and normal epithelium. 
In contrary, epithelial changes of phonotraumatic lesions are documented in other studies. 
The epithelial changes may be related to the hyperactivity and high turnover rate of the basal 
cells of the vocal fold epithelium. Dikkers et al. (F.G. Dikkers & Nikkels, 1995) reported that the 
basal cells of their lesion specimens displayed the signs of decrease in the amount of condensed 
chromatin and increase in the sizes of their nucleoli, vesicles and mitochondria. These cellular 
responses together with the thickened epithelium may be the typical reactions to phonotrauma in 
all benign vocal fold lesions (nodules, polyps, cyst, Reinke’s edema, granuloma and broad-based 
thickening). Various epithelial abnormalities are also reported for benign vocal fold lesions: 
atrophy, hyperplasia, keratosis, parakeratosis, and dyskeratosis. A study (Loire et al., 1988) using 
optical microscopy reported that vocal nodules exhibited a range of epithelial abnormalities 
across their patients, in which dyskeratosis (82%) and parakeratosis (66%) were the most 
commonly observed. Atrophic epithelium and irregular thickness of epithelium were observed in 
some of the polyps and Reinke’s edema respectively but in a less occurrence. Another study 
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(Kotby et al., 1988) using electron microscopy also reported similar observation. Vocal nodules 
showed greater thickness and keratinization of epithelium than vocal polyps. Paradoxically, 
atrophic epithelium in nodules and epithelial hyperplasia in polyps were reported in another 
study (van der Velden et al., 1996). The discussion is further complicated by another histological 
study of nodules, polyps and Reinke’s edema (Marcotullio, Magliulo, Pietrunti, & Suriano, 
2002). The investigators classified the epithelial changes into five categories: normal epithelium, 
basal hyperplasia, hyperkeratosis, keratosis-hyperplasia and dysplasia. Nodules, polyps and 
Reinke’s edema exhibited as either normal epithelium (nodules: 39.79%; polyps: 40.65%; 
Reinke’s edema: 44.12%) or hyperkeratosis (nodules: 47.95%; polyps: 41.75%; Reinke’s edema: 
30.88%) in their specimens. Lastly, two studies (F.G. Dikkers & Nikkels, 1995; Neves et al., 
2004) both reported that diverse types of epithelial abnormalities were present among the 
phonotraumatic lesions. In sum, benign vocal fold lesions do not necessarily have epithelial 
changes in response to chronic phonotrauma. Also, even epithelial abnormality exist among 
some patients with benign vocal fold lesions, the isolated abnormality is not specific to the lesion 
type.  
The second issue is about the chronicity (age) of the vocal fold lesions. Marcotullio et al. 
(Marcotullio et al., 2002) propose that nodules and Reinke’s edema are younger lesions than 
polyps. The investigators categorized the changes in the lamina propria into five phases of 
maturation: edematous (the least mature), edematous angiomatous, angiomatous, angiomatous-
hyaline and hyaline (the most mature). Their histological results suggest that vocal nodules and 
Reinke’s edema are in the earlier edematous stage, whereas vocal polyps are in the more 
advanced stage of edematous-angiomatous. Another study by Wallies et al. (Wallis et al., 2004) 
subjected both videostroboscopic images and histological pictures to blinded otolaryngologist 
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and voice pathologist for clinical diagnosis. The investigators conclude that no definitive 
histological difference can be made between nodules and polyps. The only significant difference 
is the size of the lesion, which polyps (> 0.3 cm) are bigger than nodules (< 0.3 cm). The 
investigators further propose that nodules and polyps are on the same pathological process in a 
continuum. That is, if nodules are left alone and with repeated phonotrauma, the nodules may 
transform into a more advanced polyps. 
Contrary to the conjecture that polyps are the more advanced lesions than nodules, Kotby 
et al. (Kotby et al., 1988) claimed that polyps are younger than nodules. The investigators 
reported that polyps had a thinner epithelium than nodules using light microscopy in their study, 
which suggested a less long-standing nature of polyps. This claim is supported by Dikkers et al. 
(F. G. Dikkers & Nikkels, 1999). The investigators reasoned that polyps are the youngest, 
nodules are older, and Reinke’s edema is the mostly advanced lesion based on the clinical 
management of these lesions. Patients with vocal polyps tend to seek medical consultation at the 
very early stage, whereas patients with Reinke’s edema tend to delay from months to years 
before getting diagnosed and surgically excised. Having said that, Dikkers et al. did not consider 
that nodules, polyps and Reinke’s edema represent the same pathological continuum, which is 
against Wallis et al.’s proposal (Wallis et al., 2004). Dikker et al.’s exposition is that these 
lesions are distinctive in histological and stroboscopic features. Also, patients seldom exhibit 
such lesion transformation, for instance, polyps will develop into nodules over time.  
B.1.3 Vocal fold nodules 
Vocal fold nodules are macroscopically described as round, sessile, white/opague, 
bilaterally symmetric lesions (M. Hirano, 1981; Johns, 2003; Pontes, Kyrillos, Behlau, De Biase, 
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& Pontes, 2002). Vocal fold nodules usually locate on the free margin of the anterior two-thirds 
of the vocal folds (M. Hirano, 1981; Johns, 2003). The size of nodules is suggested to be less 
than 0.3 cm (Wallis et al., 2004).   
An array of histological features in relation to vocal fold nodule is reported. The 
appearance of nodules varies from edema to fibrosis (M. Hirano, 1981; Pontes et al., 2002). 
Also, the vasculature of nodules varies from normal blood flow and absence of haemorrhage 
(Courey et al., 1996; F.G. Dikkers & Nikkels, 1995; Loire et al., 1988; Pontes et al., 2002; Sone, 
Sato, Hayashi, Fujimoto, & Nakashima, 2006), microstromal haemorrhages and vascular 
proliferation (Kotby et al., 1988; Wallis et al., 2004) and hyaline deposition (Loire et al., 1988). 
Inflammatory cell infiltration and edematous lake had been reported as absent (F.G. Dikkers & 
Nikkels, 1995; Kotby et al., 1988) but are later rejected by another study (Wallis et al., 2004). 
Furthermore, the epithelium varies from atrophy (van der Velden et al., 1996) to different 
degrees of keratinisation (Kotby et al., 1988; Loire et al., 1988). Although vocal nodules present 
great diversity of the aforementioned histology, disruption of basement membrane zone (BMZ) 
in vocal nodules is commonly reported.  
First, the BMZ architecture of vocal nodules appears disorganized in the form of: 
reduplication of the lamina densa, disorientation of the anchoring fibres, disorganization of the 
attachment plaque, separation of the epithelium from the beneath superficial lamina propria 
(Gray, 1989, 1991, 1997; Gray et al., 1995; Gray & Titze, 1988; Gray et al., 1987), irregular 
thickened with zones of blurring (Loire et al., 1988), gapping of the intercellular junctions, 
absence of basal lamina, and perpendicular arrangement of elastic fibres to the BMZ (F. G. 
Dikkers & Nikkels, 1999). Second, abnormal increase in protein depositions are observed in the 
BMZ, which include laminin (Neves et al., 2004), collagen IV (Courey et al., 1996; Kotby et al., 
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1988) and fibronectin (Courey et al., 1996). The average thickness on collagen type IV and 
fibronectin staining in the BMZ is estimated as 1.88 μm (range from 0.3 to 3.0 μm) and 1.63 μm 
(range from 0.5 to 2.0 μm) respectively (Courey et al., 1996). The abnormal deposition of these 
BMZ components result a thickened epithelium (80.85 μm) of vocal nodules (Kotby et al., 1988) 
in general. Lastly, epithelial cell degeneration is reported in the form of cytoplasmic vacuoles 
and disrupted cell-cell (desmosomal) junctions (F. G. Dikkers et al., 1993).  
The BMZ is the injury-prone location along the vocal folds in response to phonotrauma. 
BMZ bears strong shearing and impact stresses from the epidermis to the thyroarytenoid muscle 
during vocal fold vibration (Gray et al., 1995). These stresses may induce tissue inflammatory 
response of the vocal folds. A study reported heavy immunoreactivity of iNOS (inducible form 
of nitric oxide synthase) on the epithelium and relatively faint 3-NT accumulation (3-
nitrotyrosine) in the tissue samples of vocal nodules using immunohistochemistry (Kang et al., 
2005). The investigators speculate that the production of inflammatory cytokines, NO and other 
toxic metabolites are ensued from the stress-induced iNOS. This inflammatory response may 
exacerbate the healing process, leading to the formation of vocal nodules.  
Other than inflammation-induced injury, phonatory stresses may also contribute to the 
structural disruption of the BMZ architecture. These stresses may damage the anchoring fibres in 
the BMZ and result the separation between the epithelium and the lamina propria. This 
separation may create a pocket for interstitial fluid resulting edema. The increased accumulation 
of adhesion molecules (collagen IV, laminin, and fibronectin) in the BMZ may correspond to the 
healing response of “patching” the torn tissues (Courey et al., 1996; Gray et al., 1995). However, 
this healing process may be disrupted by repetitive injury, re-separation of the epithelium and the 
superficial lamina propria and reattachment of epithelium/BMZ complex during continuous 
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phonation (Gray, 1991). As a result, the vocal folds are healed in a disorganized way with a 
thickened BMZ and excessive deposition of adhesion molecules. Also, the deposition of 
fibronectin is relatively permanent and leads to increased stiffness of the vocal folds, which in 
turn affects vocal fold vibration (Gray, 1991). Further, the disorganized BMZ may predispose the 
individuals at risk of exacerbating the existing lesion. As a result, complete resolution of vocal 
nodules in response to voice therapy is very rare as seen in clinic. 
B.1.4 Vocal fold polyp(s) 
Vocal fold polyps have heterogeneous appearance: sessile or pedunculated, translucent to 
red, and unilateral or bilateral lesions (F. G. Dikkers & Nikkels, 1999; Johns, 2003). Vocal fold 
polyps usually locate on the middle musculo-membranous region of the vocal folds (F. G. 
Dikkers & Nikkels, 1999). The size of polyps is suggested to be bigger than 0.3 cm (Wallis et al., 
2004).   
In vocal polyps, changes in the structure of epithelium, the size of epithelial cells and 
distribution of epithelial cells are not commonly reported (Carriero et al., 2000). Sometimes, 
keratinisation (Kotby et al., 1988) or hyperplasia (van der Velden et al., 1996) with irregularities 
may occur in the epithelium of polyps. The thickness of epithelium in polyps is estimated as 
about 66 μm, compared to 80.85 μm that of nodules (Kotby et al., 1988). Alternation of the BMZ 
n polyps is not commonly reported as well. Abnormal deposition of collagen type IV and 
fibronectin are not commonly observed in the BMZ of polyps (Courey et al., 1996; F. G. Dikkers 
et al., 1993). The average thickness on collagen type IV and fibronectin staining in the BMZ is 
estimated as 0.84 μm (range from 0.5 to 2.0 μm) and 1.21 μm (range from 0.5 to 5.0 μm) 
respectively (Courey et al., 1996). Also, collagen type IV is relatively less in amount in the BMZ 
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than those in the lamina propria, which may predispose a risk for the separation of the BMZ from 
superficial lamina propria.  
Vascularization is within the superficial lamina propria is commonly reported in polyps. 
Various forms of vascularization are observed: ranging from vascular to fibrotic to mixoid 
(Johns, 2003; Kotby et al., 1988; Sone et al., 2006). The vessels were commonly in longtitudinal 
or transver orientation with abrupt reductions and diltations in calibre of blood vessels (De Biase 
& Pontes, 2008).  Increased hyaluronic acid (F.G. Dikkers & Nikkels, 1995; F. G. Dikkers & 
Nikkels, 1999) and fibronectin (Courey et al., 1996) may accumulate around the neovasculature. 
The presence of recent bleeding, deposition of iron and fibrin, and thrombosis confirm the 
diagnosis of polyps from nodules (F.G. Dikkers & Nikkels, 1995). A speculation is that 
phonotrauma may create a haemorrhagic response of capillary damage and increase in vascular 
permeability (Gray et al., 1995; Sone et al., 2006). After prolonged irritation, vocal polyps may 
form larger areas of telangiectasias (enlarged blood vessels), associated with haemorrhage and 
fibrin formation (Wallis et al., 2004). Another speculation is, rather than the direct mechanical 
damage to blood vessels from phonotrauma, the inflammatory process at the lamina propria or 
the histologic alterations (e,g, fibrous protein depositions) in the development of polyps, might 
modify the orientation of the vessels (De Biase & Pontes, 2008).  
Two studied used laser Doppler flowmetry to compare the blood flow in benign vocal 
fold lesions with normal vocal folds. In general, vocal fold polyps had significantly higher blood 
flow than normal vocal folds (Stec et al., 2007). A higher mean ratio of blood flow (72%) in 
polyps was reported, compared to 21.8% in nodules (Sone, Sato, Hayashi, Fujimoto, & 
Nakashima, 2006).   Capillary damage may lead to edema, bleeding and leakage of fibrin (F. G. 
Dikkers & Nikkels, 1999) and subsequently the formation of fibrinous exudates, which makes up 
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the major volume of the polyps (Loire et al., 1988). These exudates may appear as a loose 
network or in capacious clumps, which are connected by endothelial cells or connective tissues 
(Loire et al., 1988).  
Besides abundant vascularity, the extracellular matrix components of the lamina propria 
are less disturbed in polyps (F.G. Dikkers & Nikkels, 1995). Some polyps exhibit abnormally 
perpendicular orientation of elastic fibres to the basement membrane, which is probably induced 
by the phonatory forces (F.G. Dikkers & Nikkels, 1995). A study reported the changes in 
messenger ribonucleic acid (mRNA) expression of a number of extracellular matrix components 
in polyps (Thibeault, Gray, Li et al., 2002). Results indicated an upregulation of the gene for 
procollagen -1, which is a marker for neo-collagen synthesis. Matrix metalloproteinases -1 and -
12 were downregulated, which are responsible for the breakdown of collagen and elastin 
respectively. Hyaluronic acid synthase 2 were also downregulated, which is an important enzyme 
for hyaluronic synthesis. These changes may alter the viscoelastic property of the superficial 
lamina propria, and predispose a risk of vocal fold scarring. Also, upregulation of fibronectin and 
downregulation of fibromodulin were also noted in polyps, which indicate an increase in 
stiffness of the vocal folds. Overall, the total gene expression scores were high in polyps. This 
high gene activity may account for the acute condition of polyps. This speculation is 
substantiated by another study using complementary deoxyribonucleic (cDNA) microarray 
analysis (Duflo et al., 2006). The investigators identified 65 genes to differentiate polyps from 
Reinke’s edema. In polyps, SPARC, SPARCL1 and Col6A3 were the three significantly 
overexpressed genes, which are responsible for extracellular remodeling, cell growth and repair 
proliferation. Col1A2, Col3A1, Col5A2, PRCAM1 and ITGB2 were also overexpressed in 
polyps, which are responsible for fibroblast proliferation and inflammatory processes. Therefore, 
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polyps are likely in an inflammatory condition with active fibroblasts for healing (Duflo et al., 
2006).  
Lastly, the role of inflammation in the pathophysiology of vocal polyps remains to be 
elucidated. Vocal polyps showed significanylg higher levels of metalloproteinase (MMP)-2, 
MMP-9 and cyclooxygenase (COX)-2 in stromal spindle cells, vascular endothelial cells and 
inflammatory cells, compared to normal vocal folds. These three markers are associated with 
microvascular permeability, tissue remodeling and angiogenesis, which these three processes 
may play an important role in the development and growth of polyps (Karahan et al., 2009).  
Besides the aforesaid inflammatory processes, inflammatory cell infiltration has been 
reported as either absent (Kotby et al., 1988) or present (Loire et al., 1988). Nitric oxide (NO) is 
an important inflammatory mediator during inflammatory process. NO is generated by iNOS 
(inducible form of nitric oxide synthase) and 3-NT (3-nitrotyrosine) is a biological footprint of 
the toxic NO metabolite perosynitrite (Beckman, Beckman, Chen, Marshall, & Freeman, 1990; 
Fukuto, 1995). A study using immunohistochemistry reported that both iNOS (inducible form of 
nitric oxide synthase) and 3-NT (3-nitrotyrosine) were more intense on the epithelium and 
parachyma in their tissue samples of vocal polyps, compared to those of vocal nodules (Kang et 
al., 2005). The investigators suggest that the increased NO may damage the vocal fold tissue by 
its own toxic actions and/or through the production of 3-NT. This iNOS/NO action may 
contribute to the formation of polyps (Kang et al., 2005). Shear stress during phonation may 
account for the expression of iNOS as suggested by studies from other tissue domains (Cai, Xin, 
Pollock, & Pollock, 2000; Gosgnach, Messika-Zeitoun, Gonzalez, Philipe, & Michel, 2000; 
Kang et al., 2005). On the other hand, inflammatory cytokines, interleukin-1 beta (IL-1β) and 
prostaglandin E2 (PGE2), may also take part of the iNOS expression for polyps. In an 
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intraoperative human study, PGE2 was more dominant than IL-1β in the laryngeal secretion 
samples collected from subjects with polyps and cysts (Branski, Verdolini, Rosen, & Hebda, 
2004), whereas IL-1β was more dominantly expressed in subjects with epithelial-based vocal 
fold lesions (vocal fold cancer and recurrent respiratory papilloma). A speculation is that PGE2 
may contribute to the upregulation of iNOS expression in polyps. 
At the same time, the involvement of iNOS/NO in polyps is questioned by the results of a 
cDNA microarray study of vocal polyps and Reinke’s edema (Duflo et al., 2006). NO is known 
to induce oxidative stress, which reacts with superoxide anion (O2-) to yield peroxynitrite 
(ONOO-) (Beckman, Beckman, Chen, Marshall, & Freeman, 1990). If iNOS/NO have an 
important pathogenic role in polyps, a cellular defence mechanism of providing protection 
against oxidative stress should be turned on. However, genes that involve in such defence 
mechanism, such as MAP2K3, SOD1, GPX2 and GTSA2, were only overexpressed in Reinke’s 
edema but not in polyps. This finding indicates that polyps may not be induced by oxidative 
stress, which is in contrary to Kang et al.’s (2005) speculation. Further research is appreciated to 
investigate the importance of iNOS/NO in the injury and healing mechanism for polyps and 
other benign vocal fold lesions.  
B.1.5 Vocal fold cyst 
Vocal fold cysts can be a massive growth or a discrete and whitish lesion (Milutinovic & 
Bojic, 1996). Cysts are either classified as mucous retention cysts or epidermoid inclusion cysts 
and each of them can locate in either Reinke’s space (sub-epithelial) or near the vocal ligament 
(Verdolini et al., 2006). Mucous retention cysts consist of a very thin wall with a cavity 
collecting translucent mucous (Johns, 2003; Milutinovic & Bojic, 1996). Mucous retention cysts 
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are probably associated with an obstructed mucous gland duct or phonotrauma (Johns, 2003; 
Milutinovic & Bojic, 1996; Verdolini et al., 2006). Epidermoid (or squamous) inclusion cysts 
usually have a thickened wall and appear as fusiform masses with desquamated keratin 
accumulation in the subepithelial layer (Johns, 2003; Milutinovic & Bojic, 1996). Epidermoid 
cysts are believed to be related to phonotrauma or to congenital defects (Verdolini et al., 2006).  
In vocal fold cysts, changes in vasculature are varied. Some cysts may have interrupted 
fibronectin distribution due to increased vasculature (Courey et al., 1996). Some may present 
vessels with longtitudinal, transverse of tangled orientation. Changes in calibre and tortuosity of 
blood vessels, specifically, diltations, abrupt reduction, or tortuosities, were also reported (De 
Biase & Pontes, 2008).  
Regarding the epithelial changes, cyst lesion may be lined with either columnar or 
squamous epithelium, in which having about 10 to 30 cellular layers (Loire et al., 1988; Shvero 
et al., 2000). Especially for the epidermoid inclusion cyst, keratinisation is progressively 
occurred (Loire et al., 1988). The cells with viable nuclei are observed to be desquamated into 
the cavity of the cyst (Loire et al., 1988).  
The thickness of the basement membrane zone (BMZ) for both mucous retention and 
epidermoid inclusion cysts is similar. The average thickness of the BMZ is estimated about 1.04 
μm on collagen type IV staining and 1.14 μm on fibronectin staining, which is in between the 
thickness of nodules and polyps (Courey et al., 1996). Abnormal deposition and distribution of 
collagen type IV and fibronectin are not commonly observed throughout the BMZ and the 
superficial lamina propria (Courey et al., 1996). For the mucosa layer, cysts are reported more 
commonly as fibrous than edematous (Loire et al., 1988). The injury and healing mechanism of 
cysts are not clear. Some insights may be able to obtain from an intraoperative human study of 
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biomarkers in surface laryngeal secretions from patients with laryngeal pathology (Branski et al., 
2004). Prostaglandin E2 (PGE-2) was more dominant than interleukin-1 beta (IL-1β) in the 
laryngeal secretion samples collected from subjects with cysts. PGE-2 is a mediator that involves 
in ubiquitous stages of wound healing, whereas IL-1β is a marker of acute inflammatory stage. 
This finding suggests that cysts are not likely in an acute inflammation condition.  
B.1.6 Reinke’s edema 
Reinke’s edema, which is edematous and swollen in the superficial lamina propria, is also 
known as polypoid vocal fold, polypoid degeneration, chronic polypoid corditis and chronic 
edematous hypertrophy (Sato, Hirano, & Nakashima, 1999; Verdolini et al., 2006). Reinke’s 
edema appears as a unilateral or bilateral, pale-white and fluid-filled swelling. Reinke’s edema 
can be sessile or mobile during phonation (F.G. Dikkers & Nikkels, 1995). The histological 
differentiation of Reinke’s edema from nodules and polyps is difficult (Neves et al., 2004).  
The epithelium has been reported as normal (Tillmann et al., 1995) or irregularly 
thickened along the lesion: varying from thinner, acanthotic, parakeratotic to duplicate 
epithelium (Loire et al., 1988). Minimal collagen disarrangement of Reinke’s edema was 
reported in the region underneath vocal fold epithelium using picrosirious polarization method 
(Sakae et al., 2008).  
The basement membrane zone (BMZ) for Reinke’s edema is reported as normal without 
any pathological alternations in some studies (Gray et al., 1995; Loire et al., 1988). Sparse 
collagen type IV and fibronectin deposition is noted in the BMZ (Courey et al., 1996). The 
average thickness of BMZ is reported as 0.75 μm on both collagen type IV and fibronectin 
staining, which is the thinnest among nodules, polyps and cysts (Courey et al., 1996). At the 
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same time, some studies report significantly thickened BMZ for Reinke’s edema (F.G. Dikkers 
& Nikkels, 1995; Volic et al., 1996). Hyperplastic, hyperkeratotic and parakeratotic BMZ may 
occur in some patients with Reinke’s edema (Volic et al., 1996).  
The vasculature in the superficial lamina propria (Reinke’s space) is remarkably 
disrupted in Reinke’s edema. Hypervascularization and dilated blood vessels with packed red 
blood cells are reported in the Reinke’s space (F.G. Dikkers & Nikkels, 1995; Gray et al., 1995; 
Loire et al., 1988; Sato et al., 1999). Compared to the parallel direction of blood vessels in 
normal vocal fold mucosa, pathological blood vessel networks in loop or branch forms for 
Reine’s edema were observed under contact telescopy (Jovanovic et al., 2007). Also, mucosal 
“blue lines” were observed in subepithelial well-developed hollow spaces. The “blue lines” may 
be formed by the decreased blood flow by mechanically compressed surgace layers in chronic 
traumatic edema (Jovanovic et al., 2008). The blood vessels have thin endothelium (Jovanovic et 
al., 2007) with many small pores (fenestrae) and vesicles (Sato et al., 1999). The basement 
membrane of the blood vessel walls is thickened by the increased depositions of collagen type IV 
and fibronectin surrounded (Courey et al., 1996; F.G. Dikkers & Nikkels, 1995). As a result, the 
blood vessels increase their permeability and subsequently plasma leaks into surrounding space 
through the small pores of the blood vessels (Sato et al., 1999). That may explain why vascular 
lake and increased fibrin deposition are observed in the specimens of Reinke’s edema under 
electron microscopy (Gray et al., 1995; Sato et al., 1999). Furthermore, some pericytes and 
endothelial cell are degenerated and lose their functions of maintaining the vascular walls, 
resulting vessel occlusion and fragile blood vessels (Sato et al., 1999). Vascular endothelial 
growth factor is present in cytoplasm of inflammatory cells and fibroblasts within Reinke’s space 
(Sato, 1999). This growth factor may contribute to the increase in vessel permeability and 
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fragility. These changes in the vasculature may lead to accumulation of edema in the 
extracellular matrix of the superficial lamina propria (F.G. Dikkers & Nikkels, 1995; Sato et al., 
1999) and may exacerbate the disrupted organization of connective fibres in the lamina propria 
(Volic et al., 1996).  
Phonotrauma may account for the disorganized matrix of lamina propria in Reinke’s 
edema (F.G. Dikkers & Nikkels, 1995). The connective tissues in the superficial lamina propria 
for Reinke’s edema are described as highly ramified fissured spaces (Tillmann et al., 1995) with 
short, torn, scattered connective fibres (elastin and collagen) (Gray et al., 1995; Volic et al., 
1996) and minimal fibronectin (Gray et al., 1995). Some of the Reinke’s edema may have 
unusually perpendicular orientation of elastic fibres to the basement membrane zone (BMZ) in 
Reinke’s edema (F.G. Dikkers & Nikkels, 1995). In a study using picrosirius polarization 
method, both collagen type I and III fibers were fragmented, loosely arranged and intermized 
with different amounts of myxoid stroma in the deeper regions of the superficial lamina propria 
(Sakae et al., 2008). The lack of structure fibrous proteins and glycoproteins in the lamina 
propria may cause the vocal folds with excessive propensity for deformability and so prone to 
injury (Gray et al., 1995).  
The healing mechanism of Reinke’s edema may not be fibroblast-dominant because 
excess collagen deposition is not commonly reported in Reinke’s edema (Gray et al., 1995). A 
speculation is that Reinke’s edema get looped in the inflammatory stage and fails to transit to the 
later healing phase (Thibeault, Gray, Li et al., 2002). A study reported the changes in messenger 
ribonucleic acid (mRNA) expression of a number of extracellular matrix components in Reinke’s 
edema (Thibeault, Gray, Li et al., 2002). Similar to polyps, an upregulation of the gene for 
procollagen-1, downregulations of matrix metalloproteinases 1 and 12 and hyaluronic acid 
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synthase 2 are indicated in Reinke’s edema. These changes may alter the viscoelastic property of 
the superficial lamina propria and predispose a risk of vocal fold scarring. In contrast to polyps, 
fibronectin is downregulated and fibromodulin is upregulated in Reinke’s edema, which may 
contribute to the less stiffness phenotype of Reinke’s edema. Overall, the total gene expression 
scores are lower in Reinke’s edema than that in polyps. The high gene activity of polyps may be 
related to its chronic inflammatory condition (Thibeault, Gray, Li et al., 2002). Further, an 
complementary deoxyribonucleic (cDNA) microarray study (Duflo et al., 2006) elucidated the 
injury and healing mechanisms of Reinke’s edema. In Reinke’s edema, MAP2K3, SOD1, GPX2, 
and GTSA2 were the four significantly overexpressed genes, which are responsible for the 
protection against oxidative stress. Also, gene CASP9, CCNG2 and SP100 were overexpressed, 
which are responsible for cellular regulation and protection to prevent lesion progression and/or 
cell differentiation. Therefore, Reinke’s edema is likely induced by oxidative stress. Also, a 
cellular defence mechanism is turned on to protect the tissue against the oxidative injury. This 
defence mechanism is important for the system to avoid tumour growth and develop cancer. 
B.1.7  Tissue mobilization therapy for phonotrauma 
The aims of tissue mobilization therapy for acute and chronic phonotrauma have different 
orientations. For acute phonotrauma, tissue mobilization aims to alter mechanical signalling in 
order to suppress inflammation by attenuating the pro-inflammatory responses and escalating the 
anti-inflammatory signals (Branski et al., 2006). This effect is important to limit the detrimental 
events during acute inflammation, such as oxidative damage and debridement actions of 
inflammatory cells to the mucosal tissue. Second, mucous secretions are usually accumulated 
during initial inflammatory stage of healing. The oscillatory movement of the mucosa during the 
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phonation may assist in moving mucous secretions off the vocal folds (Behrman & Sulica, 2003). 
The absence of phonatory mucosal wave may result globus sensation in larynx, which induce 
coughing and throat-clear to exacerbate tissue damage. Lastly, the oscillation of the mucosal 
wave associated with mobilization may increase capillary perfusion and migration of 
inflammatory cells (Behrman & Sulica, 2003). These changes may help to bypass a prolonged 
inflammatory phase and avoid a full-scale of healing response. As such, the probability of scar 
formation is minimized in long term. 
For chronic phonotraumat, tissue mobilization targets to resolve the established 
disorganization of matrix proteins in the mucosa. For example, vocal fold nodules (F. G. Dikkers 
& Nikkels, 1999) are characterized by abnormal arrangement of elastic fibres, which are lined 
perpendicularly to the basement membrane (F. G. Dikkers & Nikkels, 1999). Also, intense 
fibronectin and collagen depositions are accumulated in the lamina propria (Gray et al., 1995; 
Kotby et al., 1988). Fibronectin deposition is a relatively permanent event, which increase the 
stiffness of the vocal folds (Gray et al., 1995). Tissue mobilization may (1) improve the 
orientation of provisional matrix parallel to the stress lines of the normal fibres, (2) stimulate the 
expression of matrix metalloproteinases (MMPs) for regulating matrix turn-over during the 
remodeling phase of healing and (3) prevent the tissue atrophy by immobilization (Huang & 
Ingber, 1999; Keller, 2006; Kim et al., 1999; Martin & Wood, 2002; Moore et al., 2005; 
Noorlander et al., 2002; Seliktar et al., 2003; Wang & Thampatty, 2006). The absence of 
dynamic shear force and medial impact force may exacerbate disarrangement of these proteins 
and result in a permanent lesion (Behrman & Sulica, 2003).  
Among all types of vocal exercise, resonant voice exercise is the one that implements the 
concepts of tissue mobilization in healing phonotrauma. Resonant voice is defined as “easy 
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phonation involving anterior oral vibrations and comparatively large-amplitude and low-impact 
vocal fold vibrations” (Berry et al., 2001; Peterson et al., 1994; Verdolini, 2000; Verdolini et al., 
1998; Verdolini et al., in preparation). The exercise primarily involves the production of easy 
sustained /m/ sounds with a focus on anterior oral vibrations in a comfortable pitch range and 
then extends to the higher pitch ranges. Details regarding resonant voice exercises are reported in 
the manual of the Lessac-Madsen Resonant Voice Therapy Program (Verdolini, 2000). The 
benefits of resonant voice exercise are two-fold: optimizing vocal fold physiological functioning 
and mucosal healing. The laryngeal configuration in resonant voice involves barely ab/adducted 
vocal folds, which has been shown to yield the greatest acoustic outputs with the least amount of 
inter-vocal fold impact stress during phonation (Berry et al., 2001; Peterson et al., 1994; 
Verdolini et al., 1998). Regarding the wound healing benefits, the large-amplitude vibrations 
induce certain forms of vocal fold tissue mobilization, which may cause cell deformation and 
subsequently induce therapeutic mechanical signalling for wound healing. Also, the low-impact 
vibratory property of resonant voice minimizes further vocal fold injury or inflammatory 
response.  
Another similar vocal exercise is Vocal Function Exercise (Roy et al., 2001; Sabol et al., 
1995; Stemple et al., 1994). Vocal Function Exercise basically involves the practice of 
maximally sustained vowels and pitch glides. The primary principle is to coordinate among 
respiratory, laryngeal and vocal tract functions in order to optimize vocal performance. Although 
Vocal Function Exercise is initially contrived to improve vocal fold physiology, the exercise 
itself may also have potential wound healing benefits. The maximally sustained phonation 
associated with Vocal Function Exercise involves relatively large mid-lateral vocal fold 
movement yet barley ab/adducted vocal folds to optimize the glottic closure for pulmonary 
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preservation. At the same time, the pitch glides involve some forms of tissue stretching, which 
may induce therapeutic mechanical signalling for mucosal healing.  
B.2 NON-PHONATORY BIOMECHANICAL INJURY: PHONOSURGERY 
According to Classification Manual for Voice Disorders-I (CMVD-I) (Verdolini et al., 2006), 
vocal fold scar is defined as “a permanent change to the microarchitecture of the lamina propria, 
consisting of a loss of the viscoelastic properties of the tissue”. Vocal fold scarring can be 
induced by inflammation, or more commonly following micro-phonosurgery of vocal fold 
lesions (S. Hirano, 2005). Numerous studies employ animal models to characterize the 
histological changes in both acute and chronic vocal fold scarring from surgical trauma.  
Vocal fold scar is regarded as a fibrous tissue resulting from a complete wound healing 
process (S. Hirano, 2005; Thibeault, 2005).  Animal vocal fold scar is characterized by fibrosis 
(increase in collagen or procollagen during the early stages of healing) or a disorganized collagen 
scaffolding (loss of regular 3-dimensional collagen structure at the end of healing) (Thibeault, 
2005). Also, numerous extracellular matrix components are altered during vocal fold scarring as 
seen in animals. Specifically, decreased elastin, increased fibronectin, decreased decorin and 
decreased fibromodulin are reported, although variations across animal species are noted 
(Thibeault, 2005). This alteration of the fibrous and interstitial proteins affects the vocal fold 
cover-body relationship and the propagation of normal mucosal wave, which severely affects 
one’s voice quality (Thibeault, 2005). Figures B1 to B4 summarize the changes of the 
extracellular matrix components in rats, rabbits, canines and pigs respectively in the literature. 
Detailed descriptions of the changes for each component are given shortly. 
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The translation from animal findings to human is a challenge. Results from a histological 
study of human scarred vocal folds were barely consistent with the animal counterparts (S. 
Hirano et al., 2008).  A wide invidual differences in the extracellular matrix deposition of human 
scarred vocal folds were observed. Inconclusive results were drawn about the deposition of 
elastin, fibronectin and hyaluronan in human scarred vocal folds. Less decorin deposition in the 
superficial lamina propria and excessive collagen deposition in the form of thick bundles 
throughout the lamina propria were observed following deep cordectomy, compared to shallow 
cordectomy.   
The difference in the vocal fold architecture and the amount of vocal use between animal 
and human is acknowledged in the literature (Benninger et al., 1996). Another major concern of 
using animal surgical model to mimic the situation in human following phonosurgery is that the 
initial tissue state between these two models is fundamentally different. In current animal 
models, the surgical procedure is done on healthy vocal fold tissue, whereas in human the 
surgical procedure is done on pre-inflamed or pathologic vocal fold tissues. Further research can 
inflame or injure the animal vocal folds before performing the surgical procedure and examine if 
the healing outcomes are different from those without pre-inflamed or pre-injured animal vocal 
folds.  
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Figure B1. Schematic representation of collagen, collagen type I, collagen type III, fibronectin and 
hyaluronan in injured rat vocal folds. 
Rat vocal fold scarring
Day 3 Day 5 Day 7 Day 14 Week 4 Month 2 Month 3
Collagen (Tateya et al., 2005, 2006) Collagen I (Tateya et al., 2005, 2006) Collagen III (Tateya et al., 2005, 2006)
Fibronectin (Tateya et al., 2005, 2006) Hyaluronan (Tateya et al., 2005,2006)
CONTROL LEVEL
INCREASED DEPOSITION
DECREASED DEPOSITION
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Figure B2. Schematic representation of procollagen, collagen, elastin, fibronectin and hyaluronan in 
injured rabbits vocal folds. 
Rabbit vocal fold scarring
Month 2 Month 6
Procollagen (Thibeault et al., 2002, 2004) Collagen (Thibeault et al., 2002, 2004) Elastin (Thibeault et al., 2002, 2004)
Fibronectin (Thibeault et al., 2003) Hyaluronan (Thibeault et al., 2002, 2004)
CONTROL LEVEL
INCREASED DEPOSITION
DECREASED DEPOSITION
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Figure B3. Schematic representation of procollagen, collagen, elastin fibronectin and hyaluronan in injured 
canine vocal folds. 
Canine vocal fold scarring
Month 2 Month 6
Procollagen (Rousseau et al., 2003) Collagen (Hirano et al., 2003; Rousseau et al., 2003)
Elastin (Rousseau et al., 2003) Fibronectin (Hirano et al., 2003)
Hyaluronan (Rousseau et al., 2003)
CONTROL LEVEL
INCREASED DEPOSITION
DECREASED DEPOSITION
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Figure B4. Schematic representation of collagen and hyaluronan in injured pig vocal folds. 
B.2.1 Cellularity 
A report by Tateya et al. (I. Tateya, Tateya, Lim, Sohn, & Bless, 2006) is the only published 
study that investigate cell proliferation during acute vocal fold scarring. In a rat model, 
immunohistochemical staining were performed for (1) vimentin, a marker for fibroblasts; (2) 
alpha-smooth muscle actin, a marker for myofibroblasts; (3) CD68, a marker for macrophages 
and (4) 5-bromo-2-deoxyuridine, a marker for newly proliferated cells at four time points: Day 1, 
3, 5 and 14 following vocal fold mucosal stripping. At day 1 post injury, epithelization and 
fibroblast proliferation started. At day 3 post injury, the proliferation of fibroblasts in the lamina 
propria was at peak. Of note, only the fibroblasts in the lamina propria actively proliferated in 
Pig vocal fold scarring
Day 3 Day 10 Day 15
Collagen (Rousseau et al., 2004) Hyaluronan (Rousseau et al., 2004)
CONTROL LEVEL
INCREASED DEPOSITION
DECREASED DEPOSITION
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this study. Fibroblasts in the macula flava (vocal fold stellate cells) did not proliferate actively in 
response to injury. This observation suggest that the vocal fold stellate cells in the macula flava 
have different functions from those in lamina propria in response to vocal fold injury and repair. 
At day 7, the total number of cells decreased about 33 folds and stayed low by the endpoint of 
the experiment at Day 14 post injury. Myofibroblasts and macrophages were found to minimally 
proliferate at all time points. These finding suggests that extracellular matrix deposition may start 
from Day 3 in injured rat vocal folds. Another study (Branski, Rosen, Verdolini, & Hebda, 2005a) 
also reported massive infiltration of cells and neo-lamina propria at day 3 following mucosal 
stripping in a rabbit model, although specific cell types were not identified in that study.  
B.2.2 Cytokines and growth factors 
Four studies investigate the profiles of various inflammatory mediators in rat and rabbit 
following vocal fold stripping (Branski, Rosen, Verdolini, & Hebda, 2005b; Lim, Tateya, Tateya, 
Munoz-Del-Rio, & Bless, 2006; Rousseau, Ge, Ohno, French, & Thibeault, 2008; Welham, Lim, 
Tateya, & Bless, 2008). Except the study of Branski et al. focusing on protein levels, the other 
three studies were looking at the messenger RNA (mRNA) expressions of inflammatory 
mediators following vocal fold injury. 
A rat study (Welham et al., 2008) used real-time reverse transcription-polymerase chain 
reaction to measure in vivo mRNA for a panel of inflammatory mediators, compared to the 
control side of vocal folds, focusing on the time window of first hour following surgery. 
Compared to the injured controls, gene expressions of cyclooxygenase 2 (COX-2), interleukin-
1beta (IL-1β), tumour necrosis factor-alpha (TNF-α) and hyaluronan synthase 1 (HAS-1) were 
significantly up-regulated. Researchers suggested that platelets, resident cells and some early 
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arriving immune cells were probably the cell source for these mediators at such early time 
window of inflammation and healing. 
Another related rat study (Lim et al., 2006) used a similar protocol described above by 
focusing on a later time window of inflammation: 4hr, 8hr, 16hr, 24 hr and 72 hr postoperatively. 
Results indicate a time-dependent expression profile of the inflammatory mediators. Nuclear 
factor-kappa B (NF-κB), IL-1β, TNF-α, and HAS-1 had peak expressions at 4 and 8 hours. From 
8 to 16 hours, procollagen III expression decreased. At 16 hours, hyaluronan synthase 2 (HAS-2) 
was peak. At 24 hours, interferon gamma (IFN-γ) expression decreased. At 72 hours, 
transforming growth factor beta (TGF-β), HAS-2, procollagen I and procollagen III expressions 
were all at peak. For all time points, COX-2 expressions were significantly higher than the 
controls, whereas elastin expressions were similar to expression levels of the controls. 
The investigators suggested that the simultaneous peaks of IL-1β, NF-κB and TNF-alpha 
expressions during the first 8 hours post injury induced the expression of HAS-1 and HAS-2 for 
hyaluronan production at the later time points. The decrease of procollagen III expression during 
8 to 16 hours post injury might be related to the upregulation of collagenase by the actions of IL-
1β and TNF-α. Also, at 16 hr time-point, the expression profiles were the most various. This 
time-point is speculated as an induction point of various cytokine signalling pathways in order to 
build up the mediator levels to a physiological level for later actions (Lim et al., 2006). At 72 
hours, the upregulation of TGF-β expression might induce extracellular matrix deposition 
associated with HAS-2 and procollagen I and III. Elastin level was not significantly expressed 
from the starting point till the end point of the study at 72 hours post-injury. This finding 
suggests that elastin does not involve in acute inflammation.  
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The expression profile described in Lim et al.’s rat study is generally matched with the 
cell progression in Tateya et al.’s rat study (I. Tateya et al., 2006). Tateya et al. reported that the 
proliferation of fibroblasts in the lamina propria was peak at Day 3 (72 hours) post injury. At the 
same time, Lim et al. reported that TGF-β, HAS-2, procollagen I and procollagen III expressions 
were all at peak at Day 3 (72 hours). Although previous study (Sato et al., 2006) suggests that the 
stellate cells in the macula flava rather than the fibroblasts in the lamina propria are the main cell 
source of hyaluronan and collagen production, stellate cells are minimally proliferated in injured 
vocal folds (I. Tateya et al., 2006). Combining the findings of these two studies suggest that 
fibroblasts in the lamina propria are activated by tissue injury for wound repair, whereas the 
fibroblasts in the macula flava contribute to the maintenance of normal tissue. Also, the activated 
fibroblasts in the lamina propria may secrete a significant amount of growth factors and matrix 
proteins for repair around Day 3 post injury. 
A rabbit vocal fold scarring study (Rousseau, Ge, Ohno et al., 2008) investigated the 
termporal mRNA profiles of MMP-1, MMP-9, fibronectin as well as collagen types I and III up 
to 72 hours following vocal fold stripping. Compared to the control speciments, time-dependent 
changes of these mRNAs were reported. MMP-1 and MMP-9 expression was significantly up-
regulated at 4, 7, 24, 48, and 72 hours post-injury. Fibronectic expression was significantly up-
regulated during 24-72 hours after injury, which may act as the provisional matrix for coming 
inflammatory and healing cell adhesion and migration. Collagen types I and III were 
significantly up-regulated at 72 hours post-injury, which is consistent with the fibroblast 
proliferative phase in injured rabbit vocal folds (Branski et al., 2005a).  
Another rabbit scarring study (Branski et al., 2005b) investigated the temporal 
expressions of two inflammatory mediators: IL-1β and prostaglandin 2 (PGE-2) extending up to 
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21 days following vocal fold stripping. The corresponding mediator expression was measured 
from the concentrations of these two mediators in the surface laryngeal secretions. IL-1β had 
peak concentration at Day 1 and returned to baseline by Day 7 post injury. At the same time, 
PGE-2 was peak at Day 7 and remained elevated by the end point of the experiment, i.e., Day 21 
following injury.  
Although the validity of laryngeal secretion analysis for the vocal folds is awaiting for 
empirical confirmation, two other studies (Lim et al., 2006; Sandulache et al., 2007) may provide 
some indirect data to support the use of laryngeal secretion analysis. First, Lim et al.’s rat vocal 
fold study reported that IL-1β messenger ribonucleic acid (mRNA) expression at the tissue level 
was peak at 4 and 8 hrs post injury, whereas Branski et al.’s (Branski et al., 2005a) rabbit study 
reported that the same mediator at the secreted protein level (laryngeal secretion) was peak at 
Day 1 post injury. The time lag for the IL-1β concentration between that of tissue and of 
secretion can be explained by the process from gene translation to extracellular secretion of IL-
1β. Second, one rabbit  upper airway mucosal wound healing study evaluated directly the 
correspondence of  IL-1β and PGE-2 from both subglottic airway secretions and the underlying 
subglottic tissue (Sandulache et al., 2007). Their results indicate that the up-regulation of 
inflammatory mediators in tissue mRNA levels is in parallel with that in secretion protein levels, 
although the changes in the tissue levels are greater that of the secretion levels after injury. The 
difference can be explained by the fact that mucosal secretions represent only one of several 
compartments into which inflammatory and wound healing mediators are partitioned and 
significant portions are being retained within the tissue. Although Lim et al.’s study (2006) used 
a different species (rat) and Sandulache et al.’s study used a different location of mucosal injury 
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(subglottic) compared to Branski et al.’s rabbit vocal fold study, these two studies seem to 
support the validity of laryngeal secretion analysis as a window of airway inflammation. 
B.2.3 Collagen 
Collagen fibres are the important structural protein of the vocal folds. Collagen levels in scarred 
vocal folds have been studied in rats (T. Tateya, Tateya, Sohn, & Bless, 2005, 2006), rabbits 
(Branski et al., 2005a; Rousseau, Hirano et al., 2004; Thibeault, Gray, Bless et al., 2002), pigs 
(Rousseau, Sohn, Montequin, Tateya, & Bless, 2004) and canines (S. Hirano, Bless, Rousseau et 
al., 2003; Rousseau et al., 2003). Different forms of collagens are studied, namely, procollagen 
(Rousseau, Hirano et al., 2004; Rousseau et al., 2003; Thibeault, Gray, Bless et al., 2002), 
collagen (S. Hirano, Bless, Rousseau et al., 2003; Rousseau, Hirano et al., 2004; Rousseau et al., 
2003; Rousseau, Sohn et al., 2004; Thibeault, Gray, Bless et al., 2002) and collagen types I and 
III (T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et al., 2006).  
In a rat study (T. Tateya, Tateya, Sohn, & Bless, 2006), the expression patterns of 
collagen types I and III were examined at 5 time points, i.e., Day 1, 3, 5, 7, and 14 following 
vocal fold mucosa stripping. Epithelization and granulation tissue was first observed at Day 3. 
The epithelium became thinner and approached to a single epithelial cell layer as observed in the 
controls at Day 7. The epithelization was complete with a single epithelial cell layer at the 
wound sites by Day 14. Collagen type I expression was strong and widespread throughout the 
lamina propria. Collagen type I was first indicated at Day 2 and then is peak at Day 5. 
Subsequently, the level of collagen type I decreases significantly from Day 5 to Day 7 and 
became stabilized until the endpoint of the experiment, i.e., Day 14. 
 225 
 Collagen type III expression was also strong and widespread, which was first indicated 
at Day 1. Then, the level of collagen type III increased and remained intense from Day 3 to 14. 
The investigators speculate that the collagen type III may contribute to the scaffold of the 
granulation tissue and collagen type I may enhance the strength for the new tissue. Further, the 
remodeling phase may start around day 7, in which collagen type III begins to replace collagen 
type I.  
The collagen dynamics during the later remodeling phase of vocal fold scarring is 
described in a rat study (T. Tateya, Tateya, Sohn, & Bless, 2005). The collagen accumulation 
was examined at four time points, i.e., Week 2, 4, 8 and 12 following operation. Overall, 
collagen types I and III were more intense in the scarred vocal folds than that of controls at all 
time points. Collagen type III expression was constantly high for the 12 weeks, whereas collagen 
type I expression reduced from Week 2 until 8 and then stabilized until Week 12. Also, the total 
collagen level (type I plus type III) was peak at Week 2 and 4 and then declined and became 
stable during Week 8 and 12. Combining to the results of this study with the previously 
mentioned study on acute rat vocal fold scarring (T. Tateya et al., 2005; T. Tateya, I. Tateya, J. 
H. Sohn et al., 2006), the remodeling phase in vocal fold wounds can be characterize as: Day 7 - 
the start of remodeling; Week 2 and 4 - active remodeling phase and Week 8 - stable remodeling 
phase.  
Collagen production seems to start relatively late in other larger animals. A rabbit study 
(Thibeault et al., 2002) showed that procollagen I (a marker of new collagen synthesis) was 
abundant in the superficial lamina propria, whereas collagen was sparse at 2 months 
postoperatively. Also, the collagen scaffold appeared disorganized than that of the control vocal 
folds. This observation suggests that the wound is still undergoing matrix deposition and does 
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not enter into the remodeling phase at 2 months following injury. The disorganized collagen 
scaffolding may account for the increased stiffness and viscosity of the scarred tissue. 
Subsequently, another rabbit study (Rousseau, Hirano et al., 2004) reported that procollagen was 
declined to the control level, whereas collagen was significantly increased at 6 months following 
vocal fold mucosa stripping. Also, collagen was found throughout the lamina propria and 
appeared thick and organized in the scarred vocal folds. The findings from these two rabbits 
suggest that the remodeling phase may not begin until 6 months postoperatively and may take up 
to 1 year. However, in another rabbit study (Branski et al., 2005a), mature collagen fibres were 
seen as early as Day 7, which suggests the initiation of remodeling phase.  
One conjecture for this discrepancy is related to the use of trichrome stain for collagen 
detection. Compared to the immunohistochemistry method, trichrome stain is less sensitive and 
less specific if the collagen is in small deposits, thin and immature (T. Tateya, I. Tateya, J. H. 
Sohn et al., 2006). Therefore, the use of trichrome stain may underestimate the amount of 
collagen in the wounds during the first 6 months of Thibeault and Rousseau et al.’s rabbit studies 
because the collagen fibres were still immature and thin during that time. However, this 
conjecture can not apply to Branski et al.’s study (2005) because trichome stain was also used. 
However, mature collagen fibres were observed at a very early time point, i.e., Day 7 after 
injury. Further research is needed to examine the effects of various staining methods in relation 
to different forms of collagen. 
In two canine studies (S. Hirano, Bless, Rousseau et al., 2003; Rousseau et al., 2003), 
collagen levels were similar to the control vocal folds at 2 months postoperatively. Collagen was 
primarily present in the extracellular matrix and minimally around the walls of the blood vessels 
of the lamina propria (S. Hirano et al., 2003). At the same time, procollagen was abundant in the 
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scarred tissues at 2 months but declined to the control level at 6 months (Rousseau et al., 2003). 
On the other hand, collagen density was significantly increased and the collagen fibres formed 
thick yet disorganized bundles (S. Hirano, Bless, Rousseau et al., 2003; Rousseau et al., 2003) at 
6 months postoperatively. Lastly, a pig study (Rousseau et al., 2004) reported that the collagen 
levels were stable during the first 10 days and then started to increase at Day 15 following vocal 
fold mucosa stripping.  
B.2.4 Elastin 
Elastin is a structural protein that is responsible for vocal fold recoil. The expression of elastin 
for vocal folds scarring are studied in rabbits (Rousseau, Hirano et al., 2004; Thibeault, Gray, 
Bless et al., 2002) and canines (Rousseau et al., 2003).  
At 2 months following surgery, both rabbits and canines indicated decreases in the elastin 
levels in the lamina propria (Rousseau et al., 2003; Thibeault et al., 2002). Also, the elastin fibres 
appeared as shorter, tangled and disorganized. At 6 months following surgery, the elastin density 
was similar to the control sample in rabbits (Rousseau, Hirano et al., 2004) but was significantly 
less than the controls in canines (Rousseau et al., 2003). In both cases, elastin fibres were still 
disorganized throughout the entire scarred lamina propria following 6 months of surgery.   
B.2.5 Fibronectin  
Fibronectin is an important adhesion protein, which provides a scaffold for cell migration during 
wound healing and relates to fibrosis at the site of injury. The expressions of fibronectin for 
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scarred vocal folds are studied in rats (T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et 
al., 2006), rabbits (Thibeault et al., 2003), and canines (S. Hirano et al., 2003). 
In an acute rat model (T. Tateya, I. Tateya, J. H. Sohn et al., 2006), fibronectin deposition 
was first indicated by day 1, which began earlier than epithelization and granulation. Fibronectin 
remained at high levels up to the end point of the experiment, i.e., Day 14. The strong expression 
of fibronectin was concomitantly with collagen deposition and collagen remodeling during Day 3 
to 14 (Week 2) in this rat study. Another rat study (T. Tateya et al., 2005) reported the expression 
of fibronectin from Week 2 to 12 postoperatively. The level of fibronectin was peak at Week 2 
and remained significantly high at Week 4. Then, the concentration of fibronectin started to 
decrease from Week 8 until Week 12. At the end point of the study (i.e., Week 12), the 
concentration of fibronectin was slightly higher that those of the controls. Combining these two 
rat studies (T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et al., 2006), fibronectin was 
peak in the first 4 weeks post injury, which indicates the acute phase of wound healing. By then, 
tissue remodeling became slow and the scar was mature approximately two months (8 weeks) 
following vocal fold injury. 
In a rabbit model (Thibeault et al., 2003), immunohistological examination showed 
significantly increase in fibronectin content than the controls at two months postoperatively. In 
contrary to the aforementioned rat model, increased fibronectin was found to be occurred with 
low collagen level in another rabbit study (Thibeault et al., 2002). The investigators speculated 
that the two-month-old scar is regarded as immature in rabbits after surgical trauma. This 
speculation is substantiated by a canine study of vocal fold scarring (S. Hirano et al., 2003). That 
study used immunohistochemical and image analyses to examine the expressions of fibronectin 
and several other adhesion molecules (cadeherin, syndecan-1 and syndecan-4) on the canine 
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vocal folds at both 2 and 6 months following vocal fold stripping. A significant increase in 
fibronectin and syndecan-4 were found in the superficial lamina propria at both 2 and 6 months, 
whereas co-deposition of collagen with fibronectin was only reported at 6 months post injury. 
Other adhesion proteins did not significantly increase after vocal fold injury. The increase of 
fibronectin and syndecan-4 may contribute to the increased viscoelasticity of the scarred vocal 
folds. Further, the characteristics of scar at 2 and 6 months were different, which suggest that the 
2-month scar are not yet mature and stable.  
B.2.6 Decorin and fibromodulin 
Decorin is a proteoglycan that is abundant in the superficial lamina propria of the vocal folds. 
Decorin plays a contributing role in collagen binding and the kinetics of collagen fibril 
formation. Fibromodulin is also a proteoglycan that helps in regulating collagen synthesis.  In a 
rabbit vocal fold scarring study (Thibeault et al., 2003), immunohistological examination 
indicate that decorin and fibromodulin were both significantly decreased 60 days following 
surgery. Decrease in decorin level may change collagen organization, leading to abnormal vocal 
fold architecture. Also, decrease in fibromodulin may promote more collagen synthesis, leading 
to scar formation. 
B.2.7 Hyaluronan 
Hyaluronan is a glycosaminoglycan that is abundant in the superficial lamina propria of the vocal 
folds. Hyaluronan plays an important role for shock absorption and maintaining optimal 
viscoelasticity of the vocal folds. The expressions of hyaluronan in scarred vocal folds are 
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studied in rats (T. Tateya et al., 2005; T. Tateya, I. Tateya, J. H. Sohn et al., 2006), rabbits 
(Rousseau, Hirano et al., 2004; Thibeault, Gray, Bless et al., 2002; Thibeault, Rousseau, 
Welham, Hirano, & Bless, 2004), canines (Rousseau et al., 2003) and pigs (Rousseau, Sohn et 
al., 2004). 
In a rat model (T. Tateya, I. Tateya, J. H. Sohn et al., 2006), hyaluronan was first 
indicated by Day 3, peak at Day 5 and then started to decline until the end point of the 
experiment, i.e., Day 14. This trend is similar to a rabbit model (Thibeault, Rousseau, Welham, 
Hirano, & Bless, 2004), in which the level of HA was peak at Day 5 following vocal fold 
stripping. Also, another pig study (Rousseau, Sohn et al., 2004) reported that hyaluronan was 
significantly reduced in the injured vocal folds than that of the controls at all three time points of 
the study, i.e., Day 3, 10 and 15 following vocal fold mucosa stripping. Compared to the rat and 
rabbit models, the first hyaluronan accumulation was fairly late in pigs. Hyaluronan was not 
indicated until Day 15 post injury in pig vocal folds. The investigators (Rousseau, Sohn et al., 
2004) suggest that hyaluronan is particularly important during the first few days during 
inflammatory and proliferative phases of wound healing. The absence and minimally expressed 
hyaluronan during the acute phase of vocal fold scarring may affect the vocal fold ultrastructure 
and contribute to the increased phonation threshold pressure and the decreased vocal economy in 
long term.  
For the studies with longer observation time, a rat study (T. Tateya et al., 2005) reported 
that hyaluronan density remained significantly lower than that of the control levels at all time 
points of the experiment, i.e., Week 2, 4, 8 and 12 following surgery. This finding is similar to a 
rabbit study and a canine study, which hyaluronan levels were similar to the control levels at 2 
months (Rousseau et al., 2003; Thibeault et al., 2002) and 6 months (Rousseau et al., 2003; 
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Rousseau, Sohn et al., 2004) post injury. The low level of hyaluronan may associate with the 
increased stiffness of the scarred vocal folds (Rousseau, Sohn et al., 2004). Lastly, the 
distribution of hyaluronan in scarred vocal folds is reported to be different from that of normal 
vocal folds. In scarred vocal folds, hyaluronan distribute throughout all layers of the lamina 
propria, whereas hyaluronan is primarily located in the deep lamina propria of normal vocal 
folds in the pig study (Rousseau, Sohn et al., 2004).  
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APPENDIX C 
MATHEMATICAL AND COMPUTATIONAL MODELS IN MEDICINE 
The purpose of this chapter is to (1) discuss system modeling and simulation for clinical 
research; (2) discuss two approaches in simulation modeling: equation based and agent based; 
and (3) overview current mathematical and computational models for a range of clinical diseases.  
C.1 NEW TECHNOLOGIES ARE NEEDED TO DEVELOP PREDICTIVE, 
PREVENTIVE AND PERSONALIZED MEDICINE 
Current treatment paradigms for clinical diseases are reactive. Both surgical and 
behavioural approaches focus on treating pre-existing tissue changes, which are typically late in 
their development. Also, some genes may predispose to the susceptibility to vocal fold injury and 
so an individual may be more prone to a particular disease. Furthermore, human differ 
remarkably with each other relating to genetic polymorphisms. Health care is beginning 
revolutionized towards a predictive, preventive and personalized mode (Hood, 2003; Hood, 
Heath, Phelps, & Lin, 2004; Latterich, 2005; Vodovotz, 2006; Vodovotz, Clermont, Chow, & 
An, 2004). A long-range goal is to generate a technology that can: (1) identify molecular 
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signatures or biomarkers that are predictive of disease or treatment outcome; (2) characterize 
individual’s probabilistic future health history for a range of diseases concerned and design 
preventive treatment program for the highly probable disease; and (3) prescribe personalized 
treatment regimes for individual patients depending on their unique probabilistic future health 
histories. Predictive, preventive and personalized medicine may extend the normal life spans by 
10 to 30 years. Modeling-simulation, a working methodology of systems biology, is required in 
this endeavour (Hood, 2003; Hood et al., 2004; Vodovotz, 2006; Vodovotz et al., 2004). 
C.2 PURPOSES OF MODELING AND SIMULATION 
C.2.1 Modeling 
Modeling is a typical research practice and theory testing method to solve problems when the 
structures or processes underlying a real-world system are difficult to observe and measure 
directly or controlled experimentation is infeasible or too expensive.  
A model is an abstraction of a real-world system.  A model aims to represent a real-world 
system to a certain degree that establishes correct quantitative relationship between the real-
world system and the model of this real system. If the model is formulated as a computer 
program, it is known as a computer model. Models can be characterized by various dimensions 
(Table C1). The choice of dimension depends on the problems of interest and practicability. For 
example, for a model whose analytical solution does not exist or may be very difficult to find, 
simulation modeling rather than analytical modeling may be applied.  
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Table C1. Dimensions of a model and the related descriptions and examples. 
Model 
Dimensions 
Description Example 
Formal vs 
Judgmental 
A formal model is formed by equations and 
formulas. 
A judgemental model is formed by the 
deductions and assessments from an 
individual’s experience or verbal 
description. 
Formal: a mathematical 
expression 
Judgmental: expert opinion 
   
Causal vs 
correlation 
A causal model reflects cause-effect 
relationship. A correlational model does not 
reveal such causal relationship. 
Causal: almost not exist 
Correlational: weather 
forecasting 
   
Deterministic vs 
Stochastic 
A deterministic model generates the output 
to a given input by one fixed law. A 
stochastic model generates the output from a 
set of possible responses based on random or 
a fixed probability distribution. 
Deterministic: differential 
equations  
Stochastic: agent based 
   
Dynamic vs 
Static 
A dynamic model describes the time-spread 
behaviour in a system. A static model 
describes the system at a given instant of 
time and in an assumed state of equilibrium. 
Dynamic: a cartoon; 
differential equations 
Static: a photo 
   
Analytical vs 
Numerical 
(simulation) 
An analytic model is formed by explicit 
equations that permit a solution. A 
numerical (simulation) model is that the 
solution is obtained by experimentating the 
model rather than by an explicit solution 
algorithm. 
Analytical: any mathematical 
models that can be solved 
Numerical/Simulation: most 
models written in partial 
differential equations 
 
Modeling is an iterative process of abstraction, model building, model analysis, model 
optimization and model implementation. First, theoretical assumptions of system structures and 
processes are abstracted to build a model. During model building, a model is parameterized via a 
set of parameter settings. These settings allow the model to be adapted to different situations of 
the same system. Then, the modeller uses the information from the target system to set or 
estimate the parameters in order to optimize the model performance. Lastly, the model is 
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implemented and the model output is compared with real-world data for validation purpose. 
Some discrepancy between the model outputs and the real-world outcomes are common, which 
is known as model error (Edmonds, 2005).   
Models are used in three ways: (1) for explanatory purpose, (2) for predictive purpose 
and (3) for simulation purpose (MacFarlane, 1986 ). The following paragraphs first discuss the 
distinction between explanatory models and predictive models. The next section discusses 
simulation models. Simply speaking, an explanatory model answers “how” and “why” questions, 
whereas a predictive model answers “what” questions.  
An explanatory model aims to provide an explanation of how structures and mechanisms 
underlying a target system contribute to the observed behaviour of the system. To provide such 
explanation, a model requires the information about the initial conditions and the observed data 
from the target system. An explanatory model can give a candidate explanation of how and why 
the outcomes in the target system come from its initial conditions. The validity of explanatory 
model can be tested with known empirical data. A common testing method is to divide the data 
into in-sample and out-of-sample sections, then models are calibrated with the in-sample data 
and models are evaluated to see if they match the out-of-sample section to a sufficient degree  
(Edmonds, 2005; MacFarlane, 1986 ). 
A predictive model is used in order to make inference about what is going to happen in 
the future based on the current knowledge of the system. The predictions do not need to have 
100% accuracy but simply accurately enough for the modeller’s purpose. Compared to 
explanatory models, predictive models require much more information for model building. If the 
prediction is beyond a certain time limit or the systems exhibit chaotic behaviour, impossibly 
large amount of information is required to predict the systems’ future behaviour. As a matter of 
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fact, the real world has finite amounts of useful information and this explains why our predictive 
ability to future is so limited (Edmonds, 2005; MacFarlane, 1986 ). 
C.2.2 Simulation 
Simulation is the process of model implementation or execution. A simulation model is whose 
solution is obtained by executing the model, instead of solving by an explicit algorithm. A set of 
rules or mathematical equations defines how a simulation model changes over time, given its 
current state. To execute the model, a computer program is required to take the model through 
time and to update the state and event variables in the model simultaneously. The time steps can 
be discrete or continuous.   
Traditionally, a formal model is built by mathematical equations in order to find 
analytical solutions for explaining or predicting the behaviour of the target system from a set of 
parameters and initial conditions. If the model can be solved analytically, simulation approach is 
not needed. However, there are many mathematical equations that simply do not have analytical 
solutions. This problem is not rare, especially when (1) the model is very complex with many 
interacting components; (2) the interactions of the components are nonlinear; (3) time dynamics 
is important; and (4) the model contains random variables. For these situations, a complete 
numeration of all possible states is impossible. Simulation is applied to generate a sample of 
representative scenarios for a model. Therefore, simulation is very useful to explore complex 
models and to establish possible processes and outcomes by manipulating the parameters of the 
models (Edmonds, 2005).  
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C.3 GENERAL FRAMEWORK OF MODELING-SIMULATION IN SYSTEMS 
BIOLOGY 
The focus of systems biology is to capture all components and interactions of a target functional 
system and its underlying dynamics. To achieve these goals, systems biology has to tackle a 
large volume of data and a level of complexity that cannot be modelled with simple graphics 
alone. In systems biology, computer-aided modeling and simulation is indispensable. Computers 
not only help to store and compile data in an efficient way but also help to integrate data into 
network models for simulation purposes.  
In clinical research, a model is to provide an abstract representation of the information 
obtained from experimental observations on the structure and function of a specific biological 
functional element. This functional element can have different levels of complexity, ranging 
from simple enzyme reactions to signal transduction pathways to cell mitosis to organ functions 
or even to whole human being. Modeling-simulation assists system-level analysis of biological 
systems in three aspects. First, models enable to describe the structure of the interactions that 
govern system behaviour. Second, models integrate and summarize the current knowledge that 
can facilitate cross-discipline communication. Third, models enable to simulate system responses 
given specified perturbation and to give quantitatively accurate predictions that can be 
experimentally verified (Butcher, 2007; Butcher, Berg, & Kunkel, 2004; Ideker, Galitski, & 
Hood, 2001).  
System modeling and simulation involves four major steps: (1) component identification 
and modeling, (2) system perturbation and monitoring; (3) model refining and (4) model testing. 
The idea of this framework is to transfer a descriptive and qualitative model to a statistical or 
probabilistic model (Ideker et al., 2001).  
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1. Component identification and model building. The first step is to define all the 
components of the target system to formulate an initial mathematical model. Ideally, 
using existing biochemical and genetic knowledge for component identification is the 
best because no prior assumptions are intervened in the model. However, when prior 
knowledge about the target system is limited, hypothetical interactions among the 
components can be involved. In that way, the initial model becomes descriptive.  
2. Experimental perturbation. The second step is to systematically perturb and monitor the 
components of the target systems. Perturbation can be genetic, such as, gene deletions, 
gene overexpressions or undirected mutations. Perturbation can also be environmental, 
such as, changes in temperature, growth conditions or growth factors stimulation. High-
throughput technologies are needed to measure the corresponding responses to each 
perturbation and to integrate the data from multiple experiments. The measures should be 
taken at multiple levels of the system, such as, messenger ribonucleic acid (mRNA) 
expression, protein expression, and protein function. The observed data are then 
integrated into the initial mathematical model (Step 1).  
3. Model calibration and optimization. The third step is to refine the model until model 
predictions are closely matched with experimental observations. A goodness-of-fit 
measure is commonly used to evaluate agreements between predictions and observations. 
If disagreement exists between the predicted and observed responses, alternative 
hypotheses are proposed to refine the model structure or function in order to maximize 
the goodness of fit. However, the proposed refinements may result multiple models 
whose predictions are in good agreement with the known empirical data but with 
different underlying hypotheses. To differentiate these models, Step 4 is required.  
4. Iterative model testing. The last step is to design and perform new perturbation 
experiments that can distinguish among multiple model hypotheses. During model 
refinement (Step 3), multiple models with competing hypotheses may be resulted. 
Current data set (Step 2) are insufficient to distinguish these models and thus new 
perturbations and measurements are required to discriminate the models. New 
perturbations should be able to elicit differentiated system responses among the models. 
After a set of new perturbations are identified, steps 2 to 4 are repeated to expand and 
optimize the model continually over successive refinements. The goal is to bring 
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experimental data and model predictions into close agreement by iterative testing, so that 
model predictions can accurately represent biological reality.  
C.4 PROMISES OF SYSTEM MODELING AND SIMULATION IN CLINICAL 
RESEARCH 
Physiologic systems, whatever in their healthy and pathologic states, exhibit a remarkable 
variability of structural patterns and temporal behaviours. Classical homeostasis, linear 
constructs and reductionist methodologies are inadequate to understand such physiological 
complexity (Goldberger, 2006). For example, reductionist strategy contributes in identification 
of numerous biomarkers that characterize an array of diseases. These biomarkers may have 
beneficial and/or adverse effects on the body, depending on the amount and timing of their 
production. With these functional dependencies, reductionist approach is limited to differentiate 
the roles of biomarkers -- are the markers merely signatures of immunologic response or are the 
markers actually involved in the pathophysiology of disease (Neugebauer, Willy, & Sauerland, 
2001; Tjardes & Neugebauer, 2002)? To answer these questions, prohibitively large number of 
animal or in vitro experiments is anticipated (1) to collect comprehensive data in considering all 
temporal and contextual factors and (2) to extract useful information and pattern from such huge 
quantities of data. In order to overcome the limitations of animal and in vitro experiments, 
systems biology is an alternative approach in studying complex processes, like in 
pathophysiology. Systems biology helps to (1) handle a plethora of components and interactions 
within complex processes simultaneously; (2) quantify interrelationships (organization or 
structure) and interactions (dynamics or behaviour) of genes, proteins and metabolites; and (3) to 
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integrate this information into visible working models that can provide predictive hypotheses to 
elucidate emergent phenomena behind complex processes (Hood et al., 2004; Kitano, 2002a, 
2002b; Wolkenhauer, 2001). For a detailed discussion of system-level analysis, please refer to 
Chapter 5, Section 5.5.2. 
Mathematical and computational modeling-simulation are the essential tools for system 
analysis in clinical research, especially in knowledge discovery (data-mining) and simulation-
based analysis (Kitano, 2002a, 2002b). Modeling is used to transfer real-world components and 
interactions into an abstracted representation. For knowledge discovery, model abstraction is 
useful to conceptualize the “hidden order/pattern” behind the observed phenomena (e.g., 
immunologic response) from huge volume of experimental data (e.g., proteomic data). Building 
a conceptual framework is helpful to explain unknown relationship, to make predictions, to 
formulate hypotheses for designing experiments and to suggest which variables to measure and 
the rationale (Wolkenhauer, 2001). For instance, knowledge discovery has been extensively 
applied to predict protein structure from genetic sequence, for instance (Baldi & Brunak, 2001). 
 On the other hand, simulation-based analysis is to test hypotheses with computer (in 
silico) experiments and then to provide predictions to be tested by in vivo/in vitro experiments 
(Kitano, 2002a, 2002b). In clinical research, simulation-based analysis can sharpen our 
understanding and intuition of a particular (patho-) physiological process. Simulations from 
computer-executable models predict a range of scenarios relevant to the properties of systems. 
These simulation outputs are compared with known empirical data to evaluate the validity of the 
underlying assumption of systems. Inconsistent findings reflect that the validity of the underlying 
assumption of the models or the prior knowledge to the target system is in question. In that case, 
hypotheses of the models have to be revised until they pass the validation process. A validated 
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model can then be used to provide predictions to be tested by in vivo and in vitro experiments as 
well as to explore problems that are not feasible to experimental inquiry. Modeling-simulation 
approach has improved our understanding of various biological phenomena, such as, bifurcation 
analysis of cell cycles (Borisuk & Tyson, 1998; Chen et al., 2000; Lovrics et al., 2006) and 
metabolic analysis (Covert, Knight, Reed, Herrgard, & Palsson, 2004; Edwards, Ibarra, & 
Palsson, 2001). The application of modeling-simulation to clinical practice is acknowledged in 
drug discovery and gene therapy to pursue the goal of predictive, preventive and personalized 
clinical care (Hood, 2003; Hood et al., 2004; Kitano, 2002a, 2002b). 
To sum, by direct modeling-simulating a complex system, one can observe, manipulate 
and understand the behaviour of the whole system in a more efficient way. As such, modeling-
simulation can improve both of biological sight and insight into mechanisms within complex 
systems (Goldenfeld & Kadanoff, 1999; Kitano, 2002a, 2002b; Vicsek, 2002).  
C.5 CHALLENGES OF MODELING-SIMULATION IN CLINICAL RESEARCH 
Application of modeling-simulation is still in its infancy in clinical research. Challenges are 
described as follows. First, building a full-scale human model or even a whole-cell model is 
difficult at the current stage of technology (Kitano, 2002a, 2002b). Existing models focus on 
relatively specific processes at particular scales, such as, at the metabolic pathway level. 
Simulation of a full-scale model has to integrate multiple models, which are heterogeneous in 
terms of scales, resolutions and modalities. For example, some biochemical processes may take 
place in the order of millisecond, whereas some are in the order of hours or days; some 
biological phenomena is best modelled by stochastic computation or differential equations, 
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whereas some biological processes have to use a combination of both methods. Although 
forming integrative models across scales and modalities seems impossible at the time of this 
writing, profiling data from high-throughput assays may help to incorporate biological 
complexity at multiple levels: multiple interacting molecular pathways, multiple interacting cell 
types and multiple different environments (Butcher, 2007; Butcher et al., 2004). These data 
provide a solid foundation for cross-scale model building. 
Second, a question that is always asked during model building is “what the level of 
details should be”. Incorporating every single known interaction into a model is demanding. 
Subsequently, parameter estimations for models can also be complicated with the number of 
parameters. Estimates may need to come from diverse experiments, which may give dramatically 
different values for parameters. Moreover, model calibration with known biological or clinical 
data becomes even more challenging. Models may be able to show high-level resemblances 
between the emergent properties of models and real-world phenomena. However, calibrating 
models that produce confirmable regularities of real-world systems is challenging.  
Lastly, the modeling-simulation approach has been challenged for its over-interpretation 
of model outputs (Edmonds, 2005; Latterich, 2005). Confusion between explanatory and 
predictive types of model may happen in systems biology. The origin of concern is that 
biological systems are regarded as complex adaptive systems (Bradbury, 2002). Behaviour of 
these systems is regarded as unpredictable owing to their extreme sensitivity to initial conditions 
as well as adaptation and self-organization of component parts (Bradbury, 2002). Therefore, the 
models of complex adaptive systems are explanatory at best but not predictive in strict sense. 
One can run the models to generate a distribution of scenarios and use the outputs to understand 
the underlying process of the target systems (Rand et al., 2003). However, the model outputs 
 243 
cannot be considered to conclude as predictions about the target systems. Even though one may 
find a good correlation between model outputs and experimental data, correlation alone is not a 
strong scientific proof per se (Latterich, 2005). Furthermore, if the models are constructed as 
predictive, the models should be validated against unknown data to the modeller. However, these 
“predictive” models sometimes are erroneously validated as explanatory models – using in-
sample and out-of-sample data set from a same system (Edmonds, 2005). As such, researchers 
have to be very cautious when making justification and interpretation of model outcomes.  
C.6 MODELING TECHNIQUES: EQUATION-BASED AND AGENT-BASED 
MODELING  
C.6.1 General Overview 
Equation-based modeling and agent-based modeling are the widely accepted simulation 
techniques in studying biological complexity. The basic structures of these two models are 
distinctive. Each of the models has its own strengths and limitations and are considered 
complementary (Vodovotz et al., 2004). Table C2 summarizes the principles, properties, 
strengths and limitations of equation-based and agent-based modeling. 
Equation-based and agent-based modeling have a common. Both models realize the real 
world consisting of two entities, which are individuals and observables (van Dyke Parunak, 
Savit, & Riolo, 1998). Each individual is characterized by a unique set of traits. Individuals 
interact with each other through their behaviour and affect the values of observables. For 
instance, individuals can be understood as “people in a city”, who “do things” over time. 
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Observables can be understood as “the economy of the city”, which are “measurable 
characteristics” of interest. Equation-based modeling and agent-based modeling treat individuals 
and observables differently in the way of modeling their relationship among entities and the level 
of focus. 
The first fundamental difference between equation-based and agent-based modeling is 
how to model the relationship among entities. Equation-based modeling begins with a set of 
mathematical equations that express relationship among observables. These equations may be 
algebraic, or they may capture system dynamics over time (ordinary differential equations) or 
over time and space (partial differential equations). The interacting behaviours of the individuals 
are not explicitly represented in equation-based models. On the other hand, agent-based 
modeling begins with the behaviours that express the interactions among individuals. These 
behaviours may involve multiple individuals directly (e.g., men marry women) or indirectly 
through a shared environment (e.g., men and women compete for a job). Individuals affect the 
values of observables by their actions. However, the direct relationships among observables are 
not informed but rather emerge in agent-based models (van Dyke Parunak et al., 1998).  
 The second fundamental difference between equation-based and agent-based modeling is 
the level at which the model focuses on. A system is composed of interacting individuals. Some 
of the observables can only be expressed at the system level (e.g., the economy of a city), while 
some may be defined at the individual level (e.g., the monthly salary of people in a city). 
Equation-based modeling primarily uses observables at the system level to drive the model’s 
dynamics. On the other hand, agent-based modeling is not driven by system-level information. 
Agent-based modeling maps its building block “agents” to the individuals of the target systems. 
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Then, agent-based modeling use observables at the individual level to define agent behaviours 
(van Dyke Parunak et al., 1998).   
 
Table C2. Comparison of equation-based and agent-based modeling (Bonabeau, 2002; Neugebauer & 
Tjarders, 2004; van Dyke Parunak et al., 1998).  
 Equation-based modeling Agent-based modeling 
Principle The dynamics of the system is modelled as a 
collection of differential equations and 
constitutes the mathematical foundations of 
Newtonian determinism. The response of the 
system is determined by solving the differential 
equations.  
Objects (“agents”) are created by abstraction from the 
real world objects. Different classes of agents are created 
to represent their individual properties.  Rules of 
interaction are then fed into the system. The behaviour of 
the system components can be observed by running 
simulation. 
   
Properties   
Building Block Feedback loop connecting behavioural variables 
(observables). 
Individual agents connected by feedback loop. 
Unit of 
Analysis 
Structure, which is fixed over time Rules, which can be adaptive over time. 
Perspective Top-down: infer from structure to systems 
behaviour. 
Bottom-up: infer from individual agent’s behaviour to 
systems behaviour. 
Handling of 
Time 
Continuous simulation. Discrete or continuous simulation. 
Mathematical 
Formulation 
Integral equations. Logic. 
Handling of 
Randomness 
Deterministic: no random elements. Stochastic: contains random (probabilistic) elements. 
   
Strengths Amenable to mathematical systems analysis, e.g., 
bifurcation theory. 
“One-to-one modeling”: “Agents” can be applied directly 
to its “real-world” counterparts.  
 Requires good experimental evidence to derive 
valid coefficients. 
Models are explicitly based on the formulation of the 
investigated mechanisms. 
 No need to have an exact definition of the states 
of physiological systems. 
Suitable for mapping the spatial structure of processes. 
  The model computation is parallel rather than sequential, 
which is closer to reality. 
   
Limitations Difficult to separate mathematical phenomena 
from physiological reality. 
Technical limitations of agent complexity and number of 
agents. 
 Difficult to implement spatial structure of the real 
world into the model. 
Analysis is limited to spatial events. The model has to be 
transferred into differential equations for a mathematical 
analysis. 
 Analytical approach will be failed if the model is 
composed of partial differential equations. 
Numerical method has to be applied to analyze 
the model. 
 
 The construction of adequate differential 
equation is very demanding because the 
corresponding coefficients have to be determined 
with a high degree of precision. 
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C.6.2 Equation-based Modeling 
Equation-based model is composed of a series of (usually nonlinear) differential equations that 
describe the change of the states of the variables with time. Equation-based modeling is formal 
and rigorously quantitative to simulate a system. Equation-based modeling is continuous, which 
does not model discrete events. The structure of an equation-based model is fixed and is 
organized by interacting feedback loops. Equation-based modeling is particularly suitable for the 
human physiology when the laws of nature (e.g., Newton's law of gravitation, Newton’s three 
laws of motion, the ideal gas laws, Mendel’s laws, the laws of supply and demand, etc.) apply. 
Circulatory system and respiratory system are the good exemplars for equation-based modeling 
(Neugebauer & Tjarders, 2004; Vodovotz et al., 2004). 
Constructing an equation-based model with adequate differential equations that can 
accurately represent human physiology is a non-trivial task. To approach a target system in 
equation-based modeling, one has to quantitatively formulate system behaviour as a number of 
interacting feedback loops, balancing or reinforcing, and delay structures (Borshchev & Filippov, 
2004). A typical feedback-rich equation-based model is composed of several dozens to several 
hundreds of equations (Borshchev & Filippov, 2004). The model has to go through an iterative 
process of expansions and reductions until a minimal feedback structure in terms of number of 
differential equations is identified to adequately simulate a predefined reference mode of the 
target system (Scholl, 2001). 
Usually, the differential equations in equation-based models have to be derived from 
known and hypothesized kinetics of the components of biological systems (Vodovotz et al., 
2004). The parameters of the equations usually represent the average concentrations of various 
components in the systems, such as, cell types or inflammatory mediators. Also, the coefficients 
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of the equations, which specify a model to its target system, have to be determined with high 
precision, either by experiments, statistical methods or expert knowledge (Neugebauer & 
Tjarders, 2004; Vodovotz et al., 2004). Ordinary differential equations are usually applied to 
characterize time-dependent dynamics of systems. When spatial dynamics is an issue as well, 
partial differential equations have to be applied instead. If a model is composed of complex 
ordinary differential equations or partial differential equations, analytical approach is usually 
failed to solve the equations. In that case, numerical approach (i.e., simulation), which is 
commonly with the aid of computers, has to be applied to solve the equations. The other 
approach is to employ the methods from nonlinear dynamics analysis, such as, bifurcation 
analysis, to explore the dynamics of the systems without solving the equations (Kitano, 2002a, 
2002b; Vodovotz et al., 2004). The mathematical structure and tools for analysis of equation-
based models are discussed in the following paragraphs. 
C.6.3 Mathematical structure and tools for analysis for equation-based modeling 
A classical example of equation-based modeling is the problem of population growth. 
The question of interest is what the population will be in the coming years. A simplified model 
for this problem is an exponential model. That is, the rate of change of the population is 
proportional to the existing population. The equation is written as: 
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P is the population. t is time. k is a rate constant. The initial condition population is P0. 
The solution of this equation is Pt = P0ekt. 
A more complex biological model is given herein. For the ease of understanding, Figure 
C1 presents a “stock-flow” diagram of neutrophil dynamics in an equation-based model. Briefly, 
the diagram has two basic variables: (1) “stocks”, representing the states of the system, and (2) 
“flows,” representing an activity that changes the stock magnitude. The “flow” connects the 
“stocks/ states” in the model. The flow is not a constant but is the rate of change in the stock at 
any instant of time. In calculus terminology, that instantaneous rate of change of the system is 
the derivative of stock with respect to time t. 
 
 
 
dP
dt
= kP
Rate of change 
of the 
population 
Existing 
population 
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To model biological systems, states of the system is usually specified by the 
concentrations of all cellular and biochemical components involved at any instant of time 
(Tyson, Chen, & Novak, 2001; Tyson, Csikasz-Nagy, & Novak, 2002). The rate of change of the 
concentration for each component is formulated as differential equations in equation-based 
modeling. The equations inform how much each concentration will change in the next small 
interval of time. To know the temporal progression of each component, the rate constants have to 
be specified and the differential equations have to be solved by integration. However, most of the 
Figure C1. A schematic dynamics of neutrophils in an equation-based model. The rectangular 
boxes represented the two “stocks/ states” of neutrophils over time: resting and activated states. The broad 
arrows are “flows/rates”. The flows include: (1) “Neu-recruitment” -- the process at which neutrophils are 
recruited to the wound site, and (2) “Neu-activation” -- the process at which resting neutrophils are 
converted to activated neutrophils. These two flows can be affected by systematic variables: (1) tissue 
damage and (2) mechanical stimuli induced by tissue mobilization. The diamond boxes (e.g., TGF-β) are 
auxiliary variables. They can inhibit (e.g., IL-10) or stimulate (e.g., TGF-β) the neutrophil recruitment and 
activation processes directly (e.g., IL-10) or indirectly (e.g., TGF-β). Lastly, both resting and activated 
neutrophils die at their respective death rate.  
 
Resting
Neutrophils
Neu-RecruitmentInitial number of  
Neutrophils
Neu-Activation
Death rate of 
resting neutrophils
Tissue damage
+
Tissue damage Mechanical stimuli
+ +/-
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TNF-α
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Activated
Neutrophils
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-
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time, the rate constants are not measurable and alternative methods are required to find the 
solution of the equations. Tools from system dynamics provide an alternative solution for 
equation-based modeling analysis. Bifurcation analysis is one of the tools, which has been 
widely used in biological modeling (Day et al., 2006; Reynolds et al., 2006; Tyson et al., 2001; 
Tyson et al., 2002). 
Simply put, bifurcation theory is the analysis of a dynamical system of ordinary 
differential equations under parameter variation. Bifurcation analysis is powerful to describe how 
a system behaves over time with its parameter(s), because it predicts what kind of behaviour 
(systems in equilibrium or in oscillation) occurs where in parameter space. Bifurcation analysis 
traces time-dependent changes in the state of the system in a multidimensional space. For a 
biological system, each dimension can be realized as concentration of a particular cell type or 
protein involved. The bifurcation solution to an equation-based model is the topological features 
(e.g., the number of stationary points or periodic orbits) of the system over time under various 
conditions. “Steady states” and “oscillations” are the two critical solutions from bifurcation 
analysis. Biological interpretation of “steady state” is that the rates of change in the 
concentrations of cell or proteins involved are all identically zero. In other words, at a steady 
state, cell or protein concentrations are unchanged in time. On the other hand, the biological 
interpretation of “oscillations” is that the concentrations of cell or protein change in time and 
repeat themselves after a certain time-point (Tyson et al., 2002).  
Both “steady state” and “oscillatory” solutions can be either stable or unstable. Stable 
means that any perturbations has little temporal effect to drive the system away from its original 
state (steady or oscillatory) and the system return to its original state very quickly. Unstable 
means that some perturbations grow larger with time and the system leaves its original state 
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(steady or oscillatory). Stable solutions represent physiologically observable states of the system, 
whereas unstable solutions make the existence of the state to be known only indirectly (Tyson et 
al., 2002).  
The bifurcation solutions of a dynamical system depend on the parameters in the 
equation-based models. Parameter variation may lead to quantitatively or qualitative different 
behaviour of the system. The qualitative change of the solutions of a dynamical system is known 
as “bifurcations”, which is of interest for researchers. For example, a stable oscillatory state may 
lose its stability or even disappear, and a steady solution may kick into existence. “Bifurcation 
points” is the particular values of parameter(s) at which bifurcations occur (Tyson et al., 2002). 
Scientists are interested in searching for the bifurcation points in system behaviour and see how 
to control the physiological properties of a system by manipulating the involved parameters.  
C.6.4 Strength and limitations of equation-based modeling 
The advantage of equation-based modeling over agent-based modeling is its suitability 
for rigorous mathematical analysis. Equation-based modeling allows characterization of system 
behaviour using standard techniques, such as bifurcation analysis. However, equation-based 
models are rigid in structure and lacks the capability to modify them, which is one of the 
strengths of agent-based modeling (Scholl, 2001). Also, equation-based modeling lies on the 
assumption of homogeneous mixing of individuals and the application of mean-field 
approximation. That is, individuals are identical or can at least be represented by some “average” 
type. However, recent notion suggests that system dynamics are more realistic to be modelled by 
treating individuals in a heterogeneous way (van Dyke Parunak et al., 1998). In that sense, agent-
based modeling provides a perfect alternative in that avenue. 
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C.6.5 Agent-based Modeling 
Agent-based modeling or individual-based modeling is a relatively new approach for system 
modeling and simulation, which studies macro-level world through defining micro-level of a 
system. Agent-based modeling is stochastic modeling that simulates the behaviour of real-world 
systems under random conditions (Gilbert & Bankes, 2002). "Agents" are the building blocks in 
agent-based models. Agents represent the component parts of a system that contribute to the 
system’s behaviour. Agent behaviour is defined by a set of rules, which is implemented during 
the simulation process. The rules can involve mathematical equations or "If…Then" conditional 
statements. On the basis of these rules, a virtual environment is created to allow agents to 
respond and interact, and to allow for the quantitative visualization of the emergent behaviour. 
C.6.6 Suitability of agent-based modeling in clinical research 
Agent-based modeling is particularly suitable for modeling complex adaptive systems, 
e.g., biological systems (Holland, 1992, 1995; Mitchell, 2003). Complex adaptive systems are 
composed of diverse entities that interact nonlinearly and dynamically. These systems display 
self-organization and adaptation to produce emergent structures and behaviours, which cannot be 
easily predicted (Cilliers, 2005). In biology, the interactions are often context-dependent and 
time-dependent, which makes biological systems adaptive. Also, biological systems are 
described as “complex” from three aspects: constitutive complexity (complex structure), 
dynamic complexity (complex functional processes) and evolved complexity (complex 
evolutionary processes) (Mitchell, 2003). Agent-based modeling provides a robust and flexible 
framework to encompass these three complexities.  
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For constitutive complexity, agent-based modeling assumes heterogeneous mixing of 
individuals and acknowledges the difference between the basic units in the target systems. Also, 
agent-based models are flexible in its structure, which is opposition to equation-based modeling. 
Equation-based modeling has to make hypotheses about the global structure of the system a 
prior and then try to validate with a top-down procedure. Agent-based modeling allows 
specifying model structures both by posing constraints on the model as a whole (top-down) or by 
specifying the organization of agents individually (bottom-up). Moreover, agent-based models 
are inherently compositional/ modular in structure. Multiple models or multiple scales in 
physiologic organization can be integrated in the same agent-based models, without rebuilding a 
new model. The assumption of heterogeneous mixing and the structural flexibility enriches 
agent-based models to generate diverse structure patterns for modeling-simulation purpose 
(Mitchell, 2003; Neugebauer & Tjarders, 2004). 
For dynamic complexity, agents’ rules are adaptive. The rule-based simulation allows 
modeling the context- and time-dependent nature of biological functions. The rules can be 
formulated in a way that agents can participate in multiple pathways and processes at different 
time or in different environments. Thus, agents are able to perform complex interactions with 
others (Griffin, 2006; Mitchell, 2003).  
For evolved complexity, agent-based modeling is able to encode history-dependent 
events. Each agent has unique entities and their history-dependent behaviours can change and 
adapt each others to produce new sets of behaviour. The history of an agent forms part of the 
model’s history and in turn feedback to the model to determine the agent’s current behaviour. 
The recursive agent-agent and agent-environment interactions create the continuously evolving 
processes as observed in biological systems (Griffin, 2006; Mitchell, 2003). 
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Last but not least, the robustness and flexibility of agent-based models allow for the 
addition of new components in existing models. This advantage is important to accommodate the 
quickly changing landscape of knowledge in clinical research. Agent-based modeling has been 
applied to study various fields of medical science, for instance, immunology (An, 2001, 2004; 
Day et al., 2006; Gammack, Ganguli, Marino, Segovia-Juarez, & Kirschner, 2005; Melby, 2004; 
G. Muller, Grebaut, & Gouteux, 2004; J. Muller, Kretzschmar, & Dietz, 2000; Reynolds et al., 
2006; Robbins & Garrett, 2005; Tay & Jhavar, 2005; Vodovotz et al., 2006; Vodovotz et al., 
2004), tumour growth (C. Athale, Mansury, & Deisboeck, 2005; C. A. Athale & Deisboeck, 
2006; Mansury & Deisboeck, 2004a, 2004b; Mansury, Kimura, Lobo, & Deisboeck, 2002; 
Zhang, Athale, & Deisboeck, 2007), vasculature (Peirce, Van Gieson, & Skalak, 2004) and stem 
cells (d'Inverno & Prophet, 2005). Therefore, agent-based modeling appears to be the most direct 
initial approach to simulate the mechanism of biological systems, and to encode complicated 
history-dependent internal cellular and molecular events (An, 2005; Smallwood, Holcombe, & 
Walker, 2004; Vodovotz et al., 2004; Walker, Hill, Wood, Smallwood, & Southgate, 2004).  
C.6.7 General principles of agent-based modeling 
The principle of agent-based modeling is that agents are created by abstraction from the 
real-world entities of interest. An agent-based model contains a system of numerous yet 
heterogeneous agents (ranging from tens to thousands) and the relationships between them. 
Different classes of agents are characterized by their function and behaviour. The rules of 
interaction (computer algorithms) among the agents are fed into the system. The rules are usually 
derived from theory or empirical data. If simulation is run, the behaviour of the system 
components can be observed. Beyond examining the component behaviour, the modeller is able 
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to explore possible underlying mechanisms that synthesize the observed emergent phenomena. 
For instance, system behaviour can be explored by varying the initial conditions of the models, 
or by imposing some restraints on the models, or by changing the rules of interactions (An, 2001; 
Bonabeau, 2002; Griffin, 2006; Holland, 1995; Neugebauer & Tjarders, 2004; Srbljinovic & 
Skunca, 2003; Troisi, Wong, & Ratner, 2005).  
The idea behind agent-based modeling is that decision making is distributed among 
agents. Agents can operate individually but can also compete and cooperate with other agents 
and their environment. Both micro-level patterns (e.g., local behaviour and interaction between 
the agents) and macro-level phenomena (e.g., collective behaviour emerging from agents’ 
individual characteristics) are observable in agent-based models. Agent-based modeling creates a 
virtual environment for artificial agents to inhabit. Agents perceive the state of the environment, 
and then operate in respect to the information they acquire. Agents may change themselves or 
change others’ in their environment accordingly. Agents’ actions are goal-oriented and they 
evolve. Agents have intentions to actively change the state of the environment in order to achieve 
their goals according to their internalized decision plan. Except being goal-directed, agents may 
also have cognitive properties (such as adaptation, memory and learning) to seek information or 
communicate intentions. The aforementioned characteristics permit the agents to participate in 
complex interactions and thus synthesize unanticipated behaviours at the global level (An, 2001; 
Bonabeau, 2002; Griffin, 2006; Holland, 1995; Neugebauer & Tjarders, 2004; Srbljinovic & 
Skunca, 2003; Troisi et al., 2005).  
The rules in agent-based models are considered as “generative rules”, which are not 
exactly the same as the rules/laws of traditional science. Generative rules determine how the 
agents behave in their virtual environment over time. Generative rules use feedback and learning 
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algorithms to permit agents adapting to their environment over time. As agents’ information 
exchanges and interactions take place during simulation, agents and their governing rules evolve 
and produce complex biological processes that may have some resemblance to the real world 
(An, 2001; Bonabeau, 2002; Griffin, 2006; Holland, 1995; Neugebauer & Tjarders, 2004; 
Srbljinovic & Skunca, 2003; Troisi et al., 2005). Finding a set of generative rules that can mimic 
real-world behaviour is the main interest of scientists for system control and prediction.  
Bonabeau (2002) explicitly describes a set of conditions when to use agent-based 
modeling at best.  
1. When the interactions among the agents are complex, nonlinear, discontinuous, discrete 
and can be characterized by thresholds, if-then rules or nonlinear coupling. 
2. When spatial aspect is important and the agents’ positions are not fixed. 
3. When the population and the agent’ interactions are heterogeneous and when averages do 
not work. 
4. When the agents exhibit complex behaviour, including memory, path-dependence, 
hysteresis, non-markovian behaviour, temporal correlations (learning and adaptation). 
5. When stochasticity applies to the agents’ behaviour.  
For biological systems, these five conditions are satisfied in essence. The questions now 
become how to translate the entities and relationships from biological knowledge into the 
framework of agent-based modeling. 
C.6.8 Modeling agents and rules in biological systems 
The first step in building an agent-based model is to identify the biological entities that 
can be modelled by agents (Griffin, 2006; Mitchell, 2003). The definition of a biological entity 
depends on the model itself. Not all biological entities need to be modelled by agents. Entities 
can be differentiated as passive or active. Passive entities have no behaviour of their own. Any 
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changes in their states are due to other components of the model, such as, other entities and 
global changes. Passive entities can be modelled by object type, instead by agent type. On the 
other hand, active entities have both state and a defined behaviour. Active entities act on their 
environment, such as objects and other agents. Active entities can be modelled by agents. Object 
type and agent type are specified differently in terms of state variables and state transition rules 
in agent-based modeling. For example, in a wounded environment, inflammatory cells 
(neutrophils and macrophage) and repair cells (fibroblasts) can be modelled by agents because 
these cells have state (rest/ activated) and they secrete biochemical substrates to affect other 
agents and the environment. On the other hand, the secreted biochemical substrates can be 
regarded as the objects in agent-based modeling.  
Agents are sensitive and are able to change their environment. Rules determine agents’ 
interactions with their environment and which part of the model compose agents’ environment. 
An environment is defined relative to an agent and can be dynamic. The environment of an agent 
include: objects, other agents and state variables.  
Interactions between agents and their environment can be direct or indirect. Mediated 
interactions are those indirect interactions between agents and the environment. For example, 
when an agent communicates with another agent, a set of conditions have to be met for the 
information to be transmitted. An intermediate system component, namely, “mediator”, exists to 
ensure that the communication take place when the conditions are met. A biological example is 
that molecule A is the catalyst for a reaction between molecules B and C. In agent-based 
modeling, molecule A only performs the role of catalysis when molecule A encounters 
molecules B and C at the same time. In other times, molecule A performs other roles according 
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to its own sets of rules, which are not related to the reaction between B and C. For this case, A is 
the “mediator” for the interaction between B and C. 
Agent-based modeling offers a means for coping with structural complexity of biological 
systems. Agent-based modeling allows different aspects of biological entities to be expressed 
and enables them to have multiple roles at the same time. For example, molecule A (an entity) 
can act as an inhibitor for molecular B-C reaction and can also act as a stimulator for molecular 
D-E reaction at the same time. Also, different reactions and signalling pathways can be defined 
as different groups or sub-models in agent-based modeling. These groups can interact with each 
other and molecules (entities) can participate in different groups at the same time. Therefore, 
agent-based modeling is suitable to model the interdependent and concurrent relationship of 
different sub-systems in physiology. Lastly, agent-based modeling captures the physical-spatial 
aspects of entity and system behaviour. Agent behaviour can be expressed in physical-spatial 
terms, making the simulation of spatio-temporal dynamics more tractable in agent-based models. 
 
C.6.9 Strengths of agent-based modeling 
Agent-based modeling is a useful tool for the development of new theories and the 
formulation of existing theories. Agent-based modeling is regarded as more explanatory than 
predictive. By performing in silico experiments, agent-based modeling improves human intuition 
of the modelled phenomena. Agent-based modeling has also been suggested to have the 
following advantages (An, 2001; Neugebauer et al., 2001; Pogson, Smallwood, Qwarnstrom, & 
Holcombe, 2006; Troisi et al., 2005). 
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First, the programming languages are relatively intuitive and concrete in agent-based 
modeling. The rules identified in basic science are easier to translate into the rules in agent-based 
modeling than the mathematical equations in equation-based modeling. Emergent phenomena 
can be modelled by simple rules governing the behaviour of the agents. Second, agent-based 
modeling is modular in structure, which is lacking in equation-based modeling. This structural 
flexibility enables agent-based models to be constructed as various sub-systems to model 
different scales of physiologic organization. For example, a cellular model can encapsulate 
another lower-order molecular model. Third, agent-based modeling allows simulating 
heterogeneous components, whereas is difficult to implement in equation-based modeling. 
Fourth, agent-based modeling is basically a bottom-up approach, which permits model 
construction in the absence of knowledge at the global, aggregate level. Since agent-based 
modeling does not have top-down assumption in the programme, new information about the 
agents can be coded into existing models without the need to rebuild the simulation. Lastly, 
agent-based modeling has built-in “randomness” feature through the use of random number 
generators in the model. Thus, agent-based modeling can produce stochastic behaviour, which 
acknowledges the issue of variability in population dynamics as observed in the real world.  
C.6.10 Limitations of agent-based modeling 
The first limitation is that agent-based modeling is computationally intensive. Agent-
based models are built by numerous local agents and thus simulating the behaviour of all of the 
agents can be extremely computation intensive and time demanding. Therefore, agent-based 
modeling may encounter computational problem when modeling large systems. Second, agent-
based modeling does not allow for formal mathematical analysis of the model, such as 
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bifurcation analysis and sensitivity analysis. Therefore, system dynamics and emergent 
properties are only discovered through simulation. Lastly, agent-based modeling usually 
generates a massive amount of data for each parameter configuration and so agent-based 
modeling is relatively difficult to validate and calibrate with real-world data. 
C.7 MODELING-SIMULATION IN DISEASE AND TREATMENT 
Systems biology simulations begin with molecular and cellular levels, such as, feedback circuit 
for bacteria chemotaxis (Alon, Surette, Barkai, & Leibler, 1999; Mello & Tu, 2003; Yi, Huang, 
Simon, & Doyle, 2000), heart-beat rhythm (Gonze, Halloy, Leloup, & Goldbeter, 2003; 
Gunawan & Doyle, 2007; Leloup & Goldbeter, 1998, 2004; Leloup, Gonze, & Goldbeter, 1999), 
signal-transduction pathway (Bhalla, 2002; Bhalla & Iyengar, 1999, 2001; Cho, Johansson, & 
Wolkenhauer, 2005; Eungdamrong & Iyengar, 2004; Schoeberl, Eichler-Jonsson, Gilles, & 
Muller, 2002), cell cycles (Chen et al., 2000; Ciliberto, Novak, & Tyson, 2003; Csikasz-Nagy, 
Kapuy, Gyorffy, Tyson, & Novak, 2007; Lovrics et al., 2006; Novak, Csikasz-Nagy, Gyorffy, 
Chen, & Tyson, 1998) and red blood cells (Jamshidi, Edwards, Fahland, Church, & Palsson, 
2001; Ni & Savageau, 1996a, 1996b). Currently, research begins towards large-scale simulations 
to integrate multiple scales of models from genetics to physiology. For example, attempts are 
undertaking to create a virtual heart that represents its essential features in silico (computer-
generated) (Bassingthwaighte, 2000; Bassingthwaighte, Qian, & Li, 1999; Noble, 2002; Rudy, 
2000). Most recently, simulation models for various diseases are developed for predicting 
disease development and designing novel therapy. This section reviews selected simulation 
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models for infectious disease, inflammatory responses, and wound healing to elucidate the 
application of system modeling in clinical research. 
C.7.1 Infectious Disease: influenza virus infection 
Influenza virus infections have been simulated by equation-based modeling (Baccam, 
Beauchemin, Macken, Hayden, & Perelson, 2006; Bocharov & Romanyukha, 1994; Hancioglu, 
Swigon, & Clermont, 2007). Bocharov et al. (1994) proposed an exhaustive ordinary differential 
equation model of the infection to influenza virus infection, which focused on the control of the 
infection by the innate, cellular and humoral immune response. The model consists of 10 
equations, which represent 12 different cell populations with more than 60 parameters. The 
simulation results expected that at the peak of infection, approximately 30% to 50% of the 
epithelial cells in the upper respiratory tract would be damaged due to viral infection. Moreover, 
sensitivity analysis of the model indicates that the parameters representing virus-epithelial cells 
relationship have more control on the disease progression rather than the effects of antiviral 
immune (innate, cellular and humoral) response.  
 Later, a study (Baccam et al., 2006) presented another ordinary differential 
equation model of influenza virus infection. Three models are developed in that study: (1) a 
target cell-limited model, (2) a target cell-limited model with delayed virus production and (3) a 
target cell limited models with delayed virus production and innate interferon response. “Target 
cell-limited” refers when influenza virus infection is limited by the availability of susceptible 
target epithelial cells more than the control of immune response.  Model validation was carried 
out by fitting the data from an experimental report of H1N1 influenza A/Hong Kong/123/77 
infection. Their simulation results expected that the inclusion of delayed virus production (i.e., 
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delay from time of infection to viral production) is crucial for building viral dynamic model. 
Also, their simulation anticipated that a single viral-infected cell could spread the infections 
rapidly by infecting about 22 new cells. The infection slowed down when target epithelial cells 
were consumed. During the peak of infection at days 2 to 3, approximately 33% to 67% of target 
epithelial cells would be destroyed. This finding suggests that influenza infection can be cell-
limiting. Furthermore, the model reproduced the presence of two virus titer peaks versus time as 
seen in some patients. This bimodal behaviour can be explained by the model with innate 
interferon response. The peak of interferon levels occurred after the first viral titer peak due to 
the delay in interferon synthesis from infected cells. As the infection diminished due to target 
cell limitation, the levels of infected cells and interferon dropped as well. The drop in interferon 
levels allowed the remaining infected cells to increase their viral production, leading to the 
second viral titer peak. 
Most recently, another study presented a model of immune response to influenza virus 
infection, which aimed to explore the effect of initial viral load to the progression of disease 
(Hancioglu et al., 2007). Same as Bocharov et al.’s model (1994), Hancioglu’s model also 
focuses on the control of the infection by innate, cellular and humoral immunity. This model has 
10 ordinary differential equations with two parameters. Their simulation results suggest that (1) 
small initial viral load results asymptomatic disease; (2) intermediate viral load leads to typical 
disease progression and (3) high viral load results severe disease progression. Furthermore, the 
absence of humoral (virus-specific antibodies) immunity results a recurrence of infection 
followed by a transition to a chronic state with nontrivial persistent viral load. 
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C.7.2 Acute Inflammation 
Acute inflammatory responses are induced from various forms of stresses, such as bacterial 
infection, viral infection, mechanical trauma or autoimmunity (Nathan, 2002). Inflammatory 
process often leads to healing and recovery from infections but can also results organ 
dysfunction and fatality (Vodovotz, 2006). Acute inflammation has been simulated by equation-
based modeling (Chow et al., 2005; Day et al., 2006; Kumar, Clermont, Vodovotz, & Chow, 
2004; Reynolds et al., 2006; Vodovotz et al., 2006) and agent-based modeling (An, 2004). Two 
studies demonstrate the proof of concept of the potential use of in silico clinical trials for sepsis 
(An, 2004; Clermont et al., 2004). 
Kumar et al. (Kumar et al., 2004) reported a three-variable ordinary differential equation 
model of acute inflammation. The model consists of a pathogen and two inflammatory 
mediators. In the model, an infectious agent triggered an early inflammatory mediator to kill the 
pathogen and later another inflammatory mediator was triggered to further exacerbate 
inflammation. The model was able to reproduce the health state and various negative states as 
observed in septic patients. Their simulation results also point out that the clinical presentations 
of sepsis arise from diverse underlying physiological states and thus different therapeutic 
approaches are required. 
Later, a study (Reynolds et al., 2006) reported a four-variable model of acute 
inflammation. This model is expanded from Kumar et al.’s (2004) model by incorporating an 
anti-inflammatory mediator in the system. The anti-inflammatory mediator in the model has the 
functions of (1) inhibiting the build-up of pro-inflammatory mediator and the tissue damage, and 
(2) promoting further production of anti-inflammatory mediator. Their simulation results suggest 
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that the rates of dynamic anti-inflammatory response may be modified therapeutically to yield 
optimal healing outcome after pathogenic infection. 
Furthermore, another study used the same four-variable model of acute inflammatory 
response (Day et al., 2006) to explore the effects of repeated administration of endotoxin 
(bacterial lipopolysaccharide) on the system. Their model was capable to display the clinical 
scenarios of endotoxin tolerance and potentiation from a single parameter set with repeated 
endotoxin challenges. This finding suggests that various biological responses (endotoxin 
tolerance and potentiation) to repeated bacterial infection are dynamic manifestations of a unified 
acute inflammatory response.   
In the line of this research, a study reported the work of calibrating an acute inflammatory 
model to experimental data in mice with endotoxemia, surgical trauma or surgical trauma 
followed by haemorrhage (Chow et al., 2005). The model was capable to predict a dose range of 
endotoxin leading to death of mice, despite being calibrated on data from non-lethal 
inflammatory insults. The most current model was calibrated to simulate acute inflammation in 
mice, swine and human in order to scale up the model to the whole-patient level (Vodovotz, 
2006). 
Lastly, two papers demonstrate the application of inflammation modeling for in silico 
clinical trails. An equation-based model (Clermont et al., 2004) was set up to create a population 
of 1,000 simulated “patients” with different clinical profiles. Then, these “patients” were 
submitted to one of three types of anti-sepsis therapy (anti-tumour necrosis factor neutralizing 
antibodies). Their simulation results suggest that anti-tumour necrosis factor therapy can be 
effective and harmful to the patients, depending on the dose and duration of treatment as well as 
the patient’s clinical profiles. Another published work used agent-based model (An, 2001) to 
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simulate acute inflammatory responses to infectious and non-infectious tissue injury. The model 
focuses at cellular level with the interface between endothelial cells, blood-borne inflammatory 
cells and mediators. This model was able to reproduce the dynamics of inflammatory response as 
reported in the literature. Also, the model was able to reproduce qualitative patterns of the 
adverse outcomes of administrating anti-inflammatory therapy to acute inflammation as reported 
in the literature. 
C.7.3 Wound Healing 
Two agent-based models are reported that extend the simulation window from acute 
inflammatory response to later healing response in the context of diabetic foot ulcers (Mi, 
Riviere, Clermont, Steed, & Vodovotz, 2007) and acute vocal fold phonotrauma (N. Y. Li et al., 
2008).   
C.7.4 Diabetic foot ulcer 
An agent-based model was developed to examine the genesis of diabetic foot ulcer 
(DFU) and to test in silico possible therapies (a neutralizing anti-tumour necrosis factor antibody, 
latent transforming growth factor-β1 and a mediator that increase the activation of endogenous 
latent transforming growth factor-β1) for DFU (Mi et al., 2007). Regarding models for skin 
wound healing, several papers have reported to use partial differential equations (Sherratt & 
Murray, 1990) or agent-based model (Walker et al., 2004) to simulate the wound closure of 
epithelial cell monolayer. Also, equation-based model based on mechanical theory is reported to 
simulate dermal wound contraction (Tranquillo & Murray, 1992, 1993). Subsequently, models 
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for skin wound healing with the expansion of cell types and extracellular matrix are reported as 
well (Dallon, Sherratt, & Maini, 2001; Olsen, Sherratt, & Maini, 1995) However, no models 
have been developed to investigate the relationship between inflammation and wound healing in 
the context of DFU.  
Mi et al.’s DFU model includes cells (neutrophils, macrophages, fibroblasts), 
inflammatory cytokines (interleukin-1β, tumour necrosis factor-α, transforming growth factor-
β1, interleukin-10), extracellular matrix (collagen), and a tissue damage function functionally 
analogous to alarm/danger signal. The model was calibrated using data on the skin would healing 
literature. The DFU model was able to reproduce the basic cellular and molecular responses in 
wound healing. Also, the simulation results suggested that reduced expression of transforming 
growth factor-β1 would lead to the aberrant skin healing of DFU. Furthermore, an interesting 
finding from this study is that all DFU therapies would have similar treatment effects of curing 
DFU as indicated in their in silico clinical trials. 
C.7.5 Vocal folds in phonotrauma 
A patient-specific agent-based model was developed for vocal fold inflammation, with 
the goal of identifying individually optimized treatments (N. Y. Li et al., 2008). Specifically, an 
agent-based model of generic vocal fold injury was developed using data from the wound 
healing literature and from experimental measures of inflammatory cytokines in human laryngeal 
secretions (Clark, 1998; Verdolini et al., in preparation; Verdolini et al., 2003). Similar to Mi et. 
al.’s DFU model (Mi et al., 2007), the phonotrauma model includes cells (neutrophils, 
macrophages, fibroblasts), inflammatory cytokines (interleukin-1β, tumour necrosis factor-α, 
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transforming growth factor-β1, interleukin-10), extracellular matrix (collagen), and a tissue 
damage function. The model was calibrated using data from baseline human cytokine levels in 
laryngeal fluid, immediately after phonotrauma induction, and following a 4-hr treatment (voice 
rest, “tissue mobilization exercises,” or spontaneous speech) (Verdolini et al., in preparation). 
Multiple runs of the model were carried out. The model reproduced subject-specific cytokine 
trajectories. Six of nine times, the model predicted empirically obtained cytokine values—not 
used for model calibration—at 24 hr. Predicted cytokine and tissue damage levels for 
spontaneous speech were significantly worse than for either voice rest or tissue mobilization 
exercises (p < 0.001), which were equivalent. These results demonstrate that the complex 
inflammatory/healing response is amenable to model-guided prediction and individualized 
therapy. Also, this translational science has potential for high impact in health care, especially as 
a model for future extension to other domains.  
In addition to the development of a patient-specific agent-based model of vocal fold 
inflammation, a parallel development of an ordinary differential equation model has been 
pursued in the interest of cross-platform comparison of results (N. Y. K. Li et al., 2006). To test 
the validity in our agent-based model, “model docking” was used. “Model docking” is a well-
vetted validation strategy based on a comparison of predictions of different models across an 
array of user input data. The finding of similar predictions in agent-based and equation-based 
models would increase confidence in the underlying assumptions made in the current agent-
based model. In that study, the agent-based and equation-based models predicted similar cellular 
and molecular patterns of the inflammatory and wound healing responses under low initial 
damage. However, the models’ results diverged in their predictions of inflammatory and wound 
healing responses for a high initial insult. Stated differently, with low initial damage, both 
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models seemed to be robust to structural differences and limitations. However, beyond a given 
threshold of the input damage, the models did not “dock.” It is unclear whether this threshold is 
beyond commonly observed intensities of phonotrauma. Encouragingly, the agent-based and 
equation-based models both anticipated that net collagen deposition is peak on Day 9 post-injury. 
This predictive pattern helps to generate a hypothesis for a “wet-lab” experiment designed to 
identify putative mediators or enzymes correlated with the predicted collagen curves. 
Currently, first-generation agent-based model of acute phonotrauma is developed to 
predict expected time-varying pro- and anti-inflammatory responses to physical insult to vocal 
fold tissue as a function of initial inflammatory profile. However, this biological model is 
currently limited in terms of the number of inflammatory mediators and extracellular matrix 
substances represented and empirical support for longer-term outcomes in humans (e.g. 3 week 
follow-up). As important, the model lacks the ability to receive input from physical models of 
phonation (e.g., finite-element models of vocal fold vibration) because data about the 
quantitative links between physical output (mechanical stress distributions on vocal folds) and 
biological consequences is lacking. Future direction is (1) to establish the quantitative links 
between physical output and biological consequences empirically for augmenting the current 
model and (2) to generate a large database of biological responses in phonotrauma for model 
validation purposes. 
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C.8 CONCERNS OF CURRENT MATHEMATICAL MODELS IN CLINICAL 
RESEARCH 
The aforementioned system models in clinical research are excellent examples of how much we 
still need to learn about health and diseases. This research also indicates that the strategy of 
combining in vivo/ in vitro and in silico tools will prove a useful tool in this quest. At the same 
time, mathematical models in clinical applications are commonly criticized that either the models 
perform poorly when compared to experimental data or too simplistic to capture the dynamics of 
interest. One of the major challenges for existing models is the lack of high quality human 
clinical data for model calibration and validation. The iterative process of calibration-validation 
is extremely important to improve model validity and predictability. Otherwise, the models 
become explanatory rather than predictive at best. Moreover, research on how to evaluate a 
model is sparse. The study of comparing agent-based and equation-based model for acute 
phonotrauma demonstrates that cross-platform analysis is a useful tool to evaluate the underlying 
assumption of models and drives hypotheses for testing empirically (N. Y. K. Li et al., 2006). 
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APPENDIX E 
[ABM RULES OF THE HUMAN PONOTRAUMA MODEL] 
Parameter Descriptions Rules 
Extent of mucosal damage 
created by user-defined 
magnitude 
Initial damage = ( Magnitude 1.5 ) * ( 2 + a random integer  
greater than or equal to 0, but strictly less than 5) 
  
Extent of ECM fragmentation 
caused by initial damage  
Native ECM (collagen, elastin and hyaluronan) that is 2 units 
around the damage will be degraded. 
  
Extent of ECM degradation 
induced by TNF-α 
If TNF-α>10, native ECM (collagen, elastin and hyaluronan) 
will be degraded to ECM fragments. 
  
Extent of collagen degradation 
induced by MMP-8 
If MMP-8>10, native collagen will be degraded to collagen 
fragments. 
  
ECM fragments serve as 
danger signals 
Each ECM fragment (collagen, elastin and hyaluronan)  
creates a damage signal. 
  
Magnitude of impact stress 
from resonant voice exercise 
(RVIS) 
RVIS = 5 
  
Magnitude of impact stress 
from spontaneous speech 
(SSIS) 
SSIS = 10 
  
Magnitude of vibratory stress 
from resonant voice exercise 
(RVVS) 
RVVS = 10 
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Parameter Descriptions Rules 
Magnitude of vibratory stress 
from spontaneous speech 
(SSVS) 
SSVS = 10 
  
Effect of the 4-hr resonant 
voice exercise on mucosal 
tissue 
If the time step is between 5 and 13, create a number of RVIS 
* 20 platelets in damaged area. 
If the time step is between 5 and 13, create a number of RVSS 
neutrophils in blood capillary. 
  
Effect of the 4-hr spontaneous 
speech on mucosal tissue 
If the time step is between 5 and 13, create a number of SSIS * 
20 platelets in damaged area. 
If the time step is between 5 and 13, create a number of SSSS 
neutrophils in blood capillary. 
  
Number of platelets created by 
initial mucosal damage 
Number of platelets = Extent of mucosal damage created by 
user-defined magnitude 
  
TGF-β1 secreted by platelets TGF-β1 = TGF-β1 + 0.1 
  
IL-1β secreted by platelets IL-1β = IL-1β + (baseline-IL-1β * 0.1) 
  
MMP-8 secreted by platelets MMP-8 = IL-1β + (baseline-MMP-8 * 0.1) 
  
Platelet lifespan 0.5 to 1 day 
  
Inflammatory mediator 
diffusion speed  
IL-1β = 0.5 unit/step 
IL-6 = 0.5 unit/step 
IL-8 = 0.5 unit/step 
IL-10 = 0.5 unit/step 
TNF-α = 0.5 unit/step 
TGF-β1 = 0.5 unit/step 
FGF = 0.5 unit/step 
MMP-8 = 0.5 unit/step 
  
Inflammatory mediator 
degradation speed 
IL-1β = 0.02 unit/step  
IL-6 = 0.02 unit/step 
IL-8 = 0.02 unit/step 
IL-10 = 0.5 unit/step 
TNF-α = 0.02 unit/step 
TGF-β1 = 0.02 unit/step 
FGF = 0.02 unit/step 
MMP-8 = 0.02 unit/step 
  
New hyaluronan lifespan 0.5 to 1 day 
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New collagen repairs tissue 
damage 
Damage on the patch and the eight surrounding patches of the 
new deposited collagen will be repaired. 
  
New elastin repairs tissue 
damage 
Damage on the patch and the eight surrounding patches of the 
new deposited elastin will be repaired. 
  
New hyaluronan repairs tissue 
damage 
Damage on the patch and the eight surrounding patches of the 
new deposited hyaluronan will be repaired. 
  
  
Initial number of circulated 
neutrophils  
50 
  
Number of neutrophils 
circulating in the blood  
If no damage, the number of neutrophils in the blood will be 
added by 8 every two hour.  
  
Number of neutrophils 
circulating in the blood relating 
to damage 
If total-damage > 0, the number of neutrophils in the blood will 
be added by (8 + total-damage * 0.01) every two hour.  
  
Chemoattractant factors for 
neutrophils  (Neu-chemo) 
Neu-chemo =  IL-1β + TNF-α + TGF-β1 + FGF + IL-6 + IL-8 
+ collagen fragments 
  
Neutrophils are attracted by 
chemoattractants 
Neutrophils will move one step towards the patch with the 
highest concentration of neu-chemo. 
  
TNF-α (and IL-10)  stimulates 
(and inhibits) activation of 
neutrophils 
If total-damage > 0 and TNF-α > = IL-10 * 0.1, 100% of the 
change that the neutrophil is activated. 
If total-damage > 0 and TNF-α > 0 but TNF < IL-10, 25% of 
the chance that the neutrophil is activated. 
If total-damage > 0 but TNF = 0, 10% of the chance that the 
neutrophil is activated. 
  
Inflammatory mediators 
secreted by activated 
neutrophils under voice rest 
condition 
TNF-α =  TNF-α  + 1 * ( 1 / ( TGF-β1 +  IL-10 ) ) 
MMP-8 = MMP-8 + 1 * ( 250 + TNF-α ) * ( 1 / ( 1 + TGF-β1) 
  
Inflammatory mediators 
secreted by activated 
neutrophils under resonant 
voice condition 
TNF-α =  TNF-α  + 10 * ( 1 / ( TGF-β1 +  IL-10 ) ) 
MMP-8 = MMP-8 + 1 * ( 10 + TNF-α * 2 ) * ( 1 / ( 1 + TGF-
β1 * 0.5 ) 
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Inflammatory mediators 
secreted by activated 
neutrophils under spontaneous 
speech condition 
TNF-α =  TNF-α  + 1 * ( 1 / ( TGF-β1 +  IL-10 ) ) 
MMP-8 = MMP-8 + 15 * ( 100 + TNF-α * 3 ) * ( 1 / ( 1 + 
TGF-β1) 
  
Activated neutrophils clear 
ECM fragments 
Activated neutrophils will clear ECM fragments on the patches 
that the cells are on. 
  
Neutrophil lifespan 0.5 days 
  
Activated neutrophil lifespan 1 day 
  
IL-10 inhibits activated 
neutrophil survival 
Activated neutrophil age – 0.01  * IL-10 
  
Apoptosis of activated 
neutrophils 
If all damage is cleared, the chance of activated neutrophil 
apoptosis is 10%. 
  
Initial number of circulated 
macrophages  
50 
  
Initial number of residential 
macrophages  
50 
  
Number of macrophages 
circulating in the blood  
If no damage, the number of macrophages in the blood will be 
added by 1 every two hour.  
  
Number of macrophages 
circulating in the blood relating 
to damage 
If total-damage > 0, the number of macrophages in the blood 
will be added by (1 + total-damage * 0.01) every two hour.  
  
Number of tissue macrophages 
recruited relating to damage 
( 1 + total-dam * 0.01) * 2 every 6 hour 
  
Chemoattractant factors for 
macrophages  (mac-chemo) 
mac-chemo =  IL-1β + TNF-α + TGF-β1 + FGF + collagen 
fragments + elastin fragments 
  
Macrophages are attracted by 
chemoattractants 
Macrophages will move one step towards the patch with the 
highest concentration of mac-chemo. 
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IL-1β,TNF-α (and IL-10) 
stimulates (and inhibits) 
activation of macrophages 
If total-damage > 0 and (TNF-α + IL-1β - IL-10 * 0.1 > 0), 
100% of the change that the macrophage is activated. 
If total-damage > 0 and (TNF-α + IL-1β) > 0 but (TNF-α + IL-
1β - IL-10 * 0.1 < 0), 25% of the chance that the macrophage 
is activated. 
If total-damage > 0 but (TNF + IL-1β) = 0, 10% of the chance 
that the macrophage is activated. 
  
Inflammatory mediators 
secreted by activated 
macrophages under voice rest 
condition 
TNF-α = TNF-α + baseline-TNF-α * 0.05 + 1 * (1 / (1 + TGF-
β1 + IL-10)) * (1 + TNF-α+ IL-1β + number of surrounding 
hyaluronan fragments) 
IL-1β = IL-1β + baseline-IL-1β * 2 + 1 * (1 / (1 + TGF-β1 + 
IL-10)) * (15 + TNF-α + IL-1β * 15 + number of surrounding 
hyaluronan fragments) 
IL-10 = IL-10 + baseline-IL-10 * 0.01 + (1 + IL-10 * 0.1) 
IL-6 = IL-6 + baseline-IL-6 * 0.01 + 1 * (1 / (1 + IL-10)) * (1 
+ TNF-α+ IL-1β) 
IL-8 = IL-8 + baseline-IL-8 * 2 + 1 * (1 / (1 + IL-10)) * (10 + 
TNF-α * 5 + IL-1β * 5 + number of surrounding hyaluronan 
fragments) 
TGF-β1 = TGF-β1 + (1+ IL-10 + TNF-α) 
FGF = FGF + 1 
  
Inflammatory mediators 
secreted by activated 
macrophages under resonant 
voice condition 
TNF-α = TNF-α + baseline-TNF-α * 0.5 + 2 * (1 / (1 + TGF-
β1 + IL-10 + IL-6 * 0.1)) * (1 + RVIS * 0.1 + TNF-α+ IL-1β + 
number of surrounding hyaluronan fragments) 
IL-1β = IL-1β + baseline-IL-1β * 0.5 + 1 * (1 / (1 + TGF-β1 + 
IL-10 + IL-6)) * (1 + RVIS + TNF-α * 0.5 + IL-1β + number 
of surrounding hyaluronan fragments) 
IL-10 = IL-10 + baseline-IL-10 * 0.01 + 1 * (4 + IL-10 * 0.001 
+ IL-6 * 0.001) 
If steps <= 14, IL-6 = IL-6 + 0.5 * (1 + RVVS * 10) 
If steps > 14, IL-6 = IL-6 + baseline-IL-6 + 0.5 * (1 / (1 + IL-
10)) * (1 + TNF-α+ IL-1β) 
IL-8 = IL-8 + baseline-IL-8 + 1 * (1 / (1 + IL-10 * 0.5)) * (100 
+ RVIS * 0.1 + TNF-α + IL-1β * 100 + number of surrounding 
hyaluronan fragments) 
TGF-β1 = TGF-β1 + (1+ IL-10 + TNF-α) 
FGF = FGF + 1 
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Inflammatory mediators 
secreted by activated 
macrophages under 
spontaneous speech condition 
TNF-α = TNF-α + baseline-TNF-α * 1 + 1 * (1 / (1 + TGF-β1 
+ IL-10 + IL-6)) * (1 + SSIS * 0.1 + TNF-α+ IL-1β * 5 + 
number of surrounding hyaluronan fragments) 
IL-1β = IL-1β + baseline-IL-1β * 13 + 1 * (1 / (1 + TGF-β1 + 
IL-10 + IL-6)) * (1 + SSIS + TNF-α + IL-1β + number of 
surrounding hyaluronan fragments) 
IL-10 = IL-10 + baseline-IL-10 * 0.05 + 1 * (1 + IL-10 * 
0.0005 + IL-6 * 0.0005) 
If steps <= 14, IL-6 = IL-6 + 0.5 * (1 + SSVS * 10) 
If steps > 14, IL-6 = IL-6 + baseline-IL-6 + 1 * (1 / (1 + IL-10 
* 0.5)) * (1 + TNF-α+ IL-1β * 4) 
IL-8 = IL-8 + baseline-IL-8 + 10 * (1 / (1 + IL-10 * 0.5)) * (1 
+ SSIS * 0.1 + TNF-α + IL-1β * 7 + number of surrounding 
hyaluronan fragments) 
TGF-β1 = TGF-β1 + (1+ IL-10 + TNF-α) 
FGF = FGF + 1 
  
Activated macrophages clear 
ECM fragments 
Activated macrophages will clear ECM fragments on the 
patches that the cells are on. 
  
Activated macrophages 
become quiescence 
If all damage is cleared, the chance of macrophages back to 
quiescence is 3%. 
  
Circulating macrophage 
lifespan 
8hrs to 3 days 
  
Resident macrophage lifespan 60 to 120 days 
  
Activated macrophage lifespan 2 to 4 days 
  
Initial number of residential 
fibroblasts 
100 
  
Magnitude of damage to 
recruit tissue fibroblasts  
If damage > magnitude * 1.2, tissue fibroblasts will be 
recruited. 
  
Number of tissue fibroblasts 
recruited relating to damage 
( 1 + total-dam * 0.01) * 2 every 6 hour 
  
Chemoattractant factors for 
fibroblasts (fib-chemo) 
fib-chemo =  TGF-β1  
  
Fibroblasts are attracted by 
chemoattractants and its 
migration is stimulated by FGF 
Fibroblasts will move (one + mean concentration of 
surrounding FGF) step towards the patch with the highest 
concentration of fib-chemo. 
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Tissue fibroblasts differentiate 
to activated fibroblasts 
If total-damage > 0 and TGF-β1 <= 10, 100% of the change 
that the fibroblast is activated. 
If total-damage > 0 and TGF-β1 > 10, 50% of the chance that 
the fibroblast is activated. 
If total-damage > 0 but TGF-β1 = 0, 25% of the chance that the 
fibroblast is activated. 
  
Fibroblast proliferation are 
stimulated by IL-1β, TNF-α, 
FGF, low-concentration TGF-
β1 and hyaluronan fragments 
Under low concentration of TGF-β1 (between 0 to 10), the % 
of chance that activated fibroblasts will proliferate is ( 25 + log 
(1 + TGF-β1 + FGF + TNF-α + IL-1β + number of 
surrounding hyaluronan fragments) )  
 
Under high concentration of TGF-β1 (greater than 10), the % 
of chance that activated fibroblasts will proliferate is ( 25 + log 
(1 - TGF-β1 + FGF + TNF-α + IL-1β + number of surrounding 
hyaluronan fragments) ) 
  
Inflammatory mediators 
secreted by activated 
fibroblasts under voice rest 
TNF-α = TNF-α + 10 * (1 / (1 + TGF-β1 + IL-10 * 2 + number 
of surrounding new hyaluronan)) 
IL-6 = IL-6 + 0.01 * (1 / (1 + IL-10)) * (1 + TNF-α) 
IL-8 = IL-8 + 1 * (1 / (1 + IL-10 + number of surrounding new 
hyaluronan)) 
TGF-β1 = TGF-β1 + 10 + 0.5 * (1 + TNF-α + IL-10) 
FGF = FGF + 5 
  
Inflammatory mediators 
secreted by activated 
fibroblasts under resonant 
voice 
TNF-α = TNF-α + 20 * (1 / (1 + TGF-β1 + IL-10 + IL-6 + 
number of surrounding new hyaluronan)) 
If steps < = 14, IL-6 = IL-6 + 1 * ( 1 + RVVS * 10 ) 
If steps > 14, IL-6 = IL-6 + 0.5 * (1 / (1 + IL-10)) * (1 + TNF-
α) 
IL-8 = IL-8 + 0.05 * (1 / (1 + IL-10 + number of surrounding 
new hyaluronan)) 
TGF-β1 = TGF-β1 + 10 + 0.5 * (1 + TNF-α + IL-10) 
FGF = FGF + 5 
  
Inflammatory mediators 
secreted by activated 
fibroblasts under spontaneous 
speech 
TNF-α = TNF-α + 1 * (1 / (1 + TGF-β1 + IL-10 + IL-6 + 
number of surrounding new hyaluronan)) 
If steps < = 14, IL-6 = IL-6 + 1 * (1 + SSVS * 10) 
If steps > 14, IL-6 = IL-6 + 10 * (1 / (1 + IL-10)) * (1 + TNF-
α) 
IL-8 = IL-8 + 5 * (1 / (1 + IL-10 + number of surrounding new 
hyaluronan)) 
TGF-β1 = TGF-β1 + 10 + 0.5 * (1 + TNF-α + IL-10) 
FGF = FGF + 5 
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Collagen stimulation factor Collagen stimulation factor = log ( (1 + mean of surrounding 
TGF-β1 + mean of surrounding IL-6) / ( 1 + mean of 
surrounding FGF + mean of surrounding IL-1β + mean of 
surrounding IL-8) ) 
  
Collagen secreted by activated 
fibroblasts every 6 hours 
If there is damage surrounded the fibroblast and the number of 
hyaluronan fragments is higher than that of new hyaluronan, 
the % of chance that activated fibroblasts will secrete collagen 
is (50 + collagen stimulation factor). 
If there is damage surrounded the fibroblast and the number of 
hyaluronan fragments is equal to that of new hyaluronan, the % 
of chance that activated fibroblasts will secrete collagen is (25 
+ collagen stimulation factor). 
If there is damage surrounded the fibroblast and the number of 
hyaluronan fragments is lower than that of new hyaluronan, the 
% of chance that activated fibroblasts will secrete collagen is 
(10 + collagen stimulation factor). 
Elastin stimulation factor Elastin stimulation factor = log ( (1 + mean of surrounding 
TGF-β) / ( 1 + mean of surrounding FGF + mean of 
surrounding IL-1β + mean of surrounding TNF-α) ) 
  
Elastin secreted by activated 
fibroblasts every 6 hours 
If there is damage surrounded the fibroblast, the % of chance 
that activated fibroblasts will secrete elastin is (25 + elastin 
stimulation factor). 
  
Hyaluronan stimulation factor Hyaluronan stimulation factor = log ( (1 + mean of 
surrounding TGF-β1 + mean of surrounding FGF + mean of 
surrounding IL-1β + mean of surrounding TNF-α) ) 
  
Hyaluronan secreted by 
activated fibroblasts every hour 
If there is damage surrounded the fibroblast, the % of chance 
that activated fibroblasts will secrete hyaluronan is (50 + 
hyaluronan stimulation factor). 
If there is no damage surrounded the fibroblast, the % of 
chance that activated fibroblasts will secrete hyaluronan is (5 + 
collagen stimulation factor). 
  
Fibroblast lifespan 5 to 12 days 
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[ABM RULES OF THE ANIMAL SURGICAL VOCAL FOLD TRAUMA MODEL] 
Rules in shaded are different from those of the acute phonotrauma model.  
Parameter Descriptions Rules 
Extent of mucosal damage 
created by user-defined 
magnitude 
Initial damage = ( Magnitude 1.5 ) * ( 2 + a random integer  
greater than or equal to 0, but strictly less than 5) 
  
Extent of cell death caused by 
initial damage  
Cells (neutrophils, macrophages and fibroblasts) that are 2 
units around the damage will die. 
  
Extent of ECM fragmentation 
caused by initial damage  
Native ECM (collagen, elastin and hyaluronan) that is 2 units  
around the damage will be degraded. 
  
Extent of ECM degradation 
induced by TNF-α 
If TNF-α>10, native ECM (collagen, elastin and hyaluronan) 
will be degraded to ECM fragments. 
  
Extent of collagen degradation 
induced by MMP-8 
If MMP-8>10, native collagen will be degraded to collagen 
fragments. 
  
ECM fragments serve as 
danger signals 
Each ECM fragment (collagen, elastin and hyaluronan)  
creates a damage signal. 
  
Number of platelets created by 
initial mucosal damage 
Number of platelets = Extent of mucosal damage created by 
user-defined magnitude 
  
TGF-β1 secreted by platelets TGF-β1 = TGF-β1 + 0.000001 
  
IL-1β secreted by platelets IL-1β = IL-1β + 300 + (baseline-IL-1β * 0.002) 
  
MMP-8 secreted by platelets MMP-8 = IL-1β + (baseline-MMP-8 * 0.002) 
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Platelet lifespan 0.5 to 1 day 
  
Inflammatory mediator 
diffusion speed  
IL-1β = 0.5 unit/step 
IL-6 = 0.5 unit/step 
IL-8 = 0.5 unit/step 
IL-10 = 0.5 unit/step 
TNF-α = 0.5 unit/step 
TGF-β1 = 0.5 unit/step 
FGF = 0.5 unit/step 
MMP-8 = 0.5 unit/step 
  
Inflammatory mediator 
degradation speed 
IL-1β = 0.02 unit/step  
IL-6 = 0.02 unit/step 
IL-8 = 0.02 unit/step 
IL-10 = 0.5 unit/step 
TNF-α = 0.02 unit/step 
TGF-β1 = 0.02 unit/step 
FGF = 0.02 unit/step 
MMP-8 = 0.02 unit/step 
  
New hyaluronan lifespan 0.5 to 1 day 
  
New collagen repairs tissue 
damage 
Damage on the patch and the eight surrounding patches of the 
new deposited collagen will be repaired. 
  
New elastin repairs tissue 
damage 
Damage on the patch and the eight surrounding patches of the 
new deposited elastin will be repaired. 
  
New hyaluronan repairs tissue 
damage 
Damage on the patch and the eight surrounding patches of the 
new deposited hyaluronan will be repaired. 
  
  
Initial number of circulated 
neutrophils  
50 
  
Number of neutrophils 
circulating in the blood  
If no damage, the number of neutrophils in the blood will be 
added by 8 every two hour.  
  
Number of neutrophils 
circulating in the blood relating 
to damage 
If total-damage > 0, the number of neutrophils in the blood will 
be added by (8 + total-damage * 0.01) every two hour.  
  
Chemoattractant factors for 
neutrophils  (Neu-chemo) 
Neu-chemo =  IL-1β + TNF-α + TGF-β1 + FGF + IL-6 + IL-8 
+ collagen fragments 
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Neutrophils are attracted by 
chemoattractants 
Neutrophils will move one step towards the patch with the 
highest concentration of neu-chemo. 
  
TNF-α (and IL-10)  stimulates 
(and inhibits) activation of 
neutrophils 
If total-damage > 0 and TNF-α > = IL-10 * 0.1, 100% of the 
change that the neutrophil is activated. 
If total-damage > 0 and TNF-α > 0 but TNF < IL-10, 25% of 
the chance that the neutrophil is activated. 
If total-damage > 0 but TNF = 0, 10% of the chance that the 
neutrophil is activated. 
  
Inflammatory mediators 
secreted by activated 
neutrophils 
TNF-α =  TNF-α  + 8 * ( 1 / ( TGF-β1 +  IL-10 ) ) 
MMP-8 = MMP-8 + 1 * ( 1 + TNF-α ) * ( 1 / ( 1 + TGF-β1) 
  
Activated neutrophils clear 
ECM fragments 
Activated neutrophils will clear ECM fragments on the patches 
that the cells are on. 
  
Neutrophil lifespan 0.5 days 
  
Activated neutrophil lifespan 1 day 
  
IL-10 inhibits activated 
neutrophil survival 
Activated neutrophil age – 0.01  * IL-10 
  
Apoptosis of activated 
neutrophils 
If all damage is cleared, the chance of activated neutrophil 
apoptosis is 10%. 
  
Initial number of circulated 
macrophages  
50 
  
Initial number of residential 
macrophages  
50 
  
Number of macrophages 
circulating in the blood  
If no damage, the number of macrophages in the blood will be 
added by 1 every two hour.  
  
Number of macrophages 
circulating in the blood relating 
to damage 
If total-damage > 0, the number of macrophages in the blood 
will be added by (1 + total-damage * 0.01) every two hour.  
  
Number of tissue macrophages 
recruited relating to damage 
( 1 + total-dam * 0.01) * 2 every 6 hour 
  
Chemoattractant factors for 
macrophages  (mac-chemo) 
mac-chemo =  IL-1β + TNF-α + TGF-β1 + FGF + collagen 
fragments + elastin fragments 
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Macrophages are attracted by 
chemoattractants 
Macrophages will move one step towards the patch with the 
highest concentration of mac-chemo. 
  
IL-1β,TNF-α (and IL-10) 
stimulates (and inhibits) 
activation of macrophages 
If total-damage > 0 and (TNF-α + IL-1β - IL-10 * 0.1 > 0), 
100% of the change that the macrophage is activated. 
If total-damage > 0 and (TNF-α + IL-1β) > 0 but (TNF-α + IL-
1β - IL-10 * 0.1 < 0), 25% of the chance that the macrophage 
is activated. 
If total-damage > 0 but (TNF + IL-1β) = 0, 10% of the chance 
that the macrophage is activated. 
  
Inflammatory mediators 
secreted by activated 
macrophages  
TNF-α = TNF-α + 0.01 * (1 / (1 + TGF-β1 + IL-10)) * (1 + 
TNF-α+ IL-1β + number of surrounding hyaluronan 
fragments) 
IL-1β = IL-1β + 10 * (1 / (1 + TGF-β1 + IL-10)) * (35 + TNF-
α + IL-1β + number of surrounding hyaluronan fragments) 
IL-10 = IL-10 + 2 * (1 + IL-10 * 0.01) 
IL-6 = IL-6 + 1 * (1 / (1 + IL-10)) * (1 + TNF-α+ IL-1β) 
IL-8 = IL-8 + 1 * (1 / (1 + IL-10)) * (1 + TNF-α + IL-1β + 
number of surrounding hyaluronan fragments) 
TGF-β1 = TGF-β1 + 5 * (1+ IL-10 + TNF-α) 
FGF = FGF + 1 
  
Activated macrophages clear 
ECM fragments 
Activated macrophages will clear ECM fragments on the 
patches that the cells are on. 
  
Activated macrophages 
become quiescence 
If all damage is cleared, the chance of macrophages back to 
quiescence is 3%. 
  
Circulating macrophage 
lifespan 
8hrs to 3 days 
  
Resident macrophage lifespan 60 to 120 days 
  
Activated macrophage lifespan 2 to 4 days 
  
Initial number of residential 
fibroblasts 
100 
  
Magnitude of damage to 
recruit tissue fibroblasts  
If damage > magnitude * 1.2, tissue fibroblasts will be 
recruited. 
  
Number of tissue fibroblasts 
recruited relating to damage 
( 1 + total-dam * 0.01) * 2 every 6 hour 
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Chemoattractant factors for 
fibroblasts (fib-chemo) 
fib-chemo =  TGF-β1  
  
Fibroblasts are attracted by 
chemoattractants and its 
migration is stimulated by FGF 
Fibroblasts will move (one + mean concentration of 
surrounding FGF) step towards the patch with the highest 
concentration of fib-chemo. 
  
Tissue fibroblasts differentiate 
to activated fibroblasts 
If total-damage > 0 and TGF-β1 <= 10, 100% of the change 
that the fibroblast is activated. 
If total-damage > 0 and TGF-β1 > 10, 50% of the chance that 
the fibroblast is activated. 
If total-damage > 0 but TGF-β1 = 0, 25% of the chance that the 
fibroblast is activated. 
  
Fibroblast proliferation are 
stimulated by IL-1β, TNF-α, 
FGF, low-concentration TGF-
β1 and hyaluronan fragments 
Under low concentration of TGF-β1 (between 0 to 10), the % 
of chance that activated fibroblasts will proliferate is ( 25 + log 
(1 + TGF-β1 + FGF + TNF-α + IL-1β + number of 
surrounding hyaluronan fragments) )  
 
Under high concentration of TGF-β1 (greater than 10), the % 
of chance that activated fibroblasts will proliferate is ( 25 + log 
(1 - TGF-β1 + FGF + TNF-α + IL-1β + number of surrounding 
hyaluronan fragments) ) 
  
Inflammatory mediators 
secreted by activated 
fibroblasts 
TNF-α = TNF-α + 0.01 * (1 / (1 + TGF-β1 + IL-10 + number 
of surrounding new hyaluronan)) 
IL-6 = IL-6 + 1 * (1 / (1 + IL-10)) * (1 + TNF-α) 
IL-8 = IL-8 + 1 * (1 / (1 + IL-10 + number of surrounding new 
hyaluronan)) 
TGF-β1 = TGF-β1 + 1 * (1 + TNF-α + IL-10) 
FGF = FGF + 1 
  
Collagen stimulation factor Collagen stimulation factor = log ( (1 + mean of surrounding 
TGF-β1 + mean of surrounding IL-6) / ( 1 + mean of 
surrounding FGF + mean of surrounding IL-1β + mean of 
surrounding IL-8) ) 
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Collagen secreted by activated 
fibroblasts every 6 hours 
If there is damage surrounded the fibroblast and the number of 
hyaluronan fragments is higher than that of new hyaluronan, 
the % of chance that activated fibroblasts will secrete collagen 
is (50 + collagen stimulation factor). 
If there is damage surrounded the fibroblast and the number of 
hyaluronan fragments is equal to that of new hyaluronan, the % 
of chance that activated fibroblasts will secrete collagen is (25 
+ collagen stimulation factor). 
If there is damage surrounded the fibroblast and the number of 
hyaluronan fragments is lower than that of new hyaluronan, the 
% of chance that activated fibroblasts will secrete collagen is 
(10 + collagen stimulation factor). 
  
Elastin stimulation factor Elastin stimulation factor = log ( (1 + mean of surrounding 
TGF-β) / ( 1 + mean of surrounding FGF + mean of 
surrounding IL-1β + mean of surrounding TNF-α) ) 
  
Elastin secreted by activated 
fibroblasts every 6 hours 
If there is damage surrounded the fibroblast, the % of chance 
that activated fibroblasts will secrete elastin is (25 + elastin 
stimulation factor). 
  
Hyaluronan stimulation factor Hyaluronan stimulation factor = log ( (1 + mean of 
surrounding TGF-β1 + mean of surrounding FGF + mean of 
surrounding IL-1β + mean of surrounding TNF-α) ) 
  
Hyaluronan secreted by 
activated fibroblasts every hour 
If there is damage surrounded the fibroblast, the % of chance 
that activated fibroblasts will secrete hyaluronan is (50 + 
hyaluronan stimulation factor). 
If there is no damage surrounded the fibroblast, the % of 
chance that activated fibroblasts will secrete hyaluronan is (5 + 
collagen stimulation factor). 
  
Fibroblast lifespan 5 to 12 days 
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